Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☑

Filed by a Party other than the Registrant ☐

Check the appropriate box:

Filed by the RegistrantFiled by a Party other than the Registrant

CHECK THE APPROPRIATE BOX:

Preliminary Proxy Statement

Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Under Rule 14a-12Pursuant to §240.14a-12

Morgan StanleyMORGAN STANLEY

(Name of Registrant as Specified Inin Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

(1)1)

Title of each class of securities to which transaction applies:

(2)2)

Aggregate number of securities to which transaction applies:

(3)3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)4)

Proposed maximum aggregate value of transaction:

(5)5)

Total fee paid:

Fee paid previously with preliminary materials:

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the formForm or scheduleSchedule and the date of its filing.

(1)1)

Amount previously paid:

(2) 2)

Form, Schedule or Registration Statement No.:

(3) 

Filing Party:

(4) 

Date Filed:


LOGO

Notice of2019 Annual Meeting

and Proxy Statement


3) Filing Party:

LOGO

4) Date Filed:



Table of Contents


LOGO

James P. Gorman    

 

Notice of2016Annual Meeting
and Proxy Statement



Table of Contents



James P. Gorman


 

April 1, 2016

Fellow shareholder:April5, 2019

Dear fellow shareholders,

I cordially invite you to attend Morgan Stanley’s 20162019 annual meeting of shareholders that will be held on Tuesday,Thursday, May 17, 2016,23, 2019, at our offices at 2000 Westchester Avenue, Purchase, New York. I hope that you will be able to attend, and, if not, I encourage you to vote by proxy. Your vote is very important.

In addition

Morgan Stanley’s business and financial results in 2018 were the best in our history. Our mix of businesses not only provided earnings stability but also earnings growth. We will continue to grow our business by executing our strategy, and investing in our people and culture. While a robust strategy can cause a company to be successful at any point in time, a strong culture ensures enduring success over decades.

Morgan Stanley reported record revenues, pretax profit* and net income* for 2018. While we experienced a weaker fourth quarter as the ongoing dialoguemarket deteriorated near year end, firmwide net revenues were over $40 billion for the year. Each of our businesses delivered a strong performance, with Investment Banking and Wealth Management reporting their best revenues ever. Return on equity of 11.5%* was in the range we maintain withoutlined at the beginning of the year.

Our Board of Directors and management value the views of our shareholders and we have spoken withengaged in discussions on a numberbroad range of you overtopics, including our strategy, financial performance, executive compensation, corporate governance and environmental and social goals. Based on your feedback, the past year to hear your perspectives on governance, compensation and other areas of focus. The insights and priorities you shared informed several important actions we took that we believe demonstrateBoard in recent years has amended our ongoing commitment to best-in-class governance practices. Specifically, we introduced minimum share ownership requirements for our senior officers, amended the Company’s bylaws to implement proxy access provided clearerand enhanced disclosure of considerationsBoard evaluations, director orientation and decisions regarding pay, continuededucation, succession planning, Environmental, Social and Governance matters and alignment of compensation and performance. The Board is also responsible for overseeing the Firm’s practices and procedures relating to address shareholder dilution by repurchasing more shares thanculture, values and conduct and receives regular reporting on these matters.

In 2018, Mary Schapiro was elected to your Board. She brings extensive finance, risk management and regulatory expertise to the Firm. This brings the proportion of women Directors to nearly a third, and underscores our commitment to diverse talent and leadership across all levels of Morgan Stanley. Ryosuke Tamakoshi is stepping down from our Board after eight years. I thank him for his dedicated service and many contributions to the Board. We are nominating Takeshi Ogasawara to replace him as an MUFG director and know we issued, and revised and redesigned our proxy statement to more clearly communicate with shareholders. We hope to continue this open dialogue with our shareholders in the future.

2015 was a mixed year for Morgan Stanley, marked by dramatically different halves. We started the year with a strong performance delivered in constructive markets, but the market environment in the second halfwill benefit from Mr. Ogasawara’s many years of the year was more difficult. Global economic and market instability has led to a decline in our stock along with other financial services firms since last summer. Notwithstanding this near-term volatility, we made significant progress against our strategic goals, and took important steps to address areas of underperformance and position the Firm for long-term success.experience.

Morgan Stanley 2019 Proxy Statement    1


  


Morgan Stanley 2016 Proxy Statement1



Table of Contents

On an annual basis,

As we do each year, the Board of Directors and executive management team evaluate our strategic pathstrategy and lay outrefine our goals and priorities to ensure we are working for the long-term benefit of our shareholders. Last year, we established clear strategic objectives for 2018 and 2019, almost all of which allow our shareholders to measure our performance.

In Wealth Management, we achieved a record full-year profit margin of 22% in 2015. We have the potential to achieve a profit margin of 23% – 25% by 2017 through lending growth, expense discipline and organic business growth, assuming stable markets.
Our world-class Investment Banking franchise continued to rankbeen accomplished in the top threefull year 2018. With a strong and diverse global franchise in place, our management team will continue to drive forward our strategic objective of generating sustained higher returns. We will do this by expanding our competitive leadership and making appropriate investments in our businesses, while managing expenses and capital.

In addition to the right strategy, long-term and enduring success lies in having a strong culture and talented employees who live our values. At Morgan Stanley, our culture guides our employees, and our values inform everything we do.

A diverse employee base and a talented leadership pipeline are critical to delivering the best of the global league tables in advising on mergers and acquisitions and underwriting initial public offerings last year. Equity Sales & Trading demonstrated its leadership finishing the year at No. 1 in revenue market share globally for the second year in a row. However, the continued shrinking industry revenue pool, coupled with the steady increase in capital requirements, led usFirm to significantly restructure our Fixed Income and Commodities Sales & Trading business at the end of 2015. These actions will better align the capital and resources committed with the opportunity we see in a changed marketplace.

Investment Management had a weaker year given the dislocations in the equity markets in Asia, but we continue to view this business as a long-term growth opportunity andclients. We are committed to growing assets under management.
We managed our expenses diligently last year, and intendan inclusive work environment where all employees can thrive. Our commitment to further lower the expense base by $1 billion in 2017 assuming a flat revenue environment. We will continue to maintain strong compensation expense discipline and have set explicit compensation ratio targets across each of our business segments.

We increased both our common dividend and share repurchase program last year, and intend to further increase the amount of capital returned to shareholders in the years ahead, subject to regulatory approval. These priorities will set the stage for improving returns on equitydiversity is expressed as belonging as much as inclusion, and we have setnumerous initiatives aimed at providing our employees opportunities for leadership roles and empowering them to achieve the visibility and recognition they deserve.

Our long-term success will also be driven by the depth of talent and leadership across our Firm. We have an experienced management team and our businesses have a 2017 ROE target, excluding DVA,deep bench of 9%talent. I have great confidence in our senior leaders and we are excited about the future.

2018’s record year demonstrates the strength of the Firm. We are focused on supporting our clients and are prepared to 11%.

More details on our strategy andrespond to market environments appropriately. Over the long-term, we are excited about the growth opportunities across the businesses are detailed in my Letter to Shareholders. global economy.

I hope you will read this letter which also includes more detail onmy Letter to Shareholders where I discuss our cultureachievements and values, and how we are putting a rigorous focus on clients, culture and talent.opportunities for the future in greater detail. I look forward to meeting you at the Annual Meeting next month.

Thank you for your support of Morgan Stanley.

Very truly yours,


LOGO

James P. Gorman

Chairman and Chief Executive Officer





*  See page 61 for the “Notes to the Compensation Discussion and Analysis,” which provide additional information regarding the metrics referenced and non-GAAP measures.

2    Morgan Stanley 20162019 Proxy Statement



Table of Contents


TABLE OF CONTENTS

NOTICE OF 2019 ANNUAL MEETING OF SHAREHOLDERS

4

OVERVIEW OF VOTING ITEMS

5

CORPORATE GOVERNANCE MATTERS

11

LOGO

Item 1Election of Directors

11

Director SelectionSuccession and Nomination Process

11

Director Experience, Qualifications, Attributes and Skills

11

12

Director Nominees

12

13

Corporate Governance HighlightsPractices

20

21

Board Structure and Independence

20

21

Rotation of Board Leadership and Committee Appointments

21

Board Oversight

20

21

Shareholder RightsDirector Orientation and AccountabilityContinuing Education

21

22

Senior Management Succession and Development Planning

22

Annual Evaluation of Board, Committees and Independent Lead Director

21

23

Shareholder Rights and Accountability

24

Shareholder Engagement

24

Corporate Political Activities Policy Statement

22

25

Sustainability at Morgan Stanley

26

Giving Back to the Community

27

Communication by Shareholders and Other Interested Parties with the Board of Directors

22

27

Additional Corporate Governance Information Available on Corporate Governance Webpage

22

27

Director Independence

23

28

Director Attendance at Annual Meeting

25

30

Board Meetings and Committees

25

30

Board Leadership Structure and Role in Risk Oversight

28

33

Compensation Governance and Risk Management

31

36

Director Compensation

32

37

Related Person Transactions Policy

34

38

Certain Transactions

34

39

AUDIT MATTERS

3540

LOGO

Item 2Ratification of Appointment of Morgan Stanley’s Independent Auditor

35

40

Audit Committee Report

35

41

Independent Auditor’s Fees

37

42

EXECUTIVE COMPENSATION MATTERS

3843

LOGO

Item 3Company Proposal to Approve the Compensation of Executives as Disclosed in the Proxy Statement(Non-Binding Advisory Vote)

43

(Non-Binding Advisory Resolution)

38
Compensation Discussion and Analysis (CD&A)

39

44

Compensation, Management Development and Succession Committee Report

52

62

Morgan Stanley 20162019 Proxy Statement3



Table of ContentsLOGO



1585 Broadway

New York, NY 10036

NOTICE OF 20162019 ANNUAL MEETING

OF SHAREHOLDERS

TIME AND DATE
2:

10:00 p.m.a.m. (EDT) on May 17, 201623, 2019

LOCATION

LOCATION
Morgan Stanley

2000 Westchester Avenue, Purchase, New York

ITEMS OF BUSINESS

Elect the Board of Directors
Ratify the appointment of Deloitte & Touche LLP as independent auditor
Approve the compensation of executives as disclosed in the proxy statement(non-binding advisory vote)
Consider a shareholder proposal, if properly presented at the meeting
Transact such other business as may properly come before the meeting or any postponement or adjournment thereof

Elect the Board of Directors

Ratify the appointment of Deloitte & Touche LLP as independent auditor

Approve the compensation of executives as disclosed in the proxy statement (non-binding advisory resolution)

Approve the amendment of the 2007 Equity Incentive Compensation Plan

Consider two shareholder proposals, if properly presented at the meeting

Transact such other business as may properly come before the meeting or any postponement or adjournment thereof

RECORD DATE

The close of business on March 21, 201625, 2019 is the date of determination of shareholders entitled to notice of, and to vote at, the annual meeting of shareholders.

ADMISSION

ADMISSION
Only record or beneficial owners of Morgan Stanley’s common stock as of the record date, the close of business on March 21, 2016,25, 2019, or a valid proxy or representative of such shareholder, may attend the annual meeting in person. Any shareholder, proxy or representative who wishes to attend the annual meeting must present the documentation described under “How Do I Attend the Annual Meeting?” Morgan Stanley reserves the right to limit the number of representatives who may attend the annual meeting on behalf of a shareholder.

By Order of the Board of Directors,


LOGO

Martin M. Cohen

Corporate Secretary

April 1, 20165, 2019

VOTING

It is important that all of your shares are voted. You may submit your proxy to have your shares voted over the Internet or by telephone or by returning your proxy card or voting instruction form, if you receive one in the mail.

  LOGO 

BY MOBILE DEVICE

You can vote by scanning the QR Barcode on your proxy materials.

BY TELEPHONE
In the U.S. or Canada, you can vote your shares toll-free by calling 1-800-690-6903.

BY INTERNET

You can vote your shares online at www.proxyvote.com.

BY TELEPHONE

You can vote by calling the number on your proxy materials.

BY MAIL

You can vote by mail by completing, datingand signing your proxy card or voting instruction form and returning it in the postage-paid envelope.

WEBCAST

WEBCAST
If you are unable to attend the meeting in person, you may listen to the meeting atwww.morganstanley.com/ about-us-ir/index.html.about-us-ir. Please go to our website prior to the annual meeting for details.

NOTICE

We are distributing to certain shareholders a Notice of Internet Availability of Proxy Materials (Notice) on or about April 1, 2016.5, 2019. The Notice informs those shareholders how to access this proxy statement and our Annual Report on Form 10-K for the year ended December 31, 20152018 through the Internet and how to submit a proxy online.

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to Be Held on May 17, 2016:23, 2019:Our Letter to Shareholders, Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 20152018 are available free of charge on our website at
www.morganstanley.com/2016ams.2019ams.



4Morgan Stanley 20162019 Proxy Statement



Table of Contents


OVERVIEW OF VOTING ITEMS

This overview of voting items presents certain information that you should consider before voting on the items presented at this year’s annual meeting; however, you should read the entire proxy statement carefully before voting. In this proxy statement, we refer to Morgan Stanley as the “Company,” the “Firm,” “we,” “our” or “us” and the Board of Directors as the “Board.”

Item 1

Election of Directors

LOGOOur Board unanimously recommends that you vote“FOR” the election of all director nominees.

Director Nominees


Director
since

Non-
management

Other current
public boards
Morgan Stanley
Committees
Name  Occupation  Age        A  CMDS   NG  OT  R
Erskine B. BowlesPresident Emeritus of the702005YES- Facebook, Inc.MM
Independent LeadUniversity of North Carolina- Norfolk Southern
Director  Corporation
Alistair DarlingFormer Chancellor of the622016YES- None M(1)
Exchequer for the U.K. 
Thomas H. GlocerCEO of Thomson Reuters562013YES - Merck & Co., Inc.MC
Corporation (retired) 
James P. GormanChairman of the Board and CEO572010NO- None 
of Morgan Stanley 
Robert H. HerzPresident of622012YES- Federal NationalCM
Robert H. Herz LLC  Mortgage Association
   (Fannie Mae)
  - Workiva Inc.
Nobuyuki HiranoPresident and CEO of Mitsubishi642015YES- Mitsubishi UFJM
UFJ Financial Group, Inc.   Financial Group
Klaus KleinfeldChairman and CEO of Alcoa Inc.582012YES- Alcoa Inc.M
- Hewlett-Packard
  Enterprise Company
Jami MiscikCo-CEO and Vice Chair of572014YES- EMC CorporationMM
Kissinger Associates, Inc.
Donald T.Chief Accountant for the712006YES- MGIC InvestmentM C
NicolaisenU.S. Securities and Exchange  Corporation
Commission (retired)- Verizon 
  Communications Inc. 
- Zurich Insurance
  Group
Hutham S. OlayanPrincipal and director, The622006YES- International BusinessC
Olayan Group  Machines Corporation
James W. OwensChairman and CEO of Caterpillar702011YES- Alcoa Inc.MC
Inc. (retired)- International Business
  Machines Corporation
RyosukeSenior Advisor of The Bank of682011YES- NoneM
TamakoshiTokyo-Mitsubishi UFJ, Ltd.
Perry M. TraquinaCEO and Managing Partner,592015YES- eBay Inc.M
Wellington Management
Company LLP (retired)
Rayford Wilkins, Jr.CEO of Diversified Businesses of642013YES- Valero EnergyMM
AT&T Inc. (retired)  Corporation

Name, Age,

Independence

            Occupation highlights

Director
since

A:Other current
U.S.-listed public boards
Morgan Stanley
Committees
  A  CMDS  N&G    OT    R  

Elizabeth Corley, 62

Independent

Former global Chief Executive Officer (CEO) of Allianz Global Investors (U.K.) Ltd. (AllianzGI)2018

-  Pearson plc

M

Alistair Darling, 65

Independent

Former Chancellor of the Exchequer for the U.K.2016

    None

MM

Thomas H. Glocer, 59

Independent Lead
Director

Former CEO of Thomson Reuters Corporation2013

-  Merck & Co., Inc.

MM

James P. Gorman, 60

Chairman of the Board and CEO of Morgan Stanley2010

    None

Robert H. Herz, 65

Independent

President of
Robert H. Herz LLC;
Former Chairman of Financial Accounting Standards Board
2012

-  Federal National
Mortgage Association
(Fannie Mae)

-  Workiva Inc.

CM

Nobuyuki Hirano, 67

Non-Management

Chairman of Mitsubishi UFJ Financial Group, Inc. (MUFG)2015

-  MUFG

-  Toyota Motor
Corporation

M

Jami Miscik, 60

Independent

CEO and Vice Chair of
Kissinger Associates, Inc.
2014

-  General Motors Company

CM

Dennis M. Nally, 66

Independent

Former Chairman of
PricewaterhouseCoopers
International Ltd.
2016

    None

MM

Takeshi Ogasawara, 65

Non-Management

Advisor of MUFG Bank, Ltd.

    None

M

Hutham S. Olayan, 65

Independent

Chair, principal and director of The Olayan Group2006

-  International Business
Machines Corporation (IBM)
*

C

Mary L. Schapiro, 63

Independent

Vice Chair for Global Public Policy and Special Advisor to Founder and Chairman of Bloomberg, L.P.2018

-  CVS Health Corporation

M

Perry M. Traquina, 62

Independent

Former CEO and Managing Partner, Wellington Management Company LLP2015

-  eBay Inc.

-  The Allstate
Corporation

MC

Rayford Wilkins, Jr., 67

Independent

Former CEO of Diversified Businesses of AT&T Inc.2013

-  Caterpillar Inc.

-  Valero Energy
Corporation

MC

A:Audit Committee

CMDS: Compensation, Management

Development and Succession Committee

N&G: Nominating and Governance Committee

OT:Operations and Technology Committee

R: Risk Committee

C:Chair

CMDS:M:Compensation, Management

R:Risk CommitteeM:Member
Development and Succession Committee
NG:Nominating and Governance Committee


*(1) Effective May 17, 2016, Mr. Darling will join the Risk Committee.     Retiring at IBM’s 2019 annual meeting.

Morgan Stanley 20162019 Proxy Statement5



Table of Contents

OVERVIEW OF VOTING ITEMS


The Morgan Stanley Board of Directors

Board Tenure Balance

 Board Independence

Average Tenure: 4.7 years upon election
at the annual meeting*

LOGO

* Average tenure of director nominees is calculated based on length of completed Board service from date of initial election through the date of the annual meeting.

 

Board Independence

Average Tenure:4.6 years upon election at the annual meeting

All members of all committees arenon-management, and the Board benefits from anengaged Independent Lead Director with expansive responsibilities

LOGO

 International Experience

 Director Experience, Qualifications, Attributes and Skills

 LOGO

Europe Middle East Australia North America Asia

LOGO

Leadership (including strategic planning) (13) International / Global Perspective (11) Financial Services / Market Experience (10) Finance / Accounting Expertise (11) Risk Management (10) Operations / Technology (9) Talent (management development and succession) (10) Public Policy / Sustainability (6) Public Company Experience / Corporate Governance (10)


International Experience Board Succession and Diversity

5 new directors since 2016 (upon election at annual meeting)

 

Sector Experience(1)

31% female directors

9 directors who are current or former CEOs


(1)Reflects certain directors’ experience in more than one sector.

6 directors born outside the United States

Corporate Governance Highlights

Board Structure
and Independence
Eight new directors since 2012 who bring new skills and perspective to the Board
Upon election at the annual meeting, the average Board tenure will be approximately 4.6 years
Expansive Independent Lead Director role
 
Board Oversight

  Board Oversight  

Oversees the Company’s strategy, annual business plans, Enterprise Risk Management (ERM) framework and culture, values and conduct

Directors have complete access to senior management and other Company employees

Regular reviewreviews of succession plans for CEO and other senior executives
Director equity ownership requirement helps to align director and shareholder interests

 

Shareholder

Rights
and Accountability

Adopted proxy access (3/3/20/20) in 2015

Shareholders who own at least 25% of common stock may call a special meeting of shareholders

No supermajority vote requirements in our charter or bylaws

All directors elected annually by majority vote standard

No “poison pill” in effect

 
Annual Evaluations

Annual

Evaluations

Annual Board, Independent Lead Director, and committee self-assessments enhance performance

Includes one-on-one Board member interviews and written guidelines

Encompasses duties and responsibilities, individual director performance, Board and committee structure, culture, process and execution

Sustainability

and Giving Back

 Advance sustainable investing through our businesses

 Enhanced management of our carbon footprint and environmental and social risk

 Committed to giving back, one of our core values

Shareholder Engagement

 Investor input has led to proxy access and enhanced proxy disclosure of Board evaluations, director orientation / education, succession planning, Environmental, Social and Governance (ESG) matters, and enhanced alignment of compensation and performance


6Morgan Stanley 20162019 Proxy Statement



Table of Contents

OVERVIEW OF VOTING ITEMS


Item 2


Ratification of Appointment of Morgan Stanley’s Independent Auditor

LOGOOur Board unanimously recommends that you vote“FOR” the ratification of Deloitte & Touche’s appointment as our independent auditor.

LOGO   

See page 3540 for Audit Matters and additional information, including the Audit Committee Report and information regarding fees paid to Deloitte & Touche.


Item 3


Company Proposal to Approve the Compensation of Executives as Disclosed in the Proxy Statement (Non-Binding(Non-Binding Advisory Resolution)Vote)

LOGOOur Board unanimously recommends that you vote“FOR” this proposal.

See the “Compensation Discussion and Analysis” (CD&A) for additional informationrelating to the metrics referenced below and Section 5 of the CD&A for the notes referenced below.

2015 CEO Performance and Compensation Decision

At the start of 2015, as in prior years, the CMDS Committee established a target range of CEO compensation ($10 million to $28 million) and the factors to be considered in determining year-end compensation.

At year end, 2015 CEO compensation was set at $21 million, a 7% decrease from $22.5 million in 2014, with shareholder-aligned features: 72% deferred over three years and subject to clawback, with 39% of such deferred compensation delivered through future performance-vested equity awards.

The 2015 pay decision for the CEO was based on the CMDS Committee’s assessment of Mr. Gorman’s strong individual performance and Morgan Stanley’s progress in relation to its strategic objectives, financial performance and shareholder returns.

Morgan Stanleycontinued to successfully execute the long-term strategic objectives approved by the Board.
LOGO   See page 44 for the “Compensation Discussion and Analysis” (CD&A) and additional information relating to the metrics referenced below and see Section 5 of the CD&A for the notes referenced below.

1.Performance-Based Approach to Compensation and 2018 Performance Highlights

As in prior years, the CMDS Committee used a well-defined framework to determine CEO compensation for 2018, including establishing a target compensation range for the CEO and guidelines for the CEO performance assessment.

At year end, CEO total compensation was set at $29 million, with shareholder-aligned features:

Improved Wealth Management profit margin  75% of incentive compensation is deferred over three years and subject to 22%clawback;

  50% of incentive compensation is delivered through future performance-vested equity awards; and

  100% of deferred compensation is delivered in equity awards — an increased proportion from prior years.

The 2018 pay decision for the CEO was based on the CMDS Committee’s assessment of Mr. Gorman’s outstanding individual performance and the following:

  In 2018, the Company made substantial progress on its strategic objectives(1)(2).

2.Grew net interest income by 46% in the U.S. Bank(1)(3)
3.Initiated major restructuring after failure to achieve progress in Fixed Income and Commodities return on average common equity (ROE)
4.Ranked 1st in Institutional Equities revenue market share, 1st in Global IPOs, and 2nd in Global Announced M&A and Global Equity(4)
5.Continued to benefit from the tailwind from lower funding costs
6.Reduced compensation ratio, ex-DVA(8) in Institutional Securities to 37%(5)
7.Received a two-notch rating upgrade from Moody’s
8.Increased capital return to shareholders

LOGO


2018 - 2019 Strategic Objectives 2018 Results(3) 1 Deliver Wealth Management Pre-Tax Margin(4) of 26-28% 2 Expand Institutional Securities Penetration and Leadership 3 Position Investment Management for Growth 4 Realize Company Expense Efficiency Ratio(7) of <73% 5 Maintain Attractive Capital Return Profile Pre-Tax Margin(4) of 26.2% 8% net revenue operating growth(5); wallet share expansion across Sales & Trading and Investment Banking 9% asset management revenue operating growth(5); positive long-term net flows(6) Efficiency ratio(7) of 72.0% Maintained $6.8Bn aggregate distribution(8) ROE(9): 11.5% ROTCE(10): 13.2% ROE(9): 10%-13% ROTCE(10): 11.5%-14.5% Medium Term


Morgan Stanley 20162019 Proxy Statement7



Table of Contents

OVERVIEW OF VOTING ITEMS



Morgan Stanley delivered improved financial performance; however, Morgan Stanley’s shareholder returns trailedpeers in a challenging year for global financials, but still ranked first over the period from 2013 to 2015.

MS Firm Financials Results (2011-2015)     

MS Total Shareholder Return (TSR)(14)

Ex-DVA ($Billion)       2011       2012       2013          2014         2015       % Δ 2015
vs. 2014
   +3%
Net Revenues(9)28.630.633 233.634.5 
 +168%
Pre-tax Profit(9)2.55.05.22.9(10)7.9
 
MS ROE (2011-2015)(11)(12)


2015 CEO Compensation Elements

CEO compensation was delivered in a combination of base salary, cash bonus, deferred cash, restricted stock units (RSUs) and a long-term incentive program (LTIP) award in the form of performance stock units, as outlined in the chart below. A significant portion of CEO pay is deferred, awarded in equity, subject to future stock price performance, cancellation and clawback and, in the case of the LTIP award, subject to future achievement of specified financial goals over a three-year period.

MS 2015 CEO Compensation Elements

$ Million

% of Deferred

% of Total

2015 Total Compensation

Performance-Vested Long-Term Equity Incentive Compensation

Realizable value determined after three years (2016-2018), based equally on two performance metrics: target average ROE of 10% and shareholder returns relative to the S&P Financials Index
Shares delivered can range from 0 – 1.5x target, depending on performance relative to target. TSR portion will not exceed 1.0x if there is negative TSR for the performance period
Subject to cancellation and clawback

Deferred Incentive Compensation

Deferred Cash and Deferred Equity
Deferred over three years
Subject to cancellation and clawback

Current Compensation

Base Salary and Cash Bonus
Cash bonus was awarded consistent with the Company-wide deferral schedule


8     Morgan Stanley 2016 Proxy Statement



Table of Contents

OVERVIEW OF VOTING ITEMS



Executive Compensation Program Best Practices

Morgan Stanley’s executive compensation program is well-aligned with current best practices in corporate governance, risk management, and regulatory principles. Key features of the compensation program include:

1.Significant deferrals of compensation
2.Performance-vested long-term equity incentive award
3.Equity-based compensation
4.Clawbacks apply to all awards and cover material adverse outcomes, even absent misconduct
5.Share ownership and retention requirements
6.Prohibitions on pledging, hedging, selling short, or trading derivatives
7.No automatic vesting on change-in-control; double trigger in place
8.No excise tax protection upon a change-in-control
9.Annual risk review of incentive compensation programs
10.CMDS Committee retains an independent compensation consultant

Shareholder Engagement

At our 2015 annual meeting of shareholders, 88.6% of the votes cast were in favor of our annual “Say on Pay” proposal. In anticipation of the 2016 “Say on Pay” vote, we continued our engagement program, seeking feedback from shareholders and proxy advisory firms on a variety of topics. To align with feedback from our shareholders, the Board instituted the following changes:

Shareholder FeedbackMorgan Stanley Response

Executive
Compensation

Generally supportive
Interested in minimum share ownership requirements
Introduced minimum share ownership requirements for CEO and NEOs (10x and 6x base salary, respectively)

Proxy Access

Many shareholders are supportive of proxy access
The Board approved amendments to the Company’s bylaws in October 2015 to implement proxy access

Disclosure  The Company and certain of its businesses delivered record financial performance in 2018, as indicated in the table below.

  Over time, continued focus on expense discipline has led to strong operating leverage which, together with achievement of our multi-year strategic objectives, has helped the Company more than double itspre-tax profit, excluding DVA over the last five years from $5.2 billion to $11.2 billion(11)(16)(17).

  Solid returns have led to sufficient capital and an attractive return profile over time while also permitting investment for future growth; in 2018 the Company executed share repurchases of $4.9 billion and increased the quarterly common stock dividend to $0.30 per share from $0.25 per share (20% increase from 2017)(8)(18).

  The Company’s execution of its strategic objectives and record financial performance contributes to strong shareholder return over time; while the Company’s TSR(21) for 2018 was negative at (23%)(22), it outperformed the average of its global peers(23) and three- and five-year TSR continued to be very strong at 33% and 39%, respectively(22).

LOGO

Company Institutional Securities Wealth Management Revenue Pre-Tax Profit(11) Net Income(12) Investment Banking Revenues Equity Revenues Revenues Pre-Tax Profit(11) Pre-Tax Margin(4) $40.1Bn $11.2Bn $8.7Bn $6.1Bn $9.0Bn $17.2Bn $4.5Bn 26.2% Record #1 Globally(14)

8    Morgan Stanley 2019 Proxy Statement


OVERVIEW OF VOTING ITEMS

Suggested improvements to the proxy statement to enhance readability
Refresh of proxy design to include a proxy summary, more visuals, and clearer disclosure of considerations and decisions regarding pay

2018 CEO Compensation Determination

The 2018 pay decision for the CEO was made by the CMDS Committee, in consultation with the entire Board, based on its assessment of Mr. Gorman’s outstanding individual performance, the Company’s record performance in 2018 and substantial progress on the Company’s strategic objectives. The CMDS Committee also noted Mr. Gorman’s overall leadership with respect to Company culture, and among clients, shareholders, regulators and employees.

MS 2018 CEO Performance Evaluation            MS 2018 CEO Compensation Opportunity ($MM)

Shareholder
Dilution

LOGO

CEO compensation was delivered in a combination of base salary, cash bonus, time-vested deferred equity, and a performance-vested long-term equity incentive compensation award. A significant portion of CEO pay is deferred, awarded in equity, subject to future stock price performance, cancellation and clawback and, in the case of the performance-vested equity award, subject to future achievement of specified financial goals over a three-year period. The CMDS Committee believes this approach to executive compensation supports the Company’s pay for performance philosophy and key compensation objectives, and is consistent with shareholder feedback, best practices and regulatory principles.

Record performance in 2018 driven by revenue growth and expense discipline Substantial progress on many 2018 - 2019 strategic objectives, including medium term ROE and ROTCE targets Outstanding leadership, with respect to Company culture, and among clients, shareholders, regulators, and employees Negative TSR performance % of Incentive Compensation $29 MM Performance- Vested Long-Term Equity Incentive Compensation: 50% Time-Vested Deferred Equity: 25% Cash Bonus: 6.9 25% Base Salary 100% Equity

Shareholders remain focused on potential shareholder dilution resulting from equity compensation
The Company issued 36 million shares in 2015, less than the 59 million shares repurchased in 2015

Shareholder Engagement

At our 2018 annual meeting of shareholders, over 95% of the votes cast were in favor of our annual “Say on Pay” proposal. In anticipation of the 2019 “Say on Pay” vote, we continued our engagement program, seeking feedback from shareholders and proxy advisory firms on a variety of topics, including executive compensation, corporate governance and environmental and social goals. With respect to executive compensation, shareholders who provided feedback during our engagement program generally reported that executive compensation at Morgan Stanley was viewed as well-aligned with performance. After carefully considering shareholder feedback and other factors, the portion of CEO deferred incentive compensation awarded in equity incentive compensation was increased to 100% for 2018.



Morgan Stanley 20162019 Proxy Statement9



Table of Contents

OVERVIEW OF VOTING ITEMS


Item 4


CompanyShareholder Proposal to Amend the 2007 Equity Incentive Compensation Plan (EICP)

LOGOOur Board unanimously recommends that you vote “AGAINST” the shareholder proposal regarding an annual report on lobbying expenses.

LOGOSee page 77 for the shareholder proposal and our Board’s opposition statement.

10    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Item 1

Election of Directors

LOGOOur Board unanimously recommends that you vote“FOR” this proposal.


Proposal

Add 20 million shares to the EICP

Add regulatory factors, risk management, expense management, and contributions to community development and sustainability projects or initiatives as performance criteria that could be elements of performance-vested awards over time


Rationale

Morgan Stanley believes that awarding a portion of compensation in shares aligns employee and shareholder interests

The Company last amended the EICP in 2015 to add 25 million shares, which 92% of voting shareholders approved

The 20 million shares requested is less than the 59 million shares repurchased in 2015

Additional performance criteria will better enable performance-vested awards to be tax-deductible to Morgan Stanley under Section 162(m) of the Internal Revenue Code


Impact
Overhang(1)Burn Rate(2)
(1)Overhang represents the number of shares underlying outstanding equity awards and available for future equity awards as a percentage of weighted average common shares outstanding for the period.
(2)Burn rate represents the number of shares granted per year pursuant to equity awards as a percentage of weighted average common shares outstanding for the period.

See page 71 for the proposal to amend the Morgan Stanley 2007 Equity Incentive Compensation Plan.



Item 5-6

Shareholder Proposals

Our Board unanimously recommends that you vote “AGAINST” each shareholder proposal.

Our Board recommends you vote against the proposal to exclude votes to abstain from shareholder proposal vote counts.

Our Board recommends you vote against the proposal to adopt a policy to prohibit vesting of deferred equity awards for senior executives who resign to enter government service.

See page 79 for two proposals submitted by shareholders and our Board’s statements in opposition to each.


10     Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE

Item 1

Election of Directors

Our Board unanimously recommends that you vote “FOR” the election of all director nominees.

DIRECTOR SUCCESSION AND NOMINATION PROCESS

Key Statistics on Board Succession

5

New directors since 2016 (upon election at the annual meeting)

 

4.7 years

Average tenure of Board upon
election at the annual meeting

64

Average age of Board upon election at the annual meeting


DIRECTOR SELECTION AND NOMINATION PROCESS

Our Board currently consists of 15 directors, including two directors who are designated in accordance with the terms of the Investor Agreement between Morgan Stanley and Mitsubishi UFJ Financial Group, Inc. (MUFG), dated October 13, 2008, as amended and restated (Investor Agreement), pursuant to which Morgan Stanley agreed to take all lawful action to cause two of MUFG’s senior officers or directors to become members of Morgan Stanley’s Board. MUFG has designated Messrs. Nobuyuki Hirano and Ryosuke Tamakoshi as its representative directors pursuant to the Investor Agreement.

The Nominating and Governance Committee’s charter provides that the committee will actively seek and identify nominees for recommendation to the Board consistent with the criteria in the Morgan Stanley Corporate Governance Policies (Corporate Governance Policies), which provide that the Board values members who:

Combine a broad spectrum of experience and expertise with a reputation for integrity;

��

Have experience in positions with a high degree of responsibility;

Are leaders in the companies or institutions with which they are affiliated;

Can make contributions to the Board and management; and

Represent the interests of shareholders.


Combine a broad spectrum of experience and expertise with a reputation for integrity;

Have experience in positions with a high degree of responsibility;

Are leaders in the companies or institutions with which they are affiliated;

Can make contributions to the Board and management;

Represent the interests of shareholders; and

Possess a willingness to appropriately challenge management in a constructive manner.

While the Board has not adopted a policy regarding diversity, the Corporate Governance Policies provide that the Board will take into account the diversity of a director candidate’s perspectives, background and other relevant demographics. The Nominating and Governance Committee and the Board may also determine specific skills and experience they are seeking in director candidates based on the needs of the Company at a specific time.time in light of the Company’s long-term strategy. In considering candidates for the Board, the Nominating and Governance Committee considers the entirety of each candidate’s credentials in the context of these criteria.

The NominatingBoard is committed to the ongoing review of Board composition and Governance Committee may also consider director candidates proposed by shareholders, and in this regard, the Board has adopted the Policy Regarding Director Candidates Recommended by Shareholders.succession planning. The Nominating and Governance Committee continuously reviews the experience, qualifications, attributes, skills and tenure of the members of the Board and maintains a list of potential director candidates that is reviewed and refreshed regularly throughout the course of the year.

The Nominating and Governance Committee may also retain and terminate, in its sole discretion, a third party to assist in identifying director candidates or gathering information regarding a director candidate’s background and experience. The Nominating and Governance Committee may also consider director candidates proposed by shareholders, as provided for in the Corporate Governance Policies. Members of the Nominating and Governance Committee, the Independent Lead Director and other members of the Board interview potential director candidates as part of the selection process when evaluating new director candidates.

The Corporate Governance Policies provide that the Board expects a director to advise the Chairman and Corporate Secretary if he or she plans to join the board of directors or similar governing body of another public or private company or advisory board, or experiences other changed circumstances that could diminish his or her effectiveness as a director or otherwise be detrimental to the Company. They also provide that the Board expects a director to advise and to offer to tender his or her resignation for consideration by the Board if his or her principal occupation or employer changes. In addition, the Corporate Governance Policies provide that a director candidate should not be nominated for election if the candidate would be 72 years old at the time of election.

Morgan Stanley 2019 Proxy Statement    11


CORPORATE GOVERNANCE MATTERS

Our Board currently consists of 13 directors, including two directors who are designated in accordance with the terms of the Investor Agreement between Morgan Stanley and MUFG, dated October 13, 2008, as amended and restated (Investor Agreement), pursuant to which Morgan Stanley agreed to take all lawful action to cause two of MUFG’s senior officers or directors to become members of Morgan Stanley’s Board.

Ryosuke Tamakoshi, Senior Advisor of MUFG Bank, Ltd. (MUFG Bank), the core commercial banking unit of MUFG, who was elected to the Board, effective July 20, 2011, and subsequently elected by shareholders at the Company’s annual meetings of shareholders in 2012 through 2018, will not be standing for reelection at the 2019 annual meeting of shareholders. MUFG has designated Takeshi Ogasawara, Advisor of MUFG Bank, as a representative director under the Investor Agreement to stand for election, along with MUFG’s other representative director, Nobuyuki Hirano, at the 2019 annual meeting of shareholders.

The Nominating and Governance Committee considered the experience, qualifications and skills of Mr. Ogasawara as discussed herein and unanimously recommended that the Board nominate Mr. Ogasawara as a director for election at the 2019 annual meeting of shareholders. Based on the recommendation of the Nominating and Governance Committee, the Board unanimously nominated and recommends that Mr. Ogasawara be elected as a director at the 2019 annual meeting of shareholders.

As part of the Board’s ongoing review of Board composition and succession planning, the Nominating and Governance Committee’s third-party search firm recommended Mary L. Schapiro as a potential director candidate to the Nominating and Governance Committee. Upon the recommendation of the Nominating and Governance Committee, the Board unanimously elected Ms. Schapiro to the Board, effective July 1, 2018. The Board determined that Ms. Schapiro’s service as Chair of the U.S. Securities and Exchange Commission; Chair and Chief Executive Officer of the Financial Industry Regulatory Authority; and Chair of the Commodity Futures Trading Commission brings to the Board extensive regulatory and leadership experience, as well as markets and financial services perspective.

DIRECTOR EXPERIENCE, QUALIFICATIONS, ATTRIBUTES AND SKILLS

When the Board nominates directors for election at an annual meeting, it evaluates the experience, qualifications, attributes and skills that an individual director candidate contributes to the tapestry of the Board as a whole to assist the Board in discharging its duties. Asduties and overseeing the Company’s strategy. This evaluation is part of the Nominating and Governance Committee’s ongoing process to evaluate these attributes,Board succession planning processes as well as the Board performs anBoard’s annual self-evaluation and the Corporate Governance Policies provide that the Board expects a director whose principal occupation or employer changes, who plans to join the board of directors or similar governing body of another public or private company or advisory board, or who experiences other changed circumstances that could diminish his or her effectiveness as a director or otherwise be detrimental to the Company, to advise and to offer to tender his or her resignation for consideration by the Board. In addition, the Corporate Governance Policies provide that a director candidate should not be nominated for election if the candidate would be 72 years old at the time of election.self-evaluation.

Morgan Stanley 2016 Proxy Statement11Our Directors’ Qualifications, Attributes and Skills Are Aligned with Company Strategy



Table of Contents

CORPORATE GOVERNANCE


The Company believes that an effective board consists of a diverse group of individuals who bringpossess a variety of complementary skills.skills and a range of tenures. The Nominating and Governance Committee and the Board regularly consider these skills in the broader context of the Board’s overall composition, with a view toward constituting a board that has the best skill set and experience to oversee the Company’s business and to ensure that the Board has the appropriate mix of skills needed for the broad set of challenges that it confronts.faces.

Leadership

(including strategic

planning)

(13)

International / Global

Perspective

(11)

Financial Services /

Market Experience

(10)

Financial / Accounting

Expertise

(11)

Risk Management

(10)

Operations /

Technology

(9)

Talent

(management

development and

succession)

(10)

Public Policy /

Sustainability

(6)

Public Company

Experience /

Corporate Governance

(10)

12    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

DIRECTOR NOMINEES

Quick Facts on Our Director Nominees

12

Non-management directors

9

Directors who are current or former CEOs

6

Directors born outside of the United States

31%

Female directors

The Board has nominated the 13 director nominees below for election at the 2019 annual meeting of shareholders. The Board believes that, in totality, the mix of qualifications and the diversity of attributes and skills among the nominees enhances our Board’s effectiveness and is aligned with the Company’s long-term strategy. Our directors have a combined wealth of leadership experience derived from extensive service guiding large, complex organizations as executive leaders or board members and in government and academiapublic policy, and possess substantive knowledgea diversity of qualifications, attributes and skills applicable to our business including experience in the following areas:

Directors’ Qualifications, Attributes and Skills
BankingFinancial ServicesPublic Policy
Business DevelopmentInternational MattersRegulatory
CompensationManagement Development and Succession        Risk Management
Corporate GovernanceOperationsStrategic Planning
FinancePublic Accounting and Financial ReportingTechnology


DIRECTOR NOMINEES

long-term strategy. The Board stands for election at each annual meeting of shareholders. Each director holds office until his or her successor has been duly elected and qualified or the director’s earlier resignation, death or removal.

The Board has nominated the 14 director nominees below for election at the 2016 annual meeting of shareholders. The Board believes that, in totality, the mix of qualifications, skills and attributes among the nominees enhances our Board’s effectiveness in light of the Company’s businesses, regulatory environment and long-term strategy.

Laura D. Tyson is not standing for re-election at the annual meeting of shareholders. The Board thanks Dr. Tyson for her dedicated service to Morgan Stanley.

Pursuant to the terms of the Investor Agreement, on October 28, 2015, MUFG designated Mr. Nobuyuki Hirano as its representative director replacing Mr. Masaaki Tanaka, who served as its representative director since May 2011. In accordance with the Investor Agreement, on October 29, 2015, the Board unanimously elected Mr. Hirano to the Board, effective November 1, 2015. The Board determined that Mr. Hirano’s experience as chief executive officer (CEO) of one of the world’s largest banks brings tremendous value to the Board and to Morgan Stanley, including commercial banking and risk management expertise.

As part of the Board’s ongoing review of Board composition and succession planning, the Nominating and Governance Committee’s third-party search firm recommended Alistair Darling as a potential director candidate to the Nominating and Governance Committee. Upon the recommendation of the Nominating and Governance Committee, the Board unanimously elected Mr. Darling to the Board, effective January 1, 2016. The Board determined that Mr. Darling’s service as a former member of the British Parliament and as Chancellor of the Exchequer brings to the Board strong leadership experience, as well as insight into both the global economy and the global financial system.

Each nominee has indicated that he or she will serve if elected. We do not anticipate that any nominee will be unable or unwilling to stand for election, but if that happens, your proxy may be voted for another person nominated by the Board or the Board may reduce the number of directors to be elected.

12     

Morgan Stanley 20162019 Proxy Statement    13



Table of Contents

CORPORATE GOVERNANCE MATTERS


LOGO

  

Elizabeth Corley, 62

Independent Director

Director Since: 2018

Morgan Stanley Committees:

Erskine B. Bowles
  Nominating and Governance
Independent Lead Director

   

LOGO

Alistair Darling,
65

Independent Director

Director Since: 2016

Morgan Stanley Committees:

  Audit

  Risk

Age: 70     Director Since: 2005

Qualifications, Attributes and Skills:

Age: 62     Director Since: 2016

  

Morgan Stanley Committees:

Morgan Stanley Committees:

Qualifications, Attributes and Skills:

CMDS
Nominating

Ms. Corley’s leadership positions, including through her role as CEO of AllianzGI, bring to the Board extensive management experience as well as markets and Governance

financial services experience and international perspective.

Risk (effective May 17, 2016)
  

Professional Experience:

Professional Experience:

President Emeritus of the University of North Carolina and served as President from January 2006 through December 2010.

Served as Co-Chair of the National Commission on Fiscal Responsibility and Reform during 2010.

Senior advisor at BDT Capital Partners LLC, a private investment firm, since 2012 and serves as non-executive vice chairman. Senior advisor from 2001 to 2015 and Managing Director from 1999 to 2001 of Carousel Capital, a private investment firm. Partner at the private investment firm of Forstmann Little & Co. from 1999 to 2001 and a founder of Kitty Hawk Capital, a venture capital firm.

Began career in corporate finance at Morgan Stanley in 1969 and subsequently helped found and served as Chairman and CEO of Bowles Hollowell Connor & Co., an investment banking firm.

Served as White House Chief of Staff from 1996 to 1998 and Deputy White House Chief of Staff from 1994 to 1995. Head of the Small Business Administration from 1993 to 1994 and served as United Nations Under Secretary General, Deputy Special Envoy for Tsunami Recovery in 2005.

Qualifications, Attributes and Skills: Mr. Bowles brings to the Board his extensive experience in the financial services industry and our Company, particularly in his capacity as Independent Lead Director appointed by our independent directors, as well as in academia and his distinguished public service.

Other Current Public Company Directorships:
Facebook, Inc. and Norfolk Southern Corporation

Other Public Company Directorships in the Past Five Years:
Belk, Inc. and Cousins Properties Incorporated

Appointed to the House of Lords on December 10, 2015. Previously a member of the British Parliament, serving as a member of the House of Commons from 1987 to 2015.

Held several leadership positions, including as Chancellor of the Exchequer from 2007 to 2010, Secretary of State for Trade and Industry from 2006 to 2007, Secretary of State for Scotland from 2003 to 2006, Secretary of State for Transport from 2002 to 2006, Secretary of State for Social Security/Work and Pensions from 1998 to 2002 and Chief Secretary to the Treasury from 1997 to 1998.

Qualifications, Attributes and Skills:Mr. Darling’s service as a former member of the British Parliament and as Chancellor of the Exchequer brings to the Board strong leadership, risk management and regulatory experience, as well as insight into both the global economy and the global financial system.


Professional Experience:

Morgan StanleySenior Adviser of AllianzGI from April 2018 to April 2019,non-executive Vice Chair from March 2016 Proxy Statementto March 2018, global CEO from January 2012 to February 2016 and European CEO from 2005 to 2011.

Held various leadership positions at Merrill Lynch Investment Managers (formerly Mercury Asset Management) from 1993 to 2004, including as Managing Director and Head of the EMEA Asia Pacific Mutual Fund Business.

Began her career at Sun Alliance Life & Pensions Limited and subsequently served as a consultant and then partner at Coopers & Lybrand Management Consultants (U.K.) from 1985 to 1993.

Served two terms as Chairwoman of the Forum of European Asset Managers and served on the board of the Financial Reporting Council from 2011 to 2017.

13Other U.S. Listed Public Company Boards:


Pearson plc


TableProfessional Experience:

Appointed to the House of ContentsLords on December 10, 2015. Previously a member of the British Parliament, serving as a member of the House of Commons from 1987 to 2015.

CORPORATE GOVERNANCE


Held several leadership positions in the U.K. government, including as Chancellor of the Exchequer from 2007 to 2010, Secretary of State for Trade and Industry from 2006 to 2007, Secretary of State for Scotland from 2003 to 2006, Secretary of State for Transport from 2002 to 2006, Secretary of State for Social Security/Work and Pensions from 1998 to 2002 and Chief Secretary to the Treasury from 1997 to 1998.
  

Thomas H. Glocer
Independent Director

  

James P. Gorman
Chairman

14    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Age: 56     Director Since: 2013

Age: 57     Director Since: 2010

LOGO

Thomas H. Glocer, 59

Independent Lead Director

Director Since: 2013

Morgan Stanley Committees:

  CMDS

Audit 

Operations and Technology (Chair)

  

Professional Experience:

LOGO

Professional Experience:

James P. Gorman, 60

Chairman

Director Since: 2010

Served

Qualifications, Attributes and Skills:

Qualifications, Attributes and Skills:

Mr. Glocer’s leadership positions, including in his capacity as Independent Lead Director appointed by our independent directors and as CEO of Thomson Reuters Corporation, a news and information provider for businesses and professionals, from April 2008 through December 2011, and as CEO of Reuters Group PLC from July 2001 to April 2008. Joined Reuters Group PLC in 1993 and served in a variety of executive roles before being named CEO.

Mergers and acquisitions lawyer at the law firm of Davis Polk & Wardwell LLP from 1984 to 1993.

Qualifications, Attributes and Skills: Mr. Glocer’s leadership positions, including as CEO of Thomson Reuters Corporation, bringsbring to the Board extensive management experience as well as operational and technology experience and international perspective.

Other Current Public Company Directorships:
Merck & Co., Inc.

Other Public Company Directorships in the Past Five Years:
Thomson Reuters Corporation

Chairman of the Board and CEO of Morgan Stanley since January 2012. President and CEO from January 2010 through December 2011.

Co-President from December 2007 to December 2009, Co-Head of Strategic Planning from October 2007 to December 2009 and President and Chief Operating Officer of Wealth Management from February 2006 to April 2008.

Joined Merrill Lynch & Co., Inc. (Merrill Lynch) in 1999 and served in various positions including Chief Marketing Officer, Head of Corporate Acquisitions Strategy and Research in 2005 and President of the Global Private Client business from 2002 to 2005.

Prior to joining Merrill Lynch, was a senior partner at McKinsey & Co., serving in the firm’s financial services practice. Earlier in his career, was an attorney in Australia.

Qualifications, Attributes and Skills:

As CEO of the Company, Mr. Gorman is a proven leader with an established record as a strategic thinker backed by strong operating, business development and execution skills and brings an extensive understanding of Morgan Stanley’s businesses and decades of financial services experience.

14Professional Experience:

Founder of Angelic Ventures, LP (Angelic), a family office focusing on early-stage investments in financial technology, cyber defense and media, and Managing Partner of Angelic since 2012.

Served as CEO of Thomson Reuters Corporation, a news and information provider for businesses and professionals, from April 2008 through December 2011 and as CEO of Reuters Group PLC from July 2001 to April 2008. Joined Reuters Group PLC in 1993 and served in a variety of executive roles before being named CEO.

Mergers and acquisitions lawyer at the law firm of Davis Polk & Wardwell LLP from 1984 to 1993.

Other U.S. Listed Public Company Boards:

Merck & Co., Inc.

Professional Experience:

Chairman of the Board and CEO of Morgan Stanley 2016 Proxy Statementsince January 2012. President and CEO from January 2010 through December 2011.

Co-President



from December 2007 to December 2009,TableCo-Head of ContentsStrategic Planning from October 2007 to December 2009 and President and Chief Operating Officer of Wealth Management from February 2006 to April 2008.

Joined Merrill Lynch & Co., Inc. (Merrill Lynch) in 1999 and served in various positions, including Chief Marketing Officer, Head of Corporate Acquisitions Strategy and Research in 2005 and President of the Global Private Client business from 2002 to 2005.

CORPORATE GOVERNANCE


Prior to joining Merrill Lynch, was a senior partner at McKinsey & Co., serving in the firm’s financial services practice. Earlier in his career, was an attorney in Australia.
  

Robert H. Herz
Independent Director

  

Nobuyuki Hirano
Non-management Director

Morgan Stanley 2019 Proxy Statement    15


CORPORATE GOVERNANCE MATTERS

Age: 62     Director Since: 2012

Age: 64     Director Since: 2015

Morgan Stanley Committees:

LOGO

Robert H. Herz, 65

Independent Director

Director Since: 2012

Morgan Stanley Committees:

Audit (Chair)

Nominating and Governance

Risk
  

Professional Experience:

LOGO

Professional Experience:

Nobuyuki Hirano, 67

Non-management Director

Director Since: 2015

Morgan Stanley Committees:

  Risk

President of Robert H. Herz LLC, providing consulting services on financial reporting and other matters, since September 2010.

Chairman of the Financial Accounting Standards Board from July 2002 to September 2010 and as a part-time member of the International Accounting Standards Board from January 2001 to June 2002.

Served on the Accounting Standards Oversight Council of Canada since 2011 and as a member of the Standing Advisory Group of the Public Company Accounting Oversight Board since 2012.

Partner in PricewaterhouseCoopers, an accounting firm, from 1985 to 2002.

Qualifications, Attributes and Skills:

Qualifications, Attributes and Skills:

Mr. Herz brings to the Board extensive regulatory, public accounting, financial reporting, risk management and financial experience through his private and public roles, including as Chairman of the Financial Accounting Standards Board.

Other Current Public Company Directorships:
Federal National Mortgage Association (Fannie Mae) and Workiva Inc.

President and CEO of MUFG, one of the world’s leading financial groups, since April 2013, and since April 2016 Chairman of The Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU), the core commercial banking unit of MUFG.

Director of MUFG since June 2010 and Deputy President from October 2010 to March 2012. President and CEO of BTMU from April 2012 to March 2016 and Deputy President of BTMU from June 2009 to March 2012.

Managing Officer of MUFG from 2009 to 2010 and Senior Managing Director from 2008 to 2009 and Managing Director from 2006 to 2008 of BTMU.

Numerous senior-level positions in Japan and abroad since joining The Mitsubishi Bank, Limited in 1974, including in the Corporate Planning Office and Corporate Banking Division of The Bank of Tokyo-Mitsubishi, Ltd.

Previously served as a director of Morgan Stanley from 2009 to 2011.

Qualifications, Attributes and Skills:

In his role as Director,Chairman and former President and Group CEO at MUFG and its associated companies, Mr. Hirano brings to the Board global leadership as well as international banking, financial services, risk management and regulatory experience.

Other Current Public Company Directorships:
MUFGexpertise.

Professional Experience:

President of Robert H. Herz LLC, providing consulting services on financial reporting and other matters, since September 2010.

Chairman of the Financial Accounting Standards Board from July 2002 to September 2010 and a part-time member of the International Accounting Standards Board from January 2001 to June 2002.

Member of the Standing Advisory Group of the Public Company Accounting Oversight Board since 2012 and served on the Accounting Standards Oversight Council of Canada from 2011 to March 2017.

Partner in PricewaterhouseCoopers LLP (PwC), an accounting firm, from 1985 to 2002.

Other U.S. Listed Public Company Boards:

Federal National Mortgage Association (Fannie Mae) and Workiva Inc.

Professional Experience:

Chairman of MUFG, one of the world’s leading financial groups, since April 2019 and Director of MUFG Bank, the core commercial banking unit of MUFG, since June 2005.

President and Group CEO of MUFG from April 2013 to March 2019 and Chairman of MUFG Bank from April 2016 to March 2019.

Director of MUFG since June 2010 and Deputy President from October 2010 to March 2012. President and CEO of MUFG Bank from April 2012 to March 2016 and Deputy President of MUFG Bank from June 2009 to March 2012.

Managing Officer of MUFG from 2009 to 2010, Senior Managing Director from 2008 to 2009 and Managing Director from 2006 to 2008 of MUFG Bank.

Numerous senior-level positions in Japan and abroad since joining The Mitsubishi Bank, Limited in 1974, including in the Corporate Planning Office and Corporate Banking Division of The Bank of Tokyo-Mitsubishi, Ltd.

Previously served as a director of Morgan Stanley 2016 Proxy Statement     from 2009 to 2011.

15Other U.S. Listed Public Company Boards:


MUFG and Toyota Motor Corporation


Table of Contents

CORPORATE GOVERNANCE


  

Klaus Kleinfeld
Independent Director

  

Jami Miscik
Independent Director

16    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Age: 58     Director Since: 2012

Age: 57     Director Since: 2014

Morgan Stanley Committees:

LOGO

Jami Miscik, 60

Independent Director

Director Since: 2014

Morgan Stanley Committees:

CMDS 

Operations and Technology (Chair)

Risk

  

Professional Experience:

LOGO

Professional Experience:

Dennis M. Nally, 66

Independent Director

Director Since: 2016

Morgan Stanley Committees:

  Audit

  CMDS

Chairman and CEO of Alcoa Inc. (Alcoa), the world’s leading producer of primary aluminum and fabricated aluminum, since April 2010.

President and CEO of Alcoa from 2008 to 2010 and President and Chief Operating Officer of Alcoa from 2007 to 2008.

Served for 20 years at Siemens AG from 1987 to 2007, including as CEO and President from 2005 to 2007, as a member of the Managing Board from 2004 to 2007, and as President and CEO from 2002 to 2004 and Executive Vice President and Chief Operating Officer in 2001 of Siemens AG’s principal U.S. subsidiary, Siemens Corporation.

Qualifications, Attributes and Skills:Mr. Kleinfeld brings to the Board extensive international and senior executive experience, including in business development, operations and strategic planning at multinational organizations.

Other Current Public Company Directorships:
Alcoa and Hewlett-Packard Enterprise Company

Other Public Company Directorships in the Past Five Years:
Bayer AG (Supervisory Board) and Hewlett-Packard Company

Co-CEO and Vice Chair of Kissinger Associates, Inc. (Kissinger), a New York-based strategic international consulting firm that assesses and navigates emerging market geopolitical and macroeconomic risks for its clients, since May 2015.

President and Vice Chair of Kissinger from 2009 to 2015.

Global head of sovereign risk at Lehman Brothers from 2005 to 2008.

Central Intelligence Agency from 1983 to 2005, serving as Deputy Director for Intelligence from 2002 to 2005.

Co-Chair of the President’s Intelligence Advisory Board and served as Senior Advisor for Geopolitical Risk at Barclays Capital.

Qualifications, Attributes and Skills:

Ms. Miscik brings to the Board extensive leadership in navigating geopolitical, macroeconomic and technology risks through her private and public roles, including as Co-CEOCEO and Vice Chair of Kissinger Associates, Inc. and her service with the Central Intelligence Agency.

Other Current Public Company Directorships:
EMC Corporation

16     Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE


  
 

Donald T. Nicolaisen
Independent Director

Hutham S. Olayan
Independent Director

Age: 71     Director Since: 2006

Age: 62     Director Since: 2006

Morgan Stanley Committees:

Morgan Stanley Committees:

Audit 
Risk (Chair) 
CMDS (Chair)

Professional Experience:

Professional Experience:

Chief Accountant for the U.S. Securities and Exchange Commission (SEC) from 2003 to 2005, where he served as the principal advisor to the SEC on accounting and auditing matters and was responsible for formulating and administering the accounting program and policies of the SEC.

Partner of PricewaterhouseCoopers, an accounting firm, from 1978 to 2003 and first joined Price Waterhouse in 1967.

Led Price Waterhouse’s national office for accounting and SEC services and its financial services practice and was responsible for auditing and providing risk management advice to large, complex multinational corporations.

Qualifications, Attributes and Skills: Mr. NicolaisenNally brings to the Board over 40 years of regulatory, public accounting and financial reporting risk management and financial experience, and the varied perspectives he has gained in the private sectorincluding through his role as Chairman of PricewaterhouseCoopers International Ltd., as well as through distinguished service at the SEC.

Other Current Public Company Directorships:
MGIC Investment Corporation, Verizon Communications Inc.extensive technology and Zurich Insurance Groupmanagement experience.

Professional Experience:

CEO and Vice Chair of Kissinger Associates, Inc. (Kissinger), a New York-based strategic international consulting firm that assesses and navigates emerging market geopolitical and macroeconomic risks for its clients, since March 2017.

Co-CEO and Vice Chair of Kissinger from 2015 to 2017 and President and Vice Chair of Kissinger from 2009 to 2015.

Global head of sovereign risk at Lehman Brothers from 2005 to 2008.

Central Intelligence Agency from 1983 to 2005, serving as Deputy Director for Intelligence from 2002 to 2005.

Co-Chair of the President’s Intelligence Advisory Board from 2014 to 2017 and served as Senior Advisor for Geopolitical Risk at Barclays Capital.

Other U.S. Listed Public Company Boards:

General Motors Company

Other U.S. Listed Public Company Boards in the Past Five Years:EMC Corporation

Professional Experience:

Chairman of PricewaterhouseCoopers International Ltd., the coordinating and governance entity of the PwC network, from 2009 to July 2016.

Chairman and Senior Partner of the U.S. firm of PricewaterhouseCoopers LLP (PwC) from May 2002 to June 2009.

Joined PwC in 1974 and became a partner in 1985, serving in numerous leadership positions within PwC, including National Director of Strategic Planning, Audit and Business Advisory Services Leader and Managing Partner.

Morgan Stanley 2019 Proxy Statement    17


CORPORATE GOVERNANCE MATTERS

LOGO

Takeshi Ogasawara, 65

Non-management Director

Director Nominee

Morgan Stanley Committees:

  Operations and Technology

LOGO

Hutham S. Olayan, 65

Independent Director

Director Since:Principal 2006

Morgan Stanley Committees:

  CMDS (Chair)

Qualifications, Attributes and director since 1981Skills:

Qualifications, Attributes and Skills:

As an advisor and former Deputy President of MUFG Bank, Mr. Ogasawara brings to the Board over 35 years of banking experience and international, risk management, compliance and strategic expertise.

Ms. Olayan’s leadership positions, including as Chair of The Olayan Group, a private multinational enterprise that is a diversified global investorGroup’s board of directors and operator of commercial and industrial businesses in Saudi Arabia.

President and CEO of The Olayan Group’s U.S. operations, for almost 30 years, overseeing all investment activity inbring to the Americas.

Member of the Executive Advisory Board of General Atlanticextensive management experience and a former director of Thermo Electron Corporation.

Qualifications, Attributes and Skills: Ms. Olayan’s extensiveher financial experience in the U.S. and internationally, including in the Middle East, strengthens the Board’s global perspective.

Other Current Public Company Directorships:
International Business Machines Corporation

Morgan StanleyProfessional Experience:

Advisor to MUFG Bank since June 2016.

Director of Bank of Ayudhya Public Company Limited (Krungsri), a subsidiary of MUFG Bank in Thailand, from January 2014 to June 2018.

Deputy President of MUFG Bank from May 2012 to June 2016, Proxy Statement     and Head of Central Region of Japan of MUFG Bank from May 2012 to May 2016.

Chief Compliance Officer of MUFG Bank from May 2009 to May 2012.

Began his professional career at The Tokai Bank, Ltd., one of the legacy banks of MUFG Bank, in 1977.

17Professional Experience:



TableChair since October 2018, Vice Chair from January to October 2018 and principal and director since 1981 of ContentsThe Olayan Group, a private multinational enterprise that is a diversified global investor and operator of commercial and industrial businesses in Saudi Arabia.

Served as President and CEO of The Olayan Group’s U.S. operations for almost 30 years until December 2017, overseeing all investment activities in the Americas.

Member of the Executive Advisory Board of General Atlantic and a former director of Thermo Electron Corporation.

Other U.S. Listed Public Company Boards:

CORPORATE GOVERNANCEIBM (retiring at 2019 annual meeting)


James W. Owens
Independent Director

Ryosuke Tamakoshi
Non-management Director

Age: 70     Director Since: 2011

Age: 68     Director Since: 2011

  

Morgan Stanley Committees:

Morgan Stanley Committees:

18    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

CMDS 
Nominating and Governance (Chair) 
Operations and Technology

Professional Experience:

Professional Experience:

Chairman and CEO of Caterpillar Inc. (Caterpillar), a manufacturer of construction and mining equipment, diesel and natural gas engines and industrial gas turbines, from 2004 to 2010.

Vice Chairman of Caterpillar from 2003 to 2004 and as Group President from 1995 to 2003, responsible at various times for 13 of the company’s 25 divisions.

Vice President and Chief Financial Officer of Caterpillar from 1993 to 1995, Corporate Vice President and President of Solar Turbines Incorporated from 1990 to 1993, and managing director of P.T. Natra Raya, Caterpillar’s Indonesian joint venture, from 1987 to 1990.

Various managerial positions in the Accounting and Product Source Planning Departments from 1980 to 1987 and chief economist of Caterpillar Overseas S.A. in Geneva, Switzerland, from 1975 to 1980. Joined Caterpillar in 1972 as a corporate economist.

Served on the President’s Economic Recovery Advisory Board from 2009 to 2011.

Qualifications, Attributes and Skills: Mr. Owens’ various leadership positions, including as CEO of a major global corporation, bring to the Board extensive management experience and economics expertise and strengthen the Board’s global perspective.

Other Current Public Company Directorships:
Alcoa and International Business Machines Corporation

Senior Advisor of BTMU since June 2010.

Chairman of MUFG from October 2005 to June 2010 and as Deputy Chairman of BTMU from January 2006 to March 2008. Before the merger of the former Mitsubishi Tokyo Financial Group and UFJ Holdings, President and CEO of UFJ Holdings, Inc. and Chairman of UFJ Bank, Ltd.

Began his professional career at The Sanwa Bank, one of the legacy banks of BTMU, in 1970.

Qualifications, Attributes and Skills: As a senior officer advisor to BTMU and as former Chairman of MUFG, Mr. Tamakoshi brings to the Board over 40 years of banking experience and international, risk management and strategic expertise.

18     Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE


LOGO

  

Perry M. Traquina
Mary L. Schapiro, 63

Independent Director

Rayford Wilkins, Jr.
Independent Director

Age: 59     Director Since:2015 2018

Morgan Stanley Committees:

Age: 64     Director Since: 2013  Operations and Technology

  

LOGO

Perry M. Traquina, 62

Independent Director

Director Since: 2015

Morgan Stanley Committees:

Morgan Stanley Committees:  Audit

  Risk (Chair)

Audit 
Nominating

Qualifications, Attributes and Governance

Operations and Technology
Skills:

  

Professional Experience:

Professional Experience:

Chairman, CEO and Managing Partner of Wellington Management Company LLP (Wellington), a global, multi-asset investment management firm, serving from 2004 through June 2014 as CEO and Managing Partner and from 2004 through December 2014 as Chairman.

Partner, Senior Vice President and Director of Global Research at Wellington from 1998 to 2002 and President from 2002 to 2004.

Joined Wellington in 1980 and served in a number of executive roles before being named Chairman, CEO and Managing Partner.

Qualifications, Attributes and Skills:

Ms. Schapiro’s leadership experience, including at the SEC, FINRA and the CFTC, brings to the Board extensive legal and regulatory compliance, finance, risk management, and public policy and government affairs experience as well as markets and financial services perspective.

Mr. Traquina brings to the Board extensive senior executive, regulatory and risk management experience, as well as investor perspective and market knowledge from his over 30 years at the global investment management firm Wellington.

Other Current Public Company Directorships:
eBay Inc.

Professional Experience:

Vice Chair for Global Public Policy and Special Advisor to the Founder and Chairman of Bloomberg L.P. since October 2018.

Vice Chair of the Advisory Board of Promontory Financial Group LLC (Promontory), a leading strategy, risk management and regulatory compliance firm, from January 2014 to October 2018.

Managing director of Promontory from March 2013 to January 2014.

Chair of the Securities and Exchange Commission (SEC) from January 2009 to December 2012.

Chair and CEO of the Financial Industry Regulatory Authority (FINRA) from 2006 to 2008, and served in numerous other key executive positions at FINRA and its predecessor from 1996 to 2006, including Vice Chair and President of NASD Regulation.

Chair of the Commodity Futures Trading Commission (CFTC) from 1994 to 1996.

Other U.S. Listed Public Company Boards:

CVS Health Corporation

Other U.S. Listed Public Company Boards in the Past Five Years:

General Electric Company

Professional Experience:

Chairman, CEO and Managing Partner of Wellington Management Company LLP (Wellington), a global, multi-asset investment management firm, serving from 2004 through June 2014 as CEO and Managing Partner and from 2004 through December 2014 as Chairman.

Partner, Senior Vice President and Director of Global Research at Wellington from 1998 to 2002 and President from 2002 to 2004.

Joined Wellington in 1980 and served in a number of executive roles before being named Chairman, CEO and Managing Partner.

Other U.S. Listed Public Company Boards:

The Allstate Corporation and eBay Inc.

Morgan Stanley 2019 Proxy Statement    19


CORPORATE GOVERNANCE MATTERS

LOGO

Rayford Wilkins, Jr., 67

Independent Director

Director Since:CEO of Diversified Businesses of AT&T Inc. (AT&T), the telecommunications company, responsible for international investments, AT&T Interactive, AT&T Advertising Solutions 2013

Morgan Stanley Committees:

  CMDS

  Nominating and Customer Information Services from October 2008 to March 2012.Governance (Chair)

During his career, he served in numerous other management roles at AT&T, including as Group President, Group President of SBC Marketing and Sales, and President and CEO of Pacific Bell Telephone Company and Nevada Bell Telephone Company.

Began his career at Southwestern Bell Telephone in 1974.

Qualifications, Attributes and Skills:

Mr. Wilkins brings to the Board extensive management, technology and operational experience, as well as international perspective, through the various management positions he held at AT&T.

Other Current Public Company Directorships:
Valero Energy Corporation

Other Public Company Directorships

Professional Experience:

CEO of Diversified Businesses of AT&T Inc. (AT&T), the telecommunications company, responsible for international investments, AT&T Interactive, AT&T Advertising Solutions and Customer Information Services from October 2008 to March 2012.

During his career, he served in numerous other management roles at AT&T, including as Group President and CEO of SBC Enterprise Business Services, Group President of SBC Marketing and Sales, and President and CEO of Pacific Bell Telephone Company and Nevada Bell Telephone Company.

Began his career at Southwestern Bell Telephone in 1974.

Other U.S. Listed Public Company Boards:

Caterpillar Inc. and Valero Energy Corporation

Other U.S. Listed Public Company Boards in the Past Five Years:
América Móvil, S.A.B. de C.V.

 

Our Board unanimously recommends that you vote“FOR” the election of all director nominees. Proxies solicited by the Board will be voted“FOR” each nominee unless otherwise instructed.

20    Morgan Stanley 20162019 Proxy Statement19



Table of Contents

CORPORATE GOVERNANCE MATTERS


CORPORATE GOVERNANCE HIGHLIGHTSPRACTICES

Morgan Stanley is committed tobest-in-class governance practices, which are embodied in our Corporate Governance Policies available atwww.morganstanley.com/about/company/governance.about-us-governance. The Board initially adopted the Corporate Governance Policies in 1995 and reviews and approves them annually to ensure they reflect evolving best practices and regulatory requirements, including the New York Stock Exchange (NYSE) corporate governance listing standards and best practices at Morgan Stanley.standards. The governance practices highlighted below are reflected in the Corporate Governance Policies, our bylaws and our committee charters, as applicable.

Board Structure and Independence

Our Board represents a tapestry of complementary skills, attributes and perspectives and includes individuals with financial services experience and a diverse international background.

Directors may not stand for election if they will be 72 years old at the time of election.

Our Board conducts an ongoing review of Board composition and succession planning, resulting in substantial refreshment of the Board and a diversity of skills, attributes and perspectives on the Board.

Upon election at the annual meeting, the average tenure of the members of the Board will be approximately 4.7 years.

Our Board has a majority of independent directors. Our Chairman is the only member of management who serves as a director.

Our Independent Lead Director is selected from and by the independent directors and has expansive duties set forth in our Corporate Governance Policies. The Independent Lead Director chairs regularly scheduled executive sessions without the Chairman present. See “Board Leadership Structure and Role in Risk Oversight.”

Rotation of Board Leadership and Committee Appointments

The Independent Lead Director and committee chairs serve for approximately three to five years to provide for rotation of Board leadership and committee chairs while maintaining experienced leadership. In accordance with the Board’s rotation policy, the Board appointed Mr. Glocer as Independent Lead Director, effective September 1, 2017.

In accordance with the Board’s policy regarding the periodic rotation of committee appointments, the Board has approved the following committee appointments since the beginning of 2018:

Mr. Wilkins was appointed a member of CMDS Committee and concluded service on the Operations and Technology Committee.

Ms. Corley was appointed a member of the Nominating and Governance Committee.

Ms. Schapiro was appointed a member of the Operations and Technology Committee.

Mr. Ogasawara will be appointed a member of the Operations and Technology Committee upon his election at the annual meeting.

Board Oversight

Strategy and Annual Business Plans

The Board oversees the Company’s strategy and annual business plans. The Board:

Conducts an annual strategy offsite with the CEO, Operating Committee and senior management to review the Company’s long-term strategy.

Receives regular reporting regarding strategy at Board meetings as well as by the CEO and Operating Committee outside of regularly scheduled meetings.

Reviews the Company’s annual strategic presentation to shareholders, which summarizes the Company’s progress on the prior year’s strategic plan, provides an overview of long-term strategic priorities and includes specific financial andnon-financial goals. The Company’s 2019 strategic presentation is available atwww.morganstanley.com/about-us-ir.

Culture, Values and Conduct and Risk Management

The Board also oversees the Company’s practices and procedures relating to culture, values and conduct. The Board oversees the Company’s global ERM framework and is responsible for helping to ensure that the Company’s risks are

Morgan Stanley 2019 Proxy Statement    21


CORPORATE GOVERNANCE MATTERS

managed in a sound manner. The Board regularly reviews the Company’s risks and the responsibilities of management and the Board committees to assist the Board in its risk oversight. The Board has a separate committee responsible for operations and technology, including cybersecurity risk, and the Board receives briefings on cybersecurity.

See “Board Leadership Structure and Role in Risk Oversight” and “Board Oversight of Cybersecurity Risk.”

Access to the Company’s Regulators, Employees and Independent Advisors

Independent directors, including the Chairs of the Audit Committee and Risk Committee, meet with our primary regulator, the Federal Reserve, and other global regulators as requested. Directors also have complete and open access to senior members of management and other employees of the Company. For instance:

Board members meet with local management and independent control functions throughout the world and have visited several of our global offices.

The Independent Lead Director and committee chairs meet with management between regularly scheduled meetings for discussion of key items and to develop Board and committee agendas and provide feedback regarding information reported to the Board and on other topics to be reviewed.

The Company’s Chief Financial Officer (CFO), Chief Legal Officer (CLO) and Chief Risk Officer (CRO), as well as the heads of the Company’s operating units and other officers, regularly attend Board meetings and maintain an ongoing dialogue with Board members between Board meetings.

The CMDS Committee, in conjunction with the entire Board, annually reviews succession plans for the CEO and senior executives.

The Board, the Independent Lead Director and each committee have the right at any time to retain independent financial, legal or other advisors at the Company’s expense.

Alignment with Shareholder Interests

The director equity ownership requirement helps to align director and shareholder interests. Directors also may not enter into hedging transactions in respect of Morgan Stanley common stock or pledge Morgan Stanley common stock in connection with a margin or other loan transaction. See “Director Equity Ownership Requirement.”

Director Orientation and Continuing Education

Director education about Morgan Stanley, our strategy, control framework, regulatory environment and our industry begins when a director is elected to our Board and continues throughout his or her tenure on the Board. The Nominating and Governance Committee oversees an orientation program for new directors, which includes an overview of director duties and our Corporate Governance Policies, presentations by senior management, including the President, the CFO, CLO and CRO, on the Company’s strategy and regulatory framework, its primary business lines and control framework, and aone-on-one session with the Chairman and CEO. As directors are appointed to new committees or assume a leadership role, such as committee chair, they receive additional orientation sessions specific to such responsibilities. We also conduct educational briefings on business, governance, regulatory and control matters, and reimburse directors for reasonable costs incurred attending educational sessions on subjects that would assist them in discharging their duties.

Senior Management Succession and Development Planning

The CMDS Committee oversees CEO and senior management succession and development planning, which covers unexpected as well as planned events and is formally reviewed, in conjunction with the entire Board, at least annually.

Our CEO and our Chief Human Resources Officer review recommendations and evaluations of potential internal CEO and senior management successors, and review their qualifications, skills, accomplishments and developmental areas.

Potential internal CEO and senior management successors regularly attend Board meetings and engage with Board members periodically between Board meetings, including during preparatory meetings, client-related events and visits to our offices around the world. These interactions provide the Board with the knowledge of the Company’s executive talent that is critical to the Company’s succession planning.

22    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Annual Evaluation of Board, Committees and Independent Lead Director

Overview of Evaluation Process

The Board believes that establishing and maintaining a constructive evaluation process is essential to maintaining Board effectiveness and best corporate governance practices. Accordingly, the Nominating and Governance Committee reviews and approves the evaluation process annually so that the evaluation process continues to be effective in identifying areas to enhance the performance and effectiveness of the Board, the Independent Lead Director and the Board committees.

Multi-Step Evaluation Process

LOGO

1 Based upon N&G Committee's recommendation, Board approves annual evaluation process Candid One-On-One Discussions Held Between 2 Independent Lead Director and each Board member to assess Board performance and, as necessary, individual director performance N&G Committee Chair and each Board member to assess Independent Lead Director performance Committee Chairs and each Committee member to assess Committee performance Executive Sessions 3 Board and Committee Closed Door Executive Sessions Communicate and Implement Feedback 4 Results Reported to full Board 5 Board and committee policies and practices are revised as appropriate and results of assessment are considered in establishing future Board and committee agendas

Morgan Stanley 2019 Proxy Statement    23


CORPORATE GOVERNANCE MATTERS

This process is aided by written discussion guides used to facilitate the assessments. These guidelines are updated annually to reflect significant new developments and areas of focus as the Nominating and Governance Committee determines appropriate and encompass many factors, including:

Duties and Responsibilities

Board Structure and IndependenceComposition,
including Board Succession
Planning


Our Board represents a tapestry

Culture

Process

Information and Resources

Execution

Key Strengths/Areas for

Improvement

Areas of complementary skills, attributes and perspectives and includes individuals with financial services experience and a diverse international background.
Focus

Directors may not stand for election if they would be 72 years old at the time of election.

Ongoing review of Board composition and succession planning, resulting in eight new directors since 2012 who bring new skills and perspective to the Board. Upon election at the annual meeting, the average tenure of the members of the Board will be approximately 4.6 years.

Our Board has a majority of independent directors. Our Chairman is the only member of management who serves as a director.

Our Independent Lead Director is elected annually from and by the independent directors and has expansive duties set forth in our Corporate Governance Policies. The Independent Lead Director chairs regularly scheduled executive sessions without the Chairman present. See “Board Leadership Structure and Role in Risk Oversight.”

The Independent Lead Director and committee chairs serve for approximately 3-5 years to provide for rotation of Board leadership and committee chairs while maintaining experienced leadership.

Since 2015, the Board approved the following committee appointments in accordance with the Board’s policy regarding periodic rotation of committee assignments:
 

Ms. Olayan and Mr. Nicolaisen were appointed Chair of the CMDS

Addressing Feedback

Upon conclusion of such self-assessments, Board and committee policies and practices are revised as appropriate. The Board self-assessment process has led to enhanced Board materials, “deep dives” on certain of the Company’s businesses and control areas, enhanced coordination among Board committees, and focus on particular skills and attributes of Board candidates.

Shareholder Rights and Accountability

Our Corporate Governance Policies are consistent with the Investor Stewardship Group Corporate Governance Principles for U.S. listed companies.

All directors are elected annually; in uncontested director elections, directors are elected by a majority of votes cast.

Proxy access permits up to 20 shareholders owning 3% or more of our stock continuously for at least three years to nominate the greater of two directors or up to 20% of our Board and include those nominees in our proxy materials.

Our Board has an Independent Lead Director with expansive duties. See “Board Leadership Structure and Role in Risk Oversight — Independent Lead Director.”

Shareholders who own at least 25% of common stock have the ability to call a special meeting of shareholders.

There are no supermajority vote requirements in our charter or bylaws.

We do not have a “poison pill” in effect.

Shareholders and other interested parties may contact any of our Company’s directors.

Shareholders may submit recommendations for director candidates for consideration by the Nominating and Governance Committee at any time by sending the information set forth under “Director Candidates Recommended by Shareholders” in the Corporate Governance Policies to the Nominating and Governance Committee,and Risk Committee, respectively;

Mr. Traquina was appointed to theAudit Committee;

Messrs. Kleinfeld and Owens were appointed to theCMDS Committee;

Messrs. Bowles and Herz were appointed to theNominating and Governance Committee;and

Messrs. Hirano and Darling and Ms. Miscik were appointed to theRisk Committee.


Board Oversight

The Board oversees the Company’s strategy and annual business plans.

Conducts an annual strategy offsite with the CEO, Operating Committee and senior management to review the Company’s long-term strategy.

Receives regular reporting regarding strategy at Board meetings as well as by the CEO and Operating Committee outside of regularly scheduled meetings.

Reviews the Company’s annual strategic presentation to shareholders, which summarizes the Company’s progress on the prior year’s strategic plan, provides an overview of long-term strategic priorities and includes specific financial and non-financial goals. The Company’s 2016 strategic presentation is available at http://www.morganstanley.com/about-us-ir.

The Board oversees the Company’s practices and procedures relating to culture, values and conduct.

The Board oversees the Company’s global enterprise risk management (ERM) framework and is responsible for helping to ensure that the Company’s risks are managed in a sound manner. The Board regularly reviews the Company’s risks and the responsibilities of management and the Board committees to assist the Board in its risk oversight. See “Board Leadership Structure and Role in Risk Oversight.”

The Board has a separate committee responsible for Operations and Technology, including cybersecurity risk, and the Board receives annual briefings on cybersecurity, including an assessment from an external party.

20 Morgan Stanley, 2016 Proxy StatementSuite D, 1585 Broadway, New York, New York 10036. Under the policy, the Nominating and Governance Committee evaluates director candidates recommended by shareholders in the same manner as other director candidates. In order for director candidate recommendations to be considered for the 2020 annual meeting of shareholders, recommendations must be submitted in accordance with the policy by December 7, 2019.

Shareholder Engagement



Table

Our Board and management value the views of Contents

CORPORATE GOVERNANCE


Non-employee directors meet regularly with our primary regulator, the Federal Reserve, and other global regulators as requested.

Directors have complete and open access to senior members of management and other employees of the Company.

Board members meet with local management and independent control functions throughout the world and havevisited several of our global offices.

The Independent Lead Director and committee chairs meet with management between regularly scheduled meetingsfor discussion of key items and to develop Board and committee agendas and provide feedback regarding information reported to the Board and on other topics to be reviewed.

The Company’s Chief Risk Officer (CRO), Chief Financial Officer (CFO)and Chief Legal Officer, as well as the heads ofthe Company’s operating units and other officers, regularly attend Board meetings and maintain an ongoing dialogue with Board members between Board meetings, which is critical to the Company’s succession planning.

The CMDSCommittee annually reviews succession plans for the CEO and senior executives.

The director equity ownership requirement helps to align director and shareholder interests. Directors also may not enter into hedging transactions in respect of Morgan Stanley common stock or pledge Morgan Stanley common stock in connection with a margin or other loan transaction.

The Board, the Independent Lead Director and each committee have the right at any time to retain independent financial, legal or other advisors at the Company’s expense.


Shareholder Rights and Accountability

In 2015, the Board adopted proxy access, permitting up to 20 shareholders owning 3% or more of our stock continuously for at least three years to nominate the greater of two directors or up to 20% of our Board and include those nominees in our proxy materials.

All directors are elected annually.

In uncontested director elections, directors are elected by a majority of votes cast.

Shareholders who own at least 25% of common stock have the ability to call a special meeting of shareholders.

There are no supermajority vote requirements in our charter or bylaws.

We do not have a “poison pill” in effect.

Shareholders and other interested parties may contact any of our Company’s directors.

Shareholders may submit recommendations for director candidates for consideration by the Nominating and Governance Committee at any time by sending the information set forth in the Policy Regarding Director Candidates Recommended by Shareholders to the Nominating and Governance Committee, Morgan Stanley, Suite D, 1585 Broadway, New York, New York 10036. Under the policy, the Nominating and Governance Committee evaluates director candidates recommended by shareholders in the same manner as other director candidates. In order for director candidate recommendations to be considered for the 2017 annual meeting of shareholders, recommendations must be submitted in accordance with the policy by December 2, 2016.


Annual Evaluation of Board, Committees and Independent Lead Director

The Board conducts an annual evaluation of the performance and effectiveness of the Board, the Independent Lead Director and each of its standing committees.

The annual evaluation includes self-evaluations by each of these committees and the Board and an evaluation of the performance of the Independent Lead Director by the other independent directors led by the chair of the Nominating and Governance Committee.

This process may include one-on-one Board member interviews led by the Independent Lead Director or committee chair, as appropriate, written guidelines or such other means as the Nominating and Governance Committee determines appropriate, and may encompass such factors as duties and responsibilities, individual director performance, Board and committee membership and structure, culture, process and execution.


Morgan Stanley 2016 Proxy Statement21



Tableour shareholders and engage with them year-round on a broad range of Contents

CORPORATE GOVERNANCE


The Nominating and Governance Committee ensures that the results of such evaluations, including any suggestions to enhance the performance and effectiveness of the Independent Lead Director, the Board and its committees, are communicated to and discussed with the entire Board in executive session, the Independent Lead Director and each committee, as appropriate. Following such evaluation, Board policies and practices are revised as appropriate.


Corporate Political Activities Policy Statement

Overtopics, including our strategy, financial performance, executive compensation, corporate governance and environmental and social goals. Our Board receives reporting on feedback received from investors and shareholder voting results. In addition, management routinely engages with investors at conferences and other forums. We also speak with proxy advisors to discuss, and receive feedback on, our governance practices and executive compensation programs. Feedback from investors informs the last severalBoard’s ongoing review of governance and compensation matters. In recent years, the Board has taken action responsive to such shareholder feedback, including the adoption of amendments to our bylaws to implement proxy access and enhanced its proxy disclosure of Board evaluations, director orientation and education, succession planning, ESG matters and alignment of compensation and performance.

24    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Corporate Political Activities Policy Statement

Our Corporate Political Activities Policy Statement aims to ensure transparency of the Company’s practices and procedures regarding political activities and oversight by senior management and the Board. Our Corporate Political Activities Policy Statement:

Prohibits Morgan Stanley from making U.S. political contributions.

Provides that Morgan Stanley informs its principal U.S. trade associations not to use payments made by Morgan Stanley for election-related activity at the federal, state or local levels.

Provides that principal U.S. trade association memberships and expenditures relating to such memberships are reviewed annually with the Government Relations Department and the Nominating and Governance Committee.

Provides a link to examples of principal U.S. trade associations that the Company belongs to on the Company’s website.

Addresses oversight of lobbying activities, as well as expenditures related thereto, by the Vice Chairman of the Company who reports to the Chairman and CEO, and oversight of significant lobbying priorities and expenditures by the Nominating and Governance Committee.

Confirms that Morgan Stanley discloses publicly all U.S. federal lobbying costs as required by law, including dues attributable to lobbying by U.S. trade associations.

Provides that the Nominating and Governance Committee oversees the Corporate Political Activities Policy Statement and the activities addressed by it.

Morgan Stanley 2019 Proxy Statement    25


CORPORATE GOVERNANCE MATTERS

Sustainability at Morgan Stanley

Morgan Stanley endeavors to advance sustainability by considering ESG matters throughout our operations and businesses. We offer financial solutions and advisory services that provide positive long-term benefits for clients and shareholders, as well as for the environment and global communities. The Morgan Stanley Institute for Sustainable Investing’s (Institute) advisory board helps to ensure that our sustainability strategy is comprehensive, rigorous and innovative. ESG initiatives are overseen by the Nominating and Governance Committee and reported to the Board. Key areas of focus and highlights for 2018 include:

Prohibits

Sustainable Finance and Investing

Morgan Stanley is committed to harnessing the power of capital markets to create sustainable, long-term value for clients and stakeholders.

 We announced a public commitment to mobilize $250 billion to supportlow-carbon solutions by 2030, and deployed nearly $30 billion in the first year.

 Morgan Stanley Wealth ManagementInvesting with Impact assets reached approximately $25 billion, more than double our five-year goal of raising $10 billion from making U.S. political contributions.
2013 to 2018.

 Morgan Stanley Sustainability Research published thematic client-facing research reports on plastic, data privacy and governance.

 Morgan Stanley Investment Management, a signatory to the UN’s Principles for Responsible Investment, through its corporate governance team engaged with over 100 companies on ESG issues ranging from climate change to the opioid epidemic.

Institute for Sustainable Investing

Established in 2013, the Institute focuses on accelerating the adoption of sustainable investing strategies. Chaired by Morgan Stanley’s Chairman and CEO, an Advisory Board of prominent leaders from business, academia and leadingnon-governmental organizations guide the Institute’s work and strategic priorities.

 We expanded the Morgan Stanley Sustainable Investing Fellowship to our London office, with the goal of developing the next generation of sustainable investing professionals.

 The Institute also continued to publish content for investors focused on the integration of ESG into investment decisions, including a paper entitledWeathering the Storm: Integrating Climate Resilience into Real Assets Investing,which provides investors with a framework for understanding climate risk in the investment life cycle.

Environmental and Social Risk Management

Environmental and social risk management is a priority for Morgan Stanley. The Company’s due diligence and risk management processes are designed to identify, analyze and address potentially significant environmental and social issues that may confront us or our clients. Our processes include monitoring for emerging environmental and social risks and related trends, as well as engaging with clients and other stakeholders as appropriate.

 We met with leaders of indigenous tribes to discuss issues impacting their communities.

 We also participated in a roundtable with environmental non-governmental organizations to discuss how financial institutions are addressing climate change.

Corporate Sustainability

Morgan Stanley is committed to responsible corporate citizenship, and views strong sustainability performance as a means to reduce risk and enhance value for key stakeholders.

 We announced a five-year carbon neutrality goal, committing to source 100% of our global energy needs from renewable energy by 2022, and in 2018 created a Corporate Services Global Sustainability Council to execute on our operational sustainability strategy, which focuses on resource efficiency, renewable energy and identifying innovative ways to shrink the environmental impacts of our operations globally.

 We also developed a Supplier Code of Conduct which outlines Morgan Stanley’s expectations and requirements for vendors on sustainability and human rights issues.

26    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Giving Back to the Community

Morgan Stanley is committed to giving back to the communities where we live and work through long-lasting partnerships, community-based delivery and engaging our best asset – our employees. The impact of our philanthropic initiatives includes:

Volunteering

Giving

Community Development

 

Provides that

 Employees logged over 488,000 volunteer hours for charities around the world in 2018.

 During the 2018 Global Volunteer Month in June, including the collective efforts from Feeding Kids Around the Clock, over 48,000 employees logged over 262,000 volunteer hours in 36 countries.

 Since inception in 2009, the Morgan Stanley informs its principal U.S. trade associations not to use payments made byStrategy Challenge has provided 128 nonprofit organizations with more than 95,000 hours of pro bono services valued at over $14.6 million.

 In 2018, employees, together with the Company, the Morgan Stanley Foundation and the Morgan Stanley International Foundation, donated over $106 million.

 The Morgan Stanley Foundation granted over $5.2 million in 2018 to charities within the children’s health space focused on the fundamentals for election-related activity atchildren’s health including: wellness, nutrition and play.

 Since 2010, we have committed $18.02 billion in community development loans and investments, funding more than 99,000 affordable housing units and helping to create or retain more than 103,000 jobs.

 Since 2010, we have made 211 small-business loans and investments totaling $261.7 million across the federal, state or local levels.
U.S., including $56.6 million in 2018.

 

Communication by Shareholders and Other Interested Parties with the Board of Directors

As set forth under “Communications with the Board” in the Corporate Governance Policies, shareholders and other interested parties may contact the Board, thenon-management or independent directors, an individual director (including the Independent Lead Director or Chairman) or a committee of the Board, by writing to them at Morgan Stanley, Suite D, 1585 Broadway, New York, New York 10036. Such communications will be handled in accordance with the procedures approved by the Company’s independent directors.

Additional Corporate Governance Information Available on Corporate Governance Webpage

Provides that principal U.S. trade association memberships and expenditures relating to such memberships are reviewed annually with the Government Relations Department and the Nominating and Governance Committee.
 

Provides a link to examples of principal U.S. trade associations that the Company belongs to on the Company’s website.

Addresses oversight of lobbying activitiesby a member of the Operating Committee of the Company who reports to the Chairman and CEO, and significant lobbying priorities by the Nominating and Governance Committee.

Provides that the Nominating and Governance Committee oversees the Corporate Political Activities Policy Statement and the activities addressed by it.


Communication by Shareholders and Other Interested Parties with the Board of Directors

Shareholders and other interested parties may contact any of our Company’s directors (including the Independent Lead Director or non-management directors) by writing to them at Morgan Stanley, Suite D, 1585 Broadway, New York, New York 10036.

Such communications will be handled in accordance with the procedures approved by the Company’s independent directors.


Additional Corporate Governance Information Available on Corporate Governance Webpage

In addition to the Corporate Governance Policies and other policies described above, our corporate governance webpage includes the following:

Bylaws and Certificate of  Incorporation

  Corporate Political Activities Policy Statement

Code of Ethics and Business  Conduct

  Operating Committee Equity  Ownership Commitment

Policy Regarding Shareholder  Rights Plan

Operating Committee Equity Ownership Commitment

Charters for Board Committees

  Environmental and Social Policies

Information Regarding the Integrity Hotline



Hard copies of the materials described above are available without charge to any shareholder who requests them by writing to Morgan Stanley, Suite D, 1585 Broadway, New York, New York 10036.

22

Morgan Stanley 20162019 Proxy Statement    27



Table of Contents

CORPORATE GOVERNANCE MATTERS


Director Independence

Director Independence


The Board has adopted Director Independence Standards, which are more stringent than the independence requirements outlined in the NYSE rules in certain respects, and delineate relationships that are deemed to impair independence and categories of relationships that are not deemed material for purposes of director independence (Director Independence Standards). The Director Independence Standards, which are part of our Corporate Governance Policies available atwww.morganstanley.com/about/company/governance,about-us-governance, provide that, for a director to be considered independent, a director must meet the following categorical standards:

1. Employment and commercial relationships affecting independence

A. Current

Relationships

 

A director will not be independent if:

(i) the director is a current partner or current employee of Morgan Stanley’s internal or external auditor;

(ii) an immediate family member of the director is a current partner of Morgan Stanley’s internal or external auditor;

(iii) an immediate family member of the director (a) is a current employee of Morgan Stanley’s internal or external auditor and (b) personally works on Morgan Stanley’s audit;
(iv) the director is a current employee, or an immediate family member of the director is a current executive officer, of an entity that has made payments to, or received payments from, Morgan Stanley for property or services in an amount which, in any of the last three fiscal years, exceeds the greater of $1 million or 2% of such other company’s consolidated gross revenues; or

(v) the director’s spouse, parent, sibling or child is currently employed by Morgan Stanley.

B. Relationships

within
Preceding

Three Years

A director will not be independent if, within the preceding three years:

(i) the director is or was an employee of Morgan Stanley;

(ii) an immediate family member of the director is or was an executive officer of Morgan Stanley;

(iii) the director or an immediate family member of the director (a) was a partner or employee of Morgan Stanley’s internal or external auditor and (b) personally worked on Morgan Stanley’s audit within that time;

(iv) the director or an immediate family member of the director received more than $120,000 in direct compensation in any12-month period from Morgan Stanley, other than (a) director and committee fees and pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service) and (b) compensation paid to an immediate family member of the director who is an employee (other than an executive officer) of Morgan Stanley; or

(v) a present Morgan Stanley executive officer is or was on the compensation committee of the board of directors of a company that concurrently employed the Morgan Stanley director or an immediate family member of the director as an executive officer.


28    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

2. Relationships not deemed material for purposes of director independence

In addition to the provisions above, each of which must be fully satisfied with respect to each independent director, the Board must affirmatively determine that the director has no material relationship with Morgan Stanley. To assist the Board in this determination, it has adopted the following categorical standards of relationships that are not considered material for purposes of determining a director’s independence. Any determination of independence for a director that does not meet these categorical standards will be based upon all relevant facts and circumstances and the Board shall disclose the basis for such determination in the Company’s proxy statement.

A. Equity Ownership

 

A relationship arising solely from a director’s ownership of an equity or limited partnership interest in a party that engages in a transaction with Morgan Stanley, so long as such director’s ownership interest does not exceed 5% of the total equity or partnership interests in that other party.

B. Other Directorships

 

A relationship arising solely from a director’s position as

(i) director or advisory director (or similar position) of another company orfor-profit corporation or organization or

(ii) director or trustee (or similar position) of atax-exempt organization.


Morgan Stanley 2016 Proxy Statement23



Table of Contents

CORPORATE GOVERNANCE


C. Ordinary Course

Business

 

A relationship arising solely from transactions, including financial services transactions such as underwriting, banking, lending or trading in securities, commodities or derivatives, or from other transactions for products or services, between Morgan Stanley and a company of which a director is an executive officer, employee or owner of 5% or more of the equity of that company, if such transactions are made in the ordinary course of business and on terms and conditions and under circumstances (including, if applicable, credit or underwriting standards) that are substantially similar to those prevailing at the time for comparable transactions, products or services for or with unaffiliated third parties.

D. Contributions

A relationship arising solely from a director’s status as an executive officer of atax-exempt organization, and the contributions by Morgan Stanley (directly or through the Morgan Stanley Foundation or any similar organization established by Morgan Stanley) to the organization are less than the greater of $1,000,000 or 2% of the organization’s consolidated gross revenues during the organization’s preceding fiscal year (matching of employee charitable contributions is not included in Morgan Stanley’s contributions for this purpose).

E. Products and

Services

A relationship arising solely from a director utilizing products or services of Morgan Stanley in the ordinary course of business and on substantially the same terms as those prevailing at the time for comparable products or services provided to unaffiliated third parties.

F. Professional,

Social and Religious

Organizations

and Educational

Institutions

A relationship arising solely from a director’s membership in the same professional, social, fraternal or religious association or organization, or attendance at the same educational institution, as an executive officer or director.

G. Family Members

Any relationship or transaction between an immediate family member of a director and Morgan Stanley shall not be deemed a material relationship or transaction that would cause the director not to be independent if the standards in this Section 2 would permit the relationship or transaction to occur between the director and Morgan Stanley.


The Board has determined that 11ten of our 1413 director nominees (Messrs. Bowles,(Ms. Corley, Messrs. Darling, Glocer Herz and Kleinfeld,Herz, Ms. Miscik, Mr. Nicolaisen, Ms.Nally, Mss. Olayan and Schapiro, and Messrs. Owens, Traquina and Wilkins) are independent in accordance with the Director Independence Standards. The Board has also determined that Messrs. Davies and Kidder,Erskine Bowles, who retired from the Board during 2015,effective February 1, 2018 and James Owens, who retired from the Board effective May 24, 2018, were independent during the time they served on the Board in 2015 and Dr. Tyson, who is not standing for reelection at the annual meeting of shareholders, is independent. Mr. Gorman, our Chairman and CEO, and Messrs. Hirano and Tamakoshi, who were designated pursuant to the Investor Agreement with MUFG, have not been determined independent. Mr. Tanaka, who also retired from the Board during 2015, was designated pursuant to the Investor Agreement with MUFG and was not determined independent during the time he served on the Board in 2015.2018.

To assess independence, the Board was provided with information about relationships between the independent directors (and their immediate family members and affiliated entities) and Morgan Stanley and its affiliates, including information about the director’sdirectors’ professional experience and affiliations. In making its determination as to the

Morgan Stanley 2019 Proxy Statement    29


CORPORATE GOVERNANCE MATTERS

independent directors, the Board reviewed the categories of relationships between Morgan Stanley and the directors described above and the following specific relationships under those Director Independence Standards:

Commercial relationships (such as financial services offered by the Company to clients in the ordinary course of the Company’s business) in the last three years between Morgan Stanley and entities where the directors are employees or executive officers, or their immediate family members are executive officers (Messrs. Davies and Kleinfeld, Ms. Olayan and Dr. Tyson). In each case the fees the Company received were in compliance with the Director Independence Standards and the NYSE rules, and did not exceed the greater of $1 million or 2% of such other entity’s consolidated gross revenues in any of the last three years and were considered immaterial.

Director’s utilization of Morgan Stanley products and services offered by the Company as a client of the Company (such as Wealth Management brokerage accounts and investments in funds sponsored by the Company) in the ordinary course of the Company’s business on terms and conditions substantially similar to those provided to unaffiliated third parties (Messrs. Glocer, Herz and Kidder, Mss. Miscik and Olayan, Messrs. Owens and Traquina, Dr. Tyson and Mr. Wilkins). In each case the provision of such products and services was in compliance with the Director Independence Standards and the NYSE rules and was considered immaterial.


24Morgan Stanley 2016 Proxy Statementand entities where the directors are employees or executive officers, or their immediate family members are executive officers (Mr. Bowles and Mss. Corley, Olayan and Schapiro). In each case the fees the Company received were in compliance with the Director Independence Standards and the NYSE rules, and did not exceed the greater of $1 million or 2% of such other entity’s consolidated gross revenues in any of the last three years and were considered immaterial to director independence.

Director’s utilization of Morgan Stanley products and services offered by the Company as a client of the Company (such as Wealth Management brokerage accounts and investments in funds sponsored by the Company) in the ordinary course of the Company’s business on terms and conditions substantially similar to those provided to unaffiliated third parties (Messrs. Glocer and Herz, Ms. Miscik, Mr. Nally, Ms. Olayan and Messrs. Owens, Traquina and Wilkins). In each case the provision of such products and services was in compliance with the Director Independence Standards and the NYSE rules and was considered immaterial to director independence.

Director Attendance at Annual Meeting



Table of Contents

CORPORATE GOVERNANCE


Director Attendance at Annual Meeting

The Corporate Governance Policies state that directors are expected to attend annual meetings of shareholders. All 15 directors who were on the Board at the time, andincluding all current directors who were nominees at the time, attended the 20152018 annual meeting of shareholders.

Board Meetings and Committees

Board Meetings and Committees


Board Meetings

Our Board met 16 times during 2015.2018. Each current director attended at least 75% of the total number of meetings of the Board and committees on which such director served that were held during 20152018 while the director was a member. In addition to Board and committee meetings, our directors also discharge their duties through, among other things, informalless formal group communications, including discussions, briefings and discussionseducational sessions, with the Independent Lead Director, Chairman of the Board and CEO, members of senior management and others as appropriate regarding matters of interest.

Committees

The Board’s standing committees, their membership and the number of meetings in 20152018 are set forth below. Charters for each of our standing committees are available at our corporate governance webpage atwww.morganstanley.com/about/company/governance.about-us-governance.

All members of the Audit Committee, the CMDS Committee and the Nominating and Governance Committee satisfy the standards of independence applicable to members of such committees, including NYSE listing standards.

Each member of the CMDS Committee is a“non-employee director” as defined in Section 16 of the Securities Exchange Act of 1934.

The Board has determined that all members of the Audit Committee are independent and “financially literate” within the meaning of the NYSE listing standards and a majority of the members of the Audit Committee, including the Chair, Robert H. Herz, are “audit committee financial experts” within the meaning of the SEC rules.

All members of the Risk Committee and the Operations and Technology Committee arenon-employee directors and a majority of the members of such committees satisfy the independence requirements of the Company and the NYSE, and the Risk Committee membership satisfies other applicable legal and regulatory criteria.

30    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

All members of the Audit Committee, the CMDS Committee and the Nominating and Governance Committee satisfy the standards of independence applicable to members of such committees.

AUDIT COMMITTEE

 

Each member of the CMDS Committee is a “non-employee director” as defined in Section 16 of the Securities Exchange Act of 1934, an “outside director” as defined by Section 162(m) of the Internal Revenue Code and independent within the meaning of the NYSE listing standards.

The Board has determined that all members of the Audit Committee are independent and “financially literate” within the meaning of the NYSE listing standards and “audit committee financial experts” within the meaning of the SEC rules.

All members of the Risk Committee and Operations and Technology Committee are non-employee directors and a majority of the members of such committees satisfy the independence requirements of the Company and the NYSE, and the Risk Committee membership satisfies other applicable legal and regulatory criteria.


AUDIT(1)

Current Members

Robert H. Herz (Chair)
Thomas H. Glocer
Donald T. Nicolaisen

Alistair Darling

Dennis M. Nally

Perry M. Traquina

19Meetings Held in 20152018 15

 

Primary Responsibilities

●   

Oversees the integrity of the Company’s consolidated financial statements and system of internal controls.

Oversees risk management and risk assessment guidelines in coordination with the Board, Risk Committee and Operations and Technology Committee and reviewsRisk Committee.

  Reviews the major legal and compliance risk exposures of the Company.
Company and the steps management has taken to monitor and control such exposures.

Selects, determines the compensation of, evaluates and, when appropriate, replaces the independent auditor.

Oversees

  Reviews and assesses the qualifications, independence and performance of the independent auditor, andpre-approves audit and permittednon-audit services.

Oversees the performance of the head of the Company’s Head of Internal Audit Department (Global Audit Director), who reports functionally to the Audit Committee, and the internal audit function.

After review, recommends to the Board the acceptance and inclusion of the annual audited consolidated financial statements in the Company’s Annual Report onForm 10-K.

See also “Audit Matters.”


Morgan Stanley 2016 Proxy Statement25



Table of Contents

CORPORATE GOVERNANCE


COMPENSATION, MANAGEMENT DEVELOPMENT AND SUCCESSION(2)

COMPENSATION, MANAGEMENT DEVELOPMENT AND SUCCESSION (CMDS) COMMITTEE(1)

Current Members

Hutham S. Olayan (Chair)
Erskine B. Bowles
Klaus Kleinfeld
James W. Owens

Thomas H. Glocer

Dennis M. Nally

Rayford Wilkins, Jr.

8Meetings Held in 20152018 11

 

Primary Responsibilities

●   

Annually reviews and approves the corporate goals and objectives relevant to the compensation of the CEO and evaluates his performance in light of these goals and objectives.

Determines the compensation of executive officers and other officers and employees as appropriate.

Administers the Company’s equity-based compensation plans and cash-based nonqualified deferred compensation plans.

Oversees plans for management development and succession.

Reviews and discusses the Compensation Discussion and Analysis with management and recommends to the Board its inclusion in the proxy statement.

Reviews

  Oversees the Company’s incentive compensation arrangements, including with appropriate input from the CRO, to help ensure that such arrangements are consistent with the safety and soundness of the Company and do not encourage excessive risk-taking, and are otherwise consistent with applicable related regulatory rules and guidance.

Reviews and approves the Company’s equity retention and ownership policies for executive officers and other officers and employees, as appropriate.

See also “Compensation Governance and Risk Management.”


Morgan Stanley 2019 Proxy StatementNOMINATING AND    31


CORPORATE GOVERNANCE(3) MATTERS

NOMINATING AND GOVERNANCE COMMITTEE

Current Members
James W. Owens

Rayford Wilkins, Jr. (Chair)
Erskine B. Bowles

Elizabeth Corley

Robert H. Herz
Rayford Wilkins, Jr.

4Meetings Held in 20152018 4

 

Primary Responsibilities

●   

  Oversees succession planning for the Board and Board leadership appointments.

Reviews the overall size and composition of the Board taking into consideration the skills, attributes and experience of each Board member.
its committees.

Identifies and recommends candidates for election to the Board.

Recommends committee structure and membership.
 

  Oversees the orientation program for newly elected directors.

Reviews annually the Corporate Governance Policies.

Oversees and approves the process and guidelines for the annual evaluation of performance and effectiveness of the Independent Lead Director, the Board and its committees.

Reviews and approves related person transactions in accordance with the Company’s Related Person Transactions Policy.

Oversees

  Reviews the director compensation.
compensation program.

Reviews the Company’s Corporate Political Activities Policy Statement.

OverseesStatement and oversees political activities, of the Morgan Stanley Political Action Committee, the Company’s significant lobbying priorities and expenditures attributable to lobbying in the U.S., and expenditures related to principal U.S. trade associations.

Oversees the Company’s philanthropic programs and social responsibility, environmental and environmentalsustainability matters.


26Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE


OPERATIONS AND TECHNOLOGY

OPERATIONS AND TECHNOLOGY COMMITTEE(2)

Current Members

Jami Miscik (Chair)

Thomas H. Glocer (Chair)
Jami Miscik

Mary L. Schapiro

Ryosuke Tamakoshi
Rayford Wilkins, Jr.

6Meetings Held in 20152018 5

 

Primary Responsibilities

●   

Oversees the Company’s operations and technology strategy, including trends that may affect such strategy.

Reviews the major operations and technology risk exposures of the Company, including information security, fraud and cybersecurity risks, and the steps management has taken to monitor and control such exposures.

Reviews the operations and technology budget and significant operations and technology expenditures and investments.

Reviews operations and technology metrics.
 

Oversees risk management and risk assessment guidelines and policies regarding operations and technology risk.

Oversees the Company’s business continuity planning.

  See also “Board Leadership Structure and Role in Risk Oversight — Board Oversight of Cybersecurity Risk.”


32    RISK(4)Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

RISK COMMITTEE

Current Members
Donald T. Nicolaisen

Perry M. Traquina (Chair)

Alistair Darling

Nobuyuki Hirano

Jami Miscik
Laura D. Tyson

8Meetings Held in 20152018 9

 

Primary Responsibilities

●   

Oversees the Company’s global ERM framework.

  Oversees the Company’s capital, liquidity and funding planning and strategy.

Oversees the major risk exposures of the Company, including market, credit, operational, liquidity, funding, reputationalmodel and franchiseliquidity risk, against established risk measurement methodologies and the steps management has taken to monitor and control such exposures and reviews significant reputational risk, franchise risk, new product risk, emerging risks and regulatory matters.

  Oversees the risk identification framework.

Oversees the Company’s risk appetite statement, including risk tolerance levels and limits, and tolerances.

Reviews capital, liquidity and fundingthe ongoing alignment of the Risk Appetite Statement with the Company’s strategy and related guidelines and policies.
capital plans.

Reviews the contingency funding plan, effectiveness of the Company’s Basel III advanced systems, Comprehensive Capital Analysis and internal capital adequacy assessment processReview,mid-cycle Dodd-Frank Act Stress Testing submissions and capital plan.
the Company’s Volcker Compliance Program, Title I Resolution Plan and Recovery Plan.

Oversees risk management and risk assessment policies and guidelines.

Oversees the performance of the CRO who(who reports functionally to the Risk Committee and the CEO) and the risk management function.

See also “Board Leadership Structure and Role in Risk Oversight—Oversight — Board Role in Risk Oversight.”


(1)Effective May 19, 2015,July 1, 2018, Mr. TraquinaWilkins joined the CMDS Committee.

(2)Effective July 1, 2018, Ms. Schapiro joined the Operations and Technology Committee, and Mr. DaviesWilkins concluded service on the AuditOperations and Technology Committee.
(2)Effective May 19, 2015, Ms. Olayan was appointed Chairat the 2019 annual meeting of Messrs. Kleinfeld and Owens joined, and Messrs. Nicolaisen and Kidder concludedshareholders, Mr. Tamakoshi will conclude service on the CMDS Committee.
(3)Effective May 19, 2015,Board and Operations and Technology Committee and, upon his election by shareholders, Mr. Herz joined, and Messrs. Kidder and Kleinfeld concluded service on, the Nominating and Governance Committee. Effective August 1, 2015, Mr. Bowles joined the Nominating and Governance Committee.
(4)Effective May 17, 2016, Mr. DarlingOgasawara will join the Risk Committee. Effective May 19, 2015, Mr. Nicolaisen joinedOperations and was appointed Chair of, Ms. Miscik joined, and Messrs. Davies and Owens concluded service on, the Risk Committee. Effective November 1, 2015, Mr. Hirano joined, and Mr. Tanaka concluded service on, the RiskTechnology Committee.

Morgan Stanley 2016 Proxy Statement27Board Leadership Structure and Role in Risk Oversight



Table of Contents

CORPORATE GOVERNANCE


Board Leadership Structure and Role in Risk Oversight

Board Leadership Structure

The Board is responsible for reviewing the Company’s leadership structure. As set forth in the Corporate Governance Policies, the Board believes that the Company and its shareholders are best served by maintaining the flexibility to have any individual serve as Chairman of the Board based on what is in the best interests of the Company at a given point in time, taking into consideration, among other things:

The composition of the Board;
The role of the Company’s Independent Lead Director;
The Company’s strong corporate governance practices;
The CEO’s working relationship with the Board; and
The challenges specific to the Company.

The composition of the Board;

The role of the Company’s Independent Lead Director;

The Company’s strong corporate governance practices;

The CEO’s working relationship with the Board; and

The challenges specific to the Company.

The Board has determined that the appointment of a strong Independent Lead Director (as described below), together with a combined Chairman and CEO, serveserves the best interests of the Company and its shareholders. By serving in both positions, the CEOChairman and ChairmanCEO is able to draw on his detailed knowledge of the Company to provide the Board, in coordination with the Independent Lead Director, leadership in focusing its discussions and review of the Company’s strategy. In addition, a combined role of CEOChairman and ChairmanCEO ensures that the Company presents its message and strategy to shareholders, employees and clients with a unified voice. The Board believes that it is in the best interest of the Company and its shareholders for Mr. Gorman to serve as Chairman and CEO at this time, considering the strong role of our Independent Lead Director and other corporate governance practices providing independent oversight of management as set forth below.

Independent Lead Director

The Corporate Governance Policies provide for an independent and active Independent Lead Director who is appointed and reviewed annually by the independent directors with clearly defined leadership authority and responsibilities.

Morgan Stanley 2019 Proxy Statement    33


CORPORATE GOVERNANCE MATTERS

Our Independent Lead Director, Erskine B. Bowles,Thomas H. Glocer, was appointed by our other independent directors and hasas part of his formal duties and responsibilities including:shall:

Presiding

Board Governance and Leadership

Advising the Chairman and CEO

Board Effectiveness and

Succession Planning

 Preside at all meetings of the Board at which the Chairman is not present including at executive sessions of the independent and non-management directors;

Having

 Have the authority to call, and lead,non-management director sessions composed only of and independent director sessions

 Help facilitate communication among the Chairman, the CEO and thenon-management and independent directors, or independent directors;

Servingincluding serving as liaison between the Chairman and the independent directors;
directors

Advising the Chairman of the Boardon the Board’s informational needs;

Approving Approve the types and forms of information sent to the Board;
Board

 Solicit thenon-management directors for advice on agenda items for meetings of the Board and executive sessions to help facilitate Board focus on key issues and topics of interest to the Board

 Be available, if requested, to meet with the Company’s primary regulators

 Be available, if requested by major shareholders, for consultation and direct communication in accordance with the Corporate Governance Policies

Approving

 Communicate with the Chairman and the CEO between meetings and act as a “sounding board” and advisor

 Advise the Chairman and the CEO of the Board’s informational needs

 Collaborate with the Chairman and the CEO in developing the agenda for meetings of the Board

 Approve Board meeting agendas
and the schedule of Board meetings to assure that there is sufficient time for discussion of all agenda items and requesting, if necessary, the

 Have authority to request inclusion of additional agenda items;items

 Communicate with the Chairman and

the CEO and other members of management, as appropriate, about decisions reached, suggestions and views expressed bynon-management directors in executive sessions or outside of Board meetings

Making himself available, if requested by major shareholders,

 Lead the annual evaluation of the performance and effectiveness of the Board including consultation with eachnon-management director regarding Board performance and effectiveness and, as necessary, individual director performance

 Help facilitate the efficient and effective functioning and performance of the Board

 Help facilitate discussion and open dialogue amongnon-management directors during Board meetings, executive sessions and outside of Board meetings

 Consult with the Chair of the Nominating and Governance Committee on Board succession planning and Board Committee appointments

 Coordinate with the Chair of the Nominating and Governance Committee on recruiting and interviewing candidates for consultation and direct communication.the Board

 Consult with the Chair of the CMDS Committee on the annual evaluation of the performance of the CEO

28Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE


Independent Oversight of Management

The Company’s corporate governance practices and policies ensure substantial independent oversight of management. For instance:

The Board has a majority of independent and non-management directors.Eleven of the 14 director nominees are independent as defined by the NYSE listing standards and the Company’s more stringent Director Independence Standards. Thirteen of 14 director nominees are non-management directors. All of the Company’s directors are elected annually.
The Board’s key standing committees are composed solely of non-management directors.The Audit Committee, the CMDS Committee, and the Nominating and Governance Committee are each composed solely of independent directors. The Operations and Technology Committee and Risk Committee are chaired by independent directors and consist of a majority of independent directors and include only non-management directors. The committees provide independent oversight of management.
The Board’s non-management directors meet regularly in executive session.The non-management directors meet regularly in executive session without management present and, consistent with the NYSE listing standards, at least annually, the independent directors meet in executive session. These sessions are chaired by the Independent Lead Director.

The Board has a majority of independent andnon-management directors. Ten of the 13 director nominees are independent as defined by the NYSE listing standards and the Company’s more stringent Director Independence Standards. Twelve of the 13 director nominees arenon-management directors. All of the Company’s directors are elected annually.

The Board’s key standing committees are composed solely ofnon-management directors. The Audit Committee, the CMDS Committee and the Nominating and Governance Committee are each composed solely of independent directors. The Operations and Technology Committee and the Risk Committee are chaired by independent directors, consist of a majority of independent directors and include onlynon-management directors. The committees provide independent oversight of management.

The Board’snon-management directors meet regularly in executive session. Thenon-management directors meet regularly in executive session without management present and, consistent with the NYSE listing standards, at least annually, the independent directors meet in executive session. These sessions are chaired by the Independent Lead Director.

34    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

Board Role in Risk Oversight

Effective risk management is vital to the success of Morgan Stanley. The Board has oversight for the Company’s global ERM framework, which integrates the roles of the Company’s risk management functions into a holistic enterprise to facilitate the incorporation of risk assessment into decision-making processes across the Company, and is responsible for helping to ensure that the Company’s risks are managed in a sound manner. The Board regularly reviews the Company’s risks and the responsibilities of management and the Board committees to assist the Board in its risk oversight.

Coordination Among Board Committees Regarding Risk Oversight


Board of Directors
Strategic risk
Culture, values and conduct
Audit
Operations and
Technology
RiskCMDSNominating and
Governance
Legal risk
Compliance risk
Performance assessment and compensation of the Head of Internal Audit
Operations risk
Technology risk
Cybersecurity
ERM framework
Risk appetite statement
Market risk
Credit risk
Operational risk
Liquidity and funding risk
Capital
Reputational/franchise risk
Performance assessment and compensation of CRO
Performance assessment and compensation of CEO and other executive officers
Succession planning
Risk review of incentive compensation arrangements
Governance Risk


Morgan Stanley 2016 Proxy Statement29



Table of Contents

CORPORATE GOVERNANCE


TheRisk Committeeassists Board committees assist the Board in oversight of the oversight of:

The Company’s global ERM framework;
The major risk exposures of the Company, including market, credit, operational, liquidity, funding, reputational and franchise risk, against established risk measurement methodologies and the steps management has taken to monitor and control such exposures;
The Company’s risk appetite statement, including risk limits and risk tolerance, which are reviewed and approved annually;
The Company’s significant risk management and risk assessment guidelines and policies; and
The performance of the CRO, who reports to the CEO and the Risk Committee.

risks set forth below, coordinating as appropriate. In fulfilling its duties, the Risk Committee receives reports:

From the CRO, CFO and Corporate Treasurer regarding major risk exposures of the Company, including market, credit, operational, liquidity, funding, and capital;
From the Head of Internal Audit on reviews of risk management, liquidity and capital functions;
From the Company’s Strategic Transactions Committee and CCAR/Resolution and Recovery Planning Committee; and
Regarding significant reputational risk, franchise risk, new product risk, emerging risks and regulated matters relating to its authority.

The Risk Committee reports toaddition, the entire Board receives reporting on a regularquarterly basis regarding cross-enterprise risks, including strategic, reputational, and the entire Board attends quarterly Risk Committee meetings.

TheAudit Committeeassists the Boardculture, values and the Risk Committee in the oversight of the major legal and compliance risk exposures of the Company and the steps management has taken to monitor and control such exposure, as well as, in coordination with the Risk Committee and the Operations and Technology Committee, guidelines and policies that govern the process for risk assessment and risk management.

TheOperations and Technology Committeehas responsibility for oversight of operations and technology risk, including cybersecurity (also reviewed with the Board).

TheCMDS Committeereviews the Company’s incentive compensation arrangements, including with the CRO, to help ensure that such arrangements are consistent with the safety and soundness of the Company and do not encourage excessive risk-taking, and are otherwise consistent with applicable related regulatory rules and guidance.

conduct risk. The committees report to the entire Board on a regular basis.basis and have overlapping directors, invite Chairs of other committees and other directors to attend meetings, as appropriate given topics of discussion, and hold joint meetings as necessary to discharge their duties.

LOGO

Coordination Among Board Committees Regarding Risk Oversight Strategic risk Culture, values and conduct risk Reputational risk Legal risk Compliance risk Performance assessment and compensation of Global Audit Director Operations risk Technology risk Cybersecurity risk (also reviewed with full Board) Information security Risk Fraud risk Risk management Framework Risk appetite Statement Credit risk Market risk Operational risk Liquidity and funding risk Performance assessment and compensation of CEO and other executive officers Management succession planning Risk review of incentive compensation arrangements Governance risk Board succession Planning Board of Directors Audit Committee Risk Committee Operations and Technology Committee CMDS Committee Nominating and Governance Committee Model risk Capital Performance assessment and compensation of CRO

The Board has also authorized theFirm Risk Committee,, a management committee appointed and chaired by the CEO that includes the most senior officers of the Company, including the CRO, Chief Legal OfficerCLO and CFO, to oversee the Company’s global ERM framework. The Firm Risk Committee’s responsibilities include oversight of the Company’s risk management principles, procedures and limits and the monitoring of capital levels and material market, credit, operational, model, liquidity, and funding, legal, compliance operational, franchise and regulatoryreputational risk matters, and other risks, as appropriate, and the steps management has taken to monitor and manage such risks. The Company’s risk management is further discussed in Part II, Item 7A of the Company’s Annual Report on Form10-K for the year ended December 31, 2015 (20152018 (2018 Form10-K).

Board Oversight of Cybersecurity Risk

Cybersecurity risk is overseen by the Board as well as the Operations and Technology Committee. The Operations and Technology Committee has primary responsibility for oversight of information and cybersecurity operations. In accordance with its charter, the Operations and Technology Committee receives regular reporting at each quarterly meeting from senior officers in the Information and Technology Department and the Firm Risk Management Department on information security, fraud and cybersecurity risk as well as the steps management has taken to monitor and control

Morgan Stanley 2019 Proxy Statement    35


CORPORATE GOVERNANCE MATTERS

such exposures. Such reporting includes updates on the Company’s cybersecurity program, the external threat environment and the Company’s programs to address and mitigate the risks associated with the evolving cybersecurity threat environment.

The Operations and Technology Committee also receives an annual independent assessment of key aspects of the Company’s cybersecurity program from an external party and holds joint meetings with the Audit Committee and Risk Committee as necessary and appropriate. The Chair of the Operations and Technology Committee regularly reports to the full Board on cybersecurity risks and other matters reviewed by the Operations and Technology Committee. The full Board also receives separate presentations on cybersecurity risk. The Board (or a committee thereof) reviews and approves the Global Cybersecurity Program Policy, the Global Information Security Program Policy and the Global Technology Policy at least annually. Senior management, including the senior technology officers mentioned above, also discuss cybersecurity developments with the Chairs of the Operations and Technology Committee and the Risk Committee between Board and committee meetings, as necessary.

Assessment of Leadership Structure and Risk Oversight

The Board has determined that its leadership structure is appropriate for the Company. Mr. Gorman’s role as CEO, his existing relationship with the Board, his understanding of Morgan Stanley’s businesses and strategy, and his professional experience and leadership skills uniquely position him to serve as Chairman and CEO, while the Company’s Independent Lead Director position enhances the overall independent functioning of the Board. The Board believes that the combination of the Chairman and CEO, the Independent Lead Director and the Chairs of the Audit, CMDS, RiskNominating and Governance, Operations and Technology, Committees provideand Risk committees provides the appropriate leadership to help ensure effective risk oversight by the Board.

30Morgan Stanley 2016 Proxy StatementCompensation Governance and Risk Management



Table of Contents

CORPORATE GOVERNANCE


Compensation Governance and Risk Management

The CMDS Committee actively engages in its duties and follows procedures intended to ensure excellence in compensation governance. The CMDS Committee:

Retains an independent compensation consultant and evaluates the independence of such consultant and other advisors as required by any applicable law, regulation or listing standard. The CMDS Committee’s compensation consultant, Pay Governance, assists the CMDS Committee in collecting and evaluating external market data regarding executive compensation and performance and advises the CMDS Committee on developing trends and best practices in executive compensation and equity and incentive plan design. In performing these services, Pay Governance met regularly with the CMDS Committee, including without management present. Pay Governance does not provide any other services to the Company or its executive officers. The Company has affirmatively determined that no conflict of interest has arisen in connection with the work of Pay Governance as compensation consultant for the CMDS Committee.
Regularly reviews (i) Company performance with respect to execution of long-term strategy and evaluates executive performance in light of such achievements;(ii) executive compensation strategy, including the competitive environment and the design and structure of the Company’s compensation programs to ensure that they are consistent with and support our compensation objectives; and (iii) market trends and legislative and regulatory developments affecting compensation in the U.S. and globally.
Reviews the Company’s incentive compensation arrangements, including with the Company’s CRO, to help ensure that such arrangements are consistent with the safety and soundness of the Company and do not encourage excessive risk-taking, and are otherwise consistent with applicable related regulatory rules and guidance. The CRO concluded that the Company’s current compensation programs for 2015 do not incentivize employees to take unnecessary or excessive risk and that such programs do not create risks that are reasonably likely to have a material adverse effect on the Company.
Grants senior executive annual incentive compensation after a comprehensive review and evaluation of Company, business unit and individual performance for the year, both on a year-over-year basis and as compared to our key competitors, and reviews its compensation decisions with our Board for executive officers and other senior executives.
Together with senior management, oversees the Company’s controls regarding the year-end compensation process, which have been designed to be consistent with our regulators’ principles for safety and soundness, including policies and procedures for funding and allocating the incentive compensation pool and the use of discretion in determining individual incentive compensation awards; processes for identifying “risk-taking” employees; and processes to administer incentive compensation clawback and cancellation features.

Retains an independent compensation consultant and evaluates the independence of such consultant and other advisors as required by any applicable law, regulation or listing standard. The CMDS Committee’s compensation consultant, Pay Governance, assists the CMDS Committee in collecting and evaluating external market data regarding executive compensation and performance and advises the CMDS Committee on developing trends and best practices in executive compensation and equity and incentive plan design. In performing these services, Pay Governance met regularly with the CMDS Committee, including without management present, and separately with the CMDS Committee Chair. Pay Governance does not provide any other services to the Company or its executive officers. The Company has affirmatively determined that no conflict of interest has arisen in connection with the work of Pay Governance as compensation consultant for the CMDS Committee.

Regularly reviews (i) Company performance with respect to execution of strategic objectives and evaluates executive performance in light of such performance; (ii) executive compensation strategy, including the competitive environment and the design and structure of the Company’s compensation programs to ensure that they are consistent with and support our compensation objectives; and (iii) market trends and legislative and regulatory developments affecting compensation in the U.S. and globally.

Together with the CRO, oversees the Company’s incentive compensation arrangements to help ensure that such arrangements are consistent with the safety and soundness of the Company and do not encourage excessive risk-taking, and are otherwise consistent with applicable related regulatory rules and guidance. The CRO attends CMDS Committee meetings at least annually, and on an as needed basis, and reviews the Company’s incentive compensation arrangements from a risk perspective. The CRO reported to the CMDS Committee his conclusion that the Company’s current compensation programs for 2018 do not incentivize employees to take unnecessary or excessive risk and that such programs do not create risks that are reasonably likely to have a material adverse effect on the Company.

Approves senior executive annual incentive compensation after a comprehensive review and evaluation of Company, business unit and individual performance for the year, and reviews these compensation decisions with our Board.

Together with senior management, oversees the Company’s controls regarding theyear-end compensation process, which have been designed to be consistent with our regulators’ principles for safety and soundness, including policies and procedures for compensation plan governance, funding and allocating the incentive compensation pool and the use of discretion in determining individual incentive compensation awards; processes for identifying “risk-taking” employees; and processes to administer incentive compensation clawback and cancellation features.

36    Morgan Stanley 20162019 Proxy Statement31



Table of Contents

CORPORATE GOVERNANCE MATTERS


Director Compensation(1)

Director Compensation


The following table contains information with respect to the annual compensation (including deferred compensation) of ournon-employee directors earned during 20152018 with respect to his or hertheir Board service.

Director(1)     
Fees Earned or
Paid in Cash
($)(2)
     
Stock Awards
($)(3)(4)
     Option Awards
($)
     Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings ($)
     All Other
Compensation
($)
     Total
($)
Erskine B. Bowles119,167250,000369,167
Howard J. Davies*35,83335,833
Thomas H. Glocer105,000250,000355,000
Robert H. Herz106,667250,000356,667
C. Robert Kidder*31,66722,389(5)54,056
Klaus Kleinfeld85,000250,000335,000
Jami Miscik90,833250,000340,833
Donald T. Nicolaisen105,000250,000355,000
Hutham S. Olayan91,667250,000341,667
James W. Owens105,000250,000355,000
Perry M. Traquina*56,667250,000306,667
Laura D. Tyson85,000250,000335,000
Rayford Wilkins, Jr.95,000250,000345,000

Director

  Fees Earned or
Paid in Cash
($)(2)
   Stock Awards
($)(3)(4)
   Option Awards
($)
   

Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings

($)

   All Other
Compensation
($)(5)
   

Total

($)

 

Erskine B. Bowles*

   7,917                21,269    29,186 

Elizabeth Corley*

   85,833    333,333                419,166 

Alistair M. Darling

   97,500    250,000                347,500 

Thomas H. Glocer

   147,500    250,000                397,500 

Robert H. Herz

   118,333    250,000                368,333 

Jami Miscik

   107,500    250,000                357,500 

Dennis M. Nally

   97,500    250,000                347,500 

Hutham S. Olayan

   96,667    250,000                346,667 

James W. Owens*

   31,667                12,804    44,471 

Mary L. Schapiro*

   44,167    208,333                252,500 

Perry M. Traquina

   118,333    250,000                368,333 

Rayford Wilkins, Jr.

   107,500    250,000                357,500 

*Effective May 19, 2015, Messrs. Davies and Kidder retired fromMr. Bowles concluded service on the Board effective February 1, 2018 and Mr. Traquina joinedOwens concluded service on the Board. Mr. Darling was appointedBoard effective May 24, 2018, the date of the 2018 annual meeting of shareholders. Mss. Corley and Schapiro were elected to the Board effective January 1, 20162018 and received no compensation in 2015.July 1, 2018, respectively.

(1)Messrs. Gorman, Hirano Tamakoshi and TanakaTamakoshi received no compensation during 20152018 for Board service. The Directors’ Equity Capital Accumulation Plan (DECAP) imposes an aggregate limit of $750,000 on annual compensation for our non-employee directors.

(2)

Represents the portion of the annual Board and Board committee retainers that was earned, whether paid in cash or deferred at the director’s election, during 2015.2018. Cash retainers for service on the Board and Board committees during the 20152018 service period are paid semi-annually in arrears for the period beginning at the 20152018 annual meeting of shareholders (May 19, 2015)24, 2018) and concluding at the 20162019 annual meeting of shareholders (May 17, 2016)23, 2019). Amounts in the table represent cash retainers earned for a portion of the 20142017 service period (January 1, 20152018 to May 19, 2015)24, 2018) and cash retainers earned for a portion of the 20152018 service period (May 20, 201525, 2018 to December 31, 2015)2018).

   

In 2018, the Nominating and Governance Committee engaged Frederic W. Cook & Co., Inc. (FW Cook) to review our director compensation program and affirmatively determined that FW Cook is independent from management and that FW Cook’s engagement would not raise any conflict of interest. Effective November 1, 2018, based on the recommendation of the Nominating and Governance Committee following its review with FW Cook, the Board increased Board and committee retainers (other than Audit and Risk chairs) by $5,000, increased Audit and Risk committee chair retainers by $10,000, and amended DECAP to limit the deferral alternatives available to directors with respect to Elective Units, Current Units and Career Units (each defined below). The annual Board retainer for the 2015 service period for each director is $75,000. In addition, the Independent Lead Director, eachcurrent values of the Board committee chairs and each Board committee member receives additional annual retainers for the 2015 service period, asare set forth in the following table. Retainers are prorated when a director joins or leaves the Board or a committee at any time other than at the annual meeting of shareholders, and no retainers are paid if the director is elected to the Board less than 60 days prior to the annual meeting. Directors do not receive meeting fees.


PositionRetainer
($)
Independent Lead Director30,000
Committee Chairs
     Audit Committee25,000
     Compensation, Management Development and Succession Committee20,000
     Nominating and Governance Committee

Position

  20,000Retainer
($)
     Operations and Technology Committee

Board Member

20,00080,000
     Risk Committee

Independent Lead Director

20,00050,000

Committee Chairs

Audit and Risk Committees

40,000

All Other Committees

25,000

Committee Members

10,00015,000

32Morgan Stanley 2016 Proxy Statement



Table of Contents

CORPORATE GOVERNANCE


Directors can elect to receive all or a portion of their retainers on a current basis in cash or shares of common stock or on a deferred basis under the Directors’ Equity Capital Accumulation Plan (DECAP)shareholder-approved DECAP in the form of Elective Units.deferred stock units (Elective Units). Elective Units are not subject to vesting or cancellation.

Morgan Stanley 2019 Proxy Statement    37


CORPORATE GOVERNANCE MATTERS

 

Messrs. Bowles, Glocer, Owens and Traquina and Mss. Corley, Olayan and MiscikSchapiro deferred all or a portion of their cash retainers into Elective Units under DECAP. Mr. Glocer deferred all of his retainers into Elective Units for the 2014 service period and elected to receive all of his cash retainers in shares of common stock for the 2015 service period. Elective Units in lieu of cash retainers earned for the second half of the 20142017 service period were granted in arrears on May 19, 2015,24, 2018, and Elective Units or shares of common stock, as applicable, in lieu of cash retainers earned for the first half of the 20152018 service period were granted in arrears on November 19, 2015.December 1, 2018. The number of Elective Units granted on May 19, 201524, 2018 was based on $38.6392, and the number of Elective Units and shares of common stock granted on November 19, 2015 was based on $34.2019, which, in each case, represents$53.7395, the volume-weighted average price of the common stock on the grant date.

(3)

Representsdate, and the aggregate grant date fair value, determined in accordance with the applicable accounting guidance for equity-based awards,number of the annual stock unit award for the 2015 service period. The aggregate grant date fair value of annual stock unitsElective Units granted on May 19, 2015 isDecember 1, 2018 was based on $38.6392, which represents$44.273, the volume-weighted average price of the common stock on November 30, 2018 (the immediately preceding trading day).

(3)

Other than with respect to Mss. Corley and Schapiro, represents the aggregate grant date.date fair value of the annual stock unit award granted on May 24, 2018 for the 2018 service period. With respect to Ms. Corley, the amount also includes the prorated initial stock unit award granted on February 1, 2018 in connection with her election to the Board. With respect to Ms. Schapiro, the amount represents the prorated initial stock unit award granted on August 1, 2018 in connection with her election to the Board. The aggregate grant date fair value of the stock unit awards is based on the volume-weighted average prices of the common stock on the applicable grant dates as follows: $53.7395 for the annual stock unit awards; $50.4715 for Ms. Schapiro’s initial stock unit award; and $57.017 for Ms. Corley’s initial stock unit award. For further information on the valuation of these stock units, see notes 2 and 18 to the consolidated financial statements included in the 20152018 Form10-K.

 

Under DECAP, directors receive an equity award upon initial election to the Board (provided that they are elected to the Board no less than 60 days prior to the annual meeting and are not initially elected at the annual meeting) and an equity award annually thereafter on the datefirst day of the month following the annual meeting of shareholders. Initial and annual equity awards are granted 50% in the form of stock units that do not become payable until the director retires fromconcludes service on the Board (Career Units) and 50% in the form of stock units payable on the first anniversary of grant (Current Units). The grant date fair value of the initial equity award is $250,000, prorated for service until the annual meeting, and the award is fully vested upon grant. The grant date fair value of the annual equity award is $250,000 and the award is subject to monthly vesting until theone-year anniversary of the grant date. Directors may elect to extend deferral of their Career Units and Current Units beyond the scheduled payment date, subject to specified limitations.

 

Our Corporate Governance Policies include a director equity ownership requirement of five times the annual cash Board retainer.

(4)

The following table sets forth the aggregate number of shares underlying DECAP stock units outstanding at December 31, 2015.2018.


NameStock Units (#)

Name

Stock Units
(#)

Erskine B. Bowles

131,363130,267
Howard J. Davies

Elizabeth Corley

15,3147,679

Alistair M. Darling

14,553

Thomas H. Glocer

30,99960,962

Robert H. Herz

28,19642,943
C. Robert Kidder

Jami Miscik

20,059
Klaus Kleinfeld

Dennis M. Nally

25,13310,102
Jami Miscik9,314
Donald T. Nicolaisen82,558

Hutham S. Olayan

121,787158,291

James W. Owens

47,9888,136

Mary L. Schapiro

4,795

Perry M. Traquina

7,76736,879
Laura D. Tyson46,398

Rayford Wilkins, Jr.

14,39324,720

(5)

At the conclusion of Mr. Kidder’sBowles’ and Mr. Owens’ service on the Board, the Company contributed $22,000donated $20,000 to the C. Robert Kidder and Mary Kidder endowed scholarship for African American students with scholastic merit and financial need atErskine Bowles Carolina Works Fund of the University of MichiganNorth Carolina Foundation in honor of Mr. Bowles and $10,000 to the James and Kathrine Owens Fund of the North Carolina State University Alumni Association in honor of Mr. Owens. The Company also presented Mr. Kiddereach director with a gift of nominal value.

Morgan Stanley 2016 Proxy Statement33Related Person Transactions Policy



CORPORATE GOVERNANCE


Related Person Transactions Policy

Our Board has adopted a written Related Person Transactions Policy (Policy) requiring the approval or ratification by the Nominating and Governance Committee of transactions (including material amendments or modifications to existing transactions) where the Company is a participant, the transaction exceeds $120,000 and a related person (directors or director nominees, executive officers, 5% shareholders and immediate family members of the foregoing) has a direct or indirect material interest. Under the Policy,policy, in determining whether to approve or ratify such Related Person Transactions, the Nominating and Governance Committee considers all relevant facts and circumstances, including, but not limited to: the terms and commercial reasonableness of the transaction; the size of the transaction; the materiality to, and interest of, the related person and the Company in the transaction; whether the transaction would, or would be perceived to, present an improper conflict of interest for the related person; and, if the related person is an independent director, the impact on the director’s independence. Certain transactions are not subject to the Policy,policy, including

38    Morgan Stanley 2019 Proxy Statement


CORPORATE GOVERNANCE MATTERS

compensation of executive officers approved by the CMDS Committee and ordinary course commercial or financial services transactions between the Company and an entity in which a related person has an interest if the transaction is made under terms and conditions and under circumstances substantially similar to those prevailing at the time for comparable transactions with unaffiliated third parties and the related person does not otherwise have a direct or indirect material interest in the transaction.

Certain Transactions

Certain Transactions

Our subsidiaries may extend credit in the ordinary course of business to certain of our directors, officers and members of their immediate families. These extensions of credit may be in connection with margin loans, mortgage loans or other extensions of credit by our subsidiaries. These extensions of credit are made in the ordinary course of business, on substantially the same terms, including interest rates and collateral, as those prevailing at the time for comparable loans with persons not related to the lender and do not involve more than the normal risk of collectability or present other unfavorable features.

Each of MUFG, State Street Corporation (State Street), T. Rowe Price Associates, Inc. (T. Rowe Price) and BlackRock, Inc. (BlackRock) and The Vanguard Group (Vanguard) beneficially owns 5% or more of the outstanding shares of Morgan Stanley common stock as reported under “Principal Shareholders.” During 2015,2018, we engaged in transactions in the ordinary course of business with each of MUFG, State Street, T. Rowe PriceBlackRock and BlackRockVanguard, and certain of their respective affiliates, including investment banking, financial advisory, sales and trading, derivatives, investment management, lending, securitization and other financial services transactions. Such transactions were on substantially the same terms as those prevailing at the time for comparable transactions with unrelated third parties.

A child of Jeffrey Brodsky, an executive officer, is anon-executive employee of the Company and received compensation in 2018 of approximately $205,000. A child of Colm Kelleher, an executive officer, is anon-executive employee of the Company and received compensation in 2018 of approximately $127,000. The compensation and benefits for these employees was determined in accordance with the Company’s standard compensation practices applicable to similarly situated employees.

In addition to the transactions described above, as part of the global strategic alliance between MUFG and the Company, on May 1, 2010 the Company and MUFG formed a joint venture in Japan of their respective investment banking and securities businesses by forming two joint venture companies. MUFG contributed the investment banking, wholesale and retail securities businesses conducted in Japan by Mitsubishi UFJ Securities Co., Ltd. into one of the joint venture entities named Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (MUMSS). The Company contributed the investment banking operations conducted in Japan by its subsidiary, Morgan Stanley MUFG Securities Co., Ltd. (MSMS), formerly known as Morgan Stanley Japan Securities Co., Ltd., into MUMSS (MSMS, together with MUMSS, the Joint Venture). MSMS has continued its sales and trading and capital markets business conducted in Japan. The Company owns a 40% economic interest in the Joint Venture and MUFG owns a 60% economic interest in the Joint Venture. The Company holds a 40% voting interest and MUFG holds a 60% voting interest in MUMSS, while the Company holds a 51% voting interest and MUFG holds a 49% voting interest in MSMS. Other initiatives that are part of the Company’s global strategic alliance with MUFG include a loan marketing joint venture in the Americas, business referral arrangements in Asia, Europe, the Middle East and Africa, referral agreements for commodities transactions and a secondment arrangement of personnel between MUFG and the Company for the purpose of sharing best practices and expertise. On April 18, 2018, the Company entered into a sales plan (the Plan) with MUFG and Morgan Stanley & Co. LLC (MS&Co.) whereby MUFG sells shares of the Company’s common stock to the Company, through its agent MS & Co., as part of the Company’s share repurchase program. The Plan is only intended to maintain MUFG’s ownership percentage of the common stock below 24.9% in order to comply with MUFG’s passivity commitments to the Board of Governors of the Federal Reserve System and will have no impact on the strategic alliance between MUFG and the Company, including the joint venture in Japan. Without the Plan, MUFG’s ownership percentage would increase as the outstanding number of shares of common stock is reduced as the Company purchases common stock from other investors under its share repurchase program.

34     

Morgan Stanley 20162019 Proxy Statement    39



Table of Contents


AUDIT MATTERS

Item 2


Ratification of Appointment of Morgan Stanley’s Independent Auditor

LOGOOur Board unanimously recommends that you vote“FOR” the ratification of Deloitte & Touche’s appointment as our independent auditor.


The Audit Committee has the sole authority and responsibility to appoint, compensate, retain, oversee and evaluate the independent auditorregistered public accounting firm retained to audit the Company’s consolidated financial statements.statements (independent auditor). The Audit Committee reviews and assesses annually the qualifications and performance of the independent auditor and considers, as appropriate, the rotation of the independent auditor. The Audit Committee also evaluates whether it is appropriate to rotate the independent auditor and ensures the mandatory, regular rotation of the lead audit partner of the independent auditor and, in connection with such rotation, the Audit Committee is directly involved in the selection of the lead audit partner.partner, who may provide services to the Company for a maximum of five consecutive years. Commencing with the 2016 audit, the current lead audit partner from Deloitte & Touche LLP (Deloitte & Touche) was designated and is expected to serve in this capacity through the end of the 2020 audit.

As part of the Audit Committee’s annual review of Deloitte & Touche, the Audit Committee reviewed and considered, among other factors:

The results of management’s assessment that includes the results of a global management survey and interviews regarding overall historic and recent performance;

Deloitte & Touche’s independence from the Company, noting that Deloitte & Touche does not provide anynon-audit services to the Company other than those deemed permissible, as described under “Independent Auditor Fees”;

Deloitte & Touche’s tenure as independent auditor, including the benefits of its institutional knowledge of the Company, and the controls and processes in place (such as the mandatory rotation of audit partners) that help ensure Deloitte & Touche’s continued independence from the Company;

The professional qualifications of Deloitte & Touche and that of the lead audit partner and other key engagement partners;

Deloitte & Touche’s succession planning for senior Deloitte & Touche personnel on the engagement;

Deloitte & Touche’s historic and current quality of service, including candidnessof communication and interactions with the Audit Committee, independent judgment and professional integrity and objectivity;

Deloitte & Touche’s global capabilities and expertise in handling the breadth of the Company’s global operations and businesses, accounting policies and internal control over financial reporting;

The appropriateness of Deloitte & Touche’s feesrelative to both efficiency and audit quality;

External data on audit quality and performance, including recent Public Company Accounting Oversight Board (PCAOB) reports on Deloitte & Touche and peer firms;

The potential impact and advisability of selecting a different independent auditor; and

Whether retaining Deloitte & Touche is in the best interest of Morgan Stanley and its stockholders.

Based on this review, the Audit Committee has appointed Deloitte & Touche LLP (Deloitte & Touche) as independent auditor for the year ending December 31, 20162019 and presents this selection to the shareholders for ratification. The Audit Committee believes the continued retention of Deloitte & Touche is in the best interest of the Company and its shareholders. Deloitte & Touche was selected as independent auditor upon the merger creating the current Company in 1997 and has served continuously as independent auditor since that time. Deloitte & Touche will audit the Company’s consolidated financial statements included in the Annual Report on Form10-K for the year ending December 31, 20162019 and will perform other permissible,pre-approved services. The Audit Committee pre-approves all audit and permitted non-audit services that

Deloitte & Touche performs forrepresentatives will attend the Companyannual meeting. They will be available to respond to appropriate shareholder questions and is responsible forwill have the audit fee negotiations associated withopportunity to make a statement if they desire to do so. If shareholders do not ratify the engagement of Deloitte & Touche. As part of the Audit Committee’s annual review of Deloitte & Touche,appointment, the Audit Committee reviewedwill reconsider it.

Our Board unanimously recommends that you vote“FOR” the results of management’s assessmentratification of Deloitte & Touche’s performance and discussed with Deloitte & Touche its independence from the Company. In considering the appointment of Deloitte & Touche as auditor, the Audit Committee also discussed with Deloitte & Touche succession planning for senior Deloitte & Touche personnel on the engagement.

AUDIT COMMITTEE REPORT

The Audit Committee’s charter provides that the Audit Committee is responsible for the oversight of the integrity of the Company’s consolidated financial statements, the Company’s system of internal control over financial reporting, certain aspects of the Company’s risk management as described in the charter, the qualifications and independence of the Company’s independent registered public accounting firm (independent auditor), the performance of the Company’s internal auditor and independent auditor, and the Company’s compliance with legal and regulatory requirements. We have the sole authority and responsibility to appoint, compensate, retain, oversee, evaluate and, when appropriate, replace the Company’sour independent auditor. TheProxies solicited by the Board has determined that all members of the Audit Committee are “financially literate” within the meaning ofwill be voted“FOR” this ratification unless otherwise instructed.the NYSE listing standardsand “audit committee financial experts” within the meaning ofthe SEC rules.

The Audit Committee serves in an oversight capacity and is not part of the Company’s managerial or operational decision-making process. Management is responsible for the financial reporting process, including the system of internal controls, for the preparation of consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (GAAP) and for the report on the Company’s internal control over financial reporting. The Company’s independent auditor, Deloitte & Touche, is responsible for auditing those financial statements and expressing an opinion as to their conformity with GAAP and expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Our responsibility is to oversee the financial reporting process and to review and discuss management’s report on the Company’s internal control over financial reporting. We rely, without independent verification, on the information provided to us and on the representations made by management, the internal auditor and the independent auditor.

40    Morgan Stanley 20162019 Proxy Statement35



Table of Contents

AUDIT MATTERS


AUDIT COMMITTEE REPORT

The Audit Committee’s charter (available atwww.morganstanley.com/about-us-governance) provides that the Audit Committee is responsible for the oversight of the integrity of the Company’s consolidated financial statements, the Company’s system of internal control over financial reporting, certain aspects of the Company’s risk management as described in the charter, the qualifications and independence of the independent auditor, the performance of the Company’s internal auditor and independent auditor, and the Company’s compliance with legal and regulatory requirements. We have the sole authority and responsibility to appoint, compensate, retain, oversee, evaluate and, when appropriate, replace the Company’s independent auditor. As described under “Corporate Governance Matters — Corporate Governance Practices — Board Meetings and Committees,” the Board has determined that all four members of the Audit Committee are independent and “financially literate” within the meaning of the NYSE listing standards and a majority of the members of the Audit Committee, including the Chair, Robert H. Herz, are “audit committee financial experts” within the meaning of SEC rules.

The Audit Committee serves in an oversight capacity and is not part of the Company’s managerial or operational decision-making process. Management is responsible for the financial reporting process, including the system of internal controls, for the preparation of consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (GAAP) and for the report on the Company’s internal control over financial reporting. The Company’s independent auditor, Deloitte & Touche, is responsible for planning and conducting an independent audit of those financial statements and expressing an opinion as to their conformity with GAAP and expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Our responsibility is to oversee the financial reporting process and to review and discuss management’s report on the Company’s internal control over financial reporting. We rely, without independent verification, on the information provided to us and on the representations made by management, the internal auditor and the independent auditor, who generally attends each Audit Committee meeting.

The Audit Committee, among other things:

Reviewed and discussed the Company’s quarterly earnings releases, Quarterly Reports on Form 10-Q and Annual Report on Form 10-K, including the consolidated financial statements;

Reviewed the major legal and compliance risk exposures and the guidelines and policies that govern the process for risk assessment and risk management, including coordinating with the Risk Committee and the Operations and Technology Committee;

Reviewed, discussed and approved the plan and scope of the work of the internal auditor for 2015 and reviewed and discussed summaries of the significant reports to management by the internal auditor;

Approved the functional reporting of the Head of Internal Audit to the Audit Committee, and reviewed the performance and compensation of the Head of Internal Audit;

Reviewed and discussed the plan and scope of the work of the independent auditor for 2015;

Reviewed and discussed reports from management on the Company’s policies regarding applicable legal and regulatory requirements, and reviewed, discussed and approved the Company’s annual compliance plan;

Met with senior representatives of the Finance Department, Legal and Compliance Division and the Internal Audit Department; and

Met with Deloitte & Touche, the internal auditor and Company management in executive sessions.


Reviewed and discussed the Company’s quarterly earnings releases, Quarterly Reports onForm 10-Q and Annual Report on Form10-K, including the consolidated financial statements and significant accounting policies;

Reviewed the major legal and compliance risk exposures and the guidelines and policies that govern the process for risk assessment and risk management, including coordinating with the Risk Committee and the Operations and Technology Committee;

Reviewed, discussed and approved the plan and scope of the work and coverage of the internal auditor for 2018 and reviewed and discussed summaries of the significant reports to management by the internal auditor;

Reviewed the performance, compensation and independence of the Global Audit Director;

Reviewed and discussed the plan and scope of the work of the independent auditor for 2018;

Reviewed and discussed reports from management on the Company’s policies regarding applicable legal and regulatory requirements, and reviewed, discussed and approved the Company’s annual compliance plan;

Met with and received reports from senior representatives of the Finance Department, Legal and Compliance Division and the Internal Audit Department; and

Met with Deloitte & Touche, the internal auditor and Company management, including the CFO, CLO, Chief Compliance Officer and Global Audit Director in private executive sessions.

We reviewed and discussed with management, the internal auditor and Deloitte & Touche: the audited consolidated financial statements for 2015,2018, the critical accounting policies that are set forth in the Company’s Annual Report onForm 10-K, management’s annual report on the Company’s internal control over financial reporting and Deloitte & Touche’s opinion on the effectiveness of the Company’s internal control over financial reporting.

We discussed with Deloitte & Touche matters that independent registered public accounting firms must discuss with audit committees underpursuant to auditing standards of the Public Company Accounting Oversight Board (PCAOB), including, among other things, matters related to the conduct of the audit of the Company’s consolidated financial statements and the matters required to be discussed by Auditing Standard No. 16,Communication with Audit Committees, as adopted by the PCAOB. Deloitte & Touche also provided to the Audit Committee the written disclosures and the letter required by applicable requirements of the PCAOB regarding the independent auditor’s communications with the Audit Committee concerning independence and represented that it is independent from the Company.

We also discussed with Deloitte & Touche their independence from the Company, and considered if services they provided to the Company beyond those rendered in connection with their audit of the Company’s consolidated financial

Morgan Stanley 2019 Proxy Statement    41


AUDIT MATTERS

statements, reviews of the Company’s interim condensed consolidated financial statements included in its Quarterly Reports on Form10-Qand their opinion on the effectiveness of the Company’s internal control over financial reporting were compatible with maintaining their independence. We also reviewed andpre-approved, among other things, the audit, audit-related and tax services performed by Deloitte & Touche. We received regular updates on the amount of fees and scope of audit, audit-related and tax services provided.

Based on our review and the meetings, discussions and reports discussed above, and subject to the limitations on our role and responsibilities referred to above and in the Audit Committee charter, we recommended to the Board that the Company’s audited consolidated financial statements for 20152018 be included in the Company’s Annual Report onForm 10-K. We also selected Deloitte & Touche as the Company’s independent auditor for the year ending December 31, 20162019 and are presenting the selection to the shareholders for ratification.

Respectfully submitted,

Robert H. Herz, Chair
Thomas H. Glocer
Donald T. Nicolaisen

Alistair Darling

Dennis M. Nally

Perry M. Traquina

36     Morgan Stanley 2016 Proxy Statement



Table of Contents

AUDIT MATTERS


INDEPENDENT AUDITOR’S FEES

The Audit Committee is responsible for overseeing the audit fee negotiations associated with the engagement of Deloitte & Touche. The Audit Committeepre-approves categories of audit and permittednon-audit services that Deloitte & Touche may perform for the Company and sets budgeted fee levels for such services. The Company reviews proposed engagements, in conjunction with Deloitte & Touche, to confirm the proposed engagements fit within a category ofpre-approved services and such engagements are documented and reported to the Audit Committee on a quarterly basis. Any proposed service category, engagement or budgeted fee adjustment that has not beenpre-approved by the Audit Committee may be approved by the Audit Committee Chair between regularly scheduled quarterly meetings and reported to the Audit Committee at its next quarterly meeting. Any fees for services in excess of thepre-approved budgeted fees must be specifically approved.

The following table summarizes the aggregate fees (including related expenses; $ in millions) for professional services provided by Deloitte & Touche related to 20152018 and 2014.2017.

 2015 ($)         2014 ($)
Audit Fees(1)47.649.0
Audit-Related Fees(2)7.46.9
Tax Fees(3)1.41.7
All Other Fees
Total56.457.6

    2018 ($)     2017 ($) 

Audit Fees(1)

   47.2      47.9 

Audit-Related Fees(2)

   4.5      5.1 

Tax Fees(3)

   1.4      1.5 

All Other Fees

          

Total

   53.1      54.5 

(1)Audit Fees services include: the audit of our consolidated financial statements included in the Company’s Annual Report on Form10-K and reviews of the interim condensed consolidated financial statements included in our quarterly reports on Form10-Q; services attendant to, or required by, statute or regulation; comfort letters, consents and other services related to SEC and other regulatory filings; and audits of subsidiary financial statements.

(2)Audit-Related Fees services include: data verification and agreed-upon procedures related to asset securitizations; assessment and testing of internal controls and risk management processes beyond the level required as part of the consolidated audit; statutory audits and financial audit services provided relating to investment products offered by Morgan Stanley, where Morgan Stanley incurs the audit fee in conjunction with the investment management services it provides; agreed upon procedures engagements; regulatory matters; and attest services in connection with debt covenants.

(3)Tax Fees services include: U.S. federal, state and local income andnon-income tax planning and advice; U.S. federal, state and local income andnon-income tax compliance;non-U.S. income andnon-income tax planning and advice;non-U.S. income andnon-income tax compliance; and transfer pricing-related services.

Morgan Stanley offers various unconsolidated registered money market, equity, fixed income and alternative funds, and other funds (collectively, Funds). Deloitte & Touche provides audit, audit-related and tax services to certain of these unconsolidated Funds. Fees paid to Deloitte & Touche by these Funds for these services were $10.4$12 million in 20152018 and $7.3$12.8 million in 2014.2017.

A Deloitte & Touche representative will attend the annual meeting to respond to your questions and will have the opportunity to make a statement. If shareholders do not ratify the appointment, the Audit Committee will reconsider it.

Our Board unanimously recommends that you vote “FOR”42     the ratification of Deloitte & Touche’s appointment as our independent auditor. Proxies solicited by the Board will be voted “FOR” this ratification unless otherwise instructed.

Morgan Stanley 20162019 Proxy Statement37



Table of Contents


EXECUTIVE COMPENSATION MATTERS

Item 3


Company Proposal to Approve the Compensation of Executives as Disclosed in the Proxy Statement (Non-Binding(Non-Binding Advisory Resolution)Vote)

LOGOOur Board unanimously recommends that you vote“FOR” this proposal.


As required by Section 14A of the Securities Exchange Act of 1934, this proposal seeks a shareholderthe below resolution gives shareholders the opportunity to cast an advisory vote to approve the compensation of our NEOs (including foras disclosed in this purpose, our former CFO, Ms. Porat) as disclosedproxy statement pursuant to Item 402 of Regulation S-K through the following resolution:S-K:

“RESOLVED, that the Company’s shareholders approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the 20162019 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission (which disclosure includes the Compensation Discussion and Analysis and the accompanying compensation tables and related narrative).”

AlthoughAs this “Say on Pay” vote is advisory, and isthe result will not be binding on our Board, although the CMDS Committee will take into considerationconsider the outcome of the vote when evaluating the effectiveness of our executive compensation program and making future executive compensation decisions. At the 20152018 annual meeting of stockholders, more than 88%over 95% of the votes cast favoredwere in favor of our “Say on Pay” proposal. The CMDS Committee considered our “Say on Pay” result, and, inIn light of the significant majority of votes cast in favor of the 20142017 compensation of our NEOs, did not materially change the overallCMDS Committee maintained its performance-based approach to executive compensation for 2015 compensation from the prior year. However, the 2015 pay decision for the CEO of $21 million was reduced approximately 7% from $22.5 million for 2014,2018 and new share ownership requirements were introduced for our CEO (10x base salary) and our CFO, President and Chief Operating Officer (6x base salary), based on feedback from shareholders.

As discussed in the CD&A, the Board of Directors believes that our current executive compensation program appropriately links the compensation of our NEOs to our performance and properly aligns the interests of our NEOs with those of our shareholders.

We urgeAs discussed in the CD&A, the 2018 pay decision for the CEO was $29 million, with shareholder-aligned features. The Compensation Committee based its decision on its assessment of Mr. Gorman’s outstanding individual performance through the Firm’s substantial progress with respect to its strategic objectives and the Firm’s record performance in 2018. The Compensation Committee also noted Mr. Gorman’s overall leadership with respect to Firm culture, and among clients, shareholders, regulators and employees. Under Mr. Gorman’s leadership, the Firm achieved record revenues,pre-tax profit(11) and net income(12), and made substantial progress with respect to our shareholdersstrategic objectives, including delivering higher annual returns,pre-tax margin(4) in Wealth Management, and net revenue operating growth(5) and wallet share in Institutional Securities. Consistent with previous years, for 2018, 75% of CEO incentive compensation is deferred over three years and subject to read the “Overviewclawback and 50% of Voting Items,” CD&A and “Executive Compensation Tables,” which provideCEO incentive compensation is delivered in a future performance-vested equity award. In addition, 100% of CEO deferred compensation for 2018 is delivered in equity awards, an increased proportion from prior years, further aligning CEO compensation with shareholders’ interests.

For a detailed description of our executive compensation program.program, see “Overview of Voting Items,” CD&A (including Section 5 for the notes referenced above) and “Executive Compensation.”

Our Board unanimously recommends that you vote“FOR” this proposal. Proxies solicited by the Board will be voted“FOR” this proposal unless otherwise instructed.

38

Morgan Stanley 20162019 Proxy Statement    43



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


COMPENSATION DISCUSSION AND ANALYSIS (CD&A)

In this CD&A, we review the objectives and elements of Morgan Stanley’s executive compensation program, its alignment with Morgan Stanley’s performance and the 20152018 compensation decisions for our named executive officers (NEOs):

James GormanCEOChief Executive Officer
Colm KelleherPresident
Jonathan PruzanCFO as of May 1, 2015Chief Financial Officer
Ruth PoratEric GrossmanFormer CFO who served through April 30, 2015Chief Legal Officer
Gregory FlemingDaniel SimkowitzPresidentHead of WealthInvestment Management for 2015
Colm KelleherPresident of Institutional Securities for 2015
James Rosenthal               Chief Operating Officer (COO)

Effective January 6, 2016, Mr. Kelleher became President of the Company, and Mr. Fleming ceased to be an executive officer. Unless otherwise noted, the term NEO as used in this CD&A does not include Ms. Porat, due to her departure from the Company, and the term “CFO” refers to Mr. Pruzan.

The CD&A is comprised of the following sections:

Page:
1. Overview39Page:

1. Overview

44

2. Compensation Objectives and Strategy

4452

3. Framework for Making Compensation Decisions

4452

4. Compensation Decisions and Program

4857

5. Notes to the Compensation Discussion and Analysis

5161

1. Overview

1. Overview

The CMDSCommittee considers multipleseveral factors in determining executive compensation to ensure that Morgan Stanley’s compensation program is shareholder-aligned, motivating and competitive, and reflects current best practices in corporate governance, risk management and regulatory principles. The CMDS Committee takes into consideration progress with respect to the Company’s long-term strategic plan, as informed by financial and non-financial goals.

The CMDS Committee, with the advice of its independent compensation consultant, Pay Governance, places performance at the forefront of the executive compensation program. This is demonstrated inprogram, taking into consideration progress with respect to the structure of executive compensationCompany’s strategic objectives, as informed by financial and the performance results that drive compensation decisions for our NEOs.non-financial goals. The CMDS Committee’s approach to executive pay is also informed by input from shareholders. Our commitment to this performance-based approach is demonstrated in the structure of executive compensation and our CEO pay framework.

At the start of 2015, asAs in prior years, the CMDS Committee establishedused a target range ofwell-defined framework to determine CEO compensation for 2018 and the performance factors to be considered in determining year-end compensation. Atat year end CEO total compensation was set at $21$29 million, for 2015, a 7% decrease from $22.5 million in 2014, with shareholder-aligned features:

75% of incentive compensation is deferred over three years and subject to clawback;

50% of incentive compensation is delivered through future performance-vested equity awards; and

100% of deferred compensation is delivered in equity awards — an increased proportion from prior years.

72% deferred over three years and subject to clawback,
 

39% of such deferred compensation delivered through future performance-vested equity awards.


44    Morgan Stanley 20162019 Proxy Statement


COMPENSATION MATTERS

391.1 Framework for Compensation Decisions



TableThe CMDS Committee’s framework for determining CEO compensation supports and reinforces the Company’s pay for performance philosophy and incorporates the following key steps:

LOGO

Set Performance Priorities Establish Target Compensation Range Assess Performance Determine Compensation In the context of Contentsthe Companys strategic objectives, the Board sets annual performance priorities Priorities include both financial and non-financial performance metrics for the Company and its business segmentsThe CMDS Committee establishes the target CEO compensation range The range is informed by prior year CEO compensation at peer financial firms, among other factors Guidelines for performance assessment are outlined The CMDS Committee assesses Company and executive performance at year end, including: Progress in achieving the Companys strategic objectives and annual performance priorities The CEOs overall leadership The CMDS Committee determines CEO compensation after year end based on its performance assessment and discussion with the Board The CMDS Committee determines CEO compensation elements that support the Companys key compensation objectives

EXECUTIVE Each year, the CMDS Committee establishes a target compensation range for the CEO and outlines guidelines for the CEO performance assessment at year end.

MS CEO Total Compensation Range and Pay for Performance Approach

At the start of 2018, the CMDS Committee, in consultation with its independent compensation consultant, established a target range for 2018 CEO pay of $28 million or more for performance exceeding expectations to $10 million or less for performance substantially below expectations.

To inform its decision-making with respect to the appropriate target range, the CMDS Committee considers compensation information for the 16 financial companies in the S&P 100 index, as described in Section 3.1 under “Benchmarking Target CEO Pay.”

LOGO

$28 Million or More $10 Million or Less CEO performance exceeds expectationsStrong Company performance and shareholder returns CEO performance meets expectationsCompany performance and shareholder returns generally in line with peers with room for continued progress CEO performance below expectations Company performance and shareholder returns are below expectations

Morgan Stanley 2019 Proxy Statement    45


COMPENSATION MATTERS


1.1.1.2 Performance-Based Approach to Executive Compensation and 20152018 Performance Highlights

In its assessment of 20152018 performance, the CMDS Committee considered Morgan Stanley’s progress in relation to its strategic objectives, financial performance, and shareholder returns.

Strategic Objectives(1)(2)

Each year, the Board oversees the establishment of the Company’s strategic objectives and shareholders receive an overview of these objectives, as well as a summary of progress on the prior year’s strategic objectives. In 2015,2018, the Company achieved a number of importantmade substantial progress with respect to its strategic priorities, including improvement ofobjectives for 2018–2019.

LOGO

2018 2019 Strategic Objectives 2018 Results(3) Deliver Wealth Management profit margin, growth in Pre-Tax Margin(4) of26-28% Expand Institutional Securities Penetration and Leadership Position Investment Management for Growth Realize Company Expense Efficiency Ratio(7) of d73% Maintain Attractive Capital Return Profile Pre-Tax Margin(4) of 26.2% 8% net revenue operating growth(5); wallet share expansion across Sales & Trading and Investment Banking 9% asset management revenue operating growth(5); positive long-term net flows(6) Efficiency ratio(7) of 72.0% Maintained $6.8Bn aggregate distribution(8) ROE(9): 11.5% ROTCE(10): 13.2% ROE(9): 10%-13% ROTCE(10): 11.5%-14.5% Medium Term 12345

46    Morgan Stanley U.S. Bank(1), prudent expense management, and increased capital return to shareholders.2019 Proxy Statement

1.Ongoing Wealth Management upside through additional margin improvement

Achieved FY 2015 22% pre-tax margin, up from 20% in 2014(2)
One of leading Wealth Management platforms with ~$2Tn in client assets and ~16,000 financial advisors

2.Continued execution of U.S. Bank strategy in Wealth Management and Institutional Securities     

Achieved 46% NII growth in U.S. Bank versus 2014 in a flat rate environment(3)
Increased Wealth Management lending in U.S. Bank by 31% versus 2014(3)

3.Progress in Fixed Income and Commodities ROE

Failed to meet objective and subsequently initiated major restructuring
Completed exit of physical oil business

4.Maintain leadership in Institutional Equities and Investment Banking

Ranked 1st in Institutional Equities revenue market share for the second consecutive year(4)
Ranked 1st in Global IPOs, 2nd in Global Announced M&A, and 2nd in Global Equity(4)

5.Tailwind from lower funding costs

Continued to benefit as new debt issued at tighter spreads than maturing debt

6.Maintain focus on expense management

Achieved 37% Institutional Securities compensation ratio ex-DVA, down from 48% (42% excluding deferred compensation adjustments) in 2014(5)
Company-wide expense initiatives underway

7.Rating upgrade

Received two-notch upgrade from Moody’s: Morgan Stanley’s long-term senior debt rating increased from Baa2 to A3

8.Steadily increase capital return to shareholders

Received non-objection from the Federal Reserve Board to the 2015 Capital Plan, which included an increase in authorized share repurchase to $3.1 billion from $1.0 billion in the 2014 Capital Plan and the quarterly common stock dividend to $0.15 per share from $0.10 per share in the 2014 Capital Plan


COMPENSATION MATTERS

2018 Financial Performance(1)(2)(6)(7)

The Company and certain of its businesses delivered improvedrecord financial performance in 2015. Net2018. Under Mr. Gorman’s leadership, the Company achieved record revenues and income from continuing operations before taxes (Pre-tax Profit) increased in 2015 from 2014, both as reportedearnings, with net revenues of $40.1 billion compared with $37.9 billion a year ago,pre-tax profit(11) of $11.2 billion compared with $10.4 billion a year ago and excludingnet income(12) of $8.7 billion compared with $6.1 billion a year ago. Combined with continued expense discipline, the impact of Debt Valuation Adjustment (DVA)(8). ReturnCompany delivered higher annual returns producing a return on average common equity (ROE) also increasedof 11.5%(9), up significantly from 9.4% last year(13) and within the prior year, but still has room for continued improvement.Company’s 2018–2019 strategic objective of 10%–13%(9), and return on average tangible common equity of 13.2%(10), within the Company’s 2018–2019 strategic objective of 11.5%–14.5%(10).

MS Firm Financials Results
Ex-DVA ($ Billion)
20112012201320142015% Δ 2015
vs. 2014
 
 
Net Revenues(9)28.630.633.233.634.5+3%
 
 
Pre-tax Profit(9)2.55.05.22.9(10)7.9+168%
 

40     

LOGO

Company Institutional Securities Wealth Management Revenue Pre-Tax Profit(11) Net Income(12) Investment Banking Revenues Equity Revenues Revenues Pre-Tax Profit(11) Pre-Tax Margin(4) $40.1Bn $11.2Bn $8.7Bn $6.1Bn $9.0Bn $17.2Bn $4.5Bn 26.2% Record #1 Globally(14)

Morgan Stanley 20162019 Proxy Statement    47



COMPENSATION MATTERS

TableOver time, continued focus on expense discipline has led to strong operating leverage. Together with achievement of Contentsour multi-year strategic objectives, this has helped the Company more than double itspre-tax profit over the last five years. In addition, the Company has demonstrated solid returns exceeding its cost of capital, which has led to a sufficient capital base, despite share repurchases. This capital position also permits the ability to invest for future growth.

EXECUTIVE COMPENSATION


Morgan Stanley ROE (2011 – 2015)(11)(12)

Company Expense Efficiency Ratio(15), ex DVA(16) (%)

Pre-Tax Profit(17), ex DVA(16) ($Bn)

LOGO

LOGO  

LOGO

Attractive Capital Return Profile

Ability to Invest for Growth

LOGO

LOGO

LOGO

 

48    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

Shareholder Returns

Morgan Stanley’s significantThe Company’s execution of its strategic progressobjectives and improvedrecord financial performance in 2015 notwithstanding, TSR in the year trailed peers in a challenging year for global financials – only two of our eight global peers delivered positive returns. However,2018 contributes to Morgan Stanley’s strong shareholder return over the three-year period from 2013 to 2015,time. While Morgan Stanley’s TSR ranks first among peers.(21) for 2018 was negative(22), it outperformed the average of its global peers(23) and the Company’s three- and five-year TSR continued to be very strong(22).

1-Year (2018) TSR(21)(22)

3-Year (2016-2018) TSR(21)(22)

5-Year (2014-2018) TSR(21)(22)

LOGO

LOGO

LOGO

MS and Peer Total Shareholder ReturnRanks vs.

GlobalPeers(14)(23)3 of 9

3 of 9

3 of 9


Section 3.2 contains further details about Company performance; see also Section 5 “Notes to the Compensation Discussion and Analysis.”

Morgan Stanley 20162019 Proxy Statement41    49



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


1.2 Framework for1.3 Compensation Decisions and Performance EvaluationDetermination

At the start of 2015, the CMDS Committee, in consultation with its independent compensation consultant, established a target range for 2015 CEO pay of $28 million or more for superior performance to $10 million or less for performance substantially below expectations. This target range is reviewed and set annually and serves as a guideline for the CMDS Committee. To inform its decision-making with respect to the appropriate target range, the CMDS Committee considers compensation information for peers as described in Section 3.1 under “Benchmarking Target CEO Pay.”

The 20152018 pay decision for the CEO was made by the CMDS Committee, in consultation with the fullentire Board, based on the CMDS Committee’sits assessment of Morgan Stanley’s improvement in financial performance with room for continued improvement on ROE, Mr. Gorman’s strongoutstanding individual performance, through Morgan Stanley’s continued successful execution of the long-termCompany’s record performance in 2018 and substantial progress on the Company’s strategic objectives approved by the Board,objectives. The CMDS Committee also noted Mr. Gorman’s overall leadership with respect to Company culture, and Morgan Stanley’s shareholder returns as trailing peers in a challenging year for global financials.

among clients, shareholders, regulators and employees. As a result, the CMDS Committee determined that Company and individual performance warranted a 20152018 pay decision for Mr. Gorman of $21 million, 7% below Mr. Gorman’s 2014 pay of $22.5$29 million. The CMDS Committee believes that this decision appropriately aligns Mr. Gorman’s 2015 pay with 2015 performance.


The alignment of Mr. Gorman’s pay with Company performance can also be demonstrated over the longer-term by the fact that over the 2013 to 2015 period, Mr. Gorman’s realizable pay has increased only slightly and the Company’s three-year total TSR for the same period is 72%(15).

Section 3.2 contains more details about individual NEO performance. Section 4.1 contains the 2018 compensation decisions for each NEO, which follow a similar performance evaluation process.

MS 2018 CEO Performance Evaluation            MS 2018 CEO Compensation Opportunity ($MM)

LOGO1.3

Record performance in 2018 driven by revenue growth and expense discipline Substantial progress on many 2018 2019 strategic objectives, including medium term ROE and ROTCE targets Outstanding leadership, with respect to Company culture, and among clients, shareholders, regulators, and employees Negative TSR performance % of Incentive Compensation Elements$29 MM *Performance- Vested Long-Term Equity Incentive Compensation: 50% Time-Vested Deferred Equity: 25% Cash Bonus: 6.9 25% Base Salary 100% Equity

*$29 million is the amount the CMDS Committee awarded to the CEO in early 2019 for 2018 performance. This amount differs from the SEC required disclosure in the “2018 Summary Compensation Table.”

Pay in a given year is typically delivered in a combination of fixed compensation (generally, base salary), cash bonus, and deferred compensation provided in a mix of deferred cash, restricted stock units (RSUs), and a long-term incentive program (LTIP) award in the form of performance stock units. A significant portion of pay is deferred, awarded in equity, subject to future stock price performance and cancellation and clawback and, in the case of LTIP awards, subject to future achievement of specified financial goals over a three-year period. These compensation elements support the Company’s key compensation objectives, discussed in Section 2, including delivering pay for sustainable performance.

The alignment of Mr. Gorman’s 2015 pay with Company performance can also be demonstrated over the longer term given that a significant portion of pay is delivered through equity-based awards that vest over time. Notwithstanding the Firm’s strong 2018 performance, Mr. Gorman’s realizable pay over 2016-2018 is lower(-4%) than his reported pay for the same period, as a result of the change in stock price, while the Company’s three-year TSR for the same period is 33%(21)(22)(24).

50    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

The 2018 pay for the NEOs was delivered in a combination of thesethe compensation elements as outlined below.listed above, with the exception of Mr. Gorman who did not receive deferred cash and instead received 100% of his deferred compensation in equity awards (an increased proportion from prior years, further aligning CEO compensation with shareholders’ interests). The CMDS Committee believes this approach to executivethe elements and practices of our compensation isprogram are consistent with shareholder alignment, executive motivation,feedback, best practices, and regulatory principles.

Deferred Incentive Compensation

  75% of 2018 CEO incentive compensation is deferred over three years

  Clawbacks cover material adverse outcomes, even absent misconduct

  No automatic vesting onchange-in-control; double trigger in place

Performance-Vested

Long-Term Equity

Incentive Award

  CEO performance-vested award is 50% of bonus, consistent with shareholder feedback

  ROE goals were increased for awards granted as part of 2018 compensation

  Shares earned can range from 0 – 1.5x target based on three year performance against ROE and TSR goals

Equity-Based Compensation

  Significant portion of equity-based compensation aligns employee and shareholder interests, with 100% of CEO deferred compensation awarded in equity

  Meaningful share ownership and retention requirements further shareholder alignment

Best Practices

  Prohibitions on pledging, hedging, selling short or trading derivatives

  No excise tax protection upon achange-in-control

  Annual risk review

  CMDS Committee retains independent compensation consultant

Sections 4.2 and 4.3 contain more detail about the elements and key features of our compensation program.

42    Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


MS 2015 CEO Compensation Elements*

$ Million
% of Deferred
% of Total

  Performance-Vested Long-Term Equity Incentive Compensation

Realizable value determined after three years (2016-2018), based equally on two performance metrics: target average ROE of 10% and shareholder returns relative to the S&P Financials Index
Shares delivered can range from 0 – 1.5x target, depending on performance relative to target. TSR portion will not exceed 1.0x if there is negative TSR for the performance period
Subject to cancellation and clawback



  Deferred Incentive Compensation

Deferred Cash and Deferred Equity
Deferred over three years
Subject to cancellation and clawback



  Current Compensation
Base Salary and Cash Bonus
Cash bonus was awarded consistent with the Company-wide deferral schedule

$21 million is the amount the CMDS Committee awarded to the CEO in early 2016 for 2015 performance. This amount differs from the SEC required disclosure in the “2015 Summary Compensation Table.”


With the exception of Mr. Kelleher, who was identified as “Code Staff” for 2015 and whose 2015 deferred compensation structure is prescribed by the remuneration code of the U.K. Prudential Regulatory Authority, and Mr. Fleming, who did not receive an LTIP award in light of his ceasing to be a member of our Operating Committee as of January 6, 2016, the NEOs received their 2015 compensation in the same elements as described in the chart above. Ms. Porat did not receive a cash or deferred bonus for 2015 or an LTIP award, and only received base salary for 2015, as a result of her departure from the Company on April 30, 2015. Section 4.1 contains the 2015 compensation decisions for each NEO, which follow a similar performance evaluation process.

1.4 Shareholder Engagement and “Say on Pay” Vote

Morgan Stanley is committed to open and ongoing communication with our shareholders, and takes the opportunity to engage with shareholders directly on compensation and other matters to understand their perspectives and provide information about Morgan Stanley’s programs, performance assessment, and decision-making process.

A substantial majority (88.6%(over 95%) of the votes cast at the May 20152018 annual meeting of shareholders were in favor of our annual “Say on Pay” proposal. In 2015,2018, we continued our engagement program, seeking feedback from shareholders and proxy advisory firms on a variety of topics, whichincluding executive compensation, corporate governance, and environmental and social goals. The feedback that we received during the engagement program was conveyed to the CMDS Committee and the Board. Shareholders who provided feedback during our engagement program generally reported that executive compensation at Morgan Stanley was viewed as well-aligned with performance. The CMDS Committee factored shareholder feedback, including the “Say on Pay” vote results, into its consideration of executive compensation structure and determination of 2018 NEO pay levels.

After carefully considering shareholder feedback and other factors, the CMDS Committee maintained its performance-based approach to executive compensation, the portion of CEO deferred compensation awarded in equity was increased to 100% for 2018, and executive pay decreasedincreased for 20152018 after evaluation of performance against strategic and financial objectives as well as shareholder returns. The CMDS Committee also introduced minimum share ownership requirements for the

Morgan Stanley 20162019 Proxy Statement    4351



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


CEO, CFO, President,

2. Compensation Objectives and COO (see “Ownership of Our Stock – Executive Equity Ownership Commitment” for details). In response to the feedback received through shareholder engagement, the Board also amended our bylaws to implement proxy access, and we provided clearer disclosure of considerations and decisions regarding pay, continued to address shareholder dilution by repurchasing more shares than we issued, and revised and redesigned our proxy statement to more clearly communicate with shareholders (see the “Overview of Voting Items” for details).Strategy

2. Compensation Objectives and Strategy

Morgan Stanley is committed to responsible and effective compensation programs. The CMDS Committee continually evaluates the Company’s compensation programs with a view toward balancing the following key objectives, all of which support the Company’s culture and values and shareholders’ interests:

 

LOGO

Deliver Pay for
Sustainable

Performance

Emphasize variable Variable annual incentive compensationincentives and performance-vested long-term incentive compensation

Condition vesting and payment of long-term incentive compensation onincentives tied to future performance against specified financial targets that align with long-term business strategystrategic goals

Balance the objectives Consideration of delivering returns for shareholders and providing appropriate rewards to motivate superior individual performanceemployees

 

 

LOGO

Align Executive
Compensation with
with Shareholders’

Interests

Deliver a significant Significant portion of incentive compensation inis deferred, equity awards that are impacted, up or down, by future stock price performance and are subject to cancellation and clawback, over a multi-year period

Tie a significant portion of executive compensation directlyand tied to the Company'sCompany’s stock price and encourage ownership by requiring executives to retain shareswith retention requirements

Ongoing shareholder engagement to understand shareholder views

 

 

LOGO

Attract and Retain
Top Talent

Offers competitive Competitive pay levels to support the Company's objectives of continuing to attract and retain the most qualified employees in a highly competitive global talent environment for talent

Structure incentive Incentive awards to include vesting deferred payment,  and cancellation and clawback provisions that protectsretain employees and protect the Company'sCompany’s interests

 

 

LOGO

Mitigate Excessive
Risk-Taking

Structure and design compensation Compensation arrangements that do not incentivize unnecessary or excessive risk-taking that could have a material adverse effect on the Company

Annually evaluate Robust governance around review and approval of compensation programs, including from a risk perspective; review finding with CMDS Committee and independent compensation consultantperspective

 


3. Framework for Making Compensation Decisions

3. Framework for Making Compensation Decisions

3.1 Factors Considered in Compensation Decisions

The 20152018 compensation of the NEOs was determined by the CMDS Committee after consideration of Company business results, and strategic performance and individual performance, as well as competitor compensation data and, with respect to the CEO, benchmarking data, and other considerations set forth below.

Company and Individual Performance Review

To inform its decision-making process for NEO compensation for 2018, the CMDS Committee evaluated Company and individual performance. For 2018, a number of performance priorities were set by the CMDS Committee and the Board at the beginning of the year. The performance priorities are established based on a directional assessment made at the beginning of the year in light of the market environment and the Company’s strategic objectives, and their attainment ornon-attainment does not correspond to any specific compensation decision.

For 2018, the CMDS Committee reviewed performance priorities in the following areas:

o

Company and Individual Performance Review.To inform its decision-making process for NEO compensation for 2015, the CMDS Committee evaluated Company and individual performance. For 2015, a number of performance priorities were set by the CMDS Committee and the Board at the beginning of the year. The performance priorities are established based on a directional assessment made at the beginning of the year in light of the market environment and the Company’s strategic objectives, and their attainment or non-attainment does not correspond to any specific compensation decision.

For 2015, the CMDS Committee reviewed performance priorities in the following areas:


Financial performance, including ROE ex-DVA
(1)(2)(9)

o

Shareholder return

o

Capital and liquidity strength

o

Company Expense Efficiency Ratio(7)

o

Business performance and development for each primary business unit

44    Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


o

The strategic alliance with Mitsubishi UFJ Financial Group, Inc. (MUFG)

FirmCompany risk management and controls

o

Operations and technology and dataMajor infrastructure initiatives

o

Firm compensation and talent development
Standing with regulators

o

Talent development, including diversity

o

Board assessment of riskCompany culture, leadership, strategy, and reputation


Compensation Market Data

The Company uses a comparison group consisting of Bank of America Corp., Barclays Plc, Citigroup Inc., Credit Suisse Group, Deutsche Bank AG, Goldman Sachs Group Inc., JPMorgan Chase & Co., UBS AG, and Wells Fargo & Company

52    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

(Comparison Group) to understand market practices and trends, evaluate the competitiveness of our compensation programs, and inform compensation decisions. Our Comparison Group consists of companies that either directly compete with the Company for business and/or talent or are global organizations with scope, size, or other characteristics similar to those of the Company. During 2018, the CMDS Committee reviewed analyses of our competitors’ pay levels, including historical compensation data obtained from public filings and compensation surveys conducted by consultants on an unattributed basis, as well as compensation plan design.

Benchmarking Target CEO Pay

As discussed in Section 1.2, the CMDS Committee, in consultation with its independent compensation consultant, established a target range for 2018 compensation for the CEO of $28 million or more for performance exceeding expectations to $10 million or less for performance substantially below expectations. To inform its decision-making with respect to the appropriate target range, the CMDS Committee reviewed 2017 compensation levels for the 16 financial companies in the S&P 100 index (AIG, Allstate, American Express, BlackRock, Bank of New York Mellon, Capital One Financial, MasterCard, MetLife, Paypal, US Bancorp, VISA, and the five U.S. companies within the Comparison Group), which are intended to reflect institutions of similar size, scope, and complexity. The CMDS Committee then utilized the range of results as a benchmark from which to set the target range for 2018 compensation for the CEO.

Relative Pay Considerations

We place importance on the pay relationships among members of our Operating Committee because we view our Operating Committee members as highly talented executives capable of rotating among the leadership positions of our businesses and key functions. Our goal is always to be in a position to appoint our most senior executives from within our Company and to incent our people to aspire to senior executive roles. At year end, the CMDS Committee reviewed the relative differences between the compensation for the CEO and other NEOs and between the NEOs and other members of the Operating Committee.

Input and Recommendations from the CEO, Independent Directors and CMDS Committee’s  Independent Consultant

At the end of the year, Mr. Gorman presented the CMDS Committee with performance assessments and compensation recommendations for each NEO other than himself. The CMDS Committee reviewed these recommendations with its independent compensation consultant to assess whether they were reasonable compared with the market for executive talent and met in executive session to discuss the performance of our CEO and the other NEOs and to determine their compensation. In addition, the CMDS Committee and Board reviewed proposed NEO incentive compensation with Mr. Gorman, and the CMDS Committee reviewed CEO compensation with the Board (other than Mr. Gorman).

Compensation Expense Considerations

Prior to determining individual NEO incentive compensation, the CMDS Committee reviewed and considered the relationship between Company performance, total compensation expense (which includes fixed compensation costs such as base salaries, allowances, benefits, and commissions), and incentive compensation as a subset of overall compensation expense. This exercise furthers the balancing of the objectives of delivering returns for shareholders, while providing appropriate rewards to motivate superior individual performance.

Global Regulatory Principles

The Company’s compensation practices are subject to oversight by our regulators in the U.S. and internationally. For example, the Company is subject to the Federal Reserve Board’s (Federal Reserve) guidance that is designed to help ensure that incentive compensation paid by banking organizations does not encourage imprudent risk-taking that threatens the organizations’ safety and soundness. The Company is also subject to the compensation-related provisions of the Dodd-Frank Act, as well as the remuneration code of the U.K. Financial Conduct Authority and the U.K. Prudential Regulation Authority Rulebook, which prescribes the compensation structure for certain employees who are identified as material risk takers.

Tax Deductibility

Section 162(m) of the Internal Revenue Code (Section 162(m)) limits the tax deductibility of compensation for certain executive officers that is more than $1 million. Prior to the enactment of the Tax Cuts and Jobs Act, Section 162(m)

Performance against certain of the performance priorities is evaluated by the CMDS Committee on a relative basis to a comparison group comprised of Bank of America Corp., Barclays Plc, Citigroup Inc., Credit Suisse Group, Deutsche Bank AG, Goldman Sachs Group Inc., JPMorgan Chase & Co., and UBS AG (together with Wells Fargo & Company, Comparison Group). Our Comparison Group consists of companies that either directly compete with us for business and/or talent or are global organizations with scope, size, or other characteristics similar to those of the Company.
 

Compensation Market Data. The Company uses the Comparison Group to understand market practices and trends, evaluate the competitiveness of our compensation programs, and inform its compensation decisions. During 2015, the CMDS Committee reviewed analyses of our competitors’ pay levels, including historical compensation data obtained from public filings and compensation surveys conducted by consultants on an unattributed basis, as well as compensation plan design.

Benchmarking Target CEO Pay. As discussed in Section 1.2, the CMDS Committee, in consultation with its independent compensation consultant, established a target range for 2015 compensation for the CEO of $28 million or more for superior performance to $10 million or less for performance substantially below expectations. To inform its decision-making with respect to the appropriate target range, the CMDS Committee reviewed 2014 compensation levels for the following two sample groups, which are intended to reflect institutions of similar size, scope, and complexity: (i) the 13 financial companies in the S&P 100 (AIG, Allstate, American Express, Bank of New York Mellon, Capital One Financial, MasterCard, MetLife, US Bancorp, and the five U.S. companies within the Comparison Group), and (ii) the five U.S. companies within the Comparison Group. The CMDS Committee then utilized the range of results as a benchmark from which to set the target range for 2015 compensation for the CEO.

Input and Recommendations from the CEO, Independent Directors and CMDS Committee’s Independent Consultant. At the end of the year, Mr. Gorman presented the CMDS Committee with performance assessments and compensation recommendations for each NEO other than himself. The CMDS Committee reviewed these recommendations with the CMDS Committee’s independent compensation consultant to assess whether they were reasonable compared with the market for executive talent and met in executive session to discuss the performance of our CEO and the other NEOs and to determine their compensation. In addition, the CMDS Committee reviewed proposed NEO incentive compensation with the full Board (other than Mr. Gorman) in executive session.

Compensation Expense Considerations. Prior to determining individual NEO incentive compensation, the CMDS Committee reviewed and considered the relationship between Company performance, total compensation expense (which includes fixed compensation costs such as base salaries, allowances, benefits, and commissions), and incentive compensation as a subset of overall compensation expense. This exercise furthers the balancing of the objectives of delivering returns for shareholders and providing appropriate rewards to motivate superior individual performance.

Global Regulatory Principles.The Company’s compensation practices are subject to oversight by our regulators in the U.S. and internationally. Throughout 2015, senior management briefed the CMDS Committee on relevant regulatory developments, including with regard to the mix of incentive compensation and the portion of compensation that should be deferred for certain populations, as well as principles of balanced risk-taking. For example, the Company is subject to the Federal Reserve’s guidance that is designed to help ensure that incentive compensation paid by banking organizations does not encourage imprudent risk-taking that threatens the organizations’ safety and soundness. The Company is also subject to the compensation-related provisions of the Dodd-Frank Act and the remuneration code of the U.K. Prudential Regulatory Authority, which prescribes the deferred compensation structure for certain employees who are identified as “Code Staff.”

Morgan Stanley 20162019 Proxy Statement    4553



COMPENSATION MATTERS

Tableprovided an exemption from this deduction limitation for compensation that qualified as “performance-based compensation.” This exemption for “performance-based compensation” was repealed, effective for taxable years beginning after December 31, 2017. The CMDS Committee continues to have the flexibility to paynon-deductible compensation if it believes it is in the best interests of Contentsthe Company.

EXECUTIVE COMPENSATION


Relative Pay Considerations.We place importance on the pay relationships among members of our Operating Committee because we view our Operating Committee members as highly talented executives capable of rotating among the leadership positions of our businesses and key functions. Our goal is always to be in a position to appoint our most senior executives from within our Company and to incent our people to aspire to senior executive roles. At year-end, the CMDS Committee reviewed the relative differences between the compensation for the CEO and other NEOs and between the NEOs and other members of the Operating Committee.

Tax Deductibility.Section 162(m) of the Internal Revenue Code (Section 162(m)) limits the tax deductibility of compensation for certain executive officers (other than the CFO) that is more than $1 million, unless the compensation qualifies as “performance-based.” To qualify as “performance-based” compensation, the award must be based on objective, pre-established performance criteria approved by shareholders or otherwise qualify as “performance-based” under Section 162(m). While our policy, in general, is to maximize the tax deductibility of compensation paid to executive officers covered under Section 162(m), the CMDS Committee nevertheless may authorize awards or payments that might not be tax deductible if it believes they are in the best interests of the Company and its shareholders.

3.2 Evaluating Company and Individual Performance for Alignment with Executive Compensation

In determining the annual performanceincentive compensation of the CEO and other NEOs, the CMDS Committee weighed the Company’s achievement of its long-term strategic objectives, overall financial performance, progress toward long-term strategic objectives, and, as applicable, business unit performance. In 2018, Morgan Stanley’s overall 2015 financial performance was meaningfully improved, and the Company entered 2016 well positioned strategically and with strong capital and liquidity. The significant strategic progress and improved financial performance were however, not reflected in Morgan Stanley’s share price. Morgan Stanley’s TSRthe Company’s record financial performance, driven by growth in revenues and expense discipline, and the Company’s achievement of the ROE and ROTCE targets(14)(9)(10) was negative 17% for 2015, a challenging year for global financial firms. While ROE improved, it was still below expectations, and management has articulated a clear path to ROE improvement.. The CMDS Committee considered these results, as well as the performance indicated below, in determining compensation for our NEOs.

Strategic Objectives

During 2018, the Company achieved record revenues,pre-tax profit(11), and net income(12) and made substantial progress on its strategic objectives in connection with its overall strategy to continue to enhance shareholder returns, as well as other milestones:

Company

Strategic Objectives.o  Improved the Company’s Expense Efficiency RatioDuring 2015,(7) to 72% (below the objective of 73%)

oPBT(11) growth of $0.8 billion (an increase of 8% from 2017)

oBy executing on strategic objectives, over time the Company achieved several milestones in connection withcontinued to generate strong shareholder returns performing better than the average of its overall strategy to continue to enhance shareholder returns:global peers on a three and five-year basis(21)(22)(23)


Achieved Wealth Management pre-tax margin target of 22% in 2015(2).

oStrong returns and sufficient capital supported investment, with share repurchases of up to $4.9 billion and an increase in the quarterly common stock dividend to $0.30 per share from $0.25 per share (an increase of 20% from 2017)(8)(18)

oAchieved both ROE and ROTCE targets with an 11.5% ROE (an increase of 22% from 2017)(19)and a 13.2% ROTCE (an increase of 22% from 2017)(19)(20)

Business Segments

oExpanded Institutional Securities market penetration and leadership, achieving 8% net revenue operating growth(5) and increased wallet share across Investment Banking and Sales & Trading

oInvestment Banking achieved record net revenues and ranked #1 in Global Completed M&A, Global IPOs and Global Equity(25)

oAchievement of #1 ranking in Institutional Securities Equities revenue wallet share for the fifth consecutive year(14)

oWealth Management achieved record revenues, PBT(11) andpre-tax margin of 26.2%(4), reflecting continued operating leverage while investing in technology and digital offerings

oContinued execution of U.S. Bank strategy in Wealth Management and Institutional Securities to supportfocused on the dual mission of driving growth and enhancing stabilityin net interest income (46% total NII growth in U.S. Bank over the prior year) and lending (31% growth in Wealth Management lending in U.S. Bank over the prior year)(3)(26).

Progress toward a strategic solutionoContinued to advance Investment Management’s position for the Commodities franchise, with the sale of the Global Oil Merchantingbusiness.

Achievement of #1 ranking in Institutional Equitiesgrowth achieving 9% asset management revenue market share and #1 ranking globally in Initial Publicoperating growthOfferings, #2 ranking globally in Announced Mergers and Acquisitions and Global Equity(4).

Tailwind from lower funding costs as new debt issued at tighter spreads than maturing debt.

Reduction in the Institutional Securities compensation ratio excluding DVA to 37%, achieving the target of 39% orlower(5).
and positive long-term net flows(6)

54    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

Company Financial Performance(1)(2)

Management reviewed the Company’s forecasted 2018 financial performance with the CMDS Committee in December 2018, and the CMDS Committee assessed full-year actual financial results before finalizing compensation decisions in January 2019.

Received two-notch upgrade from Moody’s: Morgan Stanley’s long-term senior debt ratings increased from Baa2 toA3.

Company

Received non-objection from the Federal Reserve Board to the 2015 Capital Plan, which included share repurchase ofup to $3.1Bn and an increase in the quarterly common stock dividend to $0.15 per share from $0.10 per share.


Company Financial Performance.(6)(7)o  Management reviewed the Company’s forecasted 2015 financial performance with the CMDS Committee in December 2015, and the CMDS Committee assessed full-year actual financial results before finalizing compensation decisions in January 2016.


Company-wide. Morgan Stanley reported improved financial performance in 2015 over 2014. The CompanyreportedRecord net revenues of $35.2$40.1 billion and net income applicable to Morgan StanleyPBT(11) of $6.1$11.2 billion or $2.90 per diluted common share for 2015. Excluding the impact of DVA, for 2015 revenues were $34.5 billion and net income applicable to Morgan Stanley was $5.7 billion, or $2.70 per diluted common share. This2018 compared with net revenues

46    Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


of $34.3$37.9 billion and net income applicable to Morgan StanleyPBT(11) of $ 3.5$10.4 billion or $1.60 per diluted common share for 2014. Excluding the impact of DVA, for 2014 revenues were $33.6 billion2017

oResults reflect revenue and net income applicable to Morgan Stanley was $3.0 billion, or $1.39 per diluted common share(16)PBT growth across all business segments and continued expense discipline.

InstitutionalSecurities

Institutional Securities.o Institutional Securities reported pre-tax incomePBT of $4.7$6.3 billion in 2015, compared with pre-tax loss of $(58) million in the prior year. Excluding the impact of DVA, pre-tax income was $4.1 billion,2018 compared with a pre-tax lossPBT of $709 million in 2014(17). Results were driven by strong performance in its Sales and Trading businesses, partially offset by lower revenues in Investment Banking.

Wealth Management. Wealth Management reported pre-tax income from continuing operations of $3.3 billion compared with $3.0$5.6 billion in the prior year(11)

oResults were driven by record performance in Investment Banking and a pre-tax margincontinued strength across our Sales and Trading franchise

WealthManagement

(2)o  Record PBT of 22%$4.5 billion in 2018 compared with 20%$4.3 billion in 2014. Higher margins reflectedthe prior year(11), and apre-tax margin of 26.2% compared with 25.5% in the prior year(4)

oResults reflect strong management fees and continued execution of our U.S. Bank(26) strategy generating increased deposits and asset optimization, highernet interest income

InvestmentManagement

oPBT of $464 million in 2018 compared with $456 million in the prior year(11)

oResults reflect strong asset management fees and expense controls.
positive long-term flows
(6)

Individual Performance

In addition to the performance factors discussed above, the Committee considered the following individual contributions of the CEO and each other NEO:

James Gorman

Chief Executive Officer

Investment Management. Investment Management reported pre-tax income of $492 million in 2015 compared with$664 million in the prior year, and a pre-tax margin(2) of 21% compared with 24% in 2014. These results reflect lower investment revenues in the Merchant Banking and Real Estate Investing business.


Individual Performance. The Committee considered the following individual contributions of the CEO and each other NEO (other than Ms. Porat, who was not eligible to receive any incentive compensation for 2015 due to her departure from the Company):


Mr. Gorman’s continued outstandingOutstanding leadership of the Company, including: articulating and executing a Company-wide long-term strategy (with financial and non-financial goals) to enhance profitability and returns to shareholders;shareholders and developing strategic objectives to continue advancing the Company; contributing to record financial performance in 2018 driven by achievement of most of the multi-year performance objectives and demonstrating growth vs 2017; maintaining strong liquidity and capital positions; reducing expenses; maintainingpositions and sound risk management and controls; playing a leadershipcontinuing to act as an exceptional role model in respect of industry efforts to improveand Company culture and setconduct objectives while also strengthening employee morale and diversity; liaising with clients on a global basis to bring them the tone for enhancements to existing strong culture at the Company;full Company value proposition; and continuing to strengthen the Company’s reputation among employees,global regulators, research analysts, rating agencies, shareholders, clients and the media and regulators.

 

Colm Kelleher

President

Mr. Pruzan’s efforts

Leadership representing the Company on a global basis, including: playing a pivotal role representing the Company with sovereigns, clients, and regulators; overseeing Institutional Securities and Wealth Management, primarily responsible for record financial performance in 2018, with particularly strong results in global Equities, Investment Banking and Wealth Management; continued execution of the Company’s strategy, including with respect to strong financial controlsincreasing client wallet share, focusing on the U.S. Banks as a driver of stable revenues while continuing to invest in and processes;implement digital, advisory and banking platforms, and fostering collaboration between the businesses to grow relationships and revenues; and acting as a role model for employees instilling morale, encouraging diversity efforts and focusing on the Morgan Stanley culture through his nearly thirty years with the Company

Morgan Stanley 2019 Proxy Statement    55


COMPENSATION MATTERS

Jonathan Pruzan

Chief Financial Officer

Leadership of Finance, including: strengthening the budgetcapital management processes around risk identification, scenario design, assumptions and planningprocess that is consistent withmodels and transitioning to business as usual processes; a continued focus on managing expenses, enabling the Company’s strategic objectives; execution ofCompany to enhance its operating leverage; continuing to execute on an efficient liquidity and funding program that takes into account recent regulatory developments; driving successful capital management processes in accordance withaccounts for evolving regulatory requirements;developments, including aligning with the resolution and recovery plans; leading Company Strategy; continuing to strengthen the budget and planning process; fostering the strategic direction of the Finance Division and developing and recruiting exceptional talent, with a focus on improving diversity; and working closely with global and U.S. regulators, investors,research analysts, rating agencies, shareholders, and clients counterparties, and rating agencies.

Eric Grossman

Chief Legal Officer

Mr. Fleming’s strong business results for Wealth Management, including increased profit before tax and continuedmargin improvement in accordance with the Company’s long-term strategy; continued executionLeadership of the bank strategyLegal and Compliance Division, including: guidance and counsel to enhance bankingsenior management and lending services; and efforts to increase collaboration with Institutional Securities to enhance revenues.

Mr. Kelleher’s solid business results for Investment Banking and Equities Sales & Trading business in terms ofprofitability and revenue market share; right sizing Fixed Income and Commodities through the ongoing reduction of capital and expenses to provide for a critical and credible business for clients; completion of the exit from the physical oil business; increased collaboration with Wealth Management to enhance revenues; and continued successful management of his global role, global regulatory obligations, and client interactions across many jurisdictions.

Mr. Rosenthal’s role in advising the Board of Directors on business activities, significant litigation matters, strategic transactions, U.S. and Operating Committeeglobal regulatory relations; execution on and improvements to programs that foster ongoing compliance with applicable laws, regulations, rules, self-regulatory organization standards and codes of conduct, including the Company’s strategic and costreduction initiatives; leadershipimplementation of several support functions including Operations and Technology and Data; chairing of the Financial Holding Company Governance Committee that coordinates important cross-functional operational improvement and regulatory initiatives; and chairmannew technologies; execution of the Company’s U.S. bank subsidiariesculture objectives and spearheading the establishment of the Conduct Risk Framework while serving asco-chair of the Company’s Culture, Value & Conduct Committee; review of potentially significant franchise risks in connection with transactions, activities or clients as chair of the Global Franchise Committee; promotion of diversity and inclusion in the division; and expansion of the division’s pro bono program

Daniel Simkowitz

Head of Investment

Management

Leadership of Investment Management, including: contributing to strong year over year growth in management fees, net revenues and positive long-term flows(6); driving growth across a broad range of strategies with attractive economic and secular growth prospects including solutions, alternatives, high conviction equities and fixed income; deeply engaging with a global client base by strengthening coverage models, building strategic partnerships and collaborating on specific themes including ESG investing; focusing on integration of Mesa West Capital LLC (a premier commercial real estate credit platform), inorganic growth opportunities, and organic growth through product innovation, launching new products and scaling existing strategies across the business; engaging management across the organization, with a focus on profitable growthculture, diversity and heightened governance expectations.developing and retaining talent

56    Morgan Stanley 20162019 Proxy Statement


COMPENSATION MATTERS

     474. Compensation Decisions and Program



Table of Contents

EXECUTIVE COMPENSATION


4. Compensation Decisions and Program

4.1 Compensation Decisions

The table below shows the CMDS Committee’s 2018 compensation decisions for 2015 for the NEOs, and is different from the SEC required disclosure in the “2015“2018 Summary Compensation Table.”

Mr. GormanMr. PruzanMr. FlemingMr. KelleherMr. Rosenthal
Base Salary(a)$    1,500,000$    802,740$    1,000,000$    6,305,228$    1,000,000
Cash Bonus(b)$4,397,500$2,136,952$3,347,500$417,424$2,497,500
Deferred Equity Award (RSUs)(c)$4,626,250$1,390,702$5,451,250$3,158,001$1,751,250
Deferred Cash-based Award(d)$4,626,250$3,030,154$5,451,250$2,080,948$3,751,250
2016-2018 Performance-vested LTIP Award(e)$5,850,000$1,639,452$3,288,399$2,000,000
Total:$21,000,000$9,000,000$15,250,000$15,250,000$11,000,000

   Mr. Gorman  Mr. Kelleher  Mr. Pruzan  Mr. Grossman  Mr. Simkowitz 

 

Base Salary

 

 

 

$

 

 

1,500,000

 

 

 

 

 

 

$

 

 

1,200,000

 

 

 

 

 

 

$

 

 

1,000,000

 

 

 

 

 

 

$

 

 

1,000,000

 

 

 

 

 

 

$

 

 

1,000,000

 

 

 

 

 

Cash Bonus

 

 

 

$

 

 

6,875,000

 

 

 

 

 

 

$

 

 

6,200,000

 

 

 

 

 

 

$

 

 

4,340,000

 

 

 

 

 

 

$

 

 

3,590,000

 

 

 

 

 

 

$

 

 

4,340,000

 

 

 

 

 

Deferred Cash-based Award(a)

 

 

 

$

 

 

 

 

 

 

 

 

$

 

 

4,650,000

 

 

 

 

 

 

$

 

 

4,330,000

 

 

 

 

 

 

$

 

 

3,455,000

 

 

 

 

 

 

$

 

 

4,330,000

 

 

 

 

 

Deferred Equity Award (RSUs)(b)

 

 

 

$

 

 

6,875,000

 

 

 

 

 

 

$

 

 

6,510,000

 

 

 

 

 

 

$

 

 

1,430,000

 

 

 

 

 

 

$

 

 

1,305,000

 

 

 

 

 

 

$

 

 

1,430,000

 

 

 

 

 

2019-2021 Performance-vested LTIP Award(c)

 

 

 

$

 

 

13,750,000

 

 

 

 

 

 

$

 

 

7,440,000

 

 

 

 

 

 

$

 

 

2,900,000

 

 

 

 

 

 

$

 

 

2,150,000

 

 

 

 

 

 

$

 

 

2,900,000

 

 

 

 

 

Total:

 

 

 

$

 

 

    29,000,000

 

 

 

 

 

 

$

 

 

    26,000,000

 

 

 

 

 

 

$

 

 

    14,000,000

 

 

 

 

 

 

$

 

 

    11,500,000

 

 

 

 

 

 

$

 

 

    14,000,000

 

 

 

 

(a)As CFO effective May 1, 2015, Mr. Pruzan receives base salary of $1 million. Mr. Kelleher was identified as “Code Staff”

Deferred cash-based awards under the remuneration code of the U.K. Prudential Regulatory Authority for 2015Morgan Stanley Compensation Incentive Plan (MSCIP) are scheduled to vest and therefore, received base salary and fixed compensation in the form of allowances baseddistribute (and cancellation provisions lift) on his specific U.K. director and officer roles and responsibilities. For Mr. Kelleher, the amount shown includes base salary of £625,000 and fixed allowances of £3.5 million (for purposes of the table, such amounts were converted to U.S. dollars using the 2015 average of daily spot rates of £1 to $1.5285). Mr. Kelleher resigned from his U.K. director and officer roles effective February 5, 2016 in connection with his appointment as President of the Company and, therefore, will receive only a prorated portion of the fixed allowances for the period January 1, 2016 to February 5, 2016. As President of the Company, Mr. Kelleher receives base salary of $1.2 million retroactive to January 1, 2016.27, 2021.

(b)Mr. Kelleher’s cash bonus was paid in British pounds sterling in the amount of £273,087 (such amount was converted from U.S. dollars using the 2015 average of daily spot rates of $1 to £0.6542).
(c)

Mr. Gorman received 183,678158,795 RSUs, Mr. Kelleher received 150,365 RSUs, Mr. Pruzan received 55,21533,029 RSUs, Mr. FlemingGrossman received 216,433 RSUs, Mr. Kelleher received 125,38330,142 RSUs, and Mr. RosenthalSimkowitz received 69,53033,029 RSUs (in each case, calculated using the volume-weighted average price of Company common stock of $25.1867$43.29 on January 20, 2016,18, 2019, the grant date). The RSUs are scheduled to vest and convert to shares of Company common stock (and cancellation provisions lift) on January 28, 2019, except27, 2022; provided that 82,62050% of Mr. Kelleher’s RSUs areGorman’s RSU award is scheduled to vest and convert to shares of Company common stock in three equal annual installments and 42,762 of Mr. Kelleher’s RSUs are scheduledon January 27, 2021 to vest and convert to shares of Company common stock in July 2016 (in each case, as prescribedalign with the schedule for MSCIP awards received by the U.K. Prudential Regulatory Authority).other NEOs.

(d)(c)Deferred cash-based awards under the Morgan Stanley Incentive Compensation Plan (MSCIP) are scheduled to vest and distribute (and cancellation provisions lift) on January 22, 2018, except that Mr. Kelleher’s award is scheduled to vest and distribute (and cancellation provisions lift) in three equal annual installments (as prescribed by the U.K. Prudential Regulatory Authority).
(e)

The target number of performance stock units underlying the LTIP award granted to Mr. Gorman is 232,265317,591 stock units, to Mr. Kelleher is 171,845 stock units, to Mr. Pruzan is 65,09166,982 stock units, to Mr. KelleherGrossman is 130,56049,659 stock units and to Mr. RosenthalSimkowitz is 79,40666,982 stock units (in each case, calculated using the volume-weighted average price of Company common stock of $25.1867$43.29 on January 20, 2016,18, 2019, the grant date). Mr. Fleming did not receive an LTIP award pursuant to his separation and release agreement with the Company, described below, in light of his ceasing to be a member of our Operating Committee as of January 6, 2016.

Ms. Porat is not included in the table above because she did not receive a bonus for 2015 or a 2016-2018 LTIP award, and only received base salary for 2015, as a result of her departure from the Company on April 30, 2015. In view of her contributions to the Company over her 28-year career, Ms. Porat was treated as retirement-eligible upon her departure for purposes of her outstanding deferred awards as described in the “Potential Payments upon Termination or Change-in-Control” section of this proxy statement.

The CMDS Committee approved a separation and release agreement with Mr. Fleming dated January 22, 2016 that provides that his 2015 bonus compensation be comprised of the elements in the table above, and that he is entitled to receive benefits as described in “Potential Payments upon Termination or Change-in-Control.”

48    Morgan Stanley 20162019 Proxy Statement    57



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


4.2 Annual Compensation Program Elements

The following chart provides a brief summary of the principal elements of the Company’s 2015 annual2018 compensation program for our NEOs. Each NEO receives a base salary and is eligible to receive discretionary annual performanceincentive compensation for prior-year performance. Annual performanceincentive compensation is intended to reward NEOs for achievement of the Company’s financial and strategic objectives over the prior year and is delivered in a mix of a cash bonus aand deferred compensation in the form of deferred equity award, and, afor NEOs other than the CEO, deferred cash-based award.awards. The LTIP awards, which are deferred equity awards that are subject to future achievement of specified financial goals over a three-year period, are described in Section 4.3 “Long-Term Incentive Program”.Program.”

Purpose
  PurposeFeatures

Base Salary*Salary

Base salary reflectsoReflects level of experience and responsibility and is intended

oIntended to be competitive with salaries for comparable positions at competitors.competitors

Base salaries are reviewedoReviewed periodically and are subject to change for, among other reasons, a change in responsibilities or the competitive environment.environment

oUnchanged for NEOs in 2018

Cash Bonus

Paying a portion of compensation in cash bonus is alignedoAligned with competitive pay approaches.approaches

The portion of cash bonus is intendedoIntended to be consistent with practice among the Comparison Group. Group

oHigher compensated employees continue to be subject to higher deferral levels.levels

Deferred Equity Award 
— RSUs

Equity awards linkoLink realized value to shareholder returns and the terms

oTerms of the awards support retention objectives and mitigate excessive risk-taking over a three-year deferral period.period

Awards are subjectoSubject to cancellation for competition, cause (i.e.(i.e., any act or omission that constitutes a breach of obligation to the Company, including failure to comply with internal compliance, ethics or risk management standards, and failure or refusal to perform duties satisfactorily, including supervisory and management duties), disclosure of proprietary information, and solicitation of employees or clients.clients

Deferred Cash-Based Award –
MSCIPo

The terms of deferred cash-based awards support retention objectives and mitigate excessive risk-taking. The awards provide a cash incentive with a rate of return based upon notional reference investments over a two-year deferral period.

Awards are subjectSubject to clawback if an employee’s act or omission (including with respect to direct supervisory responsibilities) causes a restatement of the Company’s consolidated financial results, constitutes a violation of the Company’s global risk management principles, policies and standards, or causes a loss of revenue associated with a position on which the employee was paid and the employee operated outside of internal control policies.policies

Awards tooFor Operating Committee members (including NEOs) are, also subject to clawback if the CMDS Committee determines that the Operating Committee member had significant responsibility for a material adverse outcome for the Company or any of its businesses or functions.functions

**o  For LTIP, see also Section 4.3 “Long-Term Incentive Program”


*Mr. Kelleher was identified as “Code Staff” under the remuneration code of the U.K. Prudential Regulatory Authority for 2015 and, therefore, also received fixed compensation in the form of allowances based on his specific U.K. director and officer roles and responsibilities. Allowances are payable annually in cash and/or in shares of Company common stock at the end of the relevant year, subject to specified terms and conditions.
 
**Deferred Cash-Based Award — MSCIPIn addition, as “Code Staff,” Mr. Kelleher’s

oProvide a cash bonusincentive with a rate of return based upon notional reference investments over atwo-year deferral period

oTerms of awards support retention objectives and deferred incentive compensation awarded in January 2015 in respectmitigate excessive risk-taking

Performance-Vested Award — LTIP

o  Link realized value to future performance against strategic goals and shareholder returns

oTerms of 2014awards support retention objectives and mitigate excessive risk-taking over a three-year performance and in January 2016 in respect of 2015 performance are subject to clawback and repayment in certain circumstances for a minimum period of seven years following grant under the Company’s Code Staff Clawback Policy.

58    Morgan Stanley 20162019 Proxy Statement49



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


4.3 Long-Term Incentive Program

The 2016-20182019–2021 LTIP awards tie a meaningful portion of each NEO’s compensation to the Company’s long-term financial performance and reinforce the NEO’s accountability for the achievement of the Company’s financial and strategic goals by directly linking the ultimate realizable award value to prospective performance against core financial measures over a three-year period.

General Terms

The 2019-2021 LTIP awards will vest and convert to shares of the Company’s common stock at the end of the three-year performance period only if the Company achieves predetermined performance goals with respect to ROE and relative TSR, as set forth below, over the period beginning January 1, 2019 and ending December 31, 2021. These performance goals are consistent with, and drive, Morgan Stanley’s long-term strategy, reflective in the strategic objectives in Section 1.1 and the performance priorities in Section 3.1. While each participant was awarded a target number of performance stock units, the actual number of units earned could vary from zero, if performance goals are not met, to up to 1.5 times target, if performance goals are meaningfully exceeded. No participant will receive any portion of the LTIP award if the threshold performance goals are not met. The CMDS Committee increased the return on equity goals for the 2019–2021 LTIP award from 10% to 11% to earn the target payout of 1 times this portion of the award, from 11.5% to 12.5% to earn a maximum payout of 1.5 times this portion of the award, and from less than 5% to less than 6% for cancellation of this portion of the award without payout.

The LTIP awards remain subject to cancellation upon certain events until they are converted to shares of Company common stock. If, after conversion of the LTIP awards, the CMDS Committee determines that the performance certified by the CMDS Committee was based on materially inaccurate financial statements, then the shares delivered will be subject to clawback by the Company.

Performance Goals

One-half of the target LTIP award is earned based on the Company’s average ROE over the three-year performance period (MS Average ROE). The other half of the target LTIP award is earned based on the Company’s TSR over the three-year period (MS TSR) relative to the TSR of the S&P 500 Financials Index over the three-year period (Index Group TSR). The number of stock units ultimately earned will be determined by multiplying each half of the target award by a multiplier as follows:

MS Average ROE*

  Multiplier    Relative TSR**  Multiplier 

12.5% or more

   1.50   25% or more   1.50 

11%

   1.00   0%   1.00 

6%

   0.50   -50%   0.50 

Less than 6%

   0.00   Less than-50%   0.00 

General Terms. The 2016-2018 LTIP awards will vest and convert to shares of the Company’s common stock at the end of the three-year performance period only if the Company achieves predetermined performance goals with respect to ROE and relative TSR, as set forth below, over the period beginning January 1, 2016 and ending December 31, 2018. While each participant was awarded a target number of performance stock units, the actual number of units earned could vary from zero, if performance goals are not met, to up to 1.5 times target, if performance goals are meaningfully exceeded. No participant will receive any portion of the LTIP award if the threshold performance goals are not met.

The LTIP awards remain subject to cancellation upon certain events until they are converted to shares of Company common stock. If, after conversion of the LTIP awards, the CMDS Committee determines that the performance certified by the CMDS Committee was based on materially inaccurate financial statements, then the shares delivered will be subject to clawback by the Company.

Performance Goals. One-half of the target LTIP award is earned based on the Company’s average ROE over the three-year performance period (MS Average ROE). The other half of the target LTIP award is earned based on the Company’s TSR over the three-year period (MS TSR) relative to the TSR of the S&P 500 Financials Index over the three-year period (Index Group TSR). The number of stock units ultimately earned will be determined by multiplying each half of the target award by a multiplier as follows:


  MS Average ROE*     Multiplier              Relative TSR**     Multiplier  
  11.5% or more1.50    25% or more1.50  
  10%1.00    0%1.00  
  5%0.50    -50%0.50  
  Less than 5%0.00    Less than -50%0.00  

*

MS Average ROE, for this purpose, excludesexcludes: (a) the impact of DVA(16); (b) certain gains or losses associated with the sale of specified businesses,businesses; (c) specified goodwill impairments, (d) certain gains or losses associated with specified legal settlements relating to business activities conducted prior to January 1, 2011,2011; and (e)(d) specified cumulativecatch-up adjustments resulting from changes in, or application of, a new accounting rule that are not applied on a full retrospective basis. If MS Average ROE is between two of the thresholds noted in the table, the number of stock units earned will be determined by straight-line interpolation between the two thresholds.

 
**

Relative TSR is determined by subtracting the Index Group TSR from the MS TSR; however, if performance for the period is negative, the multiplier may not exceed 1.00. If Relative TSR is between two of the thresholds noted in the table, the number of stock units earned will be determined by straight-line interpolation between the two thresholds.

As described in further detail in note 2 to the “2015“2018 Grants of Plan-Based Awards, Table,” each of our NEOs (including Ms. Porat, but excluding Mr. Pruzan) received an LTIP award in 20152018 on similar terms as described above. Additionally, as described in note 3 to the “2015“2018 Option Exercises and Stock Vested, Table,” LTIP awards granted in 20132016 (2016 LTIP award) vested at 134.77%105.91% of target, based on performance over the three-year performance period ended December 31, 2015.2018. Since the inception of the program in 2009, the average of the payouts of all LTIP awards up to and including the 2016 LTIP awards is 88% of target.

Morgan Stanley 2019 Proxy Statement    59


COMPENSATION MATTERS

4.4 Additional Compensation and Benefits Information

Clawback Policies and Procedures. The Company’s independent control functions (the Internal Audit, Legal, Risk, Human Resources and Finance departments) take part in a formalized review process for identifying and evaluating situations occurring throughout the course of the year that could require clawback or cancellation of previously awarded compensation, as well as downward adjustments to current year compensation. Clawbacks of previously awarded compensation are reviewed quarterly with a committee of senior management (currently the Chief Legal Officer, CRO, Chief Human Resources Officer, COO, and Chief Compliance Officer) and reported to the CMDS Committee. In addition, the Global Incentive Compensation Discretion Policy, which was adopted by the CMDS Committee in 2011, sets forth standards for managers on the use of discretion when making annual compensation decisions and considerations for assessing risk management and outcomes.

50Clawback Policies and Procedures

Throughout the year, employee conduct matters that are escalated through the Company’s Global Conduct Risk Program are reviewed to determine whether they present situations that could require clawback or cancellation of previously awarded compensation, as well as downward adjustments to current year compensation. Clawbacks of previously awarded compensation are reviewed quarterly with the Employee Discipline Oversight Committee (a committee of senior management currently composed of the CFO, CLO, CRO, Chief Human Resources Officer (CHRO), and Chief Compliance Officer) and reported to the CMDS Committee. In addition, the Global Incentive Compensation Discretion Policy adopted by the CMDS Committee sets forth standards for managers on the use of discretion when making annual compensation decisions and considerations for assessing risk management and outcomes. Further, the Company’s control functions conduct a semi-annual review of employee conduct with respect to risk and control matters, and are asked to identify inappropriate behavior that may not be captured through other Company processes. The results of the reviews are reflected in performance feedback and considered in compensation decisions.

No Severance orChange-in-Control TaxGross-Up Protection

NEOs are not contractually entitled to cash severance payments upon termination of employment or to any golden parachute excise tax protection upon achange-in-control of Morgan Stanley.

Health and Insurance Benefits

All NEOs are eligible to participate in Company-sponsored health and insurance benefit programs available in the relevant jurisdiction to similarly situated employees. In the U.S., higher compensated employees pay more to participate in the Company’s medical plan. NEOs are also eligible to participate in Morgan Stanley’s Executive Health Program, under which each NEO is eligible to receive Company-funded access to a private primary care physician offeringon-call services and an annual executive health care assessment. Upon retirement, NEOs are eligible for Company-paid retiree health coverage for themselves and eligible dependents following any termination of employment.

Pension and Retirement

Company-provided retirement benefits in the U.S. include atax-qualified 401(k) plan (401(k) Plan) and a frozentax-qualified pension plan (the Employees Retirement Plan (ERP)). Certain NEOs may also be eligible to participate in the Company’s frozen Supplemental Executive Retirement and Excess Plan (SEREP). The SEREP, which was originally intended to compensate for the limitations imposed under the ERP and Internal Revenue Code, was amended in 2014 to cease further benefit accruals. No NEO is awarded with credited service in excess of his/her actual service under the ERP or the SEREP. Pension and retirement benefits provided to NEOs are discussed in further detail under “2018 Pension Benefits.”

Personal Benefits

The Company provides personal benefits to certain of the NEOs for competitive and security reasons. The Company’s Board-approved policy authorizes the CEO to use the Company’s aircraft. As of January 1, 2010, Mr. Gorman entered into a time-share agreement with the Company permitting him to reimburse the Company for the incremental cost of his personal use of the Company’s aircraft. Mr. Kelleher, in connection with his relocation from the U.K. to the U.S. in 2016, receives a housing allowance and tax preparation services. Personal benefits provided to NEOs are discussed in further detail under “2018 Summary Compensation Table.”

Share Usage

Morgan Stanley pays a significant portion of incentive compensation as deferred equity awards, which aligns the interests of the Company’s employees with those of its shareholders. The Company strives to maximize employee and shareholder alignment through the use of deferred equity awards, while minimizing dilution. The Company’s share repurchase program offsets the dilutive impact of these additional shares.

60    Morgan Stanley 20162019 Proxy Statement



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


No Severance or Change-in-Control Tax Gross-Up Protection.

5. Notes to the Compensation Discussion and AnalysisNEOs are not contractually entitled to cash severance payments upon termination of employment or to any golden parachute excise tax protection upon a change-in-control of Morgan Stanley.

Health and Insurance Benefits.All NEOs are eligible to participate in Company-sponsored health and insurance benefit programs available in the relevant jurisdiction to similarly-situated employees. In the U.S., higher compensated employees pay more to participate in the Company’s medical plan. NEOs are also eligible to participate in Morgan Stanley’s Executive Health Program, under which each NEO is eligible to receive Company-funded access to a private primary care physician offering on-call services and an annual executive health care assessment. Upon retirement, NEOs are eligible for Company-paid retiree medical coverage for themselves and eligible dependents following any termination of employment.

Pension and Retirement.Company-provided retirement benefits in the U.S. include a tax-qualified 401(k) plan(401(k) Plan) and a frozen tax-qualified pension plan (the Employees Retirement Plan (ERP)). Certain NEOs may also be eligible to participate in the Company’s frozen Supplemental Executive Retirement and Excess Plan (SEREP). The SEREP, which was originally intended to compensate for the limitations imposed under the ERP and Internal Revenue Code, was amended in 2014 to cease further benefit accruals. No NEO is awarded with credited service in excess of his/her actual service under the ERP or the SEREP.

Personal Benefits.The Company provides personal benefits to certain of the NEOs for competitive and security reasons. The Company’s Board-approved policy authorizes the CEO to use the Company’s aircraft. As of January 1, 2010, Mr. Gorman entered into a time-share agreement with the Company permitting him to reimburse the Company for the incremental cost of his personal use of the Company aircraft. On February 25, 2016, the CMDS Committee approved that Mr. Kelleher, in connection with his relocation from the U.K. to the U.S., would receive standard relocation benefits and continuation of his housing allowance. Personal benefits provided to NEOs are discussed in further detail under the “2015 Summary Compensation Table.”

Share Usage.Morgan Stanley pays a significant portion of incentive compensation as deferred equity awards, which aligns the interests of the Company’s employees with those of its shareholders. The Company strives to maximize employee and shareholder alignment through the use of deferred equity awards, while minimizing dilution. Since 2009, the Company has requested approval of a number of additional shares that we anticipate will be sufficient to cover only one year of grant needs. The Company has evaluated, as it does annually, whether to return to shareholders to request approval of additional shares at the 2016 annual meeting of shareholders and has determined to request 20 million shares to cover one year of grant needs – this is less than the 59 million shares the Company repurchased in 2015.


5. Notes to the Compensation Discussion and Analysis

The following notes are an integral part of the Company’s financial and operating performance described in this CD&A:

(1)U.S. Bank refers to the Company’s U.S. Bank operating subsidiaries Morgan Stanley Bank, N.A. and Morgan Stanley Private Bank, National Association, and excludes transactions with affiliated entities.
(2)Pre-tax margin is calculated as income (loss) from continuing operations before taxes as a percentage of net revenues. Pre-tax margin is a non- GAAP financial measure that the Company considers useful for investors to assess operating performance.
(3)Net interest income (NII) growth in U.S. Bank represents the total year-over-year NII percentage increase for the Company’s U.S. Bank operating subsidiaries. The increase in Wealth Management lending reflects the year-over-year growth in securities-based, tailored, and residential real estate loans conducted through the U.S. Bank.
(4)Institutional Equities revenue market share is based on the sum of the reported net revenues for the equity sales and trading businesses of Morgan Stanley and the companies within the Comparison Group (excluding Wells Fargo & Company); where applicable, the reported net revenues exclude DVA. Equity sales and trading net revenues, ex-DVA is a non-GAAP financial measure that the Company considers useful for investors to allow better comparability of period to period operating performance. The Company’s capital markets rankings are reported by Thomson Reuters as of January 4, 2016 for the period of January 1, 2015 to December 31, 2015.
(5)Institutional Securities compensation ratios, ex-DVA of 37% and 48% for 2015 and 2014, respectively, represent the segment’s compensation and benefits expense (2015: $6,467 million; 2014: $7,786 million) as a percentage of net revenues, ex-DVA (2015: $17,335 million, excluding the positive impact of $618 million from DVA; 2014: $16,220 million, excluding the positive impact of $651 million from DVA). The 2014 compensation ratio of 42% also excludes $904 million of compensation and benefits expense associated with the 2014 compensation actions. For further information regarding the incentive compensation actions taken in 2014, see pages 68 and 69 of the 2015 Form 10-K. The Institutional Securities compensation ratio, ex-DVA and the impact of the 2014 compensation actions, are non-GAAP financial measures the Company considers useful for investors to assess operating performance.

Morgan Stanley 2016 Proxy Statement51



Table of Contents

EXECUTIVE COMPENSATION


(6)A detailed analysis of the Company’s financial and operational performance for 20152018 is contained in the Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the 2015Company’s 2018 Form10-K.

(7)(2)

Information provided in this CD&A may include certainnon-GAAP financial measures. The definition of such financial measures and/or the reconciliation of such measures to the comparable GAAP figures is included in either the 20152018 Form10-K or herein.

(8)(3)DVA

2018 Results represent results against the 2018—2019 Strategic Objectives established at the beginning of 2018.

(4)

Pre-tax margin represents the change in fair value of certain of the Company’s long-term and short-term borrowings outstanding resultingincome (loss) from the fluctuation in the Company’s credit spreads and other credit factors. The Company believes that most investors assess its operating performance exclusive of DVA.

continuing operations before income taxes divided by net revenues.Pre-tax margin is a(9)non-GAAPNet revenues and pre-tax profit exclude the impact of DVA for each of the years presented. Positive (negative) revenues from DVA were: $618 million in 2015; $651 million in 2014; ($681) million in 2013; ($4,402) million in 2012; and $3,681 million in 2011. Net revenues and pre-tax profit, ex-DVA are non-GAAP financial measuresmeasure that the Company considers useful for analysts, investors and other stakeholders to assess operating performance.

(10)(5)Pre-tax profit in 2014 includes litigation costs related to residential mortgage-backed securities

Operating growth rate percentages for Institutional Securities (ISG) net revenue and credit crisis matters of $3,083 million, 2014 compensation actions of approximately $1,137 million, and a funding valuation adjustment implementation charge of $468 million. For further information regarding these items, see page 39Investment Management (IM) asset management revenue exclude the impact of the 20152018 gross ups which resulted from the adoption of the accounting update,Revenue from Contracts with Customers (Revenue Recognition). See Note 2 to the financial statements included in the 2018 Form 10-K.10-K for information on the adoption of the Revenue Recognition accounting update. In determining the growth rate percentages approximately $320 million was excluded from ISG 2018 net revenues and approximately $78 million was excluded from IM 2018 asset management revenues. Growth rate percentages excluding the impact of the adoption of the Revenue Recognition accounting update arenon-GAAP financial measures the Company considers useful for analysts, investors and other stakeholders to assess year-over-year operating performance.

(11)(6)

Long-term net flows include the equity, fixed income and alternative/other asset classes and exclude the liquidity asset class.

(7)

Company Expense Efficiency Ratio represents totalnon-interest expenses as a percentage of net revenues.

(8)

In June 2018, we received a conditionalnon-objection to our Capital Plan, where the only condition was that our capital distributions not exceed the greater of the actual distributions we made over the previous four calendar quarters, or the annualized average of actual distributions over the previous eight calendar quarters. Our 2018 Capital Plan includes the repurchase of up to $4.7 billion of outstanding common stock for the four quarters beginning in the third quarter of 2018 through the end of the second quarter of 2019, as well as an increase in the Company’s quarterly common stock dividend to $0.30 per share from the previous $0.25 per share that commenced with the dividend announced on June 28, 2018. The total amount of expected 2018 capital distributions is consistent with the $6.8 billion of actual dividends and gross share repurchases included in our 2017 Capital Plan.

(9)

The calculation of ROE usesreturn on average common equity (ROE), for both the medium term target and 2018 results, utilizes net income from continuing operations applicable to Morgan Stanley less preferred dividends as a percentage of average common equity. To determineequity, exclusive of intermittent discrete tax items. The 2018 ROE ex-DVAresult excludes intermittent net discrete tax benefits of approximately $203 million, which resulted in an approximate 30 basis point reduction in ROE. When excluding intermittent net discrete tax benefits, both the numerator and denominator were adjustedare adjusted. Beginning in 2017, income tax consequences associated with employee share-based awards are recognized in the provision for income taxes in the income statement, but are excluded from the intermittent net discrete tax items adjustment, as we anticipate conversion activity each year. ROE excluding intermittent discrete tax items is anon-GAAP financial measure that the Company considers useful for analysts, investors and other stakeholders to excludeassess operating performance.

(10)

The calculation of return on average tangible common equity (ROTCE), for both the impactsmedium term target and 2018 results, utilizes net income applicable to Morgan Stanley less preferred dividends as a percentage of DVA.average tangible common equity, exclusive of intermittent discrete tax items. Tangible Common Equity (TCE) equals common equity less goodwill and intangible assets net of allowable mortgage servicing rights. The 2018 ROTCE result excludes intermittent net discrete tax benefits of approximately $203 million, which resulted in an approximate 30 basis point reduction in ROTCE. When excluding intermittent net discrete tax benefits, both the ROE and ROE, ex-DVAROTCE numerators and denominators are adjusted. Beginning in 2017, income tax consequences associated with employee share-based awards are recognized in the provision for income taxes in the income statement, but are excluded from the intermittent net discrete tax items adjustment, as we anticipate conversion activity each year. ROTCE excluding intermittent discrete tax items and TCE arenon-GAAP financial measures that the Company considers useful for analysts, investors and other stakeholders to assess operating performance.

(11)

Pre-tax profit (PBT) represents income (loss) from continuing operations before income taxes. PBT is anon-GAAP financial measure that the Company considers useful for analysts, investors and other stakeholders to assess operating performance.

(12)

Net Income represents net income applicable to Morgan Stanley.

(13)ROE, ex-DVA is one of the measures the CMDS Committee utilizes to evaluate the Company’s financial performance. The 2015 ROE, ex-DVA of 8.0% differs from the operating ROE, ex-DVA measure of 7.0% referred to by the Company in the 2016 Strategic Update included as Exhibit 99.3 to the Company’s Current Report on Form 8-K dated January 19, 2016.

The calculation of operating ROE excludesfor 2017 utilizes net income applicable to Morgan Stanley less preferred dividends as a percentage of average common equity, exclusive of intermittent discrete tax items. For the impactsreconciliation of DVAROE, excluding intermittent discrete tax items for the year 2017, see pages 29 and 30 of the 2018 Form10-K. When excluding intermittent net discrete tax benefits recognized by the Company initems, both the ROE numerator and denominator. The impact ofdenominator are adjusted. Beginning in 2017, income tax consequences associated with employee share-based awards are recognized in the provision for income taxes in the income statement, but are excluded from the intermittent net discrete tax benefitsitems adjustment, as we anticipate conversion activity each year. ROE, excluding intermittent discrete tax items is anon-GAAP financial measure that the Company considers useful for analysts, investors and other stakeholders to assess year-over-year operating performance.

(14)

Institutional Securities Equity revenues market share is based on ROE, ex-DVA was: 0.8%the reported 2018 net revenues for the equity sales and trading businesses of Morgan Stanley and the following global peer companies: Goldman Sachs, JP Morgan Chase, Bank of America, Citigroup, Barclays, UBS Group, Deutsche Bank, and Credit Suisse.

(15)

Company Expense Efficiency Ratio represents totalnon-interest expenses as a percentage of net revenues (or in 2015; 3.3%2013, net revenues, excluding debt valuation adjustments (DVA)). For 2013, the Expense Efficiency Ratio was calculated asnon-interest expenses of $27,935 million, divided by net revenues of $33,174 million, which excludes the negative impact of $681 million from DVA. The Expense Efficiency Ratio, excluding DVA is anon-GAAP financial measure the Company considers useful for analysts, investors and other stakeholders to assess year-over-year operating performance.

(16)

DVA represents the change in 2014; 0.6%fair value resulting from the fluctuations in 2013; 0.2% in 2012;the Company’s credit spreads and 0.8% in 2011.other credit factors related to liabilities carried at fair value under the fair value option, primarily certain long-term and short-term borrowings. The Company believes that

Morgan Stanley 2019 Proxy Statement    61


COMPENSATION MATTERS

 analysts, investors and other stakeholders assess its operating performance exclusive of DVA. Effective January 1, 2016, pursuant to new accounting guidance that the Company adopted, gains and losses from DVA are presented in other comprehensive income (i.e., a component of common equity) as opposed to net revenues and net income. Prior to January 1, 2016, gains and losses from DVA are presented in trading revenues (i.e., a component of Net Revenues).

(13)(17)ROE, ex-DVA in 2014 includes

Pre-tax profit represents income (loss) from continuing operations before income taxes.Pre-tax profit for 2013 excludes the after taxnegative impact of $681 million from DVA.Pre-tax profit andPre-tax profit, excluding DVA arenon-GAAP financial measures the costsCompany considers useful for analysts, investors and charges discussed in note (10)other stakeholders to assess year-over-year operating performance.

(18)

Share repurchases represent actual sharesre-acquired during the year noted, representing a blend of two sequential Comprehensive Capital Analysis Review cycles.

(19)

The calculations of ROE and ROTCE for each year utilize net income applicable to Morgan Stanley less preferred dividends as a percentage of average common equity and average tangible common equity, respectively, exclusive of intermittent discrete tax items. The 2018 ROE and ROTCE percentages exclude intermittent net discrete tax benefits of $2,226 million.approximately $203 million (an approximate 30 basis point reduction). For further information regarding thesereconciliations of ROE and ROTCE, excluding intermittent discrete tax items for the years 2016 through 2018, see pages 3929 and 4030 of the 20152018 Form10-K. When excluding intermittent net discrete tax items, both the ROE and ROTCE numerators and denominators are adjusted. Beginning in 2017, income tax consequences associated with employee share-based awards are recognized in the provision for income taxes in the income statement, but are excluded from the intermittent net discrete tax items adjustment, as we anticipate conversion activity each year. ROE and ROTCE, excluding intermittent discrete tax items arenon-GAAP financial measures that the Company considers useful for analysts, investors and other stakeholders to assess year-over-year operating performance.

(14)(20)TSR

Tangible Common Equity (TCE) equals common equity less goodwill and intangible assets net of allowable mortgage servicing rights. TCE is anon-GAAP financial measure that the Company considers useful for analysts, investors and other stakeholders to assess capital adequacy.

(21)

Total shareholder return represents the change in share price over a period of time plus the dividends paid during such period, expressed as a percentage of the share price at the beginning of such period.period (defined herein as TSR).

(15)(22)

Source of TSR percentages and averages: Bloomberg.

(23)

Global peers include the following eight companies: Goldman Sachs, JP Morgan Chase, Bank of America, Citigroup, Barclays, UBS Group, Deutsche Bank, and Credit Suisse. Source TSR for global peers: Bloomberg.

(24)

Over the 20132016 to 20152018 period, Mr. Gorman’s realizable pay increased only slightly atdecreased approximately 1%4% compared to his pay as reported in the “2018 Summary Compensation TableTable” for the relevant years, and the Company’s three-year total TSR for the same period is 72%33%. Realizable pay for this period was $59.3$69.4 million, while Summary Compensation Table compensation for this period was $58.5$72.1 million. Realizable pay reflects the current value of the sum of base salary, cash bonus, stock awards and optionstock awards disclosed in the 2013, 2014,2016, 2017, and 20152018 proxy statements. For purposes of this calculation, equity awards were valued using the closing price of Morgan Stanleythe Company’s common stock on December 31, 2015, option awards were valued based on intrinsic value2018, and performance-vested awards were valued based on performance at target.

(16)(25)Company net revenues, ex-DVA, net income applicable

The Company’s capital markets rankings are reported by Thomson Reuters as of January 4, 2019 for the period of January 1, 2018 to December 31, 2018.

(26)

U.S. Bank refers to the Company’s U.S. Bank operating subsidiaries Morgan Stanley ex-DVA,Bank, N.A. and earnings per diluted common share, ex-DVA, are non- GAAP financial measures thatMorgan Stanley Private Bank, National Association, and excludes transactions with Morgan Stanley parent and the Company considers useful measures for investors to assess operating performance. For further information regarding these measures, see pages 42 and 43 of the 2015 Form 10-K.

(17)Institutional Securities pre-tax profit, ex-DVA excludes positive revenues from DVA of $618 million and $651 million in 2015 and 2014, respectively. Pre-tax profit, ex-DVA is a non-GAAP financial measure that the Company considers useful for investors to assess operating performance.bank subsidiaries.

Compensation, Management Development and Succession Committee ReportCOMPENSATION, MANAGEMENT DEVELOPMENT AND SUCCESSION COMMITTEE REPORT

We, the Compensation, Management Development and Succession Committee of the Board of Directors of Morgan Stanley, have reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy statement. Based on such review and discussions, we have recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement and incorporated by reference into the Company’s Annual Report on Form10-K for the year ended December 31, 20152018 filed with the SEC.

Respectfully submitted,

Hutham S. Olayan, Chair
Erskine B. Bowles
Klaus Kleinfeld
James W. Owens

Thomas H. Glocer

Dennis M. Nally

Rayford Wilkins, Jr.

5262    Morgan Stanley 20162019 Proxy Statement



Table of Contents

EXECUTIVE


COMPENSATION MATTERS


EXECUTIVE COMPENSATION TABLES

The following tables summarize the compensation of our NEOs (including for this purpose, our former CFO, Ms. Porat) in the format specified by the SEC.

2015 Summary Compensation Table

2018 Summary Compensation Table

Pursuant to SEC rules, the following table is required to include for a particular year only those stock awards and option awards grantedduring the year, rather than awards grantedafter year-end year end that were awarded for performance in that year. Through 2015, ourOur annual equity awards relating to performance in a year are made shortly after year-end.year end. Therefore, compensation in the table includes not onlynon-equity compensation awarded for services in the applicable year but, in the case of stock awards and option awards granted in the years reported in the table, compensation awarded for performance in prior years and forward-looking performance-vested compensation. A summary of the CMDS Committee’s decisions on the compensation awarded to our NEOs for 20152018 performance can be found in the CD&A.

  Name and
Principal Position
     Year     Salary
($)
(1)
          Bonus
($)
(1)(2)
          Stock
Awards
($)
(3)(4)
     Option
Awards
($)
     Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings
($)
(5)
     All Other
Compensation
($)
(6)
     Total
($)
  
James P. Gorman
Chairman and
Chief Executive Officer
20151,500,0009,023,75011,250,320149,572192,41022,116,052
20141,500,00010,077,32511,241,190195,398256,13123,270,044
20131,500,0005,408,0004,349,3442,624,999497,89328,32714,408,563
Jonathan Pruzan*
Executive Vice President
and Chief Financial Officer
2015802,7405,167,1063,472,27513,86410,6009,466,585
 
 
Ruth Porat*
Former Executive Vice
President and
Chief Financial Officer
2015333,3336,295,26260,32253,3906,742,307
20141,000,0005,901,3257,476,460388,31316,74614,782,844
20131,000,0003,623,0005,439,51925,30716,10310,103,929
Gregory J. Fleming*
Executive Vice President
and President of Wealth
Management
20151,000,0008,798,7507,948,62920,95617,768,335
20141,000,0007,293,3259,147,18117,440,506
20131,000,0004,473,0003,479,4752,425,00011,377,475
Colm Kelleher*
Executive Vice President
and President of

Institutional Securities
20156,305,228(7)2,498,372(8)8,621,073353,568272,75018,050,991
20146,795,3862,825,4959,348,854735,935317,12720,022,797
2013978,1024,293,2253,479,4752,411,665792,321385,31312,340,101
James A. Rosenthal
Executive Vice President
and Chief Operating Officer
20151,000,0006,248,7505,468,57932,25212,749,581
20141,000,0005,205,3256,474,02712,38410,40012,702,136
20131,000,0003,113,0003,189,5192,024,99710,2009,337,716

Name and

Principal Position

  Year   Salary
($)(1)
   Bonus
($)(1)(2)
   Stock
Awards
($)(3)(4)
   Option
Awards
($)
   Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings
($)(5)
   All Other
Compensation
($)(6)
   Total
($)
 

 

James P. Gorman

Chairman and Chief

Executive Officer

  

 

 

 

 

2018

 

 

 

 

  

 

 

 

 

1,500,000

 

 

 

 

  

 

 

 

 

6,875,000

 

 

 

 

  

 

 

 

 

19,748,977

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

44,662

 

 

 

 

  

 

 

 

 

28,168,639

 

 

 

 

  

 

 

 

 

2017

 

 

 

 

  

 

 

 

 

1,500,000

 

 

 

 

  

 

 

 

 

11,568,250

 

 

 

 

  

 

 

 

 

11,383,777

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

12,777

 

 

 

 

  

 

 

 

 

44,918

 

 

 

 

  

 

 

 

 

24,509,722

 

 

 

 

  

 

 

 

 

2016

 

 

 

 

  

 

 

 

 

1,500,000

 

 

 

 

  

 

 

 

 

9,698,750

 

 

 

 

  

 

 

 

 

9,958,913

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

8,971

 

 

 

 

  

 

 

 

 

39,201

 

 

 

 

  

 

 

 

 

21,205,835

 

 

 

 

 

Colm Kelleher*

President

  

 

 

 

 

2018

 

 

 

 

  

 

 

 

 

1,200,000

 

 

 

 

  

 

 

 

 

10,850,000

 

 

 

 

  

 

 

 

 

11,686,900

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

381,468

 

 

 

 

  

 

 

 

 

24,118,368

 

 

 

 

  

 

 

 

 

2017

 

 

 

 

  

 

 

 

 

1,200,000

 

 

 

 

  

 

 

 

 

13,328,750

 

 

 

 

  

 

 

 

 

6,943,628

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

330,128

 

 

 

 

  

 

 

 

 

21,802,506

 

 

 

 

  

 

 

 

 

2016

 

 

 

 

  

 

 

 

 

1,666,041

 

 

 

 

  

 

 

 

 

10,949,126

 

 

 

 

  

 

 

 

 

6,155,595

 

 

 

 

  

 

 

 

 

 

 

 

 

  

 

 

 

 

191,059

 

 

 

 

  

 

 

 

 

416,667

 

 

 

 

  

 

 

 

 

19,378,488

 

 

 

 

Jonathan Pruzan

Executive Vice President

and Chief Financial Officer

   2018    1,000,000    8,670,000    5,031,435            11,000    14,712,435 
   2017    1,000,000    6,548,750    3,173,519        45,583    44,335    10,812,187 
   2016    1,000,000    5,348,750    2,885,171        24,092    10,600    9,268,613 

Eric F. Grossman*

Executive Vice President

and Chief Legal Officer

   2018    1,000,000    7,045,000    4,604,015            47,416    12,696,431 
   2017    1,000,000    5,948,750    3,072,864        12,786    43,048    10,077,448 
                                        

Daniel A. Simkowitz

Head of Investment

Management

   2018    1,000,000    8,670,000    5,588,351            14,216    15,272,567 
   2017    1,000,000    7,148,750    3,576,139        59,608    13,698    11,798,195 
   2016    1,000,000    5,948,750    3,497,606        34,093    13,284    10,493,733 

*On March 28, 2019, the Company announced that Mr. Kelleher informed the Company of his decision to retire from his position as President effective June 30, 2019. Mr. Grossman was not an NEO for 2016.

*(1)Mr. Pruzan was elected CFO effective May 1, 2015, following Ms. Porat’s departure from the Company on April 30, 2015. Effective January 6, 2016, Mr. Kelleher was elected President of Morgan Stanley and Mr. Fleming ceased to be one of our Executive Vice Presidents and our President of Wealth Management.

Morgan Stanley 2016 Proxy Statement53



Table of Contents

EXECUTIVE COMPENSATION


(1)Includes any elective deferrals to the Company’s employee benefit plans.

(2)For 2015,2018, includes 20152018 annual cash bonus paid in February 20162019 and awards granted in January 20162019 under MSCIP for performance in 2015:2018:

  Name       2015 Cash Bonus
($)
       2015 MSCIP Award
($)
       Total
($)
  
James P. Gorman4,397,5004,626,2509,023,750
Jonathan Pruzan2,136,9523,030,1545,167,106
Ruth Porat
Gregory J. Fleming3,347,5005,451,2508,798,750
Colm Kelleher417,4242,080,9482,498,372
James A. Rosenthal2,497,5003,751,2506,248,750

Name

  2018 Cash Bonus
($)
     2018 MSCIP Award
($)
     Total
($)
 

James P. Gorman

   6,875,000            6,875,000 

Colm Kelleher

   6,200,000      4,650,000      10,850,000 

Jonathan Pruzan

   4,340,000      4,330,000      8,670,000 

Eric F. Grossman

   3,590,000      3,455,000      7,045,000 

Daniel A. Simkowitz

   4,340,000      4,330,000      8,670,000 

With the exception of Mr. Kelleher’s award, the 2015The 2018 MSCIP awards are scheduled to vest and be distributed on January 22, 2018. Mr. Kelleher’s 2015 MSCIP award is scheduled to vest and be distributed according to the following schedule as prescribed by the U.K. Prudential Regulatory Authority: 1/3 on January 23, 2017, 1/2 of remaining balance on January 22, 2018, and the remaining balance on January 28, 2019.27, 2021. MSCIP awards are subject to cancellation and clawback. For further details on 20152018 MSCIP awards, see the CD&A.

(3)For 2015,2018, consists of RSUs granted on January 21, 201519, 2018 for performance in 2014 and2017 (2017 RSUs), forward-looking 2015 LTIP awards granted on January 21, 2015,19, 2018 (2018 LTIP awards), the realizable value of which is dependent entirely on the satisfaction of predeteminedpredetermined performance goals over a three-year performance period.period, and incremental fair value recognized in 2018 upon the amendment of LTIP awards granted in 2015, 2016 and 2017 to account for the impact of the enactment of tax reform under the Tax Cuts and Jobs Act. For further details, on 2014 RSUs and 2015 LTIP awards, see “2015“2018 Grants of Plan-Based Awards Table.Awards.

Morgan Stanley 2019 Proxy Statement    63


COMPENSATION MATTERS

(4)Represents aggregate grant date fair value of stock unit awards granted during the applicable period and, for service during2018, the prior year,incremental fair value described in note 3 above computed as well as forward-looking performance-based compensation, determinedof the modification date in accordance with the applicable accounting guidance for equity-based awards.FASB ASC Topic 718.

  
The following table lists the aggregate grant date fair value of stock unit awards granted to the NEOs during 2015.2018. The aggregate grant date fair value of RSUs included in the table2017 RSUs is based on the volume-weighted average price of the common stock on the grant date, and the aggregate grant date fair value of 20152018 LTIP awards included in the table is based on the volume-weighted average price of the common stock on the grant date and the probable outcome of the performance conditions as of the grant date, in each case, as determined in accordance with applicable accounting guidance for equity-based awards.date. The value of the 20152018 LTIP awards on the grant date, assuming that the highest level of performance conditions will be achieved, is $9,750,000$19,125,000 for Mr. Gorman; $5,850,000 for Ms. Porat; $7,200,000 for Messrs. Fleming and Kelleher; and $5,175,000$9,810,000 for Mr. Rosenthal.Kelleher; $3,225,000, for Mr. Pruzan; $2,850,000 for Mr. Grossman; and $3,675,000 for Mr. Simkowitz.

Stock Unit Awards Granted During 2015 ($)
  Name       2014 RSUs       2015 LTIP Awards       Total  
James P. Gorman4,422,6756,827,64511,250,320
Jonathan Pruzan3,472,2753,472,275
Ruth Porat2,198,6754,096,5876,295,262
Gregory J. Fleming2,906,6755,041,9547,948,629
Colm Kelleher3,579,1195,041,9548,621,073
James A. Rosenthal1,844,6753,623,9045,468,579
    Stock Unit Awards Granted
During 2018 ($)
 

Name

  2017 RSUs   2018 LTIP Awards   Total 

James P. Gorman

   1,181,750    16,943,912    18,125,662 

Colm Kelleher

   1,931,250    8,691,229    10,622,479 

Jonathan Pruzan

   1,801,250    2,857,209    4,658,459 

Eric F. Grossman

   1,651,250    2,524,976    4,176,226 

Daniel A. Simkowitz

   1,901,250    3,255,889    5,157,139 

For further information on the valuation of the Company’s RSU and LTIP awards, see notes 2and 18to the consolidated financial statements included in the 2015 Form 10-K.

54Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


For further information on the valuation of the Company’s RSU and LTIP awards, see notes 2 and 18 to the consolidated financial statements included in the 2018 Form10-K.

(5)The following table lists the change in pension value and the amount of anyNo NEO had above-market earnings on nonqualified deferred compensation plansawards in 2018 and each NEO had a decrease in his pension value for the NEOs for 2015. Negative amounts included below are reflected as zero in the “2015 Summary Compensation Table”.

       Name       2015
Change in
Pension Value
($)(a)
       2015 Above-Market
Earnings on
Nonqualified
Deferred
Compensation
($)(b)
  
James P. Gorman(3,737)149,572
Jonathan Pruzan(16,640)13,864
Ruth Porat48,16212,160
Gregory J. Fleming
Colm Kelleher108,935244,633
James A. Rosenthal

(a)The “20152018 (2018 Change in Pension Value”Value). The decrease in the 2018 Change in Pension Value for each NEO is set forth in the following table.

Name

2018 Change in Pension Value ($)

James P. Gorman

(5,341)

Colm Kelleher

(112,316)

Jonathan Pruzan

(27,127)

Eric F. Grossman

(7,380)

Daniel A. Simkowitz

(32,855)

The 2018 Change in Pension Value equals the aggregate increasechange from December 31, 20142017 to December 31, 20152018 in the actuarially determined present value of the accumulated benefit under the Company-sponsored defined benefit pension plans during the measurement period. Mr. Gorman and Mr. PruzanEach NEO experienced a decrease in the present value of theirhis accumulated benefits from December 31, 20142017 to December 31, 20152018 primarily due to an increase in the discount rates described below and the plans’Company’s adoption of a new mortality table. The present value of Ms. Porat’s benefit increased because she commenced her benefit during 2015 prior to age 60, receiving early retirement subsidies. The value of Mr. Kelleher’s benefit increased due to a decrease in interest rates and the applicable exchange rate. The present values at December 31, 20152018 are based on theRP-2014 white collar mortality tables rolled back to 2006 with projection ScaleRP-2014 and then projected generationally with Scale MP-2015MP-2018 and discount rates of 4.49%4.26% for the ERP and 4.20%4.16% for the SEREP. The present values at December 31, 20142017 are based on theRP-2014 white collar mortality tables rolled back to 2006 with projection ScaleRP-2014 and then projected generationally with Scale MP-2014MP-2017 and discount rates of 4.07%3.66% for the ERP 3.83%and 3.53% for the Excess Plan component and 3.80% for the Supplemental Executive Retirement Plan (SERP) component of the SEREP. Present values are determined using an interest-only discount before retirement. Post-retirement discounts are based on interest and mortality. For each plan, the assumed benefit commencement date is the earliest age at which the NEO can receive unreduced benefits under that plan or current age, if greater.

(b)Represents the difference between market interest rates determined pursuant to SEC rules and the earnings credited on deferred compensation.
(6)The “All Other Compensation” column for 20152018 includes (a) contributions made by the Company under our defined contribution plans with respect to such period and (b) the incremental cost to the Company of perquisites and other personal benefits, as detailed below. In addition, our NEOs may participate on the same terms and conditions as other investors in investment funds that we may form and manage primarily for client investment, except that we may waive or lower applicable fees and charges for our employees.

 
(a)Messrs. Gorman, Pruzan and Rosenthal and Ms. Porat eachEach NEO received a matching contribution in the 401(k) Plan for 20152018 of $10,600. Ms. Porat$11,000 and Mr. Simkowitz also received a pension transition contribution in the 401(k) Plan for 20152018 of $6,845.$3,216.

 
(b)Mr. Gorman’s amount includes $153,588 in variable cost related to the use of the Company’s aircraft for one emergency round trip flight to Australia due to a death in Mr. Gorman’s family. Variable cost includes landing, parking and flight planning expenses; crew travel expenses; supplies and catering; aircraft fuel and oil expenses per hour of flight; maintenance, parts and external labor per hour of flight; and customs, foreign permits and similar fees, and does not include fixed costs of leasing and operating the Company aircraft. The Company imputed income to Mr. Gorman for this flight and did not provide a tax gross-up for such imputed income.
 
For Messrs. Gorman’s, Fleming’sGorman and Rosenthal’s amounts each includeGrossman, includes $20,000 related to participation infor the Company’s Executive Health Program. Ms. Porat’s amountFor Mr. Kelleher, includes $33,008 paid by$219,966 for housing payments and $143,183 for tax services related to his relocation to the U.S. The “All Other Compensation” column also includes the incremental cost to the Company (consistent with Company practice for all SEREP participants) in satisfaction of the employee portion of Federal Insurance Contributions Act (FICA) taxes due upon commencement of payment of her SEREP benefit. Mr. Kelleher’s amount includes $216,180 related to housing, as well as costs associated with Company-paid medical coverage, airport fees, and tax preparation services arising from his former expatriation assignment. For each NEO, amounts also include costs associated with the use of a Company car or a car service, travel staff and mealsassistance with travel arrangements, guest travel on business flights, and for Messrs. Gorman and Rosenthal, use of the Company travel booking service.
(7)in-office meals.For 2015, Mr. Kelleher’s base salary was £625,000 and his fixed allowances were £3,500,000. For further details on Mr. Kelleher’s 2015 fixed allowances, see the CD&A. The amount of British pounds sterling was converted to U.S. dollars using the 2015 average of daily spot rates of £1 to $1.5285.
(8)Mr. Kelleher’s 2015 cash bonus paid in February 2016 was $417,424, which was paid in British pounds sterling in the amount of £273,087. The amount of U.S. dollars was converted to British pounds sterling using the 2015 average of daily spot rates of $1 to £0.6542.

64    Morgan Stanley 20162019 Proxy Statement


COMPENSATION MATTERS

552018 Grants of Plan-Based Awards(1)



Table of Contents

EXECUTIVE COMPENSATION


2015 Grants of Plan-Based Awards Table(1)

The following table sets forth information with respect to RSUs granted to the NEOs in January 20152018 for 20142017 performance (2017 RSUs) and 2015 LTIP awards granted in January 20152018 for forward-looking performance.performance (2018 LTIP awards), and incremental fair value recognized on prior year LTIP awards in February 2018.

Grant Date
(mm/dd/yyyy)

Approval
Date
(mm/dd/yyyy)



Estimated Future Payouts
Under Equity Incentive Plan
Awards(2)

   

All Other
Stock
Awards:
Number of
Shares of
Stock or
Units
(#)(3)

All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)

Exercise
or Base
Price of
Option
Awards
($/Sh)

Grant Date
Fair Value
of Stock
and Option
Awards
($)
(4)

Name

Threshold
(#)

Target
(#)

Maximum
(#)

James P. Gorman1/21/20151/6/20150187,950281,9266,827,645
 1/21/20151/6/2015127,8834,422,675
Jonathan Pruzan1/21/20151/6/2015100,4023,472,275
Ruth Porat1/21/20151/6/20150112,770169,1554,096,587
 1/21/20151/6/201563,5752,198,675
Gregory J. Fleming1/21/20151/6/20150138,794208,1915,041,954
 1/21/20151/6/201584,0482,906,675
Colm Kelleher1/21/20151/6/20150138,794208,1915,041,954
 1/21/20151/6/2015103,4923,579,119
James A. Rosenthal1/21/20151/6/2015099,758149,6373,623,904
 1/21/20151/6/201553,3391,844,675

Name

 Grant Date
(m/d/yyyy)
  

Approval

Date
(m/d/yyyy)

  

 

Estimated Future Payouts
Under Equity Incentive Plan
Awards(2)

  All Other
Stock
Awards:
Number of
Shares of
Stock or
Units
(#)(3)
  All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
  Exercise
or Base
Price of
Option
Awards
($/Sh)
  Grant Date
Fair Value
of Stock
and Option
Awards
($)(4)
 
 Threshold
(#)
  Target
(#)
  Maximum
(#)
 

James P. Gorman

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

0

 

 

 

224,324

 

 

 

336,487

 

 

 

 

 

 

 

 

 

 

 

 

16,943,912

 

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

 

 

 

 

 

 

 

 

 

20,791

 

 

 

 

 

 

 

 

 

1,181,750

 

  

 

2/26/2018

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,623,315

 

Colm Kelleher

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

0

 

 

 

115,065

 

 

 

172,598

 

 

 

 

 

 

 

 

 

 

 

 

8,691,229

 

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

 

 

 

 

 

 

 

 

 

33,978

 

 

 

 

 

 

 

 

 

1,931,250

 

  

 

2/26/2018

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,064,420

 

Jonathan Pruzan

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

0

 

 

 

37,827

 

 

 

56,741

 

 

 

 

 

 

 

 

 

 

 

 

2,857,209

 

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

 

 

 

 

 

 

 

 

 

31,691

 

 

 

 

 

 

 

 

 

1,801,250

 

  

 

2/26/2018

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

372,976

 

Eric F. Grossman

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

0

 

 

 

33,428

 

 

 

50,143

 

 

 

 

 

 

 

 

 

 

 

 

2,524,976

 

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

 

 

 

 

 

 

 

 

 

29,052

 

 

 

 

 

 

 

 

 

1,651,250

 

  

 

2/26/2018

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

427,789

 

Daniel A. Simkowitz

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

0

 

 

 

43,105

 

 

 

64,658

 

 

 

 

 

 

 

 

 

 

 

 

3,255,889

 

 

 

1/19/2018

 

 

 

1/5/2018

 

 

 

 

 

 

 

 

 

 

 

 

33,450

 

 

 

 

 

 

 

 

 

1,901,250

 

  

 

2/26/2018

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

431,212

 

(1)

The 20152018 LTIP awards included in this table are also disclosed in the “Stock Awards” column of the “2015“2018 Summary Compensation Table” and the “2015“2018 Outstanding Equity Awards at Fiscal Year-End Table.Year-End. The 2017 RSU awards included in this table are also disclosed in the “Stock Awards” column of the “2015“2018 Summary Compensation Table,” the “2015“2018 Option Exercises and Stock Vested Table”Vested” and other than Mr. Kelleher’s Stock Bonus Award (described in note 3 below), the “2015“2018 Nonqualified Deferred Compensation Table.Compensation.” The 20152018 LTIP awards and 2017 RSUs were granted under the Morgan Stanley 2007 Equity Incentive Compensation Plan. All 2017 RSUs and 20152018 LTIP awards are subject to cancellation if a cancellation event occurs at any time prior to the scheduled conversion date. For further details on cancellation and clawback of awards, see “Potential Payments Uponupon Termination orChange-in-Control.”

56     Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


The incremental fair value included in this table was recognized on February 26, 2018 upon the amendment of LTIP awards granted in 2015, 2016 and 2017 to account for the impact of the enactment of tax reform under the Tax Cuts and Jobs Act, and is also disclosed in the “Stock Awards” column of the “2018 Summary Compensation Table.”

(2)

The 20152018 LTIP awards are scheduled to vest and convert to shares in 20182021 only if the Company satisfies predetermined performance goals over the three-year performance period consisting of 2015, 20162018, 2019 and 2017. 2020.One-half of the target 20152018 LTIP award is earned based on the Company’s average ROE over the three-year performance period (MS Average ROE). The other half of the target 20152018 LTIP award is earned based on the Company’s TSR over the three-year period (MS TSR) relative to the TSR of the S&P 500 Financials Index over the three-year period (Index Group TSR). The number of stock units ultimately earned will be determined by multiplying each half of the target award by a multiplier as follows:

follows, provided that in no event may the multiplier exceed 1.0 if MS TSR for the performance period is negative.

    MS Average ROE*Multiplier                            Relative TSR**Multiplier
11.5% or more1.50 25% or more1.50
10%1.00 0%1.00
5%0.50-50%0.50
Less than 5%0.00 Less than -50%0.00

MS Average ROE*

  Multiplier      Relative TSR**  Multiplier 

11.5% or more

   1.50    25% or more   1.50 

10%

   1.00    0%   1.00 

5%

   0.50    -50%   0.50 

Less than 5%

   0.00    Less than-50%   0.00 

 *

MS Average ROE, for this purpose, excludes (a) the impact of DVA (see Section 5 of the CD&A, note 16 for the definition of DVA), (b) certain gains or losses associated with the sale of specified businesses, (c) specified goodwill impairments, (d) certain gains or losses associated with specified legal settlements relating to business activities conducted prior to January 1, 2011, and (e)(d) specified cumulativecatch-up adjustments resulting from changes in accounting principles that are not applied on a full retrospective basis. If MS Average ROE is between two of the thresholds noted in the table, the number of stock units earned will be determined by straight-line interpolation between the two thresholds.

    
****

Relative TSR will be determined by subtracting the Index Group TSR from the MS TSR. In no event may the multiplier exceed 1.0 if MS TSR for the performance period is negative. If Relative TSR is between two of the thresholds noted in the table, the number of stock units earned will be determined by straight-line interpolation between the two thresholds.

Morgan Stanley 2019 Proxy Statement    65


COMPENSATION MATTERS

 

Each NEO is entitled to receive cash dividend equivalents on the 20152018 LTIP awards, subject to the same vesting, cancellation and payment provisions as the underlying award.

 

(3)

With the exception of Mr. Kelleher’s awards, the

The 2017 RSUs are scheduled to convert to shares on January 22, 2018. Mr. Kelleher’s RSUs are scheduled to convert to shares in three equal installments on each of January 20, 2016, January 23, 2017 and January 22, 2018, except that 32,878 of Mr. Kelleher’s RSUs (the Stock Bonus Award) plus reinvested dividend equivalents vested and converted to shares on July 21, 2015 as prescribed by the U.K. Prudential Regulatory Authority. With the exception of Mr. Kelleher’s Stock Bonus Award, the NEOs are27, 2021. Each NEO is retirement-eligible under the award terms at grant and, therefore, the awards are considered vested at grant for purposes of this proxy statement. The NEOs are entitled to receive dividend equivalents in the form of additional RSUs, subject to the same vesting, cancellation and payment provisions as the underlying RSUs.

(4)

Represents the aggregate grant date fair value of the 2017 RSUs and 2018 LTIP awards and the incremental fair value of the LTIP awards granted in 2015, 2016 and 2017 described in note 1 above computed as of the modification date in accordance with the applicable accounting guidance for equity-based awards, of the RSUs and 2015 LTIP awards.FASB ASC Topic 718. The aggregate grant date fair value of the 2017 RSUs granted on January 21, 2015 is based on $34.5835,$56.8372, the volume-weighted average price of the common stock on the grant date. The aggregate grant date fair value of 20152018 LTIP awards is based on the volume-weighted average price of the common stock on the grant date as well as the probable outcome of the performance conditions as of January 21, 2015.the grant date. For further information on the valuation of the Company’s RSUs and LTIP awards, see notes 2 and 18 to the consolidated financial statements included in the 20152018 Form10-K.

Morgan Stanley 2016 Proxy Statement     2018 Outstanding Equity Awards at FiscalYear-End57



Table of Contents

EXECUTIVE COMPENSATION


2015 Outstanding Equity Awards at Fiscal Year-End Table


The following table discloses the number of shares covered by unexercised stock options and unvested stock awards held by our NEOs on December 31, 2015.2018.

Option Awards Stock Awards
NameNumber of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
(1)(2)
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
(1)
Option
Exercise
Price
($)
(2)
Option
Expiration
Date
(mm/dd/yyyy)
Number
of Shares
or Units
of Stock
That
Have Not
Vested
(#)
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested
(#)
(3)
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested
($)
(3)
James P. Gorman354,98651.75522/17/2016370,83411,796,255
56,77266.72612/12/2016
424,73130.011/21/2018
 323,214161,61322.981/22/2018
Total1,159,703161,613370,83411,796,255
Jonathan Pruzan6,76566.72612/12/2016
Total6,765
Ruth Porat23,73766.72612/12/2016234,6937,465,589
182,02730.011/21/2018
Total205,764234,6937,465,589
Gregory J. Fleming60,67530.011/21/2018286,1179,101,402
198,588149,30022.981/22/2018
Total259,263149,300286,1179,101,402
Colm Kelleher144,55166.72612/12/2016286,1179,101,402
182,02730.011/21/2018
296,946148,47922.981/22/2018
Total623,524148,479286,1179,101,402
James A. Rosenthal121,35130.011/21/2018206,4406,566,883
249,336124,67322.981/22/2018
Total370,687124,673206,4406,566,883

   Option Awards  Stock Awards 

Name

 Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
  Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
  Option
Exercise
Price
($)
  Option
Expiration
Date
(mm/dd/yyyy)
  Number
of Shares
or Units
of Stock
That
Have Not
Vested
(#)
  Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)
  Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested
(#)(1)
  Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested
($)(2)
 

James P. Gorman

                    558,115   22,129,278 

Colm Kelleher

                    330,490   13,103,968 

Jonathan Pruzan

                    116,545   4,621,025 

Eric F. Grossman

                    108,188   4,289,681 

Daniel A. Simkowitz

                    131,498   5,213,919 

(1)

The stock option awards in this table vested and became exercisable as follows:


Option
Expiration Date
(mm/dd/yyyy)
Exercisability Schedule
2/17/201660% of the award became exercisable on 2/17/2006 and 40% of the award became exercisable on 2/16/2007
 12/12/201650% of the award became exercisable on each of 1/2/2009 and 1/2/2010
1/21/2018One-third of the award became exercisable on each of 2/2/2012, 2/2/2013 and 2/2/2014
1/22/2018One-third of the award became exercisable on each of 1/27/2014, 1/26/2015 and 1/25/2016

(2)

Stock options were granted with an exercise price equal to the fair market value of the Company’s common stock on the date of grant.


58     Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


(3)Represents the target numberConsists of performance stock units granted underunderlying LTIP awards held by the 2014 LTIP award and 2015 LTIP award that are realizable in connection with the achievement of pre-established performance targets over the applicable three-year performance period.NEOs. The NEOs may ultimately earn up toa maximum of 1.5 times the target number of performance stock units orand a minimum of nothing, based on the Company’s performance over the performance period. The 2015In accordance with SEC rules, the number of performance stock units reflected in the table represents the maximum number of units that may be earned under the LTIP award granted on January 18, 2017 (2017 LTIP award) and the 2018 LTIP award. For both the 2017 LTIP awards and 20142018 LTIP awards, the number of performance stock units reflected in the table exceeds the amount that would have been earned based on Company performance through December 31, 2018. Based on Company performance through December 31, 2018, 105.49% and 120.57% of the target number of units granted under the 2017 LTIP award and 2018 LTIP award, respectively, would have been earned by the NEO (see “2018 Grants of Plan-Based Awards” for the target number of performance stock units granted under the 2018 LTIP award). The 2017 LTIP awards and 2018 LTIP awards are scheduled to vest and convert to shares in 20182020 and 2017,2021, respectively, only if the Company satisfies the predetermined performance goals (see note 2 to the “2015“2018 Grants of Plan-Based Awards Table”Awards” for 20152018 LTIP award performance goals).

(2)The market value of the performance units is based on $31.81,$39.65, the closing price of the Company’s common stock on December 31, 2015.2018.

2015

66    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

2018 Option Exercises and Stock Vested Table


The following table contains information about the stock options exercised by NEOs during 20152018 and the RSUs and LTIP awards held by the NEOs that vested during 2015.2018.

  Option AwardsStock Awards
Name     Number of
Shares Acquired
on Exercise
(#)
     Value Realized on
Exercise ($)
     Number of
Shares Acquired
on Vesting
(#)
(1)
     Value Realized on
Vesting ($)
 James P. Gorman127,8834,422,675(2)  
221,2107,082,879(3)
Jonathan Pruzan100,4023,472,275(2)
 
Ruth Porat63,5752,198,675(2)
162,2205,194,090(3)
Gregory J. Fleming84,0482,906,675(2)
176,9685,666,303(3)
Colm Kelleher70,6132,442,077(2)
176,9685,666,303(3)
33,0971,325,892(4)
James A. Rosenthal53,3391,844,675(2)
162,2205,194,090(3)

Option AwardsStock Awards

Name

Number of
Shares Acquired
on Exercise
(#)

Value Realized on
Exercise

($)

Number of   

Shares Acquired   

on Vesting   

(#)(1)

Value Realized on
Vesting

($)

James P. Gorman

20,791   

1,181,750(2)

245,991   

9,698,444(3)

Colm Kelleher

33,978   

1,931,250(2)

138,276   

5,451,685(3)

Jonathan Pruzan

31,691   

1,801,250(2)

68,937   

2,717,972(3)

Eric F. Grossman

29,052   

1,651,250(2)

63,915   

2,519,938(3)

53,486(4)

2,812,350(4)

152,254(5)

7,964,948(5)

Daniel A. Simkowitz

33,450   

1,901,250(2)

82,410   

3,249,122(3)

(1)ConsistsExcept as set forth in notes 4 and 5, consists of the 2017 RSUs, granted on January 21, 2015 for 2014 performance, which are considered vested at grant for purposes of this proxy statement due to the NEOs’ retirement eligibility, and performance stock units underlying the 2016 LTIP awards, granted on January 31, 2013, which are considered vested on December 31, 20152018 (the last day of the three-year performance period) for purposes of this proxy statement, based on the Company’s performance over the performance period (2013 LTIP awards).period. For further details on the 2017 RSUs, see note 3 to the “2015“2018 Grants of Plan-Based Awards Table.Awards.

(2)The aggregate grant date fair value of thesethe 2017 RSUs is based on $34.5835,$56.8372, the volume-weighted average price of the Company’s common stock on the grant date.

(3)The value realized is based on $32.0188,$39.4258, the volume-weighted average price of the Company’s common stock on December 31, 2015,2018, which is the last trading day of the 20132016 LTIP awards’ performance period, for 134.77%105.91% of the target number of units underlying the 20132016 LTIP awards. The 20132016 LTIP awards converted to shares of common stock on February 25, 2016.
26, 2019.

(4)Consists of 102.765% of the target number of performance stock units underlying the LTIP award granted on January 21, 2015 (2015 LTIP award) that vested on January 1, 2018, the scheduled vesting date of the award, and converted to shares of common stock on February 27, 2018. The value realized is based on $40.0608,$52.58, the volume-weighted average price of the Company’s common stock on July 21, 2015,December 29, 2017 (the most immediately preceding trading day prior to January 1, 2018).

(5)Consists of RSUs that are considered vested for purposes of this proxy statement on January 3, 2018, the date on which the award vestedMr. Grossman became retirement-eligible pursuant to itsthe terms of the awards. The value realized is based on $52.3134, the volume-weighted average price of the Company’s common stock on January 3, 2018. 66,042 of these RSUs also converted to shares of the Company’s common stock on January 19, 2018, pursuant to their terms. The remaining 86,212 RSUs will convert to shares of the Company’s common stock on their respective scheduled conversion dates, subject to cancellation and clawback.

Morgan Stanley 2016 Proxy Statement     592018 Pension Benefits



Table of Contents

EXECUTIVE COMPENSATION


2015 Pension Benefits Table


The table below discloses the present value of accumulated benefits payable to each NEO and the years of service credited to each NEO under the Company’s defined benefit retirement plans as of December 31, 2015.2018. The material terms and conditions of these plans are described below.

NamePlan NameNumber of
Years
Credited
Service
(1)
Retirement
Age for Full
Benefits
Present Value of
Accumulated
Benefit ($)
(2)
Payments
During Last
Fiscal Year ($)
James P. GormanMorgan Stanley Employees Retirement Plan46579,983
Jonathan PruzanMorgan Stanley Employees Retirement Plan1565185,312
Ruth Porat(3)Morgan Stanley Employees Retirement Plan2057525,24920,039
Morgan Stanley Supplemental Executive25571,458,76753,641
Retirement and Excess Plan
Gregory J. Fleming
Colm KelleherMorgan Stanley U.K. Group Pension Plan(4)760197,712
Morgan Stanley Supplemental Executive25601,227,482
Retirement and Excess Plan
James A. Rosenthal

  Name                                       Plan Name  

 

Number  of
Years
Credited
Service(1)

   Retirement
Age for Full
Benefits(2)
   Present Value of
Accumulated
Benefit ($)(3)
   Payments
During Last
Fiscal Year ($)
 

 

James P. Gorman

  

Morgan Stanley Employees Retirement Plan

  

 

4

 

  

 

65

  

 

96,389

 

  

 

 

 

Colm Kelleher

  

Morgan Stanley U.K. Group Pension Plan(4)

  

 

7

 

  

 

61

  

 

204,844

 

  

 

 

  

Morgan Stanley Supplemental Executive

  

 

25

 

  

 

61

 

  

 

1,282,681

 

  

 

 

   

Retirement and Excess Plan

                    

 

Jonathan Pruzan

  

Morgan Stanley Employees Retirement Plan

  

 

15

  

 

65

  

 

227,860

  

 

 

 

Eric F. Grossman

  

Morgan Stanley Employees Retirement Plan

  

 

4

  

 

65

  

 

67,208

  

 

 

 

Daniel A. Simkowitz

  

Morgan Stanley Employees Retirement Plan

  

 

19

  

 

65

  

 

335,709

  

 

 

(1)After December 31, 2010, no further benefit accruals occur under the ERP. After September 30, 2014, no further benefit accruals occur under the SEREP. Therefore, employees may have different years of credited service under the ERP and SEREP. No NEO is awarded with credited service under the ERP or SEREP in excess of his/her actual service.

Morgan Stanley 2019 Proxy Statement    67


COMPENSATION MATTERS

(2)

(3)

The Retirement Age for Full Benefits is the earliest age at which the executive can receive unreduced benefits or current age, if greater.

The present value at December 31, 20152018 is based on theRP-2014 white collar mortality tables rolled back to 2006 with projection ScaleRP-2014 and then projected generationally with scale MP-2015MP-2018 and discount rates of 4.49%4.26% for the ERP and 4.20%4.16% for the SEREP. Present values are determined using an interest-only discount before retirement. Post-retirement discounts are based on interest and mortality. The assumed benefit commencement date is the earliest age at which the executive can receive unreduced benefits or current age, if greater.

(3)Ms. Porat commenced her benefit on May 1, 2015. The present value reflects her actual retirement benefit amounts and form of payment election of 100% Joint and Survivor for both the ERP and SEREP.

(4)

Until March 31, 2012, the Company contributed to the Morgan Stanley U.K. Group Pension Plan (U.K. Pension Plan) on behalf of Mr. Kelleher, and he remains a deferred vested participant in that plan. As of October 1, 1996, Mr. Kelleher’s accrued defined benefit under the U.K. Pension Plan was converted to an account balance, the value of which was £129,350£153,430 as of December 31, 2015.2018. The amount of British pounds sterling was converted to U.S. dollars using the 20152018 average of daily spot rates of £1 to $1.5285.$1.3351. If the value of the account balance relating to thepre-October 1996 portion of Mr. Kelleher’s U.K. Pension Plan benefit, adjusted for investment experience until the payment date, is greater than the value of the guaranteed minimum pension under the U.K. Pension Plan, no defined benefit pension is payable. If the value of the guaranteed minimum pension, determined in accordance with U.K. laws, is greater than the value of the adjusted account balance, the guaranteed minimum pension is payable, in addition to any defined contribution amount payable for the period after September 30, 1996. Mr. Kelleher had seven years of credited service in the U.K. Pension Plan at the time his accrued benefit was converted to an account balance. The amount shown in the table for Mr. Kelleher does not include defined contribution benefits that were accrued after September 30, 1996.

Employees Retirement Plan (ERP)

Substantially all of theEligible U.S. employees of the Company and its U.S. affiliates hired before July 1, 2007 were covered after one year of service by the ERP, anon-contributory defined benefit pension plan that is qualified under Section 401(a) of the Internal Revenue Code. Effective after December 31, 2010, the ERP was frozen and no further benefit accruals will occur. Benefits are generally payable as an annuity at age 65 (or earlier, subject to certain reductions in the amounts payable). Under thepre-2004 provisions of the ERP, benefits are payable in full at age 60 and reduced 4% per year for retirement between ages 55 and 60 for employees who retire after age 55 with ten10 years of service. Before the ERP was frozen, annual benefits were equal to 1% of eligible earnings plus 0.5% of eligible earnings in excess of Social Security covered compensation for each year of service. Eligible earnings generally included all taxable compensation, other than certain equity-based andnon-recurring amounts, up to $170,000 per year. ERP participants who, as of January 1, 2004, had age plus service equal to at least 65 and who had been credited with five years of service, received benefits determined under the ERP’spre-2004 benefit formula, if greater.Pre-2004 benefits equaled 1.15% of final average salary, plus 0.35% of final average salary in excess of Social Security covered compensation, in each case multiplied by credited service up to 35 years, where final average salary was base salary, up to specified limits set forth in the ERP, for the highest paid 60 consecutive months of the last 120 months of service.

60     Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION

Supplemental Executive Retirement and Excess Plan (SEREP)

The SEREP is an unfunded nonqualified plan. Effective after September 30, 2014, the SEREP was frozen and no further benefit accruals will occur. Credited service is counted starting from the first day of the month after the hire date, except that for certain excess benefits credited service begins after one year of service. The SEREP provides benefits not otherwise provided under the ERP formula because of limits in the ERP or Internal Revenue Code on eligible pay and benefits. The SEREP also provides certain grandfathered benefits and supplemental retirement income (unreduced at age 60) for eligible employees after offsetting other Company-provided pension benefits, pension benefits provided by former employers and, for January 1, 2011 through June 30, 2014, adjusted to take into account certain defined contribution plan awards. The supplemental benefit, before offsets, equals 20% of final average salary plus 2% of final average salary per year after five years (up to 50% cumulatively) plus 1% of final average salary per year after 25 years (up to 60% cumulatively), where final average salary is base salary for the highest paid 60 consecutive months of the last 120 months of service through September 30, 2014, up to a maximum annual benefit payable of $140,000 at age 60, reduced by 4% per year for payments beginning before age 60. The SEREP was restricted effective January 1, 2004 to “grandfathered” employees who as of that date met certain eligibility criteria. Grandfathering in this plan was provided to all similarly situated eligible employees and may be provided to other employees with the approval of the CMDS Committee. Benefits may be paid in various actuarially equivalent forms of annuity. Other than for small balances, no lump sums are available under this plan.

U.K. Group Pension Plan

The U.K. Pension Plan is a defined contribution plan that provided defined benefit pension accruals until October 1, 1996. The guaranteed minimum pension payable under the U.K. Pension Plan is determined in accordance with U.K. laws.

68    Morgan Stanley 20162019 Proxy Statement61



Table of Contents

EXECUTIVE


COMPENSATION MATTERS

2018 Nonqualified Deferred Compensation

2015 Nonqualified Deferred Compensation Table

The following table contains information with respect to the participation of the NEOs in the Company’s unfunded cash deferred compensation plans that provide for the deferral of compensation on a basis that is nottax-qualified, as well as with respect to RSUs granted to the NEOs that are vested but have not yet converted to shares of Morgan Stanley common stock. NEOs participate in the plans on the same terms and conditions as other similarly situated employees. The material terms and conditions of these plans are described below.

  Name      Executive
Contributions
in Last FY
($)
(1)
   Registrant
Contributions
in Last FY
($)
   Aggregate
Earnings
in Last FY
($)
(2)
   Aggregate
Withdrawals/
Distributions
($)
(3)
   Aggregate
Balance
at Last FYE
($)
(4)
James P. Gorman   Notional Leveraged Co-Investment Plan285,9382,686,739
Morgan Stanley Compensation Incentive Plan5,379,825(165,591)2,038,6606,551,200
Restricted Stock Units(5)4,422,675(4,142,957)6,500,87419,541,413
       Total9,802,500(4,022,610)8,539,53428,779,352
Jonathan PruzanKey Employee Private Equity Recognition Plan(3,091)18,48056,775
Notional Leveraged Co-Investment Plan18,30293,648
Morgan Stanley Compensation Incentive Plan1,710,225(151,177)1,489,7982,439,670
Restricted Stock Units(5)3,472,275(1,552,994)3,607,4027,713,973
       Total5,182,500(1,688,960)5,115,68010,304,066
Ruth PoratKey Employee Private Equity Recognition Plan(206)1,2323,785
Notional Leveraged Co-Investment Plan16,05282,134
Morgan Stanley Compensation Incentive Plan3,003,82587,4421,407,0493,909,067
Pre-Tax Incentive Program(23,182)909,819
Restricted Stock Units(5)2,198,675(1,596,695)4,915,4336,259,417
       Total5,202,500(1,516,589)6,323,71411,164,222
Gregory J. FlemingMorgan Stanley Compensation Incentive Plan3,795,8254,6591,648,6624,848,273
Restricted Stock Units(5)2,906,675(1,370,941)4,450,8255,885,127
       Total6,702,500(1,366,282)6,099,48710,733,400
Colm KelleherNotional Leveraged Co-Investment Plan459,9994,182,822
Morgan Stanley Compensation Incentive Plan2,442,07750,3853,621,5876,599,840
Restricted Stock Units(5)3,579,119(1,807,313)3,212,0898,603,122
Alternative Retirement Plan(124)33,484(6)
       Total6,021,196(1,297,053)6,833,67619,419,268
James A. RosenthalNotional Leveraged Co-Investment Plan7,632658,424
Morgan Stanley Compensation Incentive Plan2,607,825(10,162)1,354,5013,332,666
Restricted Stock Units(5)1,844,675(1,005,546)3,612,7533,904,432
       Total4,452,500(1,008,076)4,967,2547,895,522

Name

    Executive
Contributions
in Last FY
($)(1)
  Registrant
Contributions
in Last FY
($)
  Aggregate
Earnings
in Last FY
($)(2)
  Aggregate
Withdrawals/
Distributions
($)(3)
  Aggregate
Balance
at Last FYE
($)(4)
 

 

James P. Gorman

 

 

Notional LeveragedCo-Investment Plan(5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(173,272

 

 

 

 

 

 

 

 

 

 

 

2,412,467

 

 

 

 

Morgan Stanley Compensation Incentive Plan

 

 

 

 

5,970,750

 

 

 

 

 

 

 

 

 

 

 

(515,398

 

 

 

 

 

6,111,386

 

 

 

 

 

 

10,852,077

 

 

  

 

Restricted Stock Units(5)

 

 

 

 

1,181,750

 

 

 

 

 

 

 

 

 

 

 

 

(7,872,485

 

 

 

 

 

8,068,710

 

 

 

 

 

 

27,714,766

 

 

 

Colm Kelleher

 

 

Notional LeveragedCo-Investment Plan(5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,893

 

 

 

 

 

 

1,586,452

 

 

 

 

 

 

118,337

 

 

 

 

Morgan Stanley Compensation Incentive Plan

 

 

 

 

8,471,250

 

 

 

 

 

 

 

 

 

 

 

 

147,507

 

 

 

 

 

 

1,547,729

 

 

 

 

 

 

16,942,252

 

 

 

 

Restricted Stock Units(5)

 

 

 

 

1,931,250

 

 

 

 

 

 

 

 

 

 

 

 

(2,677,634

 

 

 

 

 

3,187,856

 

 

 

 

 

 

9,178,094

 

 

  

 

U.K. Alternative Retirement Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

170

 

 

 

 

 

 

 

 

 

 

 

 

29,135

 

(6) 

 

 

Jonathan Pruzan

 

 

Key Employee Private Equity Recognition Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,012

 

 

 

 

 

 

8,841

 

 

 

 

 

 

19,686

 

 

 

 

Morgan Stanley Compensation Incentive Plan

 

 

 

 

3,951,250

 

 

 

 

 

 

 

 

 

 

 

 

(130,183

 

 

 

 

 

4,202,497

 

 

 

 

 

 

7,267,853

 

 

  

 

Restricted Stock Units(5)

 

 

 

 

1,801,250

 

 

 

 

 

 

 

 

 

 

 

 

(1,206,364

 

 

 

 

 

6,023,282

 

 

 

 

 

 

5,019,174

 

 

 

Eric F. Grossman

 

 

Notional LeveragedCo-Investment Plan(5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18,129

 

 

 

 

 

 

 

 

 

 

 

326,797

 

 

 

 

Morgan Stanley Compensation Incentive Plan

 

 

 

 

3,551,250

 

 

 

 

 

 

 

 

 

 

 

 

(255,914

 

 

 

 

 

3,463,909

 

 

 

 

 

6,566,680

 

  

 

Restricted Stock Units(5)

 

 

 

 

6,161,295

 

 

 

 

 

 

 

 

 

 

 

 

(1,250,722

 

 

 

 

 

3,737,669

 

 

 

 

 

 

4,663,645

 

 

 

Daniel A. Simkowitz

 

 

Key Employee Private Equity Recognition Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,349

 

 

 

 

 

 

11,788

 

 

 

 

 

 

26,248

 

 

 

 

Notional LeveragedCo-Investment Plan(5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,547

 

 

 

 

 

 

 

 

 

 

 

 

244,976

 

 

 

 

Morgan Stanley Compensation Incentive Plan

 

 

 

 

4,351,250

 

 

 

 

 

 

 

 

 

 

 

 

125,034

 

 

 

 

 

 

3,530,807

 

 

 

 

 

 

8,050,205

 

 

 

 

Pre-Tax Incentive Program

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,214

 

 

 

 

 

 

 

 

 

 

 

988,873

 

 

  

 

Restricted Stock Units(5)

 

 

 

 

1,901,250

 

 

 

 

 

 

 

 

 

 

 

 

(1,335,678

 

 

 

 

 

7,696,901

 

 

 

 

 

 

5,821,289

 

 

(1)

RSU contributions represent the RSU awards granted in January 20152018 for 20142017 performance (2017 RSUs) that are considered vested at grant for purposes of this proxy statement and, with respect to Mr. Grossman, RSU awards granted in previous years (Prior Year RSUs) that are considered vested for purposes of this proxy statement as of January 3, 2018 (the date on which he became retirement-eligible under the award terms), but are subject to cancellation until the scheduled conversion dates of such awards. MSCIP contributions represent MSCIP awards granted in January 2018 for 2017 performance that are considered vested at grant for purposes of this proxy statement but are subject to cancellation until the applicable scheduled conversion dates. MSCIP contributions represent MSCIP awards granted in January 2015 for 2014 performance that are considered vested at grant for purposes of this proxy statement but are subject to cancellation until the applicable scheduled payment dates.date. The MSCIP awards reported in this table are also reported as part of the 20142017 bonus in the “2015“2018 Summary Compensation Table.” The value of the 2017 RSUs in this column (which are also included in the “Stock Awards” column of the “2015“2018 Summary Compensation Table” for 2015, the “20152018, “2018 Grants of Plan-Based Awards, Table,” and the “2015“2018 Option Exercises and Stock Vested Table”Vested”) is the aggregate grant date fair value of the RSUs based on $34.5835,$56.8372, the volume-weighted average price of the Company’s common stock on the grant date and the value of the Prior Year RSUs based on $52.3134, the volume-weighted average price of the common stock on such date.

62     Morgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


(2)

With respect to our cash-based nonqualified deferred compensation plans, represents the change in (i) the balance of the NEO’s account reflected on the Company’s books and records at December 31, 2015,2018, without giving effect to any withdrawals or distributions, compared to (ii) the sum of the balance of the NEO’s account reflected on the Company’s books and records at December 31, 20142017 and the value of any contributions made during 2015. Includes any nonqualified deferred compensation earnings that are disclosed in the “Change in Pension Value and Nonqualified Deferred Compensation Earnings” column of the “2015 Summary Compensation Table” for 2015 and described in note 5 thereto.

2018.

With respect to the RSUs, represents (i) the change in the average of the high and low prices of the Company’s common stock on December 31, 20152018 (or, if applicable, the earlier distribution date) compared to December 31, 201429, 2017 (or, if applicable, the later contribution date), as well as (ii) the amount of the vested cash dividend equivalent rights in 20152018 (which is paid to the award holder at the time dividends are paid to holders of the Company’s common stock) and dividend equivalents in the form of additional RSUs credited in 20152018 with respect to the award (which are paid to the award holder at the time that the underlying award converts to shares, subject to the same cancellation provisions as the underlying award).

(3)

Represents distributions from our cash-based nonqualified deferred compensation plans and with respect to the RSUs, conversions based on the average of the high and low prices of the Company’s common stock on the conversion date and amounts paid during 20152018 pursuant to cash dividend equivalent rights.

(4)

With respect to our cash-based nonqualified deferred compensation plans, represents the balance of the NEO’s account reflected on the Company’s books and records at December 31, 2015.2018. With respect to the RSUs, represents the number of vested units held by the NEO on December 31, 20152018 multiplied by the average of the high and low prices of the Company’s common stock on December 31, 2015.
2018.

Morgan Stanley 2019 Proxy Statement    69


COMPENSATION MATTERS

(5)TheIncludes RSUs disclosed in this table include awards that as of December 31, 20152018 had vested, but had not reached their scheduled conversion date and remained subject to cancellation, as well as RSUs and LCIP awards that had reached their scheduled conversiondistribution date, but were deferred to preserve the Company’s tax deductibility of the award, in accordance with the terms of the award.

(6)Mr. Kelleher’s aggregate balance at year-endyear end of £21,906£21,822 was converted from British pounds sterling to U.S. dollars using the 20152018 average of daily spot rates of £1 to $1.5285.
$1.3351.

The following is a description of the material terms with respect to contributions, earnings and distributions applicable to each of the following cash nonqualified deferred compensation plans and the RSUs referenced in the table above.

Key Employee Private Equity Recognition Plan (KEPER)

Under KEPER, participants were permitted to defer a portion of their cash bonus. The plan has been closed to new contributions since 2001. Contributions to KEPER are notionally invested by the Company in reference investments. Such reference investments may include investments made by Company-sponsored private equity funds, investments made by private equity funds sponsored by third parties in which the Company has acquired or will acquire a limited partner or similar interest, and investments in private equity securities that the Company makes for its own account. Distributions are made to participants following the realization of any proceeds in respect of any investment. The amounts contributed by a participant plus any earnings on participant contributions under the program remain subject to cancellation under specified circumstances.

Notional LeveragedCo-Investment Plan (LCIP)

Under LCIP, participants were permitted to allocate a portion of their deferred incentive compensation to the plan. LCIP is closed to new participants and has not been offered since 2008. For each of fiscal 2006, fiscal 2007 and fiscal 2008, participantsParticipants were permitted to allocate up to 40% of their long-term incentive compensation to LCIP. The Company contributed a notional investment in an amount equal to two times each participant’s contribution (however, for fiscal 2008, participants could elect to forgo the notional investment). Contributions are notionally invested by the Company in reference investments, which may include the Company’s proprietary investment funds, “funds of funds” that include Company proprietary investment funds and third-party investment funds, and other third-party investment funds. All amounts contributed by a participant plus any earnings on participant contributions and the Company notional investment were subject to cancellation under specified circumstances until three years after deferral. Participants generally are entitled to receive distributions in respect of their contributions plus any earnings on their contributions and on the Company notional investment on the third anniversary of grant and the tenth10th anniversary of grant, based on the valuation of the notional investments and any realizations of those investments prior to the scheduled distribution date. Participant distributions under LCIP are offset by the Company notional investment, excluding any earnings thereon.

Morgan Stanley 2016 Proxy Statement     63



Table of Contents

EXECUTIVE COMPENSATION


Morgan Stanley Compensation Incentive Plan (MSCIP)

A portion of each participant’syear-end deferred incentive compensation is granted under MSCIP. Earnings on MSCIP awards are based on the performance of notional investments available under the plan and selected by the participants. Participants may reallocate such balances periodically, as determined by the plan administrator. Until MSCIP awards reach their scheduled distribution date, they are subject to cancellation and clawback by the Company. The cancellation and clawback events applicable to MSCIP awards held by our NEOs are described in the CD&A and in “Potential Payments upon Termination orChange-in-Control.”

Pre-Tax Incentive Program (PTIP)

Under PTIP, participants were permitted to defer a portion of their cash bonus or commissions for one or more fiscal years. The plan has been closed to new contributions since 2003. Earnings on PTIP contributions are based on the performance of notional investments available under the plan and selected by the participants. Participants could generally elect the commencement date for distributions of their contributions and earnings and the number of annual installments over which to receive distributions (generally, 5, 10, 15 or 20 years). Subject to earlier distribution on death or termination of employment due to disability, no distributions may begin prior to the attainment of age 55, and no distribution may begin prior to termination of employment.

Restricted Stock Units (RSUs)

RSUs are granted under the Morgan Stanley 2007 Equity Incentive Compensation Plan or another Company equity plan as determined by the CMDS Committee. Each RSU constitutes a contingent and unsecured promise of the Company to pay the holder one share of Company common stock on the conversion date of the RSU. The RSUs included in this table are considered vested; however, the RSUs are subject to cancellation if a cancellation event occurs at any time prior to the

70    Morgan Stanley 2019 Proxy Statement


COMPENSATION MATTERS

scheduled conversion date. RSUs granted in 2012 and later are subject to clawback, as well as cancellation, prior to the scheduled conversion date. The cancellation and clawback events applicable to RSUs held by our NEOs are described in the CD&A and in “Potential Payments upon Termination orChange-in-Control.”

U.K. Alternative Retirement Plan (ARP)

The ARP is a U.K. employer financed retirement benefits scheme as defined by Her Majesty’s Revenue and Customs (HMRC). Under the ARP, eligible participants receive monthly notional contributions from the Company based on a percentage of base salary, subject to specified limits. Participants may also elect to contribute a portion of their cash bonus and distributions from certain cash-based nonqualified deferred compensation plans to the ARP. Participants include those employees who either have an accumulated pension value in the U.K. Group Pension Plan that exceeds a limit set by the U.K. government or have elected pension taxation protection available from HMRC. Earnings on ARP contributions are based on the performance of notional investments available under the ARP and selected by the participants. Participants can generally elect the commencement date for distributions at any time after age 55, so long as no distributions begin later than age 75. Distributions are currently paid in the form of a lump sum.

Potential Payments upon Termination orChange-in-Control

Potential Payments upon Termination or Change-in-Control


This section describes and quantifies the benefits and compensation to which each NEO would have been entitled under our existing plans and arrangements if his or her employment had terminated or if the Company had undergone achange-in-control, in each case on December 31, 2015. For Ms. Porat, this section describes and quantifies the benefits and compensation to which she was entitled in connection with her departure from the Company on April 30, 2015.2018.

1. General Policies

No Cash Severance

Our NEOs are not contractually entitled to cash severance payments upon any termination of employment or excise tax protection upon achange-in-control of the Company. NEOs are entitled to receive post-termination benefits that are generally available to all salaried employees, such as accrued vacation pay and death, disability and post-retirement welfare benefits, and are also eligible for Company-paid retiree medical coverage under the Morgan Stanley Grandfathered Retiree Medical Plan for themselves and eligible dependents following any termination of employment with three years of service.

64     No Enhanced Termination BenefitsMorgan Stanley 2016 Proxy Statement



Table of Contents

EXECUTIVE COMPENSATION


Following termination of employment, the NEOs are entitled to amounts, to the extent vested, due under the terms of our pension arrangements, as described under the “2015“2018 Pension Benefits, Table,” and our nonqualified deferred compensation plans, as described under the “2015“2018 Nonqualified Deferred Compensation Table.Compensation.” Our NEOs are not entitled to special or enhanced termination benefits under our pension and nonqualified deferred compensation plans as compared to other employees.

Cancellation and Clawback of Deferred Compensation

Even if aan NEO is considered vested in a deferred incentive compensation award, the award may be subject to cancellation through the distribution date in the event the NEO engages in a cancellation event or if a clawback event occurs. In general, a cancellation event includes: engaging in competitive activity during a specified period following a voluntary termination of employment; engaging in cause (i.e.(i.e., a breach of the NEO’s obligation to the Company, including a failure to comply with internal compliance, ethics or risk management standards and failure or refusal to perform duties satisfactorily, including supervisory and management duties); improper disclosure of the Company’s proprietary information; solicitation of Company employees, clients or customers during, employment and within a specified period following termination of, employment; the making of unauthorized disclosures or disparaging or defamatory comments about the Company; resignation from employment without providing the Company proper advance notice; or the failure to cooperate with or assist the Company in connection with investigations, regulatory matters, lawsuits or arbitrations following termination of employment.

Clawback of deferred compensation awards by the Company can be triggered through the applicable scheduled distribution date if the NEO had significant responsibility for a material adverse outcome for the Company or any of its businesses or functions, even absent misconduct, or if the NEO’s act or omission (including with respect to direct supervisory responsibilities) causes a restatement of the Company’s consolidated financial results, violates the Company’s global risk management principles, policies and standards, or causes a loss of revenue associated with a position on which the NEO was paid and he or she operated outside of internal control policies. Further, shares resulting from

Morgan Stanley 2019 Proxy Statement    71


COMPENSATION MATTERS

the conversion of LTIP awards are subject to clawback by the Company in the event the Company’s achievement of the specified goals was based on materially inaccurate financial statements or other performance metric criteria. With respect to certain of Mr. Kelleher’s awards granted while he was designated by the Company as Code Staff, pursuant to U.K. Prudential Regulatory Authority requirements, any amounts distributed in respect of his deferred compensation awards are subject to clawback and repayment in certain circumstances for a minimum period of seven years following grant pursuant to the Morgan Stanley Code Staff Clawback Policy.

Notice andNon-Solicitation Agreements

In addition to the cancellation and clawback events described above, each NEO is party to a Notice andNon-Solicitation Agreement that provides for injunctive relief and cancellation of deferred compensation awards if the NEO does not provide 180 days’ advance notice prior to a resignation or if the NEO improperly solicits the Company’s employees, clients or customers at any time during and foremployment or the 180 days following termination of employment.

Morgan Stanley 2016 Proxy Statement     65



Table of Contents

EXECUTIVE COMPENSATION


2. Termination of Employment /Change-in-Control

The table below sets forth the value as of December 31, 20152018 of the outstanding unvested deferred compensation awards held by the NEOs and the present value of coverage under the Morgan Stanley Grandfathered Retiree Medical Plan as of December 31, 2015. This table does not include our former CFO, Ms. Porat, whose employment terminated on April 30, 2015. Ms. Porat’s payments and benefits upon her termination are set forth below.2018.

Termination Reason  NameUnvested RSUs and
Related Dividend
Equivalents, Unvested
Stock Options and
     Unvested MSCIP Awards
($)
(1)
Unvested
LTIP Awards
and Related
     Dividend Equivalents
($)
(2)
     Retiree Medical
Coverage
(3)
Involuntary (not due to a cancellation event) / Disability / Retirement / In connection with a Change-in-Control / Death / Governmental Service TerminationJames P. Gorman$10,570,066$ 603,943
Jonathan Pruzan  $ 950,841
Gregory J. Fleming(4)$8,162,140$ 773,354
Colm Kelleher$8,162,140$ 737,625
James A. Rosenthal$5,889,604$ 632,235

Termination Reason

 Name  

Unvested RSUs and

Unvested MSCIP
Awards

($)(1)

   

Unvested

LTIP Awards

and Related

Dividend
Equivalents
($)(2)

   

Retiree Medical
Coverage

($)(3)

 

Involuntary (not due to a cancellation event) / Disability / Retirement / In connection with aChange-in-Control / Death / Governmental Service Termination

 

James P. Gorman

 

  

 

 

  

 

17,513,315

 

  

 

524,003

 

 

Colm Kelleher

 

  

 

 

  

 

10,278,275

 

  

 

246,827

 

 

Jonathan Pruzan

 

  

 

 

  

 

3,610,277

 

  

 

958,122

 

 

Eric F. Grossman

 

  

 

 

  

 

3,342,647

 

  

 

804,635

 

 

Daniel A. Simkowitz

 

  

 

 

  

 

4,075,696

 

  

 

741,725

 

(1)

As of December 31, 2015,2018, our NEOs were retirement-eligible for purposes of their outstanding RSU MSCIP and stock optionMSCIP awards, which are therefore considered vested for purposes of this proxy statement. Amounts are payable on the scheduled distribution dates, subject to cancellation and clawback provisions, except that RSUs and MSCIP awards are payable upon a termination in connection with achange-in-control and all awards are payable upon death or a governmental service termination. Options will become exercisable and remain exercisable through the expiration date. Retirement treatment may be conditioned upon advance notice of termination. Amounts payable with respect to a termination in connection with achange-in-control are conditioned upon the termination occurring within 18 months of thechange-in-control as a result of (i) the Company terminating the NEO’s employment under circumstances not involving any cancellation event, (ii) the NEO resigning from employment due to a materially adverse alteration in job responsibilities, or (iii) a change in the NEO’s principal place of employment of more than 75 miles from the current location. A “change-in-control”“change-in-control” generally means a significant change in the share ownership of the Company or composition of the Board. Governmental service termination treatment is conditioned upon satisfactory proof of a conflict of interest that necessitates divestiture of the awards and executing an agreement to repay amounts vested in connection with such termination if the NEO engages in any cancellation event.

(2)

As of December 31, 2015,2018, our NEOs were retirement-eligible for purposes of the LTIP awards; however, such awards are not considered vested for purposes of this proxy statement until the end of the performance period because these awards only deliver value if the Company achieves objective performance goals over such performance period. Amounts shown in the table reflect performance through December 31, 20152018 (the quarter ending simultaneously with the effective date of the termination), which, with the exception of a termination in connection with achange-in-control, is a substitute for performance through the three-year performance period, which would not be known until the end of such period. To facilitate timely payment of LTIP awards upon death or a governmental service termination as of December 31, 2015,2018, amounts payable with respect to these awards would instead reflect Company performance through September 30, 20152018 (the quarter ending with or before the date of the termination for which the Company’s earnings information has been released) as follows: $11,412,190$18,136,227 for Mr. Gorman; $8,810,647 for Messrs. Fleming and Kelleher; and $6,357,440$10,712,387 for Mr. Rosenthal.Kelleher; $3,773,461 for Mr. Pruzan; $3,500,321 for Mr. Grossman; and $4,258,256 for Mr. Simkowitz. For purposes of valuing LTIP awards, we have assumed a per share value of $31.81,$39.65, the closing price of the Company’s common stock on December 31, 2015.
2018.

(3)Each NEO, having met the service requirement, is eligible to elect retiree medical coverage under the Company’s Grandfatheredgrandfathered Retiree Medical Plan for themselveshimself and theirhis eligible dependents following a termination of employment for any reason. The present value is calculated assuming each NEO began retiree medical coverage on December 31, 20152018 and elected theirhis current dependent coverage type. The present value is based on theRP-2014 white collar mortality tables rolled back to 2006 with projection ScaleRP-2014 and then projected generationally with Scale MP-2015,MP-2018, a discount rate of 4.13%4.07%, and a medical inflation rate of 7.12%6.16% for 2016-20172019–2020 and ultimately settling at 4.50% by 2038.
(4)Pursuant to Mr. Fleming’s January 22, 2016 agreement with the Company relating to his termination of employment, Mr. Fleming is entitled to, in addition to the amounts disclosed in the table, continued access to office space and administrative support through his termination date (anticipated to be July 6, 2016), with a cost to the Company of approximately $140,000, and continued access to his primary care physician under the Company’s Executive Health Program through December 31, 2016.

6672    Morgan Stanley 20162019 Proxy Statement



COMPENSATION MATTERS

TableCompensation Ratio Disclosure

The ratio between the CEO’s total annual compensation and the median annual total compensation of Contents

EXECUTIVE COMPENSATION


Amounts payable in connection with Ms. Porat’s terminationall other employees of employment

Prior to her departure from the Company reported below is a reasonable estimate calculated in a manner consistent with SEC rules based on April 30, 2015, Ms. Porat satisfied the ageCompany’s compensation records and service requirementsthe methodology described below. Because SEC rules for retirement eligibility for purposes of her outstanding RSU, MSCIP and stock option awards, and therefore such awards are considered vestedidentifying the median compensated employee for purposes of this proxy statement. Such awards remain subjectdisclosure allow companies to all provisionsadopt various methodologies and utilize various assumptions, the ratio reported by other companies may not be comparable to the ratio reported by the Company.

For 2018, our last completed fiscal year, the median of the awards, including any cancellation and clawback provisions, until the applicable distribution date. With respect to her outstanding LTIP awards, such awards will convert to sharesannual total compensation of common stock on their scheduled conversion dates based on the performanceall employees of the Company through(other than the applicable three-year performance period, subject to cancellationCEO) was $142,604 and clawback provisions. Therefore, the actual valueannual total compensation of Ms. Porat’s LTIP awards will not be known until the end of the performance period. Using Company performance through December 31, 2015our CEO, as a substitute for performance through the performance period, the value as of December 31, 2015 of Ms. Porat’s LTIP awards for which the performance period had not ended was $6,696,322.

Following her departure from the Company, Ms. Porat is eligible to elect, but has not yet elected, to receive retiree medical coverage under the Morgan StanleyGrandfathered Retiree Medical Plan with a present value of $588,573as of December 31, 2015, calculated as described above. As disclosedreported in the “All Other Compensation” column of the “2015“2018 Summary Compensation Table,” was $28,168,639. Based on this information, for 2018, the ratio of the annual total compensation of the CEO to the median of the annual total compensation of all other employees of the Company was 198 to 1.

To identify the median of the annual total compensation of all employees of the Company, we took the following steps:

1.

The pay ratio rule gives companies the ability to make the median employee determination only once every three years, and we did not make a new median employee determination for 2018. The median employee determination for 2017 is described below.

We measured the employee population of the Company as of December 31, 2017 and included all employees of Morgan Stanley and its consolidated subsidiaries globally. We did not include independent contractors and leased employees. Although our employee population varies slightly from the employee population in our December 31, 2017 determination, there have not been any changes that we reasonably believe would significantly impact our pay ratio disclosure.

We selected annual total reward awarded in respect of 2017 as the consistently applied compensation measure used to identify the employee with the median of the annual total compensation of all employees (the “median employee”). Annual total reward consists of fixed compensation (e.g., base salary and allowances) and annual incentive compensation delivered in cash or equity and other variable compensation analogous to annual incentive compensation (e.g., commissions). We annualized the compensation of all permanent employees who were employed for less than the full fiscal year. We did not make anycost-of-living adjustments in identifying the median employee. Our median employee served in a similar role in 2018 and had his or her compensation adjusted based on his or her performance in that role. We determined that changes in our median employee’s compensation arrangements for 2018 did not result in a significant change to our pay ratio disclosure and, therefore, that our median employee was still reasonable to utilize for our pay ratio disclosure this year.

2.

Once we identified that our median employee selected in 2017 was still reasonable for 2018 disclosure, we then calculated the median employee’s annual total compensation for 2018 in accordance with the Summary Compensation Table requirements.

Commitment to Equitable Compensation Practices

Attracting, retaining and advancing under-represented talent is a priority for the Company, and a key aspect to this is ensuring that women and all other under-represented groups are rewarded equitably. Morgan Stanley has robust compensation practices that help to ensure that compensation and reward decisions are made fairly and consistently and are based on an individual’s role, performance and experience. The Company reviews compensation decisions for employees on an ongoing basis, including at the point of hire as well as during our annual compensation process, to help ensure that individual compensation decisions arein-line with this philosophy. A diverse workforce is key to our success, and consistent with Company practice with respectthat, we are committed to continually assessing our rewards structure and decisions to help ensure equity in pay for all SEREP participants, the Company paid $33,008 to satisfyemployees.Ms. Porat’s portion of FICA taxes due upon the commencement of payment of her SEREP benefit.

Morgan Stanley 20162019 Proxy Statement67    73



Table of Contents


OWNERSHIP OF OUR STOCK


EXECUTIVE EQUITY OWNERSHIP COMMITMENT

Members of the Company’s Operating Committee are subject to an Equity Ownership Commitment. In January 2016, based on feedback from shareholders, we revised our Equity Ownership Commitment in order to enhance the alignment between the long-term interests of our shareholders and our Operating Committee members.

The Equity Ownership Commitment now requires each of our CEO, CFO President, and COOPresident (Covered Officers) to achieve ownership of a number of shares of common stock and equity awards with a value equal to a specified multiple of his base salary within five years. Our CEO is required to achieve ownership of shares of common stock and equity awards with a value equal to 10x10 times his base salary and each other Covered Officer is required to achieve ownership of shares of common stock and equity awards with a value equal to 6xsix times his base salary. In addition, the Equity Ownership Commitment continues to impose retention requirements for Operating Committee members. Operating Committee members are required to hold common stock and equity awards equal to a percentage of common stock received from equity awards (less allowances for the payment of any option exercise price and taxes) granted to them for service on the Operating Committee (Equity Award Shares) as follows:

Our CEO is required to retain 75% of Equity Award Shares.

Each of our other Operating Committee members is required to retain 50% of Equity Award Shares acquired from equity awards granted beginning in January 2016 and thereafter, and 75% of Equity Award Shares acquired from equity awards granted prior to January 2016; provided that Operating Committee members who are Covered Officers must retain 75% of all Equity Award Shares until the applicable ownership requirement is met.


Our CEO is required to retain 75% of Equity Award Shares.

Each of our other Operating Committee members is required to retain 50% of Equity Award Shares acquired from equity awards granted beginning in January 2016 and thereafter, and 75% of Equity Award Shares acquired from equity awards granted prior to January 2016; provided that Operating Committee members who are Covered Officers must retain 75% of all Equity Award Shares until the applicable ownership requirement is met.

This commitment ties a portion of our Operating Committee members’ net worth to the Company’s stock price and provides a continuing incentive for them to work towardsuperior long-term stock price performance. Exceptions to the Equity Ownership Commitment are subject to the approval of the CMDS Committee. None of our executive officers currently have prearranged trading plans under SEC Rule10b5-1. Executive officers also are prohibited from pledging or selling short, or engaging in hedging strategiesor trading derivatives involving, Morgan Stanley securities.

DIRECTOR EQUITY OWNERSHIP REQUIREMENT

As indicatedOur Corporate Governance Policies require each independent director to retain ownership of a number of shares of Morgan Stanley common stock and equity awards with a value equal to five times the annual cash Board retainer, and to retain 100% of his or her Morgan Stanley stock unit awards (on anafter-tax basis) until such ownership requirement is met. Directors may not enter into hedging transactions in respect of Morgan Stanley common stock or pledge Morgan Stanley common stock in connection with a margin or other loan transaction. In addition, as discussed under “Director Compensation,” our independent directors generally receive an equity award upon initial election to the Board and receive an annual equity award thereafter with a grant date fair value of $250,000 (prorated in the case of the initial award) as part of their director compensation. 50%Fifty percent of each equity award granted to our independent directors does not become payable until the director retires from the Board (and may be deferred beyond retirement at the director’s election), which fosters a. We believe these equity ownership opportunities and requirements enhance the alignment of independent directors’ interests with the long-term ownership view. Directors may not enter into hedging transactions in respectinterests of Morgan Stanley common stock or pledge Morgan Stanley common stock in connection with a margin or other loan transaction.our shareholders.

6874    Morgan Stanley 20162019 Proxy Statement



Table of Contents

OWNERSHIP OF OUR STOCK


STOCK OWNERSHIP OF EXECUTIVE OFFICERS AND DIRECTORS

The following table sets forth the beneficial ownership of common stock as of February 29, 2016 by our CEO and the other executive officers named in the “2015 Summary Compensation Table” (our NEOs), directors, and by all our directors and executive officers as of February 29, 2016as a group. As of February 29, 2016, none of the common stock beneficially owned by our directors and current executive officers was pledged.

NameShares(1)   Underlying
Stock Units(2)
   Subject to
Stock Options
Exercisable
Within 60 Days
   Total(3)
NAMED EXECUTIVE OFFICERS
James P. Gorman651,725756,355966,3302,374,410
Jonathan Pruzan49,855208,2056,765264,825
Ruth Porat(4)875,481118,102205,7641,199,347
Gregory J. Fleming526,624369,678408,5631,304,865
Colm Kelleher330,760327,826772,0031,430,589
James A. Rosenthal170,766169,905495,360836,031
 
DIRECTORS AND DIRECTOR NOMINEES
Erskine B. Bowles1,000132,229133,229
Alistair Darling3,2433,243
Thomas H. Glocer2,53531,20433,739
Robert H. Herz12,96928,38241,351
Nobuyuki Hirano(5)
Klaus Kleinfeld18,19725,29843,495
Jami Miscik1,8169,37511,191
Donald T. Nicolaisen83,10283,102
Hutham S. Olayan8,000122,589130,589
James W. Owens14,35448,30462,658
Ryosuke Tamakoshi(5)
Perry M. Traquina7,8187,818
Laura D. Tyson30,53746,70477,241
Rayford Wilkins, Jr.7,76814,48822,256
ALL DIRECTORS AND EXECUTIVE OFFICERS AS OF
FEBRUARY 29, 2016 AS A GROUP (21 PERSONS)
1,538,6162,376,3452,847,3986,762,359

(1)

Each director, NEO and executive officer has sole voting and investment power with respect to his or her shares, except with respect to the following shares owned indirectly through family trusts, the sole beneficiaries of which are family members, and custodial accounts: Mr. Gorman – 40,115 shares, 1,400 shares of which he disclaims ownership; Mr. Fleming – 104,550 shares; Mr. Rosenthal – 170,197 shares; and Mr. Bowles – 1,000 shares.

(2)

Shares of common stock held in a trust (Trust) corresponding to certain outstanding restricted stock units (RSUs). Directors and executive officers may direct the voting of the shares corresponding to such RSUs. Voting by executive officers is subject to the provisions of the Trust, as described in “Information about the Annual Meeting – How Do I Submit Voting Instructions for Shares Held in Employee Plans?”. Excludes LTIP awards because executive officers may not direct the voting of any shares corresponding to such awards prior to settlement of the award.

(3)

Each NEO and director beneficially owned less than 1% of the shares of common stock outstanding. All executive officers and directors as a group as of February 29, 2016 beneficially owned less than 1% of the common stock outstanding.

(4)

Following her departure from the Company, Ms. Porat pledged 714,408 shares of common stock to a bank as collateral.

(5)

Messrs. Hirano and Tamakoshi were designated by MUFG and elected to the Board pursuant to the Investor Agreement. They are not compensated by Morgan Stanley for their service on the Board. See “Principal Shareholders” regarding MUFG’s beneficial ownership of Company common stock.


Morgan Stanley 2016 Proxy Statement     69



Table of Contents

OWNERSHIP OF OUR STOCK

STOCK OWNERSHIP OF EXECUTIVE OFFICERS AND DIRECTORS

The following table sets forth the beneficial ownership of common stock as of March 4, 2019 by our CEO and the other executive officers named in the “2018 Summary Compensation Table” (our NEOs), directors and director nominee, and by all of our directors and executive officers as a group. As of March 4, 2019, none of the common stock beneficially owned by our directors and current executive officers was pledged.

Name

  Shares(1)   

 

Underlying(2)

Stock Units   

   Subject to
Stock Options
Exercisable
Within 60 Days
   Total(3) 

NAMED EXECUTIVE OFFICERS

                    

James P. Gorman

   842,051    665,213          1,507,264 

Colm Kelleher

   624,356    354,632          978,988 

Jonathan Pruzan

   70,167    101,636          171,803 

Eric F. Grossman

   165,462    94,780          260,242 

Daniel A. Simkowitz

   79,180    108,373          187,553 

 

DIRECTORS AND DIRECTOR NOMINEE

                     

Elizabeth Corley

       7,734          7,734 

Alistair Darling

   4,136    14,657          18,793 

Thomas H. Glocer

   4,535    61,399          65,934 

Robert H. Herz

   20,885    43,251          64,136 

Nobuyuki Hirano(4)

       —           

Jami Miscik

   13,034    20,203          33,237 

Dennis M. Nally

   5,274    10,175          15,449 

Takeshi Ogasawara(4)

       —           

Hutham S. Olayan

   8,000    159,425          167,425 

Mary L. Schapiro

       4,830          4,830 

Ryosuke Tamakoshi(4)

       —           

Perry M. Traquina

       37,143          37,143 

Rayford Wilkins, Jr.

   18,986    24,897          43,883 

ALL DIRECTORS AND EXECUTIVE OFFICERS AS OF

MARCH 4, 2019 AS A GROUP (19 PERSONS)

   2,122,607    1,833,837          3,956,444 

(1)

Each director, NEO and executive officer has sole voting and investment power with respect to his or her shares, except with respect to the following shares owned indirectly through family trusts, the sole beneficiaries of which are family members: Mr. Gorman — 52,400 shares.

(2)

Shares of common stock held in a trust (Trust) corresponding to outstanding RSUs. Directors and executive officers may direct the voting of the shares corresponding to such RSUs. Voting by executive officers is subject to the provisions of the Trust, as described in “Information about the Annual Meeting — How Do I Submit Voting Instructions for Shares Held in Employee Plans?” Excludes LTIP awards because executive officers may not direct the voting of any shares corresponding to such awards prior to settlement of the award.

(3)

Each NEO and director beneficially owned less than 1% of the shares of common stock outstanding. All executive officers and directors as a group as of March 4, 2019 beneficially owned less than 1% of the common stock outstanding.

(4)Messrs. Hirano and Tamakoshi were designated by MUFG and elected to the Board pursuant to the Investor Agreement and are not compensated by Morgan Stanley for their Board service. Mr. Tamakoshi will not stand forre-election at the annual meeting of shareholders, and MUFG has designated Mr. Ogasawara for nomination to the Board in accordance with the Investor Agreement. Should he be elected to the Board, Mr. Ogasawara will be eligible to receive the applicable cash retainers for his Board service, but will not receive stock unit awards. See “Item 1 — Election of Directors — Director Succession and Nomination Process” regarding Mr. Ogasawara’s nomination for election to the Board and “Principal Shareholders” regarding MUFG’s beneficial ownership of Company common stock.

Morgan Stanley 2019 Proxy Statement    75


OWNERSHIP OF OUR STOCK

PRINCIPAL SHAREHOLDERS

The following table contains information regarding the only persons we know of that beneficially own more than 5% of our common stock.

Shares of Common Stock
Beneficially Owned
  Name and Address         Number       Percent(1)  
MUFG(2)435,269,90522.4
7-1, Marunouchi 2-chome
Chiyoda-ku, Tokyo 100-8330, Japan
State Street(3)137,364,5517.1
One Lincoln Street
Boston, MA 02111
T. Rowe Price Associates, Inc. (T. Rowe Price)(4)130,034,3226.7
100 E. Pratt Street
Baltimore, MD 21202
BlackRock, Inc. (BlackRock)(5)101,896,1785.3
55 East 52nd Street
New York, NY 10055

  
   

Shares of Common Stock
Beneficially Owned

 

 

Name and Address

  

Number

 

   

Percent(1)

 

 

MUFG(2)
7-1, Marunouchi2-chome
Chiyoda-ku, Tokyo100-8330, Japan

  

 

404,867,225

 

  

 

24.0%

 

State Street(3)
One Lincoln Street
Boston, MA 02111

  

 

130,654,531

 

  

 

7.7%

 

BlackRock(4)
55 East 52nd Street
New York, NY 10055

  

 

104,968,967

 

  

 

6.2%

 

Vanguard(5)

100 Vanguard Boulevard

Malvern, PA 19355

  

 

95,698,705

 

  

 

5.7%

 

(1)

Percentages based upon the number of shares of common stock outstanding as of the record date, March 21, 2016,25, 2019, and the beneficial ownership of the principal shareholders as reported in SEC filings in notes 2 through 5 below.

(2)

Based on the amendedForm 4, Statement of Changes in Beneficial Ownership, dated March 26, 2019, filed by MUFG (as of March 22, 2019). The Schedule 13D13D/A filed by MUFG, dated October 3, 2013 filed by MUFG. The amended Schedule 13D4, 2018, discloses that MUFG beneficially owned 420,745,409 shares and had sole dispositivevoting power and sole votingdispositive power with respect to such shares as of September 26, 2018. The Schedule 13D/A also disclosed that of the beneficially owned420,745,409 shares, reported, including 3,252,7531,377,477 shares were held solely in a fiduciary capacity by certain affiliates of MUFG as the trustee of trust accounts or the manager of investment funds, other investment vehicles and managed accounts as of September 27, 2013 for which26, 2018, and that MUFG disclaims beneficial ownership.

ownership of such shares.

(3)

Based on the Schedule 13G dated February 12, 201611, 2019 filed by State Street and State Street Bank andGlobal Advisors Trust Company, each acting in various fiduciary and other capacities (as of December 31, 2015)2018). The Schedule 13G discloses that State Street had shared dispositive power as to 137,364,551130,640,173 shares and shared voting power as to 136,788,017124,194,477 shares; and that 76,450,82874,256,826 shares beneficially owned by State Street Bank andGlobal Advisors Trust Company, a subsidiary of State Street, are held as trustee on behalf of the Trust that holds shares of common stock underlying certain restricted stock units awarded to Company employees under various of the Company’s equity-based plans.

(4)

Based on the Schedule 13G dated February 5, 2019 filed by BlackRock (as of December 31, 2018). The Schedule 13G discloses that BlackRock had sole voting power as to 92,275,473 shares and sole dispositive power as to 104,968,967 shares.

(5)Based on the Schedule 13G dated February 16, 201611, 2019 filed by T. Rowe PriceVanguard (as of December 31, 2015)2018). The Schedule 13G discloses that T. Rowe PriceVanguard had sole dispositive power as to 129,917,922 shares and sole voting power as to 48,519,511 shares. The Schedule 13G states that T. Rowe Price affirms that the Schedule 13G shall not be construed as an admission that T. Rowe Price is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
(5)Based on the Schedule 13G dated January 22, 2016 filed by BlackRock (as of December 31, 2015). The Schedule 13G discloses that BlackRock had shared voting and shared dispositive power as to 72,444 shares, sole voting power as to 89,545,8611,496,179 shares and sole dispositive power as to 101,823,73493,928,778 shares and shared voting power as to 298,912 shares and shared dispositive power as to 1,769,927 shares.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires our directors and certain of our officers to file reports with the SEC indicating their holdings of, and transactions in, our equity securities. The Company believes that our reporting persons complied with all Section 16(a) filing requirements during 2015.2018.

7076    Morgan Stanley 20162019 Proxy Statement



Table of Contents


EQUITY COMPENSATION PLAN

Item 4

Company Proposal to Amend the 2007 Equity Incentive Compensation Plan

Our Board unanimously recommends that you vote“FOR” this proposal.

Upon the recommendation of the CMDS Committee, on March 24, 2016, the Board adopted an amendment to our 2007 Equity Incentive Compensation Plan (EICP) to increase the number of shares of common stock available to be granted under the EICP by 20 million shares, and to add regulatory factors, risk management, expense management, and contributions to community development and sustainability projects or initiatives as performance measures that could be elements of performance-vested awards over time. The EICP was originally approved by shareholders on April 10, 2007 and was last amended to increase the number of shares of common stock available for grant in 2015 by 25 million shares.

Under the NYSE rules, this amendment will not be effective if our shareholders do not approve it. The proposed increase in shares, which represents approximately 1.02% of the common shares of the Company outstanding as of January 31, 2016, is less than the 59 million shares the Company repurchased in 2015. If this amendment is approved, the Company expects to have sufficient shares for grants to be made over the next year and to return to shareholders to request approval of additional shares at the 2017 annual meeting of shareholders. The proposed additional performance measures will better enable performance-vested awards to qualify as tax-deductible to the Company under Section 162(m) of the Internal Revenue Code, which the Company believes to be in the best interests of the Company and shareholders.

Morgan Stanley delivers a significant portion of incentive compensation for eligible employees in deferred equity awards (RSUs) that are impacted by future stock price performance over a multi-year period and, for senior executives, performance-vested stock units that only deliver value if the Company meets specific performance targets after three years (LTIP awards). We believe this approach to executive compensation aligns the interests of the Company’s employees with those of its shareholders and is consistent with executive motivation, best practices, and regulatory principles.

The Board believes that the EICP amendment is in the best interest of shareholders and supports this proposal for the following reasons:

In January 2016, approximately 33.8 million shares underlying equity awards were granted as part of the 2015 year-end compensation process and approximately 1.1 million shares (representing the target number of performance stock units) were granted as LTIP awards. After these grants, as of January 31, 2016, approximately 33.9 million shares were available for future equity awards under the EICP and the Company’s legacy equity plans, with only 27.5 million of such shares available under the EICP. Given the significant portion of incentive compensation paid as equity awards, the number of shares currently available under the Company’s plans is not expected to be sufficient for grants that would be made over the next year until the 2017 annual meeting of shareholders.

The Company strives to maximize employee and shareholder alignment through the use of deferred equity awards, while minimizing dilution. Since 2009, the Company has requested approval of a number of additional shares that we anticipate will be sufficient to cover only one year of grant needs. The Company has evaluated, as it does annually, whether to return to shareholders to request approval of additional shares at the 2016 annual meeting of shareholders and has determined to request 20 million shares to cover one year of grant needs, which is down from the 25 million shares approved by 92% of voting shareholders last year and less than the 59 million shares the Company repurchased in 2015.

If the proposed amendment is not approved, the Company will not have sufficient shares for grant needs and will be compelled to increase the cash-based component of employee compensation, which is contrary to regulatory guidance and could reduce the alignment of employee and shareholder interests.

If the proposed amendment is not approved, the Company will not have sufficient shares for grant needs and will lose a critical tool for recruiting, retaining and motivating employees. The Company would thus be at a competitive disadvantage in attracting and retaining talent.

Morgan Stanley 2016 Proxy Statement71



Table of Contents

EQUITY COMPENSATION PLAN

If the proposed amendment is not approved, the Company will have limited flexibility to grant performance-vested awards that are conditioned upon the attainment of criteria related to regulatory factors, risk management, expense management, and contributions to community development and sustainability projects or initiatives and that are tax deductible to the Company under Section 162(m) of the Internal Revenue Code.

The terms of our equity and other annual and long-term incentive compensation awards and our employee policies are all designed to protect shareholder interests and encourage employees to focus on the long-term success of the Company.


Employees typically cannot fully monetize equity awards until three years after grant. For example, RSUs granted for 2015 generally vest and convert to shares after three years.

The Company’s equity awards generally are subject to cancellation for, among other things, engaging in competitive activity, cause (i.e., any act or omission that constitutes a breach of obligation to the Company, including failure to comply with internal compliance, ethics or risk management standards and failure or refusal to perform duties satisfactorily, including supervisory and management duties), soliciting clients or employees, and misuse of proprietary information.

Equity awards are subject to clawback if an employee’s act or omission (including with respect to direct supervisory responsibilities) causes a restatement of the Company’s consolidated financial results, constitutes a violation of the Company’s global risk management principles, policies and standards, or causes a loss of revenue associated with a position on which the employee was paid and the employee operated outside of internal control policies. Equity awards to senior executives are also subject to clawback if the CMDS Committee determines that the individual had significant responsibility for a material adverse outcome for the Company or any of its businesses or functions, even absent misconduct.

The EICP expressly prohibits the grant of stock option restoration rights and the repricing of stock options and stock appreciation rights (including any amendment to such awards that has the effect of reducing the exercise price and any cancellation of such awards in exchange for cash or another award) other than an equitable adjustment in connection with a corporate transaction.

Our Board unanimously recommends that you vote“FOR” this proposal. Proxies solicited by the Board will be voted“FOR” this proposal unless otherwise instructed.

SUMMARY OF THE EICP AS PROPOSED TO BE AMENDED

A copy of the EICP as proposed to be amended is attached to this proxy statement as Annex A and the following summary is qualified in its entirety by reference thereto. Other than the amendment to the number of shares available under the EICP and the addition of performance measures for performance-based awards that are intended to qualify for tax deductibility under Section 162(m) of the Internal Revenue Code for which we are seeking approval under this Item 4, the EICP terms remain unchanged. The capitalized terms not otherwise defined in this summary shall have the meaning assigned to them in the EICP.

Purposes and Eligibility

The primary purposes of the EICP are to attract, retain and motivate employees, to compensate them for their contributions to our growth and profits and to encourage them to own shares of our common stock to align their interests with those of shareholders. The EICP authorizes the issuance of awards (Awards) to all officers, other employees (including newly hired employees) and consultants of the Company, non-employee directors of our subsidiaries and employees and consultants of joint ventures, partnerships or similar business organizations in which we or one of our subsidiaries has an equity or similar interest (Eligible Individuals). As of January 2016, there were approximately 55,000 Eligible Individuals who were employees of the Company and its subsidiaries.

72Morgan Stanley 2016 Proxy Statement



Table of Contents

EQUITY COMPENSATION PLAN

Administration

The CMDS Committee will administer the EICP, select the Eligible Individuals who receive Awards (Participants) and determine the form and terms of the Awards, including any vesting, exercisability, payment or other restrictions. Subject to certain limitations, the CMDS Committee may delegate some or all of its authority to one or more administrators (e.g., one or more CMDS Committee members or one or more of our officers).

Shares Available Under the EICP

Since initial shareholder approval of the EICP in 2007, the total number of shares of common stock that may be delivered pursuant to Awards will be 323 million (which takes into account the proposed 20 million share increase), of which approximately 275.5 million were already granted as of January 31, 2016, subject to adjustment pursuant to the EICP’s share counting rules as described below and to reflect certain transactions. Shares delivered under the EICP may be either treasury shares or newly issued shares. In addition to the overall limit, the EICP limits the number of shares of common stock that may be subject to stock option and stock appreciation right (SAR) awards in any single year.

Share Counting Rules

When the CMDS Committee grants an Award, the full number of shares subject to the Award is charged against the number of shares that remain available for delivery pursuant to Awards. After grant, the number of shares subject to any portion of an Award that is canceled or that expires without having been settled in shares, or that is settled through the delivery of consideration other than shares, will be available for new Awards. If shares are tendered or withheld to pay the exercise price of an Award or to satisfy a tax withholding obligation, those tendered or withheld shares will be available for new Awards. Awards granted upon assumption of, or in substitution for, outstanding awards previously granted by, or held by employees of, a company or other entity or business acquired (directly or indirectly) by the Company or with which the Company combines are not counted against the number of shares of common stock available for delivery pursuant to Awards and are not subject to the individual limit on stock options and SARs.

Awards Generally

Form of Awards. The EICP authorizes the following Awards: (i) restricted stock Awards consisting of one or more shares of common stock granted or sold to a Participant; (ii) stock unit Awards settled in one or more shares of common stock or, as authorized by the CMDS Committee, an amount in cash based on the fair market value of shares of common stock; (iii) stock option Awards consisting of the right to purchase at a specified exercise price a number of shares of common stock determined by the CMDS Committee; (iv) SARs consisting of the grant of a right to receive upon exercise of such right, in cash or common stock (or a combination thereof) as determined by the CMDS Committee, an amount equal to the increase in the fair market value of a share of common stock over the specified exercise price; (v) Qualifying Performance Awards to participants covered by Section 162(m), with the intent that such awards qualify as “performance-based compensation” under Section 162(m); and (vi) other forms of equity-based or equity-related Awards that the CMDS Committee determines to be consistent with the purposes of the EICP (Other Awards). Awards under the EICP may, at the discretion of the CMDS Committee, be made in substitution in whole or in part for cash or other compensation payable to an Eligible Individual.

Dividends and Distributions. If we pay any dividend or make any distribution to holders of our common stock, the CMDS Committee may in its discretion authorize payments (which may be in cash, common stock (including restricted stock) or stock units or a combination thereof) with respect to the shares of common stock corresponding to an Award, or may authorize appropriate adjustments to outstanding Awards, to reflect the dividend or distribution. The CMDSCommittee may make any such payments subject to vesting, deferral, restrictions on transfer or other conditions. Dividends are not paid on stock options or SARs.


Restricted Stock and Stock Units

Restricted shares awarded or sold to a Participant are outstanding shares of common stock that the CMDS Committee may subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances. Each stock unit awarded to a Participant corresponds to one share of common stock and the CMDS Committee may subject the award to vesting requirements or cancellation under specified circumstances. Upon satisfaction of the terms and conditions of a stock

Morgan Stanley 2016 Proxy Statement73



Table of Contents

EQUITY COMPENSATION PLAN

unit Award, applicable stock units will be payable, at the discretion of the CMDS Committee, in common stock or in cash equal to the fair market value on the payment date of one share of common stock. As a holder of stock units, a Participant will have only the rights of a general unsecured creditor of the Company. A Participant will not be a shareholder with respect to the shares underlying stock units unless and until the stock units convert to shares of common stock.

Stock Options and SARs

General. Stock options may be either nonqualified stock options or incentive stock options (ISOs). Upon satisfaction of the conditions for exercisability, a Participant may exercise a stock option and receive the number of shares of common stock in respect of which the stock option is exercised. Upon satisfaction of the conditions for payment, each SAR will entitle a Participant to an amount, if any, equal to the amount by which the fair market value of a share of common stock on the date of exercise exceeds the SAR exercise price. At the discretion of the CMDS Committee, SARs may be payable in common stock, cash or a combination thereof.

Exercise Price. The exercise price of stock options and SARs awarded under the EICP may not be less than 100% of the fair market value of one share of common stock on the award date; however, the exercise price per share of a stock option or SAR that is granted in substitution for an award previously granted by an entity acquired by the Company or with which the Company combines may be less than the fair market value per share on the award date if such substitution complies with applicable laws and regulations.

Prohibition on Repricing of Stock Options and SARs. The CMDS Committee may not “reprice” any stock option or SAR or make any other amendment to a stock option or SAR that has the effect of reducing its exercise price or cancel a stock option or SAR in exchange for cash or another Award, unless the repricing occurs in connection with a merger, acquisition, spin-off or other similar corporate transaction. An equitable adjustment to reflect a corporate transaction is not a prohibited repricing.

Prohibition on Restoration Option and SAR Grants. The terms of a stock option or SAR may not provide for a new stock option or SAR to be granted, automatically and without payment of additional consideration in excess of the exercise price of the underlying stock option or SAR, to a Participant upon exercise of the stock option or SAR.

Individual Limit on Stock Options and SARs. The maximum number of shares of common stock that may be subject to stock options or SARs granted to or elected by a Participant in any fiscal year will be 2,000,000 shares. This limitation does not apply to shares of common stock subject to stock options or SARs granted to a Participant pursuant to any performance formula or performance measures approved by the Company’s shareholders pursuant to Section 162(m).

Maximum Term on Stock Options and SARs. No stock option or SAR may have an expiration date that is later than the tenth anniversary of the Award date.

ISO Limit. The full number of shares of common stock available for delivery under the EICP may be delivered pursuant to ISOs, except that in calculating the number of shares that remain available for ISOs, certain share counting provisions will not apply.


Qualifying Performance Awards

These awards are intended to be granted to any individual designated by the CMDS Committee by not later than 90 days following the start of the relevant performance period (or such other time as may be required or permitted by Section 162(m)) as an individual whose compensation for such fiscal year may be subject to the limit on deductible compensation imposed by Section 162(m).

Eligible Participants. Grants of performance-based long-term incentive awards (other than stock options and stock appreciation rights) that are intended to be qualified performance-based awards under Section 162(m) (Qualifying Awards) will be limited to our officers for whom compensation may not otherwise be tax-deductible under Section 162(m). Currently, the Company expects to grant Awards to some or all members of the Company’s Operating Committee. There are currently 16such officers.

Performance Measures. The performance measures for Qualifying Awards may vary by participant and by award, and may be based upon the attainment of specific amounts of, or changes in, one or more of the following: earnings (before or after taxes); earnings per share; shareholders’ equity or return on shareholders’ equity; risk-weighted assets or

74Morgan Stanley 2016 Proxy Statement



Table of Contents

EQUITY COMPENSATION PLAN

return on risk-weighted assets; capital, capital ratios or return on capital; book value or book value per share; operating income (before or after taxes); operating margins or pre-tax margins; stock price or total shareholder return; market share (including market share of revenue); debt reduction or change in rating; cost reductions; regulatory factors; risk management; expense management; or contributions to community development or sustainability projects or initiatives.

The CMDS Committee may provide that, in measuring the achievement of the performance measures, an award may include or exclude items such as unrealized investment gains and losses, extraordinary, unusual or non-recurring items, asset write-downs, effects of accounting changes, currency fluctuations, acquisitions, divestitures, reserve-strengthening, litigation, claims, judgments or settlements, the effect of changes in tax law or other such laws or provisions affecting reported results and other non-operating items, as well as the impact of changes in the fair value of certain of the Company’s long-term and short-term borrowings resulting from fluctuations in the Company’s credit spreads and other factors (commonly referred to as DVA).

The foregoing objectives may be applicable to the Company as a whole, one or more of its subsidiaries, divisions, business units or business lines, or any combination of the foregoing, and may be applied on an absolute basis or be relative to other companies, industries or indices (e.g., stock market indices) or be based upon any combination of the foregoing. In addition to the performance measures, the CMDS Committee may also condition payment of any such award upon the attainment of conditions, such as completion of a period of service, notwithstanding that the performance measure or measures specified in the award are satisfied.

Individual Award Limits. In any one calendar year, no one participant may be granted Qualifying Awards that allow for payments with an aggregate value determined by the CMDS Committee to be in excess of $10 million. For purposes of calculating this limit, the value of Qualifying Awards that are denominated in shares will be determined by reference to the volume-weighted average price of a share of the Company on the first date of grant of such awards. For purposes of the foregoing, the CMDS Committee will determine the calendar year or years in which amounts under these Qualifying Awards are deemed paid, granted or received.


Other Awards

The CMDS Committee may establish the terms and provisions of other forms of Awards not described above that the CMDS Committee determines to be consistent with the purpose of the EICP and the interests of the Company.

Transferability

Unless otherwise permitted by the CMDS Committee, no Award will be transferable other than by will or by the laws of descent and distribution. During the lifetime of a Participant, an ISO will be exercisable only by the Participant.

Amendment and Termination

The Board or the CMDS Committee may modify, amend, suspend or terminate the EICP in whole or in part at any time and may modify or amend the terms and conditions of any outstanding Award. However, no modification, amendment, suspension or termination may materially adversely affect a Participant’s rights with respect to any Award previously made without that Participant’s consent, except that the CMDS Committee may at any time, without a Participant’s consent, amend or modify the EICP or any Award under the EICP to comply with law, accounting standards, regulatory guidance or other legal requirements. The CMDS Committee may create subplans as may be necessary or advisable to comply with non-U.S. legal or regulatory provisions. Notwithstanding the foregoing, neither the Board nor the CMDS Committee may accelerate the payment or settlement of any Award that constitutes a deferral of compensation for purposes of Section 409A of the Internal Revenue Code except to the extent the acceleration would not result in a Participant incurring interest or additional tax under Section 409A.

Term

No Awards may be made after May 15, 2017.

Morgan Stanley 2016 Proxy Statement75



Table of Contents

EQUITY COMPENSATION PLAN

Section 162(m) of the Internal Revenue Code

Section 162(m) limits the federal income tax deduction for compensation paid to the Chief Executive Officer and the three other most highly compensated executive officers (other than the Chief Financial Officer) of a publicly held corporation to $1 million per fiscal year, with exceptions for certain performance-based compensation. Such performance-based compensation may consist of awards determined by the CMDS Committee under a formula or performance criteria approved by the Company’s shareholders. Our shareholders approved the formula governing annual incentive compensation currently used by the CMDS Committee at our annual meeting on May 14, 2013. Awards of stock options, SARs or performance-based long-term incentive awards granted by the CMDS Committee under the EICP qualify for the performance-based compensation exception to Section 162(m).

EICP Benefits

Awards under the EICP will be authorized by the CMDS Committee in its sole discretion. Therefore, it is not possible to determine the benefits or amounts that will be received by any particular employees or group of employees in the future or that would have been received in 2015 had the amendment of the EICP then been in effect.

U.S. Federal Income Tax Consequences

The following is a general summary as of the date of this proxy statement of the U.S. federal income tax consequences associated with the EICP. The federal tax laws are complex and subject to change and the tax consequences for any Participant will depend on his or her individual circumstances.

Stock Units. A Participant who receives stock units will be taxed at ordinary income tax rates on the then fair market value of the shares of common stock distributed at the time of settlement of the stock units and a corresponding deduction will be allowable to the Company at that time (subject to Section 162(m)). The Participant’s tax basis in the shares will equal the amount taxed as ordinary income, and on subsequent disposition the Participant will realize long-term or short-term capital gain or loss.

Restricted Stock. A Participant who is awarded restricted stock will not be taxed at the time an Award is granted unless the Participant makes the special election with the Internal Revenue Service pursuant to Section 83(b) of the Internal Revenue Code as discussed below. Upon lapse of the risk of forfeiture or restrictions on transferability applicable to the shares comprising the Award, the Participant will be taxed at ordinary income tax rates on the then fair market value of the shares. The Company is required to withhold tax on the amount of income so recognized, and a deduction corresponding to the amount of income recognized will be allowable to the Company (subject to Section 162(m)). The Participant’s tax basis in the shares will be equal to the ordinary income so recognized. Upon subsequent disposition of the shares, the Participant will realize long-term or short-term capital gain or loss.

Pursuant to Section 83(b) of the Internal Revenue Code, the Participant may elect within 30 days of receipt of the Award to be taxed at ordinary income tax rates on the fair market value of the shares comprising such Award at the time of Award (determined without regard to any restrictions which may lapse) less any amount paid for the shares. In that case, the Participant will acquire a tax basis in the shares equal to the ordinary income recognized by the Participant at the time of Award. No tax will be payable upon the lapse or release of the restrictions or at the time the shares first become transferable, and any gain or loss upon subsequent disposition will be a capital gain or loss. In the event of a forfeiture of shares of common stock with respect to which a Participant previously made a Section 83(b) election, the Participant will generally not be entitled to a loss deduction.

Nonqualified Stock Options. The grant of a nonqualified stock option will not result in the recognition of taxable income by the Participant or in a deduction to the Company. Upon exercise, a Participant will recognize ordinary income in an amount equal to the excess of the fair market value of the shares of common stock purchased over the exercise price, and a tax deduction is allowable to the Company equal to the amount of such income (subject to Section 162(m)). Gain or loss upon a subsequent sale of any shares received upon the exercise of a nonqualified stock option generally would be taxed as either long-term or short-term capital gain or loss, depending upon the holding period of the shares sold. Certain additional rules apply if the exercise price for an option is paid in shares previously owned by the Participant.

76Morgan Stanley 2016 Proxy Statement



Table of Contents

EQUITY COMPENSATION PLAN


ISOs. Upon the grant or exercise of an ISO within the meaning of Section 422 of the Internal Revenue Code, no income will be realized by the Participant for federal income tax purposes and the Company will not be entitled to any deduction. However, the excess of the fair market value of the shares of common stock as of the date of exercise over the exercise price will constitute an adjustment to taxable income for purposes of the alternative minimum tax. If the shares are not disposed of within the one-year period beginning on the date of the transfer of such shares to the Participant or within the two-year period beginning on the date of grant of the stock option, any profit realized by the Participant upon the disposition of such shares will be taxed as long-term capital gain and no deduction will be allowed to the Company. If the shares are disposed of within the one-year period from the date of transfer of such shares to the Participant or within the two-year period from the date of grant of the stock option, the excess of the fair market value of the shares on the date of exercise or, if less, the fair market value on the date of disposition, over the exercise price will be taxable as ordinary income to the Participant at the time of disposition, and a corresponding deduction will be allowable to the Company. Certain additional rules apply if the exercise price for a stock option is paid in shares previously owned by the Participant.

SARs. The grant of SARs will not result in the recognition of taxable income by the Participant or in a deduction to the Company. Upon exercise, a Participant will recognize ordinary income in an amount equal to the then fair market value of the shares of common stock or cash distributed to the Participant. The Company is entitled to a tax deduction equal to the amount of such income (subject to Section 162(m)). Gain or loss upon a subsequent sale of any shares received upon the exercise of SARs generally would be taxed as long-term or short-term capital gain or loss, depending upon the holding period of the shares sold.

EQUITY COMPENSATION PLAN INFORMATION

The following table provides information about outstanding awards and shares of common stock available for future awards under all of Morgan Stanley’s equity compensation plans as of December 31, 2015. Morgan Stanley has not made any grants of common stock outside of its equity compensation plans.

The following information is intended to update and supplement the table and, we believe, is useful for a better understanding of “Item 4 – Company Proposal to Amend the 2007 Equity Incentive Compensation Plan.”

As of January 31, 2016, (i) the number of shares available for grant under the Company’s plans that can be used for the purpose of granting employee equity awards was approximately 33.9 million, with only 27.5 million of such shares available under the EICP; (ii) the number of outstanding full value awards (including restricted stock units and performance stock units at target) was approximately 112.5 million; (iii) the number of outstanding stock options was approximately 16.6 million; (iv) the weighted average exercise price of outstanding stock options was $52.2419; and (v) the weighted average remaining life of outstanding stock options was 1.2134 years.


  Plan Category       (a)       (b)       (c)  
  Number of securities
to be issued
upon exercise of
outstanding options,
warrants and rights
(#)(1)
Weighted-average
exercise price of
outstanding options,
warrants and rights
($)(2)
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding securities
reflected in column (a))
(#)
Equity compensation plans approved
by security holders
127,987,17152.255196,709,828(3)
Equity compensation plans not approved
by security holders
494,618(4)
Total128,481,78952.255196,709,828(5)

(1)Includes outstanding stock option, restricted stock unit and performance stock unit awards. The number of outstanding performance stock unit awards is based on the target number of units granted to senior executives.
(2)Reflects the weighted-average exercise price with respect to outstanding stock options and does not take into account outstanding restricted stock units and performance stock units, which do not provide for an exercise price.

Morgan Stanley 2016 Proxy Statement77



Table of Contents

EQUITY COMPENSATION PLAN


(3)Includes the following:
(a)39,182,870 shares available under the Morgan Stanley Employee Stock Purchase Plan (ESPP). Pursuant to this plan, which is qualified under Section 423 of the Internal Revenue Code, eligible employees were permitted to purchase shares of common stock at a discount to market price through regular payroll deduction. The CMDS Committee approved the discontinuation of the ESPP, effective June 1, 2009, such that no further contributions to the plan will be permitted following such date, until such time as the CMDS Committee determines to recommence contributions under the plan.
(b)50,848,524 shares available under the EICP (without taking into account the proposed amendment to the EICP). Awards may consist of stock options, stock appreciation rights, restricted stock, restricted stock units to be settled by the delivery of shares of common stock (or the value thereof), performance-based units, other awards that are valued by reference to or otherwise based on the fair market value of common stock, and other equity-based or equity-related awards approved by the CMDS Committee.
(c)5,948,994 shares available under the Employee Equity Accumulation Plan (EEAP), which includes 733,757 shares available for awards of restricted stock and restricted stock units. Awards may consist of stock options, stock appreciation rights, restricted stock, restricted stock units to be settled by the delivery of shares of common stock (or the value thereof), other awards that are valued by reference to or otherwise based on the fair market value of common stock, and other equity-based or equity-related awards approved by the CMDS Committee.
(d)355,243 shares available under the Tax Deferred Equity Participation Plan (TDEPP). Awards consist of restricted stock units, which are settled by the delivery of shares of common stock.
(e)374,197 shares available under DECAP. This plan provides for periodic awards of shares of common stock and stock units to non-employee directors and also allows non-employee directors to defer the cash fees they earn for services as a director in the form of stock units.
(4)As of December 31, 2015, no shares remained available for future issuance under the Financial Advisor and Investment Representative Compensation Plan (FAIRCP), which was terminated effective December 31, 2011, and the Morgan Stanley 2009 Replacement Equity Incentive Compensation Plan for Morgan Stanley Smith Barney Employees (REICP), which was terminated effective December 31, 2012. However, awards remained outstanding under these plans as of December 31, 2015. The material features of the FAIRCP and the REICP, which were not approved by shareholders under SEC rules, are as follows:
(a)FAIRCP: Financial advisors and investment representatives in Wealth Management were eligible to receive awards under FAIRCP in the form of cash, restricted stock and restricted stock units settled by the delivery of shares of common stock.
(b)REICP: REICP was adopted in connection with the Morgan Stanley Wealth Management joint venture and without stockholder approval pursuant to the employment inducement award exception under the NYSE Corporate Governance Listing Standards. The equity awards granted pursuant to the REICP were limited to awards to induce certain Citigroup Inc. employees to join the new Morgan Stanley Wealth Management joint venture by replacing the value of Citigroup awards that were forfeited in connection with the employees’ transfer of employment to Wealth Management. Awards under the REICP were authorized in the form of restricted stock units, stock appreciation rights, stock options and restricted stock and other forms of stock-based awards.
The foregoing descriptions do not purport to be complete and are qualified in their entirety by reference to the FAIRCP and REICP plan documents which, along with all plans under which awards were available for grant in 2015, are included as exhibits to the 2015 Form 10-K.
(5)As of December 31, 2015, 57,152,761 shares were available under the Company’s plans that could be used for the purpose of granting employee equity awards (EICP, EEAP and TDEPP). In January 2016, approximately 33.8 million shares were granted as part of 2015 employee incentive compensation and approximately 1.1 million shares (representing the target number of performance stock units) were granted as 2016 LTIP awards.

78Morgan Stanley 2016 Proxy Statement



Table of Contents

SHAREHOLDER PROPOSALSPROPOSAL

The Company sets forth below twoone shareholder proposalsproposal and the proponents’proponent’s supporting statements.statement. The Board and the Company accept no responsibility for the text of these proposalsthis proposal and supporting statements.statement. The Board recommends that you vote against each of the two shareholder proposals.proposal. A proposal may be voted on at the annual meeting only if properly presented by the shareholder proponent or the proponent’s qualified representative.

Item 54


Shareholder Proposal Regarding a Change in the Treatment of Abstentions for Purposes of Vote Counting

Shareholder Proposal Regarding an Annual Report on Lobbying Expenses
LOGOOur Board unanimously recommends that you vote“AGAINST” this proposal.

Newground Social Investment, SPC, 10033 – 12th Ave, NW, Seattle, Washington 98177, on behalf of the Equality Network Foundation, theBoston Common Asset Management, LLC, 200 State Street, 7th Floor, Boston, MA 02109, beneficial owner of 8611,500 shares of common stock, and Boston Common Asset Management, 84 State Street, Suite 940, Boston, Massachusetts 02109, on behalf of the Boston Common U.S. Equity Fund, the beneficial owner of 16,245 shares of common stock, havehas notified the Company that they intendit intends to present the following proposal and related supporting statement at the annual meeting.

RESOLVED: ShareholdersWhereas, we believe in full disclosure of Morgan Stanley’s direct and indirect lobbying activities and expenditures to assess whether its lobbying is consistent with its expressed goals and in the best interests of shareholders.

Resolved, the shareholders of Morgan Stanley hereby request the Boardpreparation of a report, updated annually, disclosing:

1. Company policy and procedures governing lobbying, both direct and indirect, and grassroots lobbying communications.

2. Payments by Morgan Stanley used for (a) direct or indirect lobbying or (b) grassroots lobbying communications, in each case including the amount of the payment and the recipient.

3. Description of management’s and the Board’s decision making process and oversight for making payments described in section 2 above.

For purposes of this proposal, a “grassroots lobbying communication” is a communication directed to the general public that (a) refers to specific legislation or regulation, (b) reflects a view on the legislation or regulation and (c) encourages the recipient of the communication to take action with respect to the legislation or initiateregulation. “Indirect lobbying” is lobbying engaged in by a trade association or other organization of which Morgan Stanley is a member.

Both “direct and indirect lobbying” and “grassroots lobbying communications” include efforts at the steps necessary to amend the Company’s governing documents to provide that all non-binding matters presented by shareholderslocal, state and federal levels.

The report shall be decided bypresented to the Nominating and Governance Committee and posted on Morgan Stanley’s website.

SUPPORTING STATEMENT

We encourage transparency and accountability in our company’s use of funds to lobby. Morgan Stanley spent $25,160,000 from 2010 – 2017 on federal lobbying. This figure does not include state lobbying expenditures, where Morgan Stanley also lobbies but disclosure is uneven or absent. For example, Morgan Stanley spent $532,557 on lobbying in California from 2010 – 2017. Morgan Stanley’s lobbying on tax reform has attracted media scrutiny (“Banks Pay $4M for Lobbying as Tax Reform Debated, FoxBusiness, January 29, 2018).

Morgan Stanley is a simple majoritymember of the votes cast FORChamber of Commerce, which has spent over $1.4 billion on lobbying since 1998, and AGAINST an item.is also a member of the Business Roundtable, which spent over $43 million on lobbying for 2016 and 2017 and is lobbying against the right of shareholders to file resolutions. Morgan Stanley does not disclose its trade association payments or the portions used for lobbying on its website. Morgan Stanley prohibits its payments to trade associations from being used for political contributions, but this does not cover payments used for lobbying. This leaves a serious disclosure gap, as trade associations generally spend far more on lobbying than on political contributions.

We are concerned that Morgan Stanley’s lack of lobbying disclosure presents reputational risks when its lobbying contradicts company public positions. For example, Morgan Stanley is committed to a strong climate policy shall apply to all such matters unless shareholders have approved higher thresholds, or applicable laws or stock exchange regulations dictate otherwise.globally, yet

SUPPORTING STATEMENT:

A simple-majority voting formula includes FOR and AGAINST votes, but not abstentions.

Under management’s present system, on shareholder resolutions abstentions count as AGAINST votes. This disadvantages shareholders in three ways:

1.Every abstention on a shareholder item is treated as an AGAINST vote.
Regardless of an abstaining voter’s intent, Morgan Stanley treats every abstention as ifagainst shareholder items, while not counting them against management-sponsored Director elections.
2.Counting abstentions suppresses outcomes.
By simple math, including abstentions in a formula depresses the vote result.
Counting abstentions against shareholder items is burdensome and inconsistent, because Morgan Stanley does not place this same burden on management-sponsored Director elections.
3.Counting abstentions distorts communication among shareholders and Morgan Stanley.
This distortion happens at the annual general meeting (“AGM”) of shareholders – the only time each year that owners can directly interact with Board or management.
Morgan Stanley’s voting policies create misimpressions that endure. Shareholders and the media may not be informed about voting practices at the AGM, so voting distortions are widely reported in the press and imprinted on the minds of shareholders and the public. These same distortions impact Board awareness of shareholder concern/interest.

Morgan Stanley 20162019 Proxy Statement79    77



Table of Contents

SHAREHOLDER PROPOSALSPROPOSAL


Three facts:

A CalPERS study found that 48% of S&P 500 and Russell 1000 companies employ a simple-majority standard – showing this to be a mainstream practice.

Under this proposal, shareholders retain the right to ‘send a message’ with their abstention – in fact, message-sending may be more effective because Morgan Stanley will not use abstentions to depress reported outcomes on shareholder proposals.

Any suggestion that management- and shareholder-sponsored items are treated “identically” or “equally” is false, because management-sponsored item No. 1 – Director elections – does not count abstentions.

Notable supportersthe Chamber undermined the Paris climate accord (“Paris Pullout Pits Chamber against Some of a simple-majority standard:

The US Securities and Exchange Commission (Staff Legal Bulletin No. 14, Question F.4.): “Only votes FOR and AGAINST a proposal are included in the calculation of the shareholder vote of that proposal. Abstentions… are not included in this calculation.”

Institutional Shareholder Services (“ISS” – the nation’s leading proxy reporting service): “a simple majority of voting shares should be all that is necessary to effect change regarding a company and its governance provisions.”

The Council of Institutional Investors (Governance Policy 3.7): “Uninstructed broker votes and abstentions should be counted only for purposes of a quorum.”

Vote to enhance shareholder valueIts Biggest Members,” Bloomberg, June 9, 2017). As shareholders, we believe that companies should ensure there is alignment between their own positions and good governance at Morgan Stanley: vote FOR Item 5 – Simple Majority Vote-Counting.their lobbying, including through trade associations.

STATEMENT OF THE BOARD RECOMMENDING A VOTE AGAINST THIS PROPOSAL

The Board believes that this proposal is not in the best interest of Morgan Stanley or its shareholders and opposes this proposal for the reasons discussed below:

Our voting standard appliesidentically andequallyWe are committed to Company-sponsored proposalscomplying with all applicable laws relating to political contributions and shareholder proposals. lobbying activities, including registration and reporting, and our current public disclosures provide our shareholders with extensive information on our lobbying activities.

We are subject to extensive federal, state and local lobbying registration and disclosure requirements, including the Lobbying Disclosure Act of 1995 as amended by the Honest Leadership and Open Government Act of 2007 (the Lobbying Disclosure Act) and numerous state lobbying statutes.

We are committedpublicly disclose all U.S. federal lobbying costs and the issues to which they relate pursuant to the highest standards of integrityLobbying Disclosure Act, which requires that we file reports on a quarterly basis. These reports are available athttp://lobbyingdisclosure.house.gov. We also disclose state and the best interests of our shareholderslocal lobbying costs where required by ensuring consistency, fairness and transparencylaw. Dues attributable to lobbying by U.S. trade associations are included in the application of our vote counting standard.

At this year’s annual meeting, our shareholders are being askedquarterly reports we file pursuant to vote on both Company-sponsored proposals, such as say on pay and approval of an amendment to our 2007 Equity Incentive Compensation Plan, and shareholder proposals,the Lobbying Disclosure Act. For 2018, lobbying costs, including this proposal. Forboth, abstentions will be counted and will have the same effect as a vote against.

The SEC’s proxy disclosure rules defer to state law and require registrants such as Morgan Stanley to “[d]isclose the method by which votes will be counted, including the treatment and effect of abstentions and broker non-votesunder applicable state law as well as registrant charter and bylaw provisions” (emphasis added).trade association membership dues, were not material.

Political contributions made by the Morgan Stanley Political Action Committee (which is funded solely through voluntary employee contributions) are reported to the Federal Election Commission (publicly available at www.fec.gov) and all contributions required to be disclosed under the Lobbying Disclosure Act are reported to the U.S. Congress. We provide a link to these reports on our public website.

Our public website also includes a voluntary report confirming that no corporate political contributions were made in the U.S. at the federal, state or local level.

We also voluntarily provide examples of the principal U.S. trade associations we participate in on our public website. We may not always support every position taken by these organizations or their other members but we believe that our participation in these organizations is important to the advancement of our employees’ professional development and networking and to promoting public policy objectives of importance to our shareholders, clients and employees.

Our voting standard is consistentpolitical activities, including our lobbying activities and expenditures related thereto, are subject to oversight by management and the Board.

We participate in the public policy arena on a wide range of issues that are important to our shareholders, clients and employees, including issues relating to the regulatory environment worldwide, the growth and stability of the global economy and healthy capital markets.

Our Code of Conduct (which our Board annually reviews and approves) and our Policy on U.S. Political Contributions and Activities govern our and our employees’ political activities and are designed to help ensure we and our employees act in compliance with applicable laws and regulatory requirements and with the treatmentprinciples set forth in our Corporate Political Activities Policy Statement (Policy Statement).

Our lobbying activities and expenditures related thereto are overseen by our Government Relations Department, which reports to the Vice Chairman, a member of abstentions under Delaware law.the Company’s Operating Committee who reports to the Chairman and Chief Executive Officer.

As set forth in its charter, the Nominating and Governance Committee of the Board reviews and approves our Policy Statement. It also oversees, and receives reports at least annually from the Government Relations Department on our political activities including our significant lobbying priorities, and expenditures attributable to lobbying in the U.S.

We also provide an annual report to the Nominating and Governance Committee regarding our principal trade associations, including membership dues and confirmation that we have informed our principal trade associations of the prohibition on corporate contributions in the U.S. set forth in our Policy Statement and have instructed them not to use payments made by us for election-related activity at the federal, state or local levels.

We are incorporated in Delaware and, accordingly, Delaware law governs the voting standards for action by our shareholders.
 

Our bylaws follow the general default voting standard under Delaware law and we believe that a majority of Delaware corporations in the S&P 500 adhere to this default voting standard, which is consistent with the proponents’ acknowledgement that less than 50% of S&P 500 and Russell 1000 companies have adopted the voting standard requested by the proposal.

8078    Morgan Stanley 20162019 Proxy Statement



SHAREHOLDER PROPOSAL

TableGiven the comprehensive public disclosures we already make, the creation of Contentsa separate report to shareholders detailing information already filed and publicly disclosed in accordance with extensive federal, state and local regulations would not be an efficient use of corporate resources.

SHAREHOLDER PROPOSALS


Our voting standards are clearly explained in this proxy statement and honor the intent of our shareholders.

As disclosed under the heading “What Vote Is Required and How Will My Votes Be Counted?” herein, abstentions are treated consistently for Company-sponsored proposals and shareholder proposals.

The only exception to this practice is for the election of directors. Consistent with Delaware law and many Fortune 500 companies, abstentions have no effect in our director elections, which we believe is consistent with best corporate governance, applies equally to candidates that have been nominated by the Company or a shareholder and is clearly disclosed in our proxy statement.

Our methodology honors the intent of our shareholders who consciously “abstain” and expect their abstentions to be included in the vote tabulation in the manner that is described in our proxy statement. We do not believe it is in the best interest of our shareholders or effective corporate governance to disregard these views.

Our shareholders have recently supported our vote counting methodology.

We do not believe there is justification for the proponent’s request to treat Company-sponsored and shareholder proposals differently.

Not counting abstentions would lower the approval standard for proposals and the Board believes that as a matter of good governance a proposal should receive more “for” votes than the sum of “against” and “abstain” votes in order to constitute shareholder approval.

A vote-counting proposal similar to the proponents’ proposal (but which would have applied to both Company-sponsored and shareholder proposals) was submitted to a shareholder vote at the 2015 annual meeting of shareholders and received minimal shareholder support (4.6%, calculated under both the proponents’ proposed vote counting method and our current method).

Our Board unanimously recommends that you vote“AGAINST” this proposal. Proxies solicited by the Board will be voted “AGAINST” this proposal unless otherwise instructed.

Item 6

Shareholder Proposal Regarding a Policy to Prohibit Vesting of Deferred Equity Awards for Senior Executives Who Resign to Enter Government Service

Our Board unanimously recommends that you vote“AGAINST” this proposal.

The Reserve Fund of the American Federation of Labor and Congress of Industrial Organizations, 815 Sixteenth Street, N.W., Washington, D.C. 20006, beneficial owner of 875 shares of common stock, has notified the Company that it intends to present the following proposal and related supporting statement at the annual meeting.

RESOLVED: Shareholders of Morgan Stanley (the “Company”) request that the Board of Directors adopt a policy prohibiting the vesting of equity-based awards for senior executives due to a voluntary resignation to enter government service (a “Government Service Golden Parachute”).

For purposes of this resolution, “equity-based awards” include stock options, restricted stock and other stock awards granted under an equity incentive plan. “Government service” includes employment with any U.S. federal, state or local government, any supranational or international organization, any self-regulatory organization, or any agency or instrumentality of any such government or organization, or any electoral campaign for public office.

Morgan Stanley 2016 Proxy Statement81



Table of Contents

SHAREHOLDER PROPOSALS


This policy shall be implemented so as not to violate existing contractual obligations or the terms of any compensation or benefit plan currently in existence on the date this proposal is adopted, and it shall apply only to equity awards or plan amendments that shareholders approve after the date of the 2016 annual meeting.

SUPPORTING STATEMENT:

Our Company provides its senior executives with vesting of equity-based awards after their voluntary resignation of employment from the Company to pursue a career in government service. In other words, our Company gives a “golden parachute” for entering government service. For example, Company Chairman and CEO James Gorman was entitled to $9.35 million in vesting of equity awards if he had a government service termination on December 31, 2013.

At most companies, equity-based awards vest over a period of time to compensate executives for their labor during the commensurate period. If an executive voluntarily resigns before the vesting criteria are satisfied, unvested awards are usually forfeited. While government service is commendable, we question the practice of our Company providing accelerated vesting of equity-based awards to executives who voluntarily resign to enter government service.

The vesting of equity-based awards over a period of time is a powerful tool for companies to attract and retain talented employees. But contrary to this goal, our Company’s equity incentive compensation plan’s award certificates contain a “Governmental Service Termination” clause that provides for the vesting of equity awards for executives who voluntarily resign to pursue a government service career (subject to certain conditions).

We believe that compensation plans should align the interests of senior executives with the long-term interests of the Company. We oppose compensation plans that provide windfalls to executives that are unrelated to their performance. For these reasons, we question how our Company benefits from providing Government Service Golden Parachutes. Surely our Company does not expect to receive favorable treatment from its former executives?

For these reasons, we urge shareholders to vote FOR this proposal.

STATEMENT OF THE BOARD RECOMMENDING A VOTE AGAINST THIS PROPOSAL

The Board believes that this proposal is not in the best interest of Morgan Stanley or its shareholders and opposes this proposal for the reasons discussed below:

Our Governmental Service Termination clause serves to avoid conflicts of interest and is administered in a way that protects the interests of the Company and its shareholders.

Our Governmental Service Termination clause applies equally to all Morgan Stanley employees who receive deferred incentive compensation awards, not just to senior executives.

The clause permits the vesting of an employee’s deferred incentive compensation awards granted in respect of service in prior years. In the case of performance-based RSUs, which are granted under the Company’s long-term incentive program for senior executives, only a pro rata portion of the award earned based on pre-established objective performance measures will vest, and the remainder of the award will be cancelled.

All awards vested under the Governmental Service Termination clause are subject to clawback if the employee triggers a cancellation event, which includes competitive activity.

The clause serves to avoid conflicts of interest by only applying where an employee is required by his or her new government employer to divest Morgan Stanley award holdings to avoid such a conflict.

To receive Governmental Service Termination treatment, an employee must (i) provide the Company with satisfactory proof of a conflict of interest that necessitates divestiture of his or her awards and (ii) sign an agreement to repay the awards if he or she triggers a cancellation event under the original award terms, which includes competitive activity.

82Morgan Stanley 2016 Proxy Statement



Table of Contents

SHAREHOLDER PROPOSALS


Our Governmental Service Termination clause reinforces Morgan Stanley’s culture of public service and aligns the interests of our employees with the long-term interests of the Company and its shareholders in attracting and retaining talented employees.

Morgan Stanley has a strong culture of public service and is committed to providing skills and resources to create a lasting civic impact. Our employees may be uniquely positioned to contribute meaningfully through governmental service. The Governmental Service Termination clause avoids penalizing those highly qualified employees, at any level in the Company, who desire to leave the private sector to pursue governmental service.

The Governmental Service Termination clause helps maintain strong employee relations and avoids a potential perception of unfairness. Employees who leave to work in the private sector often have their unvested awards granted in respect of service in prior years “bought out” by their new employer. The clause promotes equitable treatment of employees seeking public sector employment and removes a financial impediment to public service.

The Governmental Service Termination clause is consistent with our compensation philosophy, including the need to remain competitive in recruiting and retaining talent. We believe that this clause enhances our ability to attract key employees and avoids penalizing those who may wish to enter or return to governmental service after leaving Morgan Stanley.

Our Board unanimously recommends that you vote“AGAINST” this proposal. Proxies solicited by the Board will be voted“AGAINST” this proposal unless otherwise instructed.

Morgan Stanley 20162019 Proxy Statement83    79



Table of Contents


INFORMATION ABOUT THE ANNUAL MEETING


QUESTIONS AND ANSWERS

Why Did I Receive aOne-Page Notice Regarding the Internet Availability of Proxy Materials?

Pursuant to SEC rules, we are mailing to certain of our shareholders a Notice about the availability of proxy materials on the Internet instead of paper copies of the proxy materials. This process allows us to expedite our shareholders’ receipt of proxy materials, lower the costs of distribution and reduce the environmental impact of our annual meeting. All shareholders receiving the Notice will have the ability to access the proxy materials and submit a proxy over the Internet.It is important that you submit your proxy to have your shares voted. Instructions on how to access the proxy materials over the Internet or to request a paper copy of the proxy materials may be found in the Notice. The Notice is not a proxy card and cannot be returned to submit your vote. You must follow the instructions on the Notice to submit your proxy to have your shares voted.

How Do I Attend the Annual Meeting?

Only record or beneficial owners of Morgan Stanley’s common stock as of the record date, the close of business on March 21, 2016,25, 2019, or a valid proxy or representative of such shareholder, may attend the annual meeting in person if they comply with the admission requirements below. Guests of shareholders will not be admitted to the annual meeting.If you do not comply with the requirements set forth below, you will not be admitted to the meeting.

Valid Photo Identification. Any shareholder, or valid proxy or representative of such shareholder, must present a valid, current form of government issued photo identification, such as a driver’s license or passport, that matches the name on the documentation described below.

Proof of Ownership.

If you hold shares in street name (such as through a broker or bank), then you must present proof of ownership, such as a brokerage statement or letter from your bank or broker, demonstrating that you held Morgan Stanley common stock as of the record date, March 21, 2016.

If you hold shares in registered form,your record holder’s ownership as of the record date, March 21, 2016, must be verified on the list of registered shareholders maintained by our transfer agent.

If you hold shares in street name (such as through a broker or bank), then you must present proof of ownership, such as a brokerage statement or letter from your bank or broker, demonstrating that you held Morgan Stanley common stock as of the record date, March 25, 2019.

If you hold shares in registered form,your record holder’s ownership as of the record date, March 25, 2019, must be verified on the list of registered shareholders maintained by our transfer agent.

Proof of Representation.If you are a representative of a shareholder, then you must present valid legal documentation that demonstrates your authority to represent that shareholder.We reserve the right to limit the number of representatives who may represent a shareholder at the meeting.

Proof of Valid Proxy.

If you hold a proxy to vote shares at the annual meeting for a shareholder who holds shares in street name (such as through a broker or bank), then you must present:

Valid photo identification as described above;

A written legal proxy from the broker or bank holding the shares to the street name holder that is assignable and signed by the street name holder; and

Proof of ownership, such as a brokerage statement or letter from the bank or broker, demonstrating that the street name holder who appointed you legal proxy held Morgan Stanley common stock as of the record date, March 21, 2016.


84If you hold a proxy to vote shares at the annual meeting for a shareholder who holds shares in street name(such as through a broker or bank), then you must present:

Valid photo identification as described above;

A written legal proxy from the broker or bank holding the shares to the street name holder that is assignable and signed by the street name holder; and

Proof of ownership, such as a brokerage statement or letter from the bank or broker, demonstrating that the street name holder who appointed you legal proxy held Morgan Stanley common stock as of the record date, March 25, 2019.

If you hold a proxy to vote shares at the annual meeting for a shareholder who is a record holder, then:

You must present valid photo identification as described above;

You must present a written legal proxy to you signed by the record holder; and

The record holder’s ownership as of the record date, March 25, 2019, must be verified on the list of registered shareholders maintained by our transfer agent.

Compliance with Annual Meeting Rules of Conduct. All attendees must acknowledge that they have received and agree to abide by our Rules of Conduct. Luggage, large backpacks and other large packages are not permitted in the

80    Morgan Stanley 20162019 Proxy Statement



Table of Contents

INFORMATION ABOUT THE ANNUAL MEETING


If you hold a proxy to vote shares at the annual meeting for a shareholder who is a record holder, then


You must present valid photo identification as described above;

You must present a written legal proxy to you signed by the record holder; and

The record holder’s ownership as of the record date, March 21, 2016, must be verified on the list of registered shareholders maintained by our transfer agent.


Compliance with Annual Meeting Rules of Conduct. All attendees must acknowledge that they have received and agree to abide by our Rules of Conduct. Luggage, large backpacks and other large packages are not permitted in the annual meeting and briefcases and small handbags (including purses) are subject to search. Unless expressly agreed to by Morgan Stanley, the use of PDAs, cell phones, cameras, tablets, laptops and other recording, electronic or mobile devices is strictly prohibited at the meeting.Attendees that disrupt or impede the meeting or breach the Rules of Conduct may be removed from the meeting.


Who Can Vote at the Annual Meeting?

You may vote all shares of Morgan Stanley’s common stock that you owned as of the close of business on March 21, 2016,25, 2019, the record date for the determination of shareholders entitled to notice of, and to vote at, the annual meeting. Each share of common stock entitles you to one vote on each matter voted on at the annual meeting. On the record date, 1,939,609,7061,686,520,879 shares of common stock were outstanding.

What Is the Quorum to Hold the Meeting?

The holders of a majority of the voting power of the outstanding shares of common stock, represented in person or by proxy, constitute a quorum for the annual meeting of shareholders. Brokernon-votes and abstentions are counted for purposes of determining whether a quorum is present.

Is My Vote Confidential?

Our bylaws provide that your vote is confidential and will not be disclosed to any officer, director or employee, except in certain limited circumstances such as when you request or consent to disclosure. Voting of the shares held in the 401(k) Plan also is confidential.

How Do I Submit Voting Instructions for Shares Held Through a Broker?

If you hold shares through a broker, follow the voting instructions you receive from your broker. If you want to vote in person at the annual meeting, you must obtain a legal proxy from your broker and present it at the annual meeting. If you do not submit voting instructions to your broker, your broker may still be permitted to vote your shares in certain cases.

NYSE member brokers may vote your shares as described below.

Non-discretionary Items.All items, other than the ratification of the appointment of Morgan Stanley’s independent auditor, are “non-discretionary” items. It is critically important that you submit your voting instructions if you want your shares to count for non-discretionary items. Your shares will remain unvoted for such items if your NYSE member broker, including Morgan Stanley & Co. LLC (MS&Co.) and Morgan Stanley Smith Barney LLC (MSSB), does not receive voting instructions from you.

Discretionary Item. The ratification of the appointment of Morgan Stanley’s independent auditor is a “discretionary” item. NYSE member brokers that do not receive instructions from beneficial owners may vote on this proposal in the following manner: (1) Morgan Stanley’s subsidiaries, MS&Co. and MSSB, may vote uninstructed shares only in the same proportion as the votes cast by all other beneficial owners on the proposal; and (2) all other NYSE member brokers may vote uninstructed shares in their discretion.


If you do not submit voting instructions, the broker will submit a proxy for your shares voting discretionary items, but will not vote non-discretionary items. This results in a “broker non-vote” for non-discretionary items.

Morgan Stanley 2016 Proxy Statement     85



Table of Contents

INFORMATION ABOUT THE ANNUAL MEETING


How Do I Submit Voting Instructions for Shares Held in My Name?

If you hold shares as a record shareholder, you may have your shares voted by submitting a proxy for your shares by mail, telephone or the Internet as described on the proxy card. If you submit your proxy via the Internet, you may incur Internet access charges. Submitting your proxy will not limit your right to vote in person at the annual meeting. A properly completed and submitted proxy will be voted in accordance with your instructions, unless you subsequently revoke your proxy in accordance with the procedures described below (see “How Can I Revoke My Proxy?”).

If you submit a signed proxy card without indicating your voting instructions, the person voting the proxy will vote your shares according to the Board’s recommendations.

How Do I Submit Voting Instructions for Shares Held in Employee Plans?

If you hold shares in, or have been awarded stock units under, certain employee plans, you will separately receive directions on how to submit your voting instructions. Shares held in the following employee plans also are subject to the following rules.

401(k) Plan. The Northern Trust Company (Northern Trust), the 401(k) Plan’s trustee, must receive your voting instructions for the common stock held on your behalf in the 401(k) Plan on or before May 12, 2016. If Northern Trust does not receive your voting instructions by that date, it will vote such shares together with other unvoted, forfeited and unallocated shares in the 401(k) Plan in the same proportion as the voting instructions that it receives from other participants in the 401(k) Plan. On March 21, 2016, there were 47,359,882 shares in the 401(k) Plan.

Other Equity-Based Plans. State Street Bank and Trust Company acts as trustee for the Trust that holds shares of common stock underlying stock units awarded to employees under several of Morgan Stanley’s equity-based plans. Employees allocated shares held in the Trust must submit their voting instructions for receipt by the trustee on or before May 12, 2016. If the trustee does not receive your instructions by that date, it will vote such shares, together with shares held in the Trust that are unallocated or held on behalf of former Morgan Stanley employees and employees in certain jurisdictions outside the U.S., in the same proportion as the voting instructions that it receives for shares held in the Trust in connection with such plans. On March 21, 2016, 96,162,936 shares were held in the Trust in connection with such plans.


How Can I Revoke My Proxy?

You can revoke your proxy at any time before your shares are voted by (1) delivering a written revocation notice prior to the annual meeting to Martin M. Cohen, Corporate Secretary, Morgan Stanley, 1585 Broadway, Suite C, New York, New York 10036; (2) submitting a later proxy that we receive no later than the conclusion of voting at the annual meeting; or (3) voting in person at the annual meeting. Attending the annual meeting does not revoke your proxy unless you vote in person at the meeting.

86     Morgan Stanley 2016 Proxy Statement



Table of Contents

INFORMATION ABOUT THE ANNUAL MEETING

What Vote Is Required and How Will My Votes Be Counted?

The following table sets forth the vote standard applicable to each proposal, as determined by the Company’s bylaws and applicable regulatory guidance, at a meeting at which a quorum is present.

Proposal

Board’s
Recommendation
Vote Required to
Adopt Proposal
Effect of
Abstentions
Effect of “Broker
Non-Votes”

Election of Directors

FOR

Majority of votes cast (for and against) with respect to such director*

No Effect

No Effect

Ratification of
Appointment of Auditor

FOR

The affirmative vote of a majority of the shares of common stock represented at the annual meeting and entitled to vote thereon (for, against and abstain)

Vote Against

Not Applicable

Non-Binding Advisory
Vote to Approve
Executive Compensation

FOR

The affirmative vote of a majority of the shares of common stock represented at the annual meeting and entitled to vote thereon (for, against and abstain)

Vote Against

No Effect

Amendment of the
2007 Equity Incentive
Compensation Plan

FOR

Majority of votes cast (for, against and abstain)

Vote Against

No Effect

Shareholder ProposalsProposal

AGAINST

The affirmative vote of a majority of the shares of common stock represented at the annual meeting and entitled to vote thereon (for, against and abstain)

Vote Against

No Effect


*

Under Delaware law, if a director does not receive a majority of votes cast in an uncontested election, the director will continue to serve on the Board. Pursuant to the bylaws, each director has submitted an irrevocable letter of resignation that becomes effective, contingent on the Board’s acceptance, if the director does not receive a majority of votes cast in an uncontested director election. In such case, if a director does not receive a majority of votes cast, the Board will make a determination to accept or reject the resignation and publicly disclose its decision within 90 days after the certification of the election results.

Is My Vote Confidential?

Our bylaws provide that your vote is confidential and will not be disclosed to any officer, director or employee, except in certain limited circumstances such as when you request or consent to disclosure. Voting of the shares held in the 401(k) Plan also is confidential.

How Do I Submit Voting Instructions for Shares Held Through a Broker?

If you hold shares through a broker, follow the voting instructions you receive from your broker. If you want to vote in person at the annual meeting, you must obtain a legal proxy from your broker and present it at the annual meeting. If you do not submit voting instructions to your broker, your broker may still be permitted to vote your shares in certain cases.

Morgan Stanley 2019 Proxy Statement    81


INFORMATION ABOUT THE ANNUAL MEETING

NYSE member brokers may vote your shares as described below:

Non-discretionary Items.All items, other than the ratification of the appointment of Morgan Stanley’s independent auditor, are“non-discretionary” items. It is critically important that you submit your votinginstructions if you want your shares to count fornon-discretionary items. Your shares will remain unvoted for such items if your NYSE member broker, including MS&Co. and Morgan Stanley Smith Barney LLC (MSSB), does not receive voting instructions from you.

Discretionary Item. The ratification of the appointment of Morgan Stanley’s independent auditor is a “discretionary” item. NYSE member brokers that do not receive instructions from beneficial owners may vote on this proposal in the following manner: (1) Morgan Stanley’s subsidiaries, MS&Co. and MSSB, may vote uninstructed shares only in the same proportion as the votes cast by all other beneficial owners on the proposal; and (2) all other NYSE member brokers may vote uninstructed shares in their discretion.

If you do not submit voting instructions, the broker will submit a proxy for your shares voting discretionary items, but will not votenon-discretionary items. This results in a “brokernon-vote” fornon-discretionary items.

How Do I Submit Voting Instructions for Shares Held in My Name?

If you hold shares as a record shareholder, you may have your shares voted by submitting a proxy for your shares by mail, telephone or the Internet as described on the proxy card. If you submit your proxy via the Internet, you may incur Internet access charges. Submitting your proxy will not limit your right to vote in person at the annual meeting. A properly completed and submitted proxy will be voted in accordance with your instructions, unless you subsequently revoke your proxy in accordance with the procedures described above (see “How Can I Revoke My Proxy?”).

If you submit a signed proxy card without indicating your voting instructions, the person voting the proxy will vote your shares according to the Board’s recommendations.

How Do I Submit Voting Instructions for Shares Held in Employee Plans?

If you hold shares in, or have been awarded stock units under, certain employee plans, you will separately receive directions on how to submit your voting instructions. Shares held in the following employee plans also are subject to the following rules:

401(k) Plan. The Northern Trust Company (Northern Trust), the 401(k) Plan’s trustee, must receive your voting instructions for the common stock held on your behalf in the 401(k) Plan on or before May 20, 2019. If Northern Trust does not receive your voting instructions by that date, it will vote such shares together with other unvoted, forfeited and unallocated shares in the 401(k) Plan in the same proportion as the voting instructions that it receives from other participants in the 401(k) Plan. On March 25, 2019, there were 36,710,106 shares in the 401(k) Plan.

Other Equity-Based Plans. State Street Global Advisors Trust Company acts as trustee for the Trust that holds shares of common stock underlying stock units awarded to employees under several of Morgan Stanley’s equity-based plans. Employees allocated shares held in the Trust must submit their voting instructions for receipt by the trustee on or before May 20, 2019. If the trustee does not receive your instructions by that date, it will vote such shares, together with shares held in the Trust that are unallocated or held on behalf of former Morgan Stanley employees and employees in certain jurisdictions outside the U.S., in the same proportion as the voting instructions that it receives for shares held in the Trust in connection with such plans. On March 25, 2019, 68,494,097 shares were held in the Trust in connection with such plans.

How Can I Revoke My Proxy?

You can revoke your proxy at any time before your shares are voted by (1) delivering a written revocation notice prior to the annual meeting to Martin M. Cohen, Corporate Secretary, Morgan Stanley, 1585 Broadway, Suite C, New York, New York 10036; (2) submitting a later proxy that we receive no later than the conclusion of voting at the annual meeting; or (3) voting in person at the annual meeting. Attending the annual meeting does not revoke your proxy unless you vote in person at the meeting.

82    Morgan Stanley 2019 Proxy Statement


INFORMATION ABOUT THE ANNUAL MEETING

OTHER BUSINESS

We do not know of any other matters that may be presented for action at the meeting other than those described in this proxy statement. If any other matter is properly brought before the meeting, the proxy holders will vote on such matter in their discretion.

How Can I Submit a Shareholder Proposal or Nominate a Director for the 20172020 Annual Meeting?

Shareholders intending to present a proposal at the 20172020 annual meeting and have it included in our proxy statement for that meeting must submit the proposal in writing to Martin M. Cohen, Corporate Secretary, 1585 Broadway, Suite C, New York, New York 10036.10036 or by email to shareholderproposals@morganstanley.com. We must receive the proposal no later than December 2, 2016.7, 2019.

Shareholders intending to present a proposal at the 20172020 annual meeting(but (but not to include the proposal in our proxy statement) or to nominate a person for election as a director(but (but not to include such nominee in our proxy materials) must comply with the requirements set forth in our bylaws. The bylaws require, among other things, that our Corporate Secretary receive written notice from the record shareholder of intent to present such proposal or nomination no earlier than the close of business on the 120th day and no later than the close of business on the 90th day prior to the anniversary of the preceding year’s annual meeting. Therefore, the Company must receive notice of such a proposal or nomination for the 20172020 annual meeting no earlier than the close of business on January 17, 201724, 2020 and no later than the close of business on February 16, 2017.23, 2020. The notice must contain the information required by the bylaws.

Morgan Stanley 2016 Proxy Statement     87



Table of Contents

INFORMATION ABOUT THE ANNUAL MEETING


As described under “Corporate Governance—Governance Matters — Corporate Governance Highlights—Practices — Shareholder Rights and Accountability,” we recentlyhave adopted proxy access. Under our bylaws, shareholders who meet the requirements set forth in our bylaws may nominate a person for election as a director and include such nominee in our proxy materials. The bylaws require, among other things, that our Corporate Secretary receive written notice of the nomination no earlier than the close of business on the 150th day and no later than the close of business on the 120th day prior to the anniversary of the mailing date of the proxy statement for the preceding year’s annual meeting. Therefore, the Company must receive notice of such a nomination for the 20172020 annual meeting no earlier than the close of business on November 2, 20167, 2019 and no later than the close of business on December 2, 2016.7, 2019.

Our bylaws are available atwww.morganstanley.com/about/company/governanceabout-us-governance or upon request to our Corporate Secretary.

What Are the Costs of Soliciting Proxies for the Annual Meeting?

We will pay the expenses for the preparation of the proxy materials and the solicitation by the Board of your proxy. Our directors, officers and employees, who will receive no additional compensation for soliciting, and D.F. King & Co., Inc. (D.F. King) may solicit your proxy, in person or by telephone, mail, facsimile or other means of communication. We will pay D.F. King fees not exceeding $22,000$25,000 plus expenses. We will also reimburse brokers, including MS&Co., MSSB and other nominees, for costs they incur mailing proxy materials.

What if I Share an Address with Another Shareholder?

“Householding” reduces our printing and postage costs by permitting us to send one annual report and proxy statement to shareholders sharing an address (unless we have received contrary instructions from one or more of the shareholders sharing that address). Shareholders may request to discontinue or begin householding by contacting Broadridge Financial Services at (800) 542-1061 (U.S.)(866)540-7095 or by sending a written request to Broadridge Financial Services, Inc., Householding Department, 51 Mercedes Way, Edgewood, NY 11717. Any householded shareholder may request prompt delivery of a copy of the annual report or proxy statement by contacting us at (212)762-8131 or may write to us at Investor Relations, 1585 Broadway, New York, NY 10036.

How Can I Consent to Electronic Delivery of Annual Meeting Materials?

This proxy statement and the annual report are available on our website at www.morganstanley.com/2016ams.2019ams. You can save the Company postage and printing expense by consenting to access these documents over the Internet. If you consent, you will receive notification next year when these documents are available with instructions on how to view them and submit voting instructions. You may sign up for this service through enroll.icsdelivery.com/ms. If you hold your shares through a bank, broker or other holder of record, contact the record holder for information regarding electronic delivery of materials. Your consent to electronic delivery will remain in effect until you revoke it. If you choose electronic delivery, you may incur costs, such as cable, telephone and Internet access charges, for which you will be responsible.

88     Morgan Stanley 2016 Proxy Statement



Table of Contents

ANNEX A


MORGAN STANLEY
2007 EQUITY INCENTIVE COMPENSATION PLAN
(As Proposed to Be Amended)

1. Purpose. The primary purposes of the Morgan Stanley 2007 Equity Incentive Compensation Plan are to attract, retain and motivate employees, to compensate them for their contributions to the growth and profits of the Company and to encourage them to own Morgan Stanley Stock.

2. Definitions. Except as otherwise provided in an applicable Award Document, the following capitalized terms shall have the meanings indicated below for purposes of the Plan and any Award:

“Administrator” means the individual or individuals to whom the Committee delegates authority under the Plan in accordance with Section 5(b).

“Award” means any award of Restricted Stock, Stock Units, Options, SARs, Qualifying Performance Awards or Other Awards (or any combination thereof) made under and pursuant to the terms of the Plan.

“Award Date” means the date specified in a Participant’s Award Document as the grant date of the Award.

“Award Document” means a written document (including in electronic form) that sets forth the terms and conditions of an Award. Award Documents shall be authorized in accordance with Section 13(e).

“Board” means the Board of Directors of Morgan Stanley.

“Code” means the Internal Revenue Code of 1986, as amended, and the applicable rulings, regulations and guidance thereunder.

“Committee” means the Compensation, Management Development and Succession Committee of the Board, any successor committee thereto or any other committee of the Board appointed by the Board to administer the Plan or to have authority with respect to the Plan, or any subcommittee appointed by such Committee. With respect to any provision regarding the grant of Qualifying Performance Awards, the Committee shall consist solely of at least two “outside directors” as defined under Section 162(m) of the Code.

“Company” means Morgan Stanley and all of its Subsidiaries.

“Eligible Individuals” means the individuals described in Section 6 who are eligible for Awards.

“Employee Trust” means any trust established or maintained by the Company in connection with an employee benefit plan (including the Plan) under which current and former employees of the Company constitute the principal beneficiaries.

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the applicable rulings and regulations thereunder.

“Fair Market Value” means, with respect to a Share, the fair market value thereof as of the relevant date of determination, as determined in accordance with a valuation methodology approved by the Committee.

“Incentive Stock Option”means an Option that is intended to qualify for special federal income tax treatment pursuant to Sections 421 and 422 of the Code, as now constituted or subsequently amended, or pursuant to a successor provision of the Code, and which is so designated in the applicable Award Document.

“Morgan Stanley” means Morgan Stanley, a Delaware corporation.

“Option” or“Stock Option” means a right, granted to a Participant pursuant to Section 9, to purchase one Share.

“Other Award” means any other form of award authorized under Section 12, including any such Other Award the receipt of which was elected pursuant to Section 13(a).

Morgan Stanley 20162019 Proxy StatementA-1    83



Table of Contents

ANNEX A


“Participant” means an individual to whom an Award has been made.

“Plan” means the Morgan Stanley 2007 Equity Incentive Compensation Plan, as amended from time to time in accordance with Section 16(e).

“Qualifying Performance Award” means an Award granted pursuant Section 11.

“Restricted Stock” means Shares granted or sold to a Participant pursuant to Section 7.

“SAR” means a right, granted to a Participant pursuant to Section 10, to receive upon exercise of such right, in cash or Shares (or a combination thereof) as authorized by the Committee, an amount equal to the increase in the Fair Market Value of one Share over a specified exercise price.

“Section 162(m) Participant” means, for a given performance period, any individual designated by the Committee by not later than 90 days following the start of such performance period (or such other time as may be required or permitted by Section 162(m) of the Code) as an individual whose compensation for such performance period may be subject to the limit on deductible compensation imposed by Section 162(m) of the Code.

“Section 162(m) Performance Goals” means any performance formula that was approved by Morgan Stanley’s stockholders and the performance objectives established by the Committee in accordance with Section 11 or any other performance goals approved by Morgan Stanley’s stockholders pursuant to Section 162(m) of the Code.

“Section 409A” means Section 409A of the Code.

“Shares” means shares of Stock.

“Stock” means the common stock, par value $0.01 per share, of Morgan Stanley.

“Stock Unit” means a right, granted to a Participant pursuant to Section 8, to receive one Share or an amount in cash equal to the Fair Market Value of one Share, as authorized by the Committee.

“Subsidiary” means (i) a corporation or other entity with respect to which Morgan Stanley, directly or indirectly, has the power, whether through the ownership of voting securities, by contract or otherwise, to elect at least a majority of the members of such corporation’s board of directors or analogous governing body, or (ii) any other corporation or other entity in which Morgan Stanley, directly or indirectly, has an equity or similar interest and which the Committee designates as a Subsidiary for purposes of the Plan.

“Substitute Awards” means Awards granted upon assumption of, or in substitution for, outstanding awards previously granted by, or held by employees of, a company or other entity or business acquired (directly or indirectly) by Morgan Stanley or with which Morgan Stanley combines.

3. Effective Date and Term of Plan.

(a)Effective Date. The Plan shall become effective upon its adoption by the Board, subject to its approval by Morgan Stanley’s stockholders. Prior to such stockholder approval, the Committee may grant Awards conditioned on stockholder approval, but no Shares may be issued or delivered pursuant to any such Award until Morgan Stanley’s stockholders have approved the Plan. If such stockholder approval is not obtained at or before the first annual meeting of stockholders to occur after the adoption of the Plan by the Board, the Plan and any Awards made thereunder shall terminate ab initio and be of no further force and effect.

(b)Term of Plan.No Awards may be made under the Plan after May 15, 2017.

4. Stock Subject to Plan.

(a)Overall Plan Limit. The total number of Shares that may be delivered pursuant to Awards shall be 323,000,000as calculated pursuant to Section 4(c). The number of Shares available for delivery under the Plan shall be adjusted as provided in Section 4(b). Shares delivered under the Plan may be authorized but unissued shares or treasury shares that Morgan Stanley acquires in the open market, in private transactions or otherwise.

A-2     Morgan Stanley 2016 Proxy Statement



Table of Contents

ANNEX A


(b)Adjustments for Certain Transactions. In the event of a stock split, reverse stock split, stock dividend, recapitalization, reorganization, merger, consolidation, extraordinary dividend or distribution, split-up, spin-off, combination, reclassification or exchange of shares, warrants or rights offering to purchase Stock at a price substantially below Fair Market Value or other change in corporate structure or any other event that affects Morgan Stanley’s capitalization, the Committee shall equitably adjust (i) the number and kind of shares authorized for delivery under the Plan, including the maximum number of Shares available for Awards of Options or SARs as provided in Section 4(d), the maximum number of Incentive Stock Options as provided in Section 4(e) and the individual Qualifying Performance Award maximum under Section 11, and (ii) the number and kind of shares subject to any outstanding Award and the exercise or purchase price per share, if any, under any outstanding Award. In the discretion of the Committee, such an adjustment may take the form of a cash payment to a Participant. The Committee shall make all such adjustments, and its determination as to what adjustments shall be made, and the extent thereof, shall be final. Unless the Committee determines otherwise, such adjusted Awards shall be subject to the same vesting schedule and restrictions to which the underlying Award is subject.

(c)Calculation of Shares Available for Delivery. In calculating the number of Shares that remain available for delivery pursuant to Awards at any time, the following rules shall apply (subject to the limitation in Section 4(e)):

1. The number of Shares available for delivery shall be reduced by the number of Shares subject to an Award and, in the case of an Award that is not denominated in Shares, the number of Shares actually delivered upon payment or settlement of the Award.

2. The number of Shares tendered (by actual delivery or attestation) or withheld from an Award to pay the exercise price of the Award or to satisfy any tax withholding obligation or liability of a Participant shall be added back to the number of Shares available for delivery pursuant to Awards.

3. The number of Shares in respect of any portion of an Award that is canceled or that expires without having been paid or settled by the Company shall be added back to the number of Shares available for delivery pursuant to Awards to the extent such Shares were counted against the Shares available for delivery pursuant to clause (1).

4. If an Award is settled or paid by the Company in whole or in part through the delivery of consideration other than Shares, or by delivery of fewer than the full number of Shares that was counted against the Shares available for delivery pursuant to clause (1), there shall be added back to the number of Shares available for delivery pursuant to Awards the excess of the number of Shares that had been so counted over the number of Shares (if any) actually delivered upon payment or settlement of the Award.

5. Any Shares underlying Substitute Awards shall not be counted against the number of Shares available for delivery pursuant to Awards and shall not be subject to Section 4(d).

(d)Individual Limit on Options and SARs.The maximum number of Shares that may be subject to Options or SARs granted to or elected by a Participant in any fiscal year shall be 2,000,000 Shares. The limitation imposed by this Section 4(d) shall not include Options or SARs granted to a Participant pursuant to Section 162(m) Performance Goals.

(e)ISO Limit.The full number of Shares available for delivery under the Plan may be delivered pursuant to Incentive Stock Options, except that in calculating the number of Shares that remain available for Awards of Incentive Stock Options the rules set forth in Section 4(c) shall not apply to the extent not permitted by Section 422 of the Code.

5. Administration.

(a)Committee Authority Generally. The Committee shall administer the Plan and shall have full power and authority to make all determinations under the Plan, subject to the express provisions hereof, including without limitation: (i) to select Participants from among the Eligible Individuals; (ii) to make Awards; (iii) to determine the number of Shares subject to each Award or the cash amount payable in connection with an Award; (iv) to establish the terms and conditions of each Award, including, without limitation, those related to vesting, cancellation, payment, exercisability, and the effect, if any, of certain events on a Participant’s Awards, such as the Participant’s termination of employment with the Company; (v) to specify and approve the provisions of the Award Documents delivered to Participants in connection with their Awards; (vi) to construe and interpret any Award Document delivered under the Plan; (vii) to prescribe, amend and rescind rules and procedures relating to the Plan; (viii) to make all determinations necessary or advisable in administering the Plan and

Morgan Stanley 2016 Proxy Statement     A-3



Table of Contents

ANNEX A


Awards, including, without limitation, determinations as to whether (and if so as of what date) a Participant has commenced, or has experienced a termination of, employment; provided, however, that to the extent full or partial payment of any Award that constitutes a deferral of compensation subject to Section 409A is made upon or as a result of a Participant’s termination of employment, the Participant will be considered to have experienced a termination of employment if, and only if, the Participant has experienced a separation from service with the Participant’s employer for purposes of Section 409A; (ix) to vary the terms of Awards to take account of securities law and other legal or regulatory requirements of jurisdictions in which Participants work or reside or to procure favorable tax treatment for Participants; and (x) to formulate such procedures as it considers to be necessary or advisable for the administration of the Plan.

(b)Delegation. To the extent not prohibited by applicable laws or rules of the New York Stock Exchange or, in the case of Qualifying Performance Awards, Section 162(m) of the Code, the Committee may, from time to time, delegate some or all of its authority under the Plan to one or more Administrators consisting of one or more members of the Committee as a subcommittee or subcommittees thereof or of one or more members of the Board who are not members of the Committee or one or more officers of the Company (or of any combination of such persons). Any such delegation shall be subject to the restrictions and limits that the Committee specifies at the time of such delegation or thereafter. The Committee may at any time rescind all or part of the authority delegated to an Administrator or appoint a new Administrator. At all times, an Administrator appointed under this Section 5(b) shall serve in such capacity at the pleasure of the Committee. Any action undertaken by an Administrator in accordance with the Committee’s delegation of authority shall have the same force and effect as if undertaken directly by the Committee, and any reference in the Plan to the Committee shall, to the extent consistent with the terms and limitations of such delegation, be deemed to include a reference to an Administrator.

(c)Authority to Construe and Interpret. The Committee shall have full power and authority, subject to the express provisions hereof, to construe and interpret the Plan.

(d)Committee Discretion. All of the Committee’s determinations in carrying out, administering, construing and interpreting the Plan shall be made or taken in its sole discretion and shall be final, binding and conclusive for all purposes and upon all persons. In the event of any disagreement between the Committee and an Administrator, the Committee’s determination on such matter shall be final and binding on all interested persons, including any Administrator. The Committee’s determinations under the Plan need not be uniform and may be made by it selectively among persons who receive, or are eligible to receive, Awards under the Plan (whether or not such persons are similarly situated). Without limiting the generality of the foregoing, the Committee shall be entitled, among other things, to make non-uniform and selective determinations, and to enter into non-uniform and selective Award Documents, as to the persons receiving Awards under the Plan, and the terms and provisions of Awards under the Plan.

(e)No Liability. Subject to applicable law: (i) no member of the Committee or any Administrator shall be liable for anything whatsoever in connection with the exercise of authority under the Plan or the administration of the Plan except such person’s own willful misconduct; (ii) under no circumstances shall any member of the Committee or any Administrator be liable for any act or omission of any other member of the Committee or an Administrator; and (iii) in the performance of its functions with respect to the Plan, the Committee and an Administrator shall be entitled to rely upon information and advice furnished by the Company’s officers, the Company’s accountants, the Company’s counsel and any other party the Committee or the Administrator deems necessary, and no member of the Committee or any Administrator shall be liable for any action taken or not taken in good faith reliance upon any such advice.

6. Eligibility. Eligible Individuals shall include all officers, other employees (including prospective employees) and consultants of, and other persons who perform services for, the Company, non-employee directors of Subsidiaries and employees and consultants of joint ventures, partnerships or similar business organizations in which Morgan Stanley or a Subsidiary has an equity or similar interest. Any Award made to a prospective employee shall be conditioned upon, and effective not earlier than, such person’s becoming an employee. Members of the Board who are not Company employees will not be eligible to receive Awards under the Plan. An individual’s status as an Administrator will not affect his or her eligibility to receive Awards under the Plan.

A-4Morgan Stanley 2016 Proxy Statement



Table of Contents

ANNEX A


7. Restricted Stock. An Award of Restricted Stock shall be subject to the terms and conditions established by the Committee in connection with the Award and specified in the applicable Award Document. Restricted Stock may, among other things, be subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances.

8. Stock Units. An Award of Stock Units shall be subject to the terms and conditions established by the Committee in connection with the Award and specified in the applicable Award Document. Each Stock Unit awarded to a Participant shall correspond to one Share. Upon satisfaction of the terms and conditions of the Award, a Stock Unit will be payable, at the discretion of the Committee, in Stock or in cash equal to the Fair Market Value on the payment date of one Share. As a holder of Stock Units, a Participant shall have only the rights of a general unsecured creditor of Morgan Stanley. A Participant shall not be a stockholder with respect to the Shares underlying Stock Units unless and until the Stock Units convert to Shares. Stock Units may, among other things, be subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances.

9. Options.

(a)Options Generally. An Award of Options shall be subject to the terms and conditions established by the Committee in connection with the Award and specified in the applicable Award Document. The Committee shall establish (or shall authorize the method for establishing) the exercise price of all Options awarded under the Plan, except that the exercise price of an Option shall not be less than 100% of the Fair Market Value of one Share on the Award Date. Notwithstanding the foregoing, the exercise price of an Option that is a Substitute Award may be less than the Fair Market Value per Share on the Award Date, provided that such substitution complies with applicable laws and regulations, including the listing requirements of the New York Stock Exchange and Section 409A or Section 424, as applicable, of the Code. Upon satisfaction of the conditions to exercisability of the Award, a Participant shall be entitled to exercise the Options included in the Award and to have delivered, upon Morgan Stanley’s receipt of payment of the exercise price and completion of any other conditions or procedures specified by Morgan Stanley, the number of Shares in respect of which the Options shall have been exercised. Options may be either nonqualified stock options or Incentive Stock Options. Options and the Shares acquired upon exercise of Options may, among other things, be subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances.

(b)Prohibition on Restoration Option and SAR Grants. Anything in the Plan to the contrary notwithstanding, the terms of an Option or SAR shall not provide that a new Option or SAR will be granted, automatically and without additional consideration in excess of the exercise price of the underlying Option or SAR, to a Participant upon exercise of the Option or SAR.

(c)Prohibition on Repricing of Options and SARs. Anything in the Plan to the contrary notwithstanding, the Committee may not reprice any Option or SAR. “Reprice” means any action that constitutes a “repricing” under the rules of the New York Stock Exchange or, except as otherwise expressly provided in Section 4(b), any other amendment to an outstanding Option or SAR that has the effect of reducing its exercise price or any cancellation of an outstanding Option or SAR in exchange for cash or another Award.

(d)Payment of Exercise Price. Subject to the provisions of the applicable Award Document and to the extent authorized by rules and procedures of Morgan Stanley from time to time, the exercise price of the Option may be paid in cash, by actual delivery or attestation to ownership of freely transferable Shares already owned by the person exercising the Option, or by such other means as Morgan Stanley may authorize.

(e)Maximum Term on Stock Options and SARs. No Option or SAR shall have an expiration date that is later than the tenth anniversary of the Award Date thereof.

10. SARs. An Award of SARs shall be subject to the terms and conditions established by the Committee in connection with the Award and specified in the applicable Award Document. The Committee shall establish (or shall authorize the method for establishing) the exercise price of all SARs awarded under the Plan, except that the exercise price of a SAR shall not be less than 100% of the Fair Market Value of one Share on the Award Date. Notwithstanding the foregoing, the exercise price of any SAR that is a Substitute Award may be less than the Fair Market Value of one Share on the Award Date, subject to the same conditions set forth in Section 9(a) for Options that are Substitute Awards. Upon

Morgan Stanley 2016 Proxy StatementA-5



Table of Contents

ANNEX A


satisfaction of the conditions to the payment of the Award, each SAR shall entitle a Participant to an amount, if any, equal to the Fair Market Value of one Share on the date of exercise over the SAR exercise price specified in the applicable Award Document. At the discretion of the Committee, payments to a Participant upon exercise of an SAR may be made in Shares, cash or a combination thereof. SARs and the Shares that may be acquired upon exercise of SARs may, among other things, be subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances.

11. Qualifying Performance Awards.

(a) The Committee may, in its sole discretion, grant a Qualifying Performance Award to any Section 162(m) Participant. A Qualifying Performance Award shall be subject to the terms and conditions established by the Committee in connection with the Award and specified in the applicable Award Document, but in all events shall be subject to the attainment of Section 162(m) Performance Goals as may be specified by the Committee. Qualifying Performance Awards may be denominated as a cash amount, number of Shares or other securities of the Company, or a combination thereof. Subject to the terms of the Plan, the Section 162(m) Performance Goals to be achieved during any performance period, the length of any performance period, the amount of any Qualifying Performance Award granted and the amount of any payment or transfer to be made pursuant to any Qualifying Performance Award shall be determined by the Committee. The Committee shall have the discretion, by Section 162(m) Participant and by Award, to reduce (but not to increase) some or all of the amount that would otherwise be payable under the Award by reason of the satisfaction of the Section 162(m) Performance Goals set forth in the Award. In making any such determination, the Committee is authorized in its discretion to take into account additional factors that the Committee may deem relevant to the assessment of individual or company performance for the performance period.

(b) In any calendar year, no one Section 162(m) Participant may be granted Awards pursuant to Section 11(a) that allow for payments with an aggregate value determined by the Committee to be in excess of $10 million; provided that, to the extent that one or more Qualifying Performance Awards granted to any one Section 162(m) Participant during any calendar year are denominated in Shares, the maximum number of Shares that may underlie such awards will be determined by reference to the volume-weighted average price of a Share of the Company on the first date of grant of such awards, subject to adjustment to the extent provided in Section 4(b). In the case of a tandem award pursuant to which a Section 162(m) Participant’s realization of a portion of such award results in a corresponding reduction to a separate portion of the award, only the number of Shares or the cash amount relating to the maximum possible realization under the award shall be counted for purposes of the limitations above (i.e., without duplication). For purposes of the foregoing sentence, the calendar year or years in which amounts under Qualifying Performance Awards are deemed paid, granted or received shall be as determined by the Committee.

(c) Section 162(m) Performance Goals may vary by Section 162(m) Participant and by Award, and may be based upon the attainment of specific or per-share amounts of, or changes in, one or more, or a combination of two or more, of the following: earnings (before or after taxes); earnings per share; shareholders’ equity or return on shareholders’ equity; risk-weighted assets or return on risk-weighted assets; capital, capital ratios or return on capital; book value or book value per share; operating income (before or after taxes); operating margins or pre-tax margins; stock price or total shareholder return; market share (including market share of revenue); debt reduction or change in rating; cost reductions; regulatory factors; risk management; expense management; or contributions to community development or sustainability projects or initiatives. The Committee may provide that in measuring the achievement of the performance objectives, an Award may include or exclude items such as realized investment gains and losses, extraordinary, unusual or non-recurring items, asset write-downs, effects of accounting changes, currency fluctuations, acquisitions, divestitures, reserve-strengthening, litigation, claims, judgments or settlements, the effect of changes in tax law or other such laws or provisions affecting reported results and other non-operating items, as well as the impact of changes in the fair value of certain of the Company’s long-term and short-term borrowings resulting from fluctuations in the Company’s credit spreads and other factors. The foregoing objectives may be applicable to the Company as a whole, one or more of its subsidiaries, divisions, business units or business lines, or any combination of the foregoing, and may be applied on an absolute basis or be relative to other companies, industries or indices (e.g., stock market indices) or be based upon any combination of the foregoing. In addition to the performance objectives, the Committee may also condition payment of any such Award upon the attainment of conditions, such as completion of a period of service, notwithstanding that the performance objective or objectives specified in the Award are satisfied.

A-6Morgan Stanley 2016 Proxy Statement



Table of Contents

ANNEX A


(d) Following the completion of any performance period applicable to a Qualifying Performance Award, the Committee shall certify in writing the applicable performance and amount, if any, payable to Section 162(m) Participants for such performance period. The amounts payable to a Section 162(m) Participant will be paid following the end of the performance period after such certification by the Committee in accordance with the terms of the Qualifying Performance Award.

(e) Without further action by the Board, this Section 11 shall cease to apply on the effective date of the repeal of Section 162(m) of the Code (and any successor provision thereof).

12. Other Awards. The Committee shall have the authority to establish the terms and provisions of other forms of Awards (such terms and provisions to be specified in the applicable Award Document) not described above that the Committee determines to be consistent with the purpose of the Plan and the interests of the Company, which Awards may provide for (i) payments in the form of cash, Stock, notes or other property as the Committee may determine based in whole or in part on the value or future value of Stock or on any amount that Morgan Stanley pays as dividends or otherwise distributes with respect to Stock, (ii) the acquisition or future acquisition of Stock, (iii) cash, Stock, notes or other property as the Committee may determine (including payment of dividend equivalents in cash or Stock) based on one or more criteria determined by the Committee unrelated to the value of Stock, or (iv) any combination of the foregoing. Awards pursuant to this Section 12 may, among other things, be made subject to restrictions on transfer, vesting requirements or cancellation under specified circumstances.

13. General Terms and Provisions.

(a)Awards in General. Awards may, in the discretion of the Committee, be made in substitution in whole or in part for cash or other compensation payable to an Eligible Individual. In accordance with rules and procedures authorized by the Committee, an Eligible Individual may elect one form of Award in lieu of any other form of Award, or may elect to receive an Award in lieu of all or part of any compensation that otherwise might have been paid to such Eligible Individual; provided, however, that any such election shall not require the Committee to make any Award to such Eligible Individual. Any such substitute or elective Awards shall have terms and conditions consistent with the provisions of the Plan applicable to such Award. Awards may be granted in tandem with, or independent of, other Awards. The grant, vesting or payment of an Award may, among other things, be conditioned on the attainment of performance objectives, including without limitation objectives based in whole or in part on net income, pre-tax income, return on equity, earnings per share, total shareholder return or book value per share.

(b)Discretionary Awards. All grants of Awards and deliveries of Shares, cash or other property under the Plan shall constitute a special discretionary incentive payment to the Participant and shall not be required to be taken into account in computing the amount of salary, wages or other compensation of the Participant for the purpose of determining any contributions to or any benefits under any pension, retirement, profit-sharing, bonus, life insurance, severance or other benefit plan of the Company or other benefits from the Company or under any agreement with the Participant, unless Morgan Stanley specifically provides otherwise.

(c)Dividends and Distributions. If Morgan Stanley pays any dividend or makes any distribution to holders of Stock, the Committee may in its discretion authorize payments (which may be in cash, Stock (including Restricted Stock) or Stock Units or a combination thereof) with respect to the Shares corresponding to an Award, or may authorize appropriate adjustments to outstanding Awards, to reflect such dividend or distribution. The Committee may make any such payments subject to vesting, deferral, restrictions on transfer or other conditions. Any determination by the Committee with respect to a Participant’s entitlement to receive any amounts related to dividends or distributions to holders of Stock, as well as the terms and conditions of such entitlement, if any, will be part of the terms and conditions of the Award, and will be included in the Award Document for such Award.

(d)Deferrals. In accordance with the procedures authorized by, and subject to the approval of, the Committee, Participants may be given the opportunity to defer the payment or settlement of an Award to one or more dates selected by the Participant. To the extent an Award constitutes a deferral of compensation subject to Section 409A, the Committee shall set forth in writing (which may be in electronic form), on or before the date the applicable deferral election is required to be irrevocable in order to meet the requirements of Section 409A, the conditions under which such election may be made.

Morgan Stanley 2016 Proxy StatementA-7



Table of Contents

ANNEX A


(e) Award Documentation and Award Terms. The terms and conditions of an Award shall be set forth in an Award Document authorized by the Committee. The Award Document shall include any vesting, exercisability, payment and other restrictions applicable to an Award (which may include, without limitation, the effects of termination of employment, cancellation of the Award under specified circumstances, restrictions on transfer or provision for mandatory resale to the Company).

14. Certain Restrictions.

(a)Stockholder Rights. No Participant (or other persons having rights pursuant to an Award) shall have any of the rights of a stockholder of Morgan Stanley with respect to Shares subject to an Award until the delivery of the Shares, which shall be effected by entry of the Participant’s (or other person’s) name in the share register of Morgan Stanley or by such other procedure as may be authorized by Morgan Stanley. Except as otherwise provided in Section 4(b) or 13(c), no adjustments shall be made for dividends or distributions on, or other events relating to, Shares subject to an Award for which the record date is prior to the date such Shares are delivered. Notwithstanding the foregoing, the terms of an Employee Trust may authorize some or all Participants to give voting or tendering instructions to the trustee thereof in respect of Shares that are held in such Employee Trust and are subject to Awards. Except for the risk of cancellation and the restrictions on transfer that may apply to certain Shares (including restrictions relating to any dividends or other rights) or as otherwise set forth in the applicable Award Document, the Participant shall be the beneficial owner of any Shares delivered to the Participant in connection with an Award and, upon such delivery shall be entitled to all rights of ownership, including, without limitation, the right to vote the Shares and to receive cash dividends or other dividends (whether in Shares, other securities or other property) thereon.

(b)Transferability. No Award granted under the Plan shall be transferable, whether voluntarily or involuntarily, other than by will or by the laws of descent and distribution; provided that, except with respect to Incentive Stock Options, the Committee may permit transfers on such terms and conditions as it shall determine. During the lifetime of a Participant to whom Incentive Stock Options were awarded, such Incentive Stock Options shall be exercisable only by the Participant.

15. Representation; Compliance with Law. The Committee may condition the grant, exercise, settlement or retention of any Award on the Participant making any representations required in the applicable Award Document. Each Award shall also be conditioned upon the making of any filings and the receipt of any consents or authorizations required to comply with, or required to be obtained under, applicable law.

16. Miscellaneous Provisions.

(a)Satisfaction of Obligations. As a condition to the making or retention of any Award, the vesting, exercise or payment of any Award or the lapse of any restrictions pertaining thereto, Morgan Stanley may require a Participant to pay such sum to the Company as may be necessary to discharge the Company’s obligations with respect to any taxes, assessments or other governmental charges (including FICA and other social security or similar tax) imposed on property or income received by a Participant pursuant to the Award or to satisfy any obligation that the Participant owes to the Company. In accordance with rules and procedures authorized by Morgan Stanley, (i) such payment may be in the form of cash or other property, including the tender of previously owned Shares, and (ii) in satisfaction of such taxes, assessments or other governmental charges or, exclusively in the case of an Award that does not constitute a deferral of compensation subject to Section 409A, of other obligations that a Participant owes to the Company, Morgan Stanley may make available for delivery a lesser number of Shares in payment or settlement of an Award, may withhold from any payment or distribution of an Award or may enter into any other suitable arrangements to satisfy such withholding or other obligation. To the extent an Award constitutes a deferral of compensation subject to Section 409A, the Company may not offset from the payment of such Award amounts that a Participant owes to the Company with respect to any such other obligation except to the extent such offset is not prohibited by Section 409A and would not cause a Participant to recognize income for United States federal income tax purposes prior to the time of payment of the Award or to incur interest or additional tax under Section 409A.

(b)No Right to Continued Employment. Neither the Plan nor any Award shall give rise to any right on the part of any Participant to continue in the employ of the Company.

A-8Morgan Stanley 2016 Proxy Statement



Table of Contents

ANNEX A


(c)Headings. The headings of sections herein are included solely for convenience of reference and shall not affect the meaning of any of the provisions of the Plan.

(d)Governing Law. The Plan and all rights hereunder shall be construed in accordance with and governed by the laws of the State of New York, without regard to any conflicts or choice of law, rule or principle that might otherwise refer the interpretation of the award to the substantive law of another jurisdiction.

(e)Amendments and Termination. The Board or Committee may modify, amend, suspend or terminate the Plan in whole or in part at any time and may modify or amend the terms and conditions of any outstanding Award (including by amending or supplementing the relevant Award Document at any time); provided, however, that no such modification, amendment, suspension or termination shall, without a Participant’s consent, materially adversely affect that Participant’s rights with respect to any Award previously made; and provided, further, that the Committee shall have the right at any time, without a Participant’s consent and whether or not the Participant’s rights are materially adversely affected thereby, to amend or modify the Plan or any Award under the Plan in any manner that the Committee considers necessary or advisable to comply with any law, regulation, ruling, judicial decision, accounting standards, regulatory guidance or other legal requirement. Notwithstanding the preceding sentence, neither the Board nor the Committee may accelerate the payment or settlement of any Award, including, without limitation, any Award subject to a prior deferral election, that constitutes a deferral of compensation for purposes of Section 409A except to the extent such acceleration would not result in the Participant incurring interest or additional tax under Section 409A. No amendment to the Plan may render any Board member who is not a Company employee eligible to receive an Award at any time while such member is serving on the Board. To the extent required by applicable law or the rules of the New York Stock Exchange, amendments to the Plan shall not be effective unless they are approved by Morgan Stanley’s stockholders.

Morgan Stanley 2016 Proxy StatementA-9



Table of Contents

Our Core Values

Since our founding in 1935, Morgan Stanley has consistently delivered first-class business in a first-class way. Underpinning all that we do are four core values.



PUTTING CLIENTS FIRSTDOING THE RIGHT THING

Always keep

Keep the client’s interest first.interests first

Working

Work with colleagues to deliver the best of the

Firm to every client.client

Listen to what the client is saying and needs.needs

    

DOING THE RIGHT THING

Act with integrity.integrity

Think like an owner to create long-term shareholder value.value

Value and reward honesty, collegialitycharacter and character.diversity

Foster a collegial work environment where all employees feel a sense of belonging


LEADING WITH EXCEPTIONAL IDEAS

GIVING BACK

Win by breaking new ground.ground

Let the facts and

Leverage different points of view broaden your perspective.perspectives to gain new insight

Drive innovation

Be vigilant about what we can do better.better

    

GIVING BACK

Be generousServe our communities generously with yourour expertise, your time and your money.money

Invest in

Build a better Firm for the future of our communities and our Firm.

Mentor our next generation.through mentoring others






“Our DNA, our culture and our history

are rooted in serving our clients.”

–   

James P. Gorman

Chairman and Chief Executive Officer

Chairman and Chief Executive Officer



 
Printed with 100% wind energy. Printed with soy-based inks.



Table of ContentsLOGO



LOGO

Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY E58210-P18900-Z74362 Yes No HOUSEHOLDING ELECTION - Please indicate if you consent ! ! to receive certain future investor communications in a single package per household. MORGAN STANLEY
1585 BROADWAY
NEW YORK, C/O BROADRIDGE PO BOX 1342 BRENTWOOD, NY 10036


11717 1a. Elizabeth Corley 1e. Robert H. Herz 1h. Dennis M. Nally 1c. Thomas H. Glocer 1b. Alistair Darling 1f. Nobuyuki Hirano 1i. Takeshi Ogasawara 1d. James P. Gorman 1g. Jami Miscik 1k. Mary L. Schapiro 1j. Hutham S. Olayan 1. Election of Directors Morgan Stanley’s Board recommends a vote “FOR” the nominees listed below: 1l. Perry M. Traquina 1m. Rayford Wilkins, Jr. MORGAN STANLEY For Against Abstain Morgan Stanley’s Board recommends a vote “FOR” Proposals 2-3: 2. To ratify the appointment of Deloitte & Touche LLP as independent auditor 3. To approve the compensation of executives as disclosed in the proxy statement (non-binding advisory vote) Morgan Stanley’s Board recommends a vote “AGAINST” Proposal 4: 4. Shareholder proposal regarding an annual report on lobbying expenses Sign exactly as imprinted (do not print). If shares are held jointly, EACH holder should sign. Executors, administrators, trustees, guardians and others signing in a representative capacity should indicate the capacity in which they sign. An authorized officer signing on behalf of a corporation should indicate the name of the corporation and the officer’s title. For Against Abstain For Against Abstain SCAN TO VIEW MATERIALS & VOTE w VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Daylight Time on May 16, 2016.22, 2019. If you participate in any of the Morgan Stanley Benefit Plans, you must vote your shares no later than 11:59 p.m. EDT on May 12, 2016.20, 2019. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Daylight Time on May 16, 2016.22, 2019. If you participate in any of the Morgan Stanley Benefit Plans, you must vote your shares no later than 11:59 p.m. EDT on May 12, 2016.20, 2019. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.






TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
E01532-P73633-Z67213                    KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.


LOGO

MORGAN STANLEY

Morgan Stanley’s Board recommends a vote “FOR” the nominees listed below:
ForAgainstAbstain
1.     Election of Directors
1a.     Erskine B. Bowles
1b.Alistair Darling
1c.Thomas H. Glocer
1d.James P. Gorman
1e.Robert H. Herz
1f.Nobuyuki Hirano
1g.Klaus Kleinfeld
1h.Jami Miscik
1i.Donald T. Nicolaisen
1j.Hutham S. Olayan
1k.James W. Owens
1l.Ryosuke Tamakoshi
1m.Perry M. Traquina
1n.Rayford Wilkins, Jr.

Morgan Stanley’s Board recommends a vote “FOR” Proposals 2, 3 and 4 below:ForAgainstAbstain
2.     To ratify the appointment of Deloitte & Touche LLP as independent auditor
3.To approve the compensation of executives as disclosed in the proxy statement (non-binding advisory resolution)
4.To approve the amendment of the 2007 Equity Incentive Compensation Plan to increase the number of authorized shares and add performance measures for certain awards
Morgan Stanley’s Board recommends a vote “AGAINST” Proposals 5 and 6 below:
5.Shareholder proposal regarding a change in the treatment of abstentions for purposes of vote-counting
6.Shareholder proposal regarding a policy to prohibit vesting of deferred equity awards for senior executives who resign to enter government service


Sign exactly as imprinted (do not print). If shares are held jointly, EACH holder should sign. Executors, administrators, trustees, guardians and others signing in a representative capacity should indicate the capacity in which they sign. An authorized officer signing on behalf of a corporation should indicate the name of the corporation and the officer’s title.

Signature [PLEASE SIGN WITHIN BOX]DateSignature (Joint Owners)Date



TableE58211-P18900-Z74362 Notice of Contents

Notice of 2016 Morgan Stanley Annual Meeting of Shareholders
2000 Westchester Avenue, Purchase, New York 10577
May 17, 2016, 2 p.m., local time


2019 Morgan Stanley Annual Meeting of Shareholders 2000 Westchester Avenue, Purchase, New York 10577 May 23, 2019, 10:00 a.m., local time At the meeting, we plan to:

elect members of the Board of Directors;

ratify the appointment of Deloitte & Touche LLP as independent auditor;

approve the compensation of executives as disclosed in the proxy statement (non-binding advisory resolution);

approve an amendment to the 2007 Equity Incentive Compensation Plan;

consider two shareholder proposals; and

transact such other business as may properly come before the meeting.

elect the Board of Directors; ratify the appointment of Deloitte & Touche LLP as independent auditor; approve the compensation of executives as disclosed in the proxy statement (non-binding advisory vote); consider one shareholder proposal, if properly presented at the meeting; and transact such other business as may properly come before the meeting or any postponement or adjournment thereof. To view or print a copy of our Proxy Statement, Annual Report on Form 10-K or Letter to Shareholders, go towww.morganstanley.com/2016ams.2019ams. You may request a copy of any of these documents by calling 1-212-762-8131.

Please vote any other cards or voting instruction forms that you may receive.

PLEASE SUBMIT YOUR PROXY BY PHONE OR BY INTERNET,
OR RETURN THIS PROXY CARD AFTER SIGNING AND DATING IT ON THE REVERSE SIDE.

THIS PROXY WILL BE VOTED AS DIRECTED. IF THIS PROXY IS SIGNED, BUT NO DIRECTION IS MADE, IT WILL BE VOTED IN
ACCORDANCE WITH THE RECOMMENDATION OF MORGAN STANLEY’S BOARD OF DIRECTORS.


                     DETACH HERE IF YOU ARE SUBMITTING BY MAIL

E01533-P73633-Z67213

MORGAN STANLEY

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
FOR THE 20162019 ANNUAL MEETING OF SHAREHOLDERS, MAY 17, 2016

23, 2019 The undersigned hereby appoints Eric F. Grossman James A. Rosenthal and Martin M. Cohen, and each of them, attorneys and proxies, with full power of substitution, to represent and to vote on behalf of the undersigned all of the shares of common stock of Morgan Stanley that the undersigned is entitled in any capacity to vote if personally present at the 20162019 Annual Meeting of Shareholders to be held on May 17, 2016,23, 2019, and at any adjournments or postponements thereof, in accordance with the instructions set forth on the reverse side of this proxy card and with the same effect as though the undersigned were present in person and voting such shares. Each of the proxies is authorized in his discretion to vote for the election of another person to the Board of Directors if any nominee named herein becomes unable to serve or for good cause will not serve, upon all matters incident to the conduct of the meeting, and upon such other business as may properly come before the meeting.

BENEFIT PLAN PARTICIPANTS

I hereby direct the following to vote, in person or by proxy, all of the shares of Morgan Stanley common stock held for my benefit in Morgan Stanley benefit plans at the 20162019 Annual Meeting of Shareholders to be held on May 17, 2016,23, 2019, and at any and all adjournments or postponements thereof, as indicated on the reverse side of this voting instruction form, and, in its (or the proxies’) discretion, for the election of another person to the Board of Directors if any nominee named herein becomes unable to serve or for good cause will not serve, upon all matters incident to the conduct of the meeting, and upon such other business as may properly come before the meeting.

The Northern Trust Company (Northern Trust), as trustee under the Morgan Stanley 401(k) Plan (the "Plan").As a participant in and a named fiduciary under the Plan, I understand that (A) if I sign, date, and return this form, Northern Trust will vote or grant proxies in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions, (B) Northern Trust will vote or grant proxies for all undirected (other than pursuant to clause (A)) and/or forfeited shares, as applicable, in the same respective proportion as the shares of all participants who have timely delivered properly executed voting instructions, unless to do so would be inconsistent with Northern Trust’s duties, and (C) Northern Trust will hold my voting instructions in confidence to the extent required by applicable law or regulations or the governing instrument.

State Street Bank and Trust Company, as trustee under a trust agreement (Trust), in connection with the 1995 and 2007 Equity Incentive Compensation Plans, the 2009 Replacement Equity Incentive Compensation Plan for Morgan Stanley Smith Barney Employees, the Employees’ Equity Accumulation Plan, the Tax Deferred Equity Participation Plan and the Financial Advisor and Investment Representative Compensation Plan.I understand that, subject to the Trust’s terms, (A) if I sign, date and return this form, State Street will vote in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions, (B) State Street will vote with respect to all shares held in the Trust in connection with these plans for which no proper instructions are received (other than pursuant to clause (A)) in the same proportion as the shares held in connection with these plans for which it has received proper instructions, and (C) State Street will vote in its discretion, after due consideration, on all other matters that may properly come before the meeting.

State Street Bank and Trust Company, as trustee under the Trust, in connection with the Directors’ Equity Capital Accumulation Plan.I understand that, subject to the Trust’s terms, (A) if I do not sign, date and return this form, State Street will not vote or grant proxies with respect to these shares, and (B) if I sign, date and return this form, State Street will vote (i) in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions and (ii) in its discretion, after due consideration, on all other matters that may properly come before the meeting.

Equiniti Share Plan Trustees Limited, as trustee under a trust deed (UK SOP Trust), in connection with the Morgan Stanley UK Share Ownership Plan.I understand that, subject to the UK SOP Trust's terms, (A) I must sign, date and return this form in order for Equiniti to vote or grant proxies with respect to these shares, and (B) if I sign, date and return this form, Equiniti will vote or grant proxies in accordance with the Board of Directors' recommendation as to each proposal for which I do not give voting instructions and in its discretion on all other matters that may properly come before the meeting.

Voting instructions for benefit plan shares must be received by 11:59 P.M. (EDT) on May 12, 2016 for shares to be voted in accordance with your instructions.

• The Northern Trust Company (Northern Trust), as trustee under the Morgan Stanley 401(k) Plan (the “Plan”). As a participant in and a named fiduciary under the Plan, I understand that (A) if I sign, date, and return this form, Northern Trust will vote or grant proxies in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions, (B) Northern Trust will vote or grant proxies for all undirected (other than pursuant to clause (A)) and/or forfeited shares, as applicable, in the same respective proportion as the shares of all participants who have timely delivered properly executed voting instructions, unless to do so would be inconsistent with Northern Trust’s duties, and (C) Northern Trust will hold my voting instructions in confidence to the extent required by applicable law or regulations or the governing instrument. • State Street Global Advisors Trust Company, as trustee under a trust agreement (Trust), in connection with the Equity Incentive Compensation Plan, the Employees’ Equity Accumulation Plan, the Tax Deferred Equity Participation Plan and the 1995 Equity Incentive Compensation Plan. I understand that, subject to the Trust’s terms, (A) if I sign, date and return this form, State Street will vote in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions, (B) State Street will vote with respect to all shares held in the Trust in connection with these plans for which no proper instructions are received (other than pursuant to clause (A)) in the same proportion as the shares held in connection with these plans for which it has received proper instructions, and (C) State Street will vote in its discretion, after due consideration, on all other matters that may properly come before the meeting. • State Street Global Advisors Trust Company, as trustee under the Trust, in connection with the Directors’ Equity Capital Accumulation Plan. I understand that, subject to the Trust’s terms, (A) if I do not sign, date and return this form, State Street will not vote or grant proxies with respect to these shares, and (B) if I sign, date and return this form, State Street will vote (i) in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions and (ii) in its discretion, after due consideration, on all other matters that may properly come before the meeting. • Equiniti Share Plan Trustees Limited, as trustee under a trust deed (UK SOP Trust), in connection with the Morgan Stanley UK Share Ownership Plan. I understand that, subject to the UK SOP Trust’s terms, (A) I must sign, date and return this form in order for Equiniti to vote or grant proxies with respect to these shares, and (B) if I sign, date and return this form, Equiniti will vote or grant proxies in accordance with the Board of Directors’ recommendation as to each proposal for which I do not give voting instructions and in its discretion on all other matters that may properly come before the meeting. • Voting instructions for benefit plan shares must be received by 11:59 P.M. (EDT) on May 20, 2019 for shares to be voted in accordance with your instructions. Please help the Company reduce costs—submit your voting instructions by Internet or telephone.